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1. Abstract 
Light as an external stimulus provides a powerful and versatile tool to control chemical 
reactions and biological systems. Light is easily available and permits a high spatial and 
temporal control while minimizing systemic contamination as often associated with invasive 
methods. Efficient photocontrol of a system of interest can be achieved by introduction of 
photochromic molecules which can undergo reversible interconversion from one conformation 
into another upon exposure to distinct wavelengths of light. Azobenzene thereby represents 
one of the best studied and most commonly used photochromic molecules in this context. 
Azobenzene molecules can be reversibly transformed from a planar trans conformation into a 
non-planar, sterically more challenging cis conformation by exposure to UV or visible light. 
Introduction of azobenzene into complex systems led to a series of applications ranging from 
light-controlled smart materials and nanodevices to light control over biological processes and 
cellular functions in vitro. 
Introduction of azobenzene into desoxyribonucleic acid (DNA) afforded reversible 
photoinduced hybridization and dissociation of DNA double strands by means of UV or visible 
light irradiation. Coupling azobenzene to D-threoninol as a nucleobase surrogate led to the 
successful implementation into DNA backbones, thus paving the way for a series of 
photocontrolled applications. Photoresponsive DNA nanotechnology brought up structure-
changing DNA nanoconstructs and devices as well as functional dynamic DNA 
nanotechnology, the in vitro control of biological and cellular processes up to the emerging 
field of photopharmacology. Despite the successful establishment of photocontrol in vitro, a 
translation towards in vivo systems in hampered by the mandatory use of UV light for cis 
isomerization, disrupting DNA and cellular tissue upon UV exposure. Furthermore, efficient 
azobenzene cis isomerization requires elevated irradiation temperatures and a high synthetic 
load inside DNA duplexes to achieve efficient duplex dissociation. Many efforts have been 
performed to circumvent these prerequisites by substituting D-threoninol for other diol linkers 
or adding substituents and functional groups to azobenzene moieties in different patterns to 
optimize photophysical properties. Yet, only few of these drawbacks could be overcome by the 
performed optimization studies. 
Recent advances brought up a series of modified azobenzene molecules containing hetero 
atoms and functional moieties in all four ortho positions on both benzene rings. This substi-
tution pattern results in a significant red-shift of isomerization wavelengths accompanied by an 
increased thermal stability of the cis state. Also replacement of benzene rings by heterocycles 
as in arylazopyrazoles led to near-quantitative conversion efficiencies accompanied by high 
thermal stabilities of the cis state up to three years. The recently reported molecules provide  
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tools for a possible improvement of photocontrolled DNA duplex hybridization, bearing 
potential for improved response wavelengths, thermal stabilities of the cis state and conversion 
efficiencies between both isomers. Studies towards translation into DNA strands and DNA-
based applications have not been reported to date. 
The following dissertation catches up the potential improvement of photocontrolled DNA 
duplex hybridization. Based on the reported azobenzene and arylazopyrazole small molecules, 
a systematic feasibility study of azobenzene and arylazopyrazole photoswitches attached to 
D-threoninol was performed to optimize the photophysical properties and translate these into 
modified oligonucleotide strands. A pre-selection of synthetically accessible D-threoninol 
bound small molecule candidates was investigated empirically by UV/Vis spectroscopy in 
combination with an irradiation device providing high output LEDs to determine maximum 
response wavelengths. Reversed-phase HPLC and UV/Vis spectroscopy were utilized to 
quantify the maximum switching efficiencies and thermal stabilities of the cis states. 
Consecutive DMT-protection and phosphitylation of the D-threoninol bound photochromes 
enabled the implementation of selected photoswitches into DNA strands via solid phase DNA 
synthesis. A translation of optimized photophysical properties into DNA strands was 
investigated via reversed-phase HPLC quantification and UV/Vis spectroscopy involving 
systematically modified DNA strands and duplexes in direct comparison to the newly designed 
small molecules. Melting curve analysis of modified duplexes revealed improved duplex 
dissociation efficiencies even with a lower synthetic load as compared to the reported 
azobenzenes.  
Translation of improved photophysical properties was further demonstrated by introduction 
of arylazopyrazoles into higher order DNA systems. A double-stranded DNA catenane was 
designed and assembled to further investigate coherent and independent switching properties 
using a combination of release oligomers each containing different types of photochromes. Not 
only the catenane system was designed to determine coherent photophysical properties, but 
also the catenane building blocks were used to qualitatively demonstrate individual switching 
properties.  
Besides the development of new photochromes, further nanotechnological applications have 
been developed. Lipid-mediated self-assembling micellar nano-constructs were designed as 
carrier moieties for targeted transport of doxorubicin into cancer cells. The system consists of 
an aptamer-based cell receptor targeting unit combined with a photo-triggered doxorubicin 
release mechanism. Successful cell internalization and photo-triggered release of doxorubicin 
inside the cells was applied in vitro in H1838 non-small cell lung cancer cells. 
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1. Abstract (deutsch) 
Licht als äußerer Impuls stellt ein wirkungsvolles und vielseitiges Werkzeug zur Kontrolle 
chemischer Reaktionen und biologischer Prozesse dar. Licht ist leicht zugänglich und erlaubt 
eine hohe räumliche und zeitliche Kontrolle während systemische Kontaminationen vermieden 
werden, die häufig beim Einsatz invasiver Methoden auftreten. Effiziente Photokontrolle eines 
spezifischen Systems kann durch den Einbau photochromer Moleküle erreicht werden, die 
durch Bestrahlung mit unterschiedlichen Lichtwellenlängen eine reversible Umwandlung von 
einer Konformation in eine andere eingehen. Azobenzol stellt eines der am meisten 
verwendeten und am besten untersuchten photochromen Moleküle dar. Azobenzol kann durch 
den Einsatz von UV- und sichtbarem Licht reversibel von einer planaren trans-Konformation 
in eine nicht-planare, sterisch anspruchsvollere cis-Konformation umgewandelt werden. Der 
Einbau von Azobenzol in komplexe Systeme brachte eine Reihe von Anwendungen hervor, 
die von lichtschaltbaren Materialien und Nanomaschinen bis hin zur Lichtkontrolle von 
biologischen und zellulären Funktionen in vitro reichen. 
Durch den Einbau von Azobenzol in Desoxyribonukleinsäre (DNA) konnte mit Hilfe von UV- 
und sichtbarem Licht eine reversible Photokontrolle über die Hybridisierung und Dissoziation 
von DNA-Doppelsträngen erreicht werden. Der Einbau von Azobenzol konnte mittels eines D-
Threoninol-Linkers als Nukleobasenersatz erreicht werden und bahnte den Weg für eine Reihe 
an photoinduzierten Anwendungen. Azobenzol-modifizierte DNA wurde in einer Reihe von 
lichtgesteuerten Anwendungen etabliert, die von strukturändernden Nanokonstrukten and 
Maschinen über die funktionale lichtgesteuerte DNA-Nanotechnologie und die Photokontrolle 
von biologischen Prozessen und zellulären Funktionen in vitro bis hin zum neu aufkommenden 
Forschungsfeld der Photopharmakologie reichen. Trotz der erfolgreichen Anwendung in vitro 
ist eine Anwendung in vivo durch den notwendigen Einsatz von UV-Licht, das DNA und Zellge-
webe schädigt, stark eingeschränkt. Darüber hinaus sind erhöhte Bestrahlungstemperaturen 
und eine Vielzahl von Modifikationen in DNA-Strängen notwendig um eine effiziente Duplex-
Dissoziation zu erreichen. Zur Lösung dieser Probleme wurde D-Threoninol durch andere Diol-
Linker ersetzt oder Azobenzol in unterschiedlichen Mustern zur Optimierung der photo-
physikalischen Eigenschaften substituiert. Bisher konnten nur wenige dieser Einschränkungen 
durch die Optimierung von Azobenzolen beseitigt werden. 
Jüngste Fortschritte brachten eine Reihe substituierter Azobenzol-Moleküle mit 
Heteroatomen oder funktionellen Gruppen in allen vier ortho-Positionen an beiden 
Benzolringen hervor. Dieses Substitutionsmuster führt zu einer signifikanten Rotverschiebung 
der Absorptionswellenlängen und einer Erhöhung der thermischen Stabilität des cis-Zustands. 
Auch der Austausch eines Benzolrings durch einen heterozyklischen Ring wie bei Arylazopyra- 
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zolen führt zu nahezu quantitativen Schalteffizienzen und thermischen Stabilitäten des cis-
Zustands von bis zu drei Jahren. Diese neu beschriebenen Moleküle könnten durch 
verbesserte Absorptionswellenlängen, thermischen Stabilitäten des cis-Zustands und 
Schalteffizienzen zu einer Verbesserung der Photokontrolle über die DNA-Duplex-
Hybridisierung führen. Untersuchungen zum Einbau dieser neuen Moleküle in DNA-Stränge 
und -Duplexe sind bisher nicht bekannt. 
Die folgende Dissertation greift das Thema der Verbesserung der photokontrollierten DNA 
Duplexhybridisierung auf. Basierend auf den publizierten Azobenzolen und Arylazopyrazolen 
wurde eine systematische Studie zur Optimierung der photophysikalischen Eigenschaften D-
Threoninol-gekoppelter Photochrome und die Übertragung auf modifizierte DNA-Stränge 
angefertigt. Eine Vorauswahl synthetisch zugänglicher D-Threoninol-gebundener Photo-
chrome wurde mittels UV/Vis-Spektroskopie nach Bestrahlung mit hochenergetischen LEDs 
untersucht, um empirisch die maximalen Absorptionswellenlängen zu ermitteln. Mittels 
reversed-phase HPLC und UV/Vis-Spektroskopie wurden die maximalen Schalteffizienzen 
und thermischen Stabilitäten der cis-Zustände ermittelt. Nachfolgende DMT-Schützung und 
Phosphitylierung der D-Threoninol-gebundenen Photochrome ermöglichte den Einbau in 
DNA-Stränge mittels DNA-Festphasen-Synthese. Die Übertragung der verbesserten 
photophysikalischen Eigenschaften auf DNA-Stränge und DNA-Duplexe wurde durch einen 
Vergleich von systematisch modifizierten DNA-Strängen mit den neu synthetisierten 
Molekülen durch weitere reversed-phase HPLC-Quantifizierungen und UV/Vis-Spektroskopie 
erreicht. Schmelzkurven modifizierter Duplexe zeigten eine Verbesserung der Schalteffizienz 
bei einem geringeren Verbrauch an Photoschaltern im Vergleich mit den bereits bekannten 
Molekülen.  
Die Schalteffizienz und Praktikabilität der Moleküle wurde darüber hinaus durch den Einbau 
von Arylazopyzolen in komplexe DNA-Systeme gezeigt. Ein doppelsträngiges DNA-Catenan 
wurde für die Untersuchung kohärenter und unabhängiger Schalteigenschaften unterschied-
lich modifizierter release-Oligomere mit verschiedenen Modifikationen entworfen und assem-
bliert. Dabei wurde nicht nur das Catenan-System zur Bestimmung der Eigenschaften benutzt, 
sondern auch seine einzelnen Bauteile zur Analyse kohärenter Schalteigenschaften.  
Neben der Entwicklung neuer Photochrome wurden zeitgleich Anwendungen in der 
Nanotechnologie entwickelt. Ein Lipid-basiertes selbst-assemblierendes Mizellen-Nanocarrier-
System für den Transport und die Freisetzung von Doxorubicin in Krebszellen entwickelt. Das 
System besteht aus einer Aptamer-basierten Einheit, die an Zellrezeptoren bindet, und einem 
photoschaltbaren Doxorubicin-Freilassungs-Mechanismus. Die erfolgreiche Zellaufnahme und 
die Freisetzung von Doxorubicin wurde in vitro in H1838 Lungenkrebs-Zellen demonstriert. 
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2. Theoretical background 
2.1 Radiation and matter 
All matter exists in defined, discrete energetic ground and excited states. As a result from 
quantum theory, the energy difference between all energetic states is also quantised, i.e. the 
energetic differences between these states are quantised and a multiple of the Planck’s 
constant h. For electronic transitions, Einstein described this relation by the equation:[19-20] 
𝐸 = ℎ ∙ 𝜗 =
ℎ∙𝑐
𝜆
     (1) 
Here, E is the potential energy difference between two energetic states of an electron, h 
constitutes Planck’s-constant h = 6,63∙10-34 Js,  the electron’s frequency, λ the electron’s 
wavelength and c the velocity of light in vacuum. The quantisation of all energetic states implies 
that every system can only absorb and emit radiation with distinct energy corresponding to the 
difference between the two states, or, as described by Einstein’s equation, with light of distinct 
wavelengths.[19-20] 
Radiation can be described as the migration of electromagnetic waves throug vacuum or 
light-transmissive media, while one can distinguish between ionizing and non-ionizing 
radiation.[21] When high energy radiation (λ < 100 nm) interacts with matter, the radiation is 
reflected by the electronic structure of an atom or molecule. If the energy conversion is 
sufficient enough to remove an electron completely from the nucleus, the atom is ionized and 
leaves the positively charged nucleus behind. In case of non-ionizing radiation, the molecular 
rotation, vibration or electronic structure are excited. Radiation in the range of ultraviolet light 
(100-380 nm), visible light (380-750 nm) or infrared light (> 750 nm) is absorbed by the electron 
shell and promotes electrons to higher energetic states without complete separation from the 
core where the absorbed wavelength has the same energy corresponding to the difference 
between the ground and excited state.[22-23] 
Infrared radiation also excites the vibrational and rotational modes of molecules. The absorp-
tion of radiation by matter is best described by an exponential intensity decay, known as the 
Lambert-Beer-law (equation 2), which correlates the attenuation of light when passing through 
matter of a distinct composition.[24-25] The measured light absorbance is given by the equation:  
𝐼
𝐼0
= 𝑒−𝜀𝑐𝑑     (2) 
where I and I0 are the intensities of the initial and detected radiation, c the concentration of 
the investigated liquid medium, d the thickness of the sample and ε the extinction coefficient 
of the medium. Absorbance measurements of molecules in solution require subtraction of the 
pure solvent, a blank sample, to achieve a precise absorbance measurement.  
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The extinction coefficient resembles a relative value and is a characteristic material constant. 
According to the Franck-Condon-Principle, electrons, when excited, always possess the 
highest migration probability into excited states that are most similar to the electronic ground 
state of the system (fig. 1).[26-29] During this transition, the movement of the much lighter 
electron is enormously faster than the movement of the nucleus. Approximately, the nuclear 
position can be considered fixed, which is also called the Born-Oppenheimer-
Approximation.[31-32] 
Excited electrons can undergo different relaxation processes. The direct radiative relaxation 
of an electron back into the ground state leads to emission of radiation.[33-34] Beyond the direct 
relaxation, an electron can undergo multiple depletion steps while falling back to the ground 
state. All multiple state relaxation processes are lower in energy than the direct relaxation thus 
leading to emission of radiation with lower energy, the so-called Stokes-shift. Also thermal 
relaxation processes and energy transfer reactions are possible in deactivation processes.  
 
Fig. 1: A) Electronic excitation and relaxation processes according to the Franck-Condon-Principle for 
a diatomic molecule occur with the highest probability into states which are most similar to the groud 
state. B) One and two step electronic relaxation processes after excitation from state S0 to state S1. C) 
Absorption and emission wavelengths for electronic excitation and consecutive relaxation. The 
emission is lower in energy than the excitation, leading to higher emission wavelengths The figure 
shows an adapted version of the figures found in reference[30]. 
Resulting from a statistical energy content distribution for a large number of photons, not all 
absorbed photons contain sufficient energy higher than the activation energy of a process, 
thus not leading to the desired reaction. The fraction of absorbed photons inducing the reaction 
compared to all absorbed photons is defined as the quantum yield.[35-36] The quantum yield 
usually is a number between 0 and 1. In cases where absorbed photons induce chain 
reactions, the quantum yield can also reach values above 1. Disruption of the molecular 
structure upon absorption of light leads to photobleaching, thus preventing a molecule to 
further absorb or emit radiation with the initial intensity.[37] 
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2.2 Azobenzene chromophores 
2.2.1 Photochromism and photochromic molecules 
Photoinduced chemical isomerization of electronically excited states is well known for a 
variety of chemical species. Usually the excitation of electrons involving a C=C or an N=N 
double bond leads to formation of a single bond which permits a rotatory motion and leads to 
a change in stereo conformation. Photochromic molecules are capable of reversibly converting 
their structure from one conformation into another upon irradiation with two different 
wavelengths of light, wheras both states possess different characteristic absorption spectra.[38-
39] Most photochromic reactions are of unimolecular nature, where only electromagnetic 
radiation and the molecule or system itself are involved. In bimolecular photochromic reactions, 
the reversible process depends on two chemical species, either the same or different 
molecules, forming an addition product or two new products. All photochromic processes are 
reversible, whereas the reversible back-transformation can occur either thermally 
(thermoreversible systems) or by radiation of a different wavelength (photoreversible systems). 
Some photochromic systems can undergo a back-transformation via both pathways. 
The system’s change in conformation can result from the E->Z-isomerization of a double 
bond as reported for stilbenes (1),[40-41] azobenzenes (2)[42-45] or hemithioindigos (3)[46-48] or the 
electrocyclic ring-opening and ring-closure reaction of diarylethenes (4),[49-51] fulgides (5)[52-54] 
and spiropyrans (6)[55-56] (fig. 2). Further conformational changes can result from the reversible 
ring-closure reaction of dienes and dienophiles as in Diels-Alder cycloadditions[57] or the 
reversible donor-acceptor adduct formation and dissociation as in case of Stenhouse 
adducts.[58-59] All these types of photochromic molecules can reversibly be transformed from 
one conformation into the other upon irradiation with two different wavelengths of light. 
 
Fig. 2: Different classes of photochromic molecules. In stilbenes (1), azobenzenes (2) and hemithio-
indigos (3) a reversible E->Z-isomerization can occur on a double bond, in diarylethenes (4), fulgides 
(5) and spiropyrans (6) an isomerization can occur via electrocyclic ring opening and closing reactions. 
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2.2.2 The cis and trans state of azobenzene 
Azobenzene is one of the best studied photochromic molecules and exists in two different 
conformations.[60-62] The molecular structure is composed of two phenyl rings separated by an 
N=N double bond. In trans conformation both phenyl rings are aligned in a coplanar 
arrangement and the dipole moment is nearly zero while in cis conformation the molecule has 
a nonplanar, sterically more challenging structure with one ring bent out of plane and a dipole 
moment of 3 Debye.[63-64] A reversible transformation between both states can be achieved by 
irradiation with UV or visible light as first reported by G. S. Hartley in 1937.[65-66] Regeneration 
of the trans isomer from the cis isomer is also obtained by heating while the cis isomer can 
only be formed via UV irradiation (fig. 3). 
                
Fig. 3: Structural comparison of Azobenzene (A) and Stilbene (B): Azobenzene contains a central 
N=N double bond while stilbene contains a central ethylene bridge. Azobenzene isomerisation from 
trans to cis occurs upon irradiation with UV light and back relaxation by heating or visible light 
irradiation. 
The planar trans conformation is 50 kJ/mol more stable than the sterically more challenging 
cis conformation.[67-68] In comparison to stilbene, the N=N double bond is less reactive to 
hydrolysis and cycloaddition reactions than the C=C double bond. The UV/Vis spectrum of 
trans azobenzene  shows two different absorption maxima.[69-70] A high intensity signal at 
350 nm is characteristic for the transition of a π-electron within the N=N double bond into an 
antibonding π-orbital (fig. 4). A broader absorption band with lower intensity at 430 nm shows  
 
Fig. 4: Absorption spectra of trans and cis azobenzene (left). Azobenzene irradiation with light of a 
distinct wavelength results in the formation of a wavelength-dependent photostationary state (PSS), 
also called photostationary equilibrium (PSE), over time with a distinct composition of cis and trans 
isomer ratio (right). The figure shows an adapted version of the figure found in reference[70]. 
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the n->π* transition which is symmetry forbidden but happens anyhow due to the loss of 
aromaticity and the increase in dipole-moment upon formation of the cis state. Experiments 
showed that the isomerization rate involving visible light irradiation is twice as high compared 
to an isomerization upon UV light irradiation. Overlay of the different absorption spectra of 
trans and cis azobenzene reveals a separation of both absorption maxima. Irradiation with light 
of a distinct wavelength induces the formation of a photostationary state (PSS).[70] The fractions 
of cis and trans isomer are characteristic for every irradiation wavelength and depend on the 
reaction rate of trans to cis isomerization compared to the cis to trans isomerization. The 
equilibrium formed upon irradiation directly depends on the extent of wavelength overlap of 
both overlaid absorption spectra. Only a complete separation of absorption maxima for both 
electronic transitions or the missing absorption at a distinct wavelength for one isomerization 
process permits the quantitative formation of a single isomer. 
 
Fig. 5: Two different isomerization pathways have been reported for azobenzene's conformational 
change from trans to cis and vice versa: the rotation and inversion mechanism. While in the rotation 
mechanism the isomerization occurs via an N-N single bond (upper pathway), the inversion 
mechanism takes place around a planar transition state (lower pathway). The figure shows an adapted 
version of the figure found in reference[71]. 
Theoretical and spectroscopic studies revealed two different isomerization pathways when 
azobenzene is isomerized from trans to cis conformation and vice versa. These two 
mechanisms are the rotation and the inversion mechanism (fig. 5).[71-72] Following the rotation 
mechanism, a π-electron located in the N=N double bond is promoted into an antibonding π-
orbital, thus allowing a rotation around the remaining N-N single bond. The inversion 
mechanism on the other hand involves the excitation of a non-binding lone pair electron located 
at one of the nitrogen atoms, leading to a formal rehybridization of the N=N sp2 orbital to an 
sp1 orbital without changing the double bond character between both nitrogens (fig. 5). The 
rotational mechanism follows a molecular phenyl ring motion out of plane while the inversion  
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mechanism occurs with both coplanar rings in plane. Several studies reported both 
isomerization mechanisms for both isomerization directions and revealed a strong dependency 
on the nature of substituents and substitution patterns on both phenyl rings.[71-72] While thermal 
relaxation from cis to trans mostly occurs via the inversion mechanism, photoinduced 
isomerization from trans to cis can undergo both mechanisms whereby the inversion 
mechanism is the dominating isomerization pathway.[72-76] Nevertheless, controversial 
discussions are still ongoing in literature, indicating evidence of both isomerization pathways 
in differently substituted azobenzenes. 
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2.2.3 Synthesis of azobenzene and azobenzene derivatives 
Azobenzene and its derivatives can be obtained via six general synthesis pathways, all 
strongly depending on the chemical nature of the starting materials and the desired substitution 
pattern within the azobenzene product.[77-78] The main synthetic routes are depicted in fig. 6, 
which are: 
1) Oxidative dimerization of anilines[79-82] 
2) Reductive dimerization of nitroaromatics[83-85] 
3) Azo coupling via aromatic diazonium salts[86-88] 
4) Coupling of aromatic nitroso derivatives with anilines (Mills reaction)[89-91] 
5) Oxidation of aromatic hydrazo compounds[92-93] 
6) Reduction of azoxybenzenes[94-95] 
Depending on the nature of the desired product, azo coupling reactions can be separated 
into two main groups: homo coupling reactions, leading to symmetrically substituted 
azobenzenes, and hetero coupling reactions, resulting in azobenzenes with two differently 
substituted phenyl rings. Oxidative dimerization of anilines (1) and reductive dimerization of 
nitroaromatics (2) result in symmetrically substituted azobenzenes.  
 
Fig. 6: The following main synthetic pathways have been reported for the formation of azobenzene 
molecules: 1) Oxidative dimerization using strong oxidation agents.[79-82] 2) Reductive dimerization of 
two nitro compounds with strong reduction agents.[83-85] 3) Mills reaction of anilines and nitroso 
compounds involving glacial acetic acid.[86-88] 4) Diazotation via formation of a diazonium salt and 
consecutive coupling to aromatic systems.[89-91] 5) Oxidation of hydrazo compounds using strong 
oxidation agents.[92-93] 6) Reduction of azoxybenzenes with strong reduction agents.[94-95] All reaction 
pathways lead to symmetrically or non-symmetrically substituted azobenzene products. 
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In case of oxidative dimerization of anilines (1), a variety of strong oxidation agents like 
MnO2[80], KMnO4[81], H3BO3[82] as well as further organic and inorganic peroxides are available 
to form azobenzenes in high yields. Commonly, the oxidation agent and anilines are heated in 
organic solvents to achieve high yields. A recently published oxidation reaction involving two 
differently substituted anilines and highly reactive t-BuOCl at 0 °C and below achieved high 
reaction yields and selectivity for hetero coupling products.[98] 
Reductive dimerization of nitroaromatics (2) involving zinc powder or hydrogen transfer 
reagents in catalytic amounts also lead to symmetrically substituted azobenzenes in yields 
similar to those of oxidative dimerizations.[94-95] The classic azo coupling via diazotation of 
aromatic amines[86-88] (3) and the Mills reaction[89-91] (4) represent two methods for the 
synthesis of azobenzenes containing differently substituted phenyl moieties. Both reactions 
require the preparation of synthetic precursors, an aromatic nitroso compound in case of Mills 
type reactions or a diazonium cation for a diazotation reaction. In both cases, azobenzenes 
with differently substituted phenyl residues are formed while minimizing the formation of 
undesired azobenzene side products.  
Diazotation of aromatic amines by means of NaNO2 or HNO2 in combination with acids or 
bases leads to diazonium cations, which can be azo-coupled to form differently substituted 
aromatic or heteroaromatic residues (3).[86-88] This classic azo coupling strongly depends on 
the electronic properties of the substituents and has to be performed at 0-5 °C to avoid a 
thermal decomposition of the unstable diazonium cation. Resulting from the weak electrophilic 
nature of the diazonium cation, the reaction only takes place in presence of strong +M-
substituents. Despite all these limitations, most azo compounds are synthesized via this 
pathway since reaction yields and selective formation of the product is very high while the 
conversion time is rather low. Mills reactions (4) are carried out in glacial acetic acid at room 
temperature or elevated temperatures up to 60 °C.[91] These rather mild conditions foster the 
formation of azobenzenes with reactive or unstable substituents which are usually not 
accessible under harsh reaction conditions. 
Two further synthetic pathways for the synthesis of azobenzenes have been reported, the 
oxidation of hydrazobenzenes[92-93] (5) and the reduction of azoxybenzenes[94-95] (6). In both 
cases, the pre-formed N-N single bond requires oxidation or reduction to form the N=N double 
bond (fig. 6). Hydrazobenzenes are oxidised under mild oxidation conditions involving agents 
like H2O2, O2, MnO2 or metal complexes to form the N=N azo bridge. Reduction of 
azoxybenzenes affords LiAlH4, phosphines or reducing metals and metal complexes to yield 
azobenzenes. The use of H2SO4 or further strong acids leads to a transformation of 
azoxybenzenes into para-hydroxyazobenzenes by a Wallach rearrangement.[96] 
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A variety of further azobenzene syntheses are available in literature. More examples to be 
highlighted are the condensation of nitroaromatics with anilines under basic conditions,[97-99] 
triazene rearrangements,[100] metal-catalyzed reactions of arylhydrazines[101] and ring opening 
reactions.[102] Most of these pathways require the synthesis of complex precursors or harsh 
reaction conditions and are not suitable for synthesis of azobenzenes containing reactive 
functional groups. 
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2.2.4 Substituted azobezenes – optical tuning of photophysical properties 
Hermann Rau first described differently substituted azobenzenes and classified these into 
three different categories: azobenzenes, aminoazobenzenes and pseudostilbenes.[103-104] All 
three classes of azobenzenes are determined by the nature and positions of substituents on 
both phenyl rings (fig. 7). 
        
Fig. 7: UV/Vis absorption spectra of azobenzene (1), aminoazobenzene (2) and pseudostilbenes(3) 
molecules. Azobenzenes of the azobenzene type (solid line) exhibit a high intensity π-π* transition 
band and a small n-π* transition band. Azobenzenes of the aminoazobenzene type (dotted line) and 
pseudostilbene type (dashed line) have highly red-shifted absorption maxima and strongly overlapping 
bands in visible light region. Each absorption intensity in visible light is more intense compared to 
unmodified azobenzene. The figure shows an adapted version of the figure found in reference[105]. 
Substitution of hydrogens on one or both phenyl rings alters the relative orbital energies of 
the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital 
(LUMO) within the central N=N double bond, leading to red-shifted absorption bands in the 
corresponding UV/Vis spectra.[106-107] Electronic transitions during azobenzene isomerization 
        
Fig. 8: Molecular orbital diagram of the N=N double bond in azobenzene (left).[108] The central binding 
π-orbital is located between both nitrogen atoms wheras the π*-orbitals are distributed over both rings 
(right).[109] Relative orbital energies of the N=N-HOMO and LUMO are given for azobenzene's trans 
and cis state. The figure shows an adapted version of the figures found in references[108] and [109]. 
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always occur from the HOMO orbital into a LUMO orbital, hereby determining the energy of 
the absorbed photon as the energy difference between both orbitals (fig. 8).  
Electron donating substituents increase the relative orbital energy of the HOMO orbital and 
electron withdrawing substituents decrease the relative energy of the LUMO orbital. In both 
cases, substitution results in a decrease in energy difference between both orbitals and 
consequentially a red-shift of absorption bands. Native azobenzene containing no substitutents 
on both phenyl moieties besides hydrogen is known as azobenzene type and serves as a 
reference when discussing other azobenzene types.[45] According to the classification reported 
by H. Rau, there are two further types of azobenzenes: aminoazobenzenes and 
pseudostilbenes. Varying substitution patterns in both azobenzene classes severely affect the 
native absorption maxima, isomerization rates and thermal half-life of the cis state. 
Aminoazobenzenes contain strong electron donating residues in para position on either one 
or both phenyl rings.[110] The increased π-electron density in the π-system leads to an 
increased relative energy of the HOMO orbital as observed in a strong red-shift of both 
absorption maxima in UV/Vis spectra. Furthermore, the n->π* transition in the visible light 
region has an increased intensity accompanied by a higher overlap of both n->π*- and π->π*-
transitions. The thermal half-life of the cis state is significantly decreased by +M para 
substituents, leading to a half-life within a range of minutes to seconds due to the decrease in 
relative energy difference between HOMO and LUMO. 
Azobenzenes of the pseudostilbene type exhibit a strong electron donating and strong 
electron withdrawing moiety on both opposite phenyl para positions.[111] Pseudostilbenes are 
characterized by a strong red-shift of both n->π*- and π->π*-transitions in absorption spectra 
which can even change their relative positions towards each other. Isomerization and thermal 
back-relaxation in pseudostilbenes occur within seconds. Protonation of the N=N double bond 
through strong acids or complexation by Lewis acids further increases the relative energy of 
the n->π*-transition resulting in an improved thermal stability from a range of seconds to 
several muinutes.[112] Spectral emission of azobenzenes is generally very low for all three 
azobenzene types since the absorbed energy is converted into molecular motion, whereby 
pseudostilbenes retain light and fluorescence emission properties. 
Taking the electronic properties for all substituents in different positions on both phenyl 
residues into account permits a prediction of relative orbital energies of HOMO and LUMO and 
consequentially permits a prediction of inherited photophysical properties.[113] Consecutively, 
the sophisticated introduction of specific substituents fosters the design of azobenzene 
photoswitches with predefined photophysical properties for versatile purposes. Three general 
properties characterize an efficient photoswitch is respect to biological and in vivo applications: 
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First, a significant separation of absorption bands must be achieved to facilitate individual 
addressing of both states and maintain high conversion efficiencies between the two states. 
Second, maintaining a high thermal stability of the cis state enhances the utility timespan for 
biological applications. Last but not least, a shift of absorption maxima further into the red 
range of visible light permits a higher penetration depth and decreased negative side effects 
when azobenzenes are introduced into biological systems. An ideal photoswitch exhibits 
quantitative switching efficiencies in both isomerization directions whereby both states can be 
addressed individually in visible light range while maintaining a high thermal stability of the cis 
state. 
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2.2.5 Recent advances in azobenzene photochemistry 
The challenge of tuning azobenzene's photophysical properties emerged a variety of 
differently substituted azobenzene molecules. In 2009, the working group of F. Temps 
developed a bridged azobenzene which connects both opposite phenyl rings in ortho position 
by an additional ethylene bridge.[114-116] This bridged azobenzene exhibits strongly red-shifted 
absorption bands and allows efficient isomerization from trans to cis and vice versa both by 
use of visible light irradiation (fig. 9). 
           
Fig. 9: An ortho ethylene bridged azobenzene has been reported to have high reversible isomerization 
efficiencies between the trans and cis state by use of visible light irradiation. The molecule is shown in 
Z- and E-conformation (left) and the predicted structural conformations (middle). UV/Vis spectra of the 
trans and cis conformation reveal highly separated n->π* absorption bands in visile light range (right). 
The figure shows an adapted version of the figures found in reference[114]. 
The ortho ethylene bridge leads to a decrease in relative orbital energy for both HOMO and 
LUMO, resulting in a strong separation of both n->π* absorption bands in visible light range. 
An efficient conversion between trans and cis could be achieved with 92 % cis at 385 nm 
irradiation and near-quantitative isomerization to trans at 530 nm irradiation with a thermal half-
life of 4.5 hours at 28.5 °C. 
A similar effect could be achieved by introduction of a Lewis-acidic BF2 moieties in ortho  
 
Fig. 10: Trans to cis isomerization of a BF2-coordinated azobenzene leads to high switching 
efficiencies under visible light irradiation and represents one of the first cis convertable azobenzene 
molecules in visible light range. Coordination of the N=N double bond through the lewis-acidic BF3 
moiety strongly red-shifts the response wavelengths. The figure shows an adapted version of the 
figure found in reference[118]. 
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Fig. 11: Azobenzenes carrying amino substituents in ortho and para position at the same time have 
been reported as functional tools for biological applications in vitro and in vivo. This substitution 
oattern also leads to red-shifted response wavelengths, facilitating applications in vivo. The figure 
shows an adapted version of the figure found in reference[122]. 
position of azobenzene coordinating the central N=N double bond and thus lowering the 
relative n->π*-transition energy in both isomers (fig. 10).[117-118] The coordination permits 
electronic transitions of nonbonding π-electrons into π*-orbitals and fosters a reversible 
photocontrol in visible light range. Irradiation at 570 nm leads to 97% formation of the cis 
isomer and irradiation at 450 nm forms a PSS with 80% trans isomer. Thermal half-life of the 
cis state is reduced to 12.5 hours at room temperature.  
Aminoazobenzenes containing two amino moieties in para position gained lots of attention 
since their large red-shift of absorption wavelengths was discovered, making these molecules 
ideal candidates for applications in vitro and in vivo.[119-121] As described before, the visible light 
switching properties are accompanied by the drawback of decreased thermal half-lifes of the 
cis state down to a millisecond range. To circumvent this issue, a series of azobenzenes with 
amino residues on both ortho and para positions has been published in order to utilize the red-
shift of response wavelengths while maintaining a practicable half-life of the cis state by 
sterically challenging substituents in ortho position (fig. 11).  
Introduction of two amino moieties with different alkyl substituents in ortho position on both 
opposite rings led to a significant red-shift of absorption wavelengths while increasing the 
thermal half-life from milliseconds to seconds.[122-125] Still, the decreased thermal stability is out 
of range for a variety of applications reqiring long half-lives. Another major drawback of ortho 
aminoazobenzenes is the occurrence of photobleaching over time upon exposure to ambient 
light. 
As demonstrated by ortho aminoazobenzenes, substitution of azobenzene in ortho position 
leads to a red-shift of response wavelengths and an increased thermal stability. Further 
substitution with hetero atoms in all four ortho positions led to a series of azobenzenes with 
extraordinary photophysical properties.[126-127] The working group of G. A. Woolley reported 
red-shifted azobenzenes containing four hetero atoms or functional groups in all four ortho 
positions.[128] Introduction of methoxy moieties in all four ortho positions results in a distortion 
of the planar trans conformation and results in a blue-shift of the π->π*-transition as well as a  
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Fig. 12: Azobenzenes carrying four ortho methoxy (A), chloro (B), or bromo substituents (C) result in 
strongly red-shifted absorption bands and a separation of both n->π* transitions in visible light range. 
The substitution pattern results in near-quantitative isomerization efficiencies as well as highly stable 
cis states. The figure shows an adapted version of the figures found in reference[129]. 
red-shift of the n->π*-transition (fig. 12). Trans to cis isomerization could be achieved in near 
quantitative yields using red light and efficient back-switching was performed by heating or 
blue light. The cis state remains stable for more than two days at room temperature, lying in 
the range of unsubstituted azobenzene. Unfortunately, the molecule showed reduction in 
presence of glutathione, which therefore limits its applicability in vivo. 
Besides ortho methoxy azobenzenes, a series of azobenzenes containing four chlorine or 
bromine atoms[129] as well as four methylthio residues in ortho position[130] were developed, all 
showing cis isomerization under red light irradiation.  
The properties of the tetra ortho substitution patterns were generalized by the group of G. A. 
Woolley as reported by a series of red-shifted azobenzenes with high conversion efficiencies. 
The use of sterically challenging residues in all four ortho positions leads to a distortion of 
planarity in trans conformation, hindering these molecules from being applied in systems with 
a requirement for a planar trans conformation. 
Protonation of tetra ortho methoxy azobenzenes yielded a protonated azonium ion which 
could be observed even at pH = 7.5, a neutral pH in which azonium ions usually don't form.[131] 
The reported azonium ions exhibit a strong cis absorption maximum at 600 nm with a thermal 
half-life of the cis state of about 10 seconds, magnitudes higher than previously reported 
azonium ions. Also, a planar geometry of the protonated trans conformation could be proven 
by DFT calculations. 
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Fig. 13: Tetra ortho fluorinated azobenzenes exhibit high conversion efficiencies in visible light range 
while retaining thermal cis stabilities of 300 days at room temperature. Electron withdrawing 
substituents in all four ortho positions lead to a higher separation of n->π*-transitions in visible light 
range, resulting in almost quantitative isomerization yields upon irradiation with 420 nm and 530 nm 
light respectively. The figure shows an adapted version of the figure found in reference[132]. 
One key discovery was reported in 2012 by D. Bléger et al. with tetra ortho fluorinated 
azobenzenes.[132-134] Substituting all four ortho hydrogens by fluorine atoms highly red-shifts 
both the n->π*-transition bands including a significant separation of both absorption bands 
(fig. 13). The separation leads to an almost quantitative isomerization efficiency between both 
conformations by irradiation with blue and green light. Compared to methoxy or hetero atom 
substitution, the four fluorine atoms in ortho positions are relatively small and do not distort the 
planar trans conformation. An enormous thermal half-life of the cis state is retained with more 
than 300 days at room temperature. The high thermal stability and the intense shift of response 
wavelengths into visible light range for both isomers can be attributed to the change in polarity 
for the whole molecule when isomerizing the thermodynamically more stable trans isomer into 
cis conformation. In trans conformation all four fluorine atoms are oriented towards the center 
of the molecule resulting in a low total dipole momentum. In cis conformation, the dipole 
momentum of the molecule changes significantly and leads to the reported shift in absorption 
bands. 
Perfluorinated and perhalogenated azobenzenes with a majority of fluorine atoms have been 
reported to bend whole crystals irreversibly when irradiated with green light.[135] These merely 
fluorinated azobenzenes retain a thermal half-life of the cis state of 60 days at room 
temperature in organic solvents. Thermal stability of these highly fluorinated azobenzenes 
afforded the formation of photoresponsive crystals and measurement of different crystal 
structures. Another example of interest was published in 2014 by C. E. Weston et al.[136-139] 
Arylazopyrazoles with five-membered heterocycles containing ortho methyl moieties showed 
high thermal stabilities of the cis isomer up to 1000 days at room temperature and a near-
quantitative isomerization efficiencies in both directions (fig. 14). The response wavelength for 
cis to trans isomerization is strongly red-shifted wheras the reversed isomerization into cis  
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Fig. 14: Arylazopyrazoles carrying one (A) or three (B) methyl moieties on the pyrazole ring prove 
near-quantitative isomerization efficiencies in both isomerization directions (right). While the thermal 
stability of (A) exhibits a half-life of 10 hours at room temperature, the half-life of (B) is increased up to 
72 days at room temperature throught the additional methyl substitution. The figure is an adapted 
version of the figure found in reference[136]. 
conformation requires irradiation with UV light. Interestingly, the reported near-quantitative 
conversion efficiencies are not caused by a high separation of absorption bands, but by the 
almost vanishing absorbance intensity of one isomerization direction compared to the 
response wavelength of the other isomerization direction. These high isomerization efficiencies 
combined with the retention of high thermal stabilities of the cis state makes arylazopyrazoles 
ideal candidates for long-term in vitro applications. 
Further tuning of heteroaromatic azo molecules by the working group of M. Fuchter brought 
up a series of heterocyclic azo photoswitches with different photophysical properties.[140] The 
number and position of nitrogens in a five-membered ring, which is connected via an azo 
moiety to a phenyl moiety, strongly determines the thermal half-life of the cis state as well as 
the conversion efficiencies of both isomerization directions. Molecules with a T-shaped cis 
state revealed long-lasting half-life times while molecules with twisted moieties in the cis state 
exhibited excellent conversion efficiencies. Selective methyl substitution of the heterocyclic 
ring led to a molecule with near-quantitative isomerization efficiencies accompanied by a 
thermal stability of the cis state of 72 days at room temperature.  
Theoretical studies in this context have shown that sophostocated design of substitution 
patterns concerning phenyl or heterocyclic moieties in azo compounds facilitates the design 
and synthesis of photrochromes with predefined photophysical properties for different 
applications.[141] Beyond all these newly developed photoswitches, a vast variety of more small 
molecules is available in literature which will not be discussed in this context.[142] For most of 
these recently developed azobenzenes, the basic constructs and functional groups in para 
position have been reported. Only few of these azobenzenes and arylazopyrazoles have yet 
been translated into in vitro or in vivo systems. The main applications encompass chemical 
reaction control and protein-based applications, but incorporation of photochromes with 
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improved photophysical properties into oligonucleotides and oligonucleotide applications is 
yet to be established. Current state of the art for azobenzene modified oligonucleotides and 
photocontrol of DNA duplexes is further discussed in chapter 2.4.  
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2.3 Structure, synthesis and functionalization of DNA and RNA 
2.3.1 Primary, secondary and tertiary structures of DNA and RNA 
The structure of deoxyribonucleic acid (DNA) as the cafrrier of the human genome was first 
resolved by James Watson and Francis Crick in 1953.[143-144] DNA consists of the four 
nucleobases adenine (A), guanine (G), cytosine (C) and thymine (T), each connected to the 
1’-position of 2’-deoxy-D-ribose (fig. 15). These nucleotides form a one-dimensional 
macromolecular chain as the primary structure of DNA, where every 3’-end of the nucleotides 
is connected by a phosphate linkage to the 5’-end of each neighbouring nucleotide. The four 
nucleobases form two different complementary base pairs by hydrogen bonding following the 
Watson Crick terminology, where A pairs with T and G pairs with C. In case of ribonucleic aicd 
(RNA) the sugar-backbone consists of ribose instead of 2’-deoxyribose and uracil (U) replaces 
thymine (T) to form base pairs with adenine (A). 
 
Fig. 15: Primary and secondary structures of DNA and RNA. 1) Formation of a one-dimensional DNA 
chain through a deoxyribose backbone connected via phosphate moieties. 2) Base pairing of DNA and 
RNA nucleobases adenine (A), guanine (G), cytosine (C), thymine (T) and uracil (U) in the double 
helix center. 3) Complementary sense and antisense strands following the Watson Crick terminology 
form the DNA double strand. The figure shows an adapted version of the figure found in reference[145]. 
Nucleotide base pairing within the one-dimensional primary structure leads to the formation 
of a stable double helical structure where all nucleobases are paired in the inner part and 
phosphate backbones point outwards of the helix.[145-147] Contrary to DNA, the nucleophilic 2’-
hydroxy residue on D-ribose destabilizes RNA by a possible formation of cyclic intermediates 
with the phosphate group in presence of strong bases, which results in an intramolecular 
decomposition of RNA strands into single nucleotides. Formation of three hydrogen bonds in  
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Fig. 16: Crystal structures of A-DNA, B-DNA and Z-DNA showing the three-dimensional structures. 
The four nucleobases are coloured red (A), yellow (T), green (G) and blue (C), the sugar phosphate 
backbone is depicted in grey. The structures were adapted from PDB IDs 213D, 1BNA and 3IRQ[144a]. 
G-C-base pairs leads to a higher stabilization of double-stranded DNA and RNA compared 
to A-T- and A-U-base pairs. Enhanced stability of G-C base pairs results in an enhanced 
duplex stability as observed by a higher dissociation temperature compared to A-T-rich 
sequences, thus determining the overall stability of oligonucleotide duplexes. The DNA double 
helix exists in three different conformations: A-DNA, B-DNA and Z-DNA (fig. 16). All three 
conformations are formed under different conditions and differ in the number of base pairs per 
helix turn, number of successive repeating base pairs and spatial dimensions.  
B-DNA is the most stable and biologically most common type of DNA and is formed at low 
salt concentrations.[148-150] The helix axis is right-handed and all nucleobases are oriented in a 
vertical line along the helix axis, leading to a strong π-stacking of all base pairs. B-DNA exhibits 
10.5 bases per helix turn with a total length of about 35 Å per turn and a helix diameter of 20 
Å. In contrast to B-DNA, A-DNA and Z-DNA are formed in high salt concentrations, while all 
nucleobases are slightly displaced from the central helix axis. A-DNA has a right-handed 
helical structure similar to B-DNA and Z-DNA constitutes a left-handed helical structure with 
an opposed chain sense. Also strands with alternating G-C sequences favour the formation of 
Z-DNA.  
Beyond these three main structural motifs, other secondary structural motifs are known for 
DNA and RNA, for example triple-helices,[151-153] G-quadruplex[154-155] and i-motif structures[156-
157] all forming under different conditions. RNA mostly exists in a single-stranded form in 
biological systems, but is capable of forming two different double-stranded structures. A-RNA 
is formed at low salt concentrations and A’-RNA at high salt concentrations while both retain 
homologous structures. Both structures are similar to the A-DNA structure and consist of a 
right-handed double helix.  
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Fig. 17: Structural DNA and RNA motifs. All double-stranded regions 
(black) within the structure are called stem regions. An internal loop (blue) 
is a single-stranded region flanked by two double-stranded helices on 
both loop ends. A hairpin loop (red) is a terminal single-stranded loop 
which is only connected to one double-stranded region in the DNA strand. 
Tertiary structural motifs are three-dimensional structures built from 
secondary structural motifs. In RNA the general tendency for a formation 
of secondary and tertiary structural motifs is higher than in DNA. The 
figure shows an adapted version of the figure found in reference[160]. 
 
The extraordinary stability of the double helix makes it the most common structural motif in 
DNA and RNA. Nevertheless, both DNA and RNA show a high tendency of forming further 
secondary structural motifs. The hierarchy of structural formation highly depends on the local 
nucleotide sequence, whereby primary structure and nucleotide sequence of single strands 
determine the formation of secondary structures which further determine formation of tertiary 
and higher order structures. Important secondary structural motifs beyond the double helix are 
internal loops and stem loops, also called hairpin loops (fig. 17).[158-160] Internal loops are non-
complementary non-hybridizing single-straded regions flanked by double helices, the so-called 
stem regions. Both single-stranded areas can have different amounts of nucleotides, 
separating them into symmetric or asymmetric internal loops. A hairpin loop is a terminal 
single-stranded loop with no self-complementarity, which is limited on 3’- and 5’-end by two 
strands of the same double helix. Stable loop sizes can vary between 1 and 20 nucleotides 
per single strand. Internal loops lead to a destabilization of the DNA duplex while hairpin 
structures have an overall stabilizing effect. 
Formation of complex three-dimensional tertiary DNA and RNA structures strongly depends 
on the local base sequences and therefore the thermodynamic properties of oligonucleotide 
strands. RNA exhibits a higher tendency of forming complex three-dimensional shapes and 
structures compared to DNA. A precise prediction of secondary and tertiary DNA and RNA 
structural motifs was established by complex mathematical methods based on nearest 
neighbour parameters, i.e. the thermodynamic influence of flanking base pairs for all 
nucleotides in a specific sequence.[161-167] All mathematical models were improved by salt 
correction terms and take all possible influences of base stacking into account to approach 
melting temperature and structural motif prediction as precisely as possible. The complexity of 
further possible secondary and tertiary structural motifs exceeds a discussion in this context 
and is therefore not further described in detail. 
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2.3.2 Synthesis and functionalization of DNA and RNA 
A variety of synthetic approaches to achieve artificial oligonucleotides has emerged 
throughout the last decades.[168-175] Solid supported phosphoramidite synthesis represents the 
most advanced and current standard method for providing synthetic oligonucleotides with high 
specificity and coupling yields. The approach utilizes 5’-DMT protected 3’-phosphoramidites in 
a repeating reaction cycle which consists of four consecutive steps: deprotection, coupling, 
capping and oxidation. Synthesis of artificial oligonucleotides with predefined sequences and 
chain lengths up to 100 nucleotides are accessible by this method. An overview over the single 
reaction steps is depicted below (fig. 18). 
 
Fig. 18: Phosphoramidite method for the synthesis of oligonucleotides.[169-170] The single steps in 
each chain elongation cycle are: 1) detritylation of the DMT group, 2) activation and coupling of DMT-
protected phosphoramidite, 3) capping of non-reacted fragments, 4) oxidation of phosphorous(III) to 
phosphorous(V) and 5) detritylation of the terminal 5’-end. After step (5) the cycle can be repeated (6) 
or the oligonucleotide can be deprotected and cleaved from the solid support (7) to deliberate the 
crude assembly product. The figure shows an adapted version of the figures found in reference[175]. 
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The phosphoramidite synthesis cycle starts with a 5'-DMT protected nucleotide chemically 
bound on a controlled pore glass (CPG) support. The DMT group is deprotected in the first 
step by dichloroacetic or trichloroacetic acid in acetonitrile (deblock, 1). The resulting free 5’-
hydroxy group reacts with the phosphorous of an introduced phosphoramidite, which is 
activated by 1H-tetrazole or substituted tetrazoles in acetonitrile before coupling in the second 
step (2). All unreacted free 5'-hydroxy groups are capped by acetic anhydride and N-
methylimidazole in a THF/pyridine-mixture in the following capping step (3) to avoid undesired 
chain elongation of unreacted fragments. A mixture of iodine in THF, pyridine and water leads 
to an oxidation of the formed phosphorous(III) to phosphorous(V) in the elongated phosphate 
backbone (4). Consecutive DMT deprotection of the newly added nucleotide by trichloroacetic 
acid in dichloromethane activates the 5’-hydroxy moiety for the next coupling cycle (6), thus 
re-entering the synthesis cycle. The coupling cycle can be aborted after each coupling step 
and the synthetic oligonucleotide needs to be deprotect from the solid support. Cleavage of all 
remaining 2-cyanoethyl protecting groups and solid support cleavage are performed in a single 
step by means of 30 % aqueous ammonia 55 °C for 16 hours or a 1:1 mixture of aequous 
methylamine and 30% aqueous ammonia at lower temperatures (7). The resulting crude 
oligonucleotide requires purification by high performance liquid chromatography (HPLC) to 
yield the pure synthetic oligonucleotide. 
Artificial design and synthesis of oligonucleotides emerged a series of artificially modified 
nucleotides for biological, biomedical and nanotechnological applications. Beyond synthesis 
of native DNA and RNA, a vast variety of chemical modifications have been introduced into 
oligonucleotide strands using solid support phosphoramiditie synthesis. Ranging from 
modifications on the sugar pucker over the synthetic modification of nucleobases up to the 
introduction of modifications via sugar analoga have been reported. A recent approach uses 
chemically modified diol linkers with high structural similarity to native D-deoxyribose for 
implementation of functional moieties into oligonucleotide backbones (fig. 19).[176] Among 
these diol linkers, D-threoninol shows the highest structural similarity to natural D-deoxyribose 
and could be successfully implemented into the backbones of DNA and RNA strands for 
implementation of functional moieties.[177] D-threoninol resembles a C3-diol linker carrying a 
primary amino residue in the carbon chain. The primary amino group serves as a nucleophilic 
center for attachment of functional residues by formation of a peptide bond. Experiments 
showed that introduction of the diastereomer L-threoninol as sugar surrogate results in a 
destabilization of a modified ODN duplex since D-threoninol exhibits a higher structural 
similarity to the right-handed chirality of the DNA helix axis compared to L-threoninol.[178] 
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Fig. 19: Structural comparison of natural D-deoxyribose 
(A), D-threoninol (B) and L-threoninol (C). D-threoninol 
exhibits a high structural similarity to natural D-deoxyri-
bose and is commonly used as a sugar surrogate in DNA 
backbones to introduce functional groups. 
Even complete artificial basepairs and backbones have been reported in recent literature, 
mimicking natural DNA and RNA base pairs and backbones.[179-180] Besides the straight 
forward synthesis of nucleotide analoga, the introduction of functional moieties into 
oligonucleotide backbones via click chemistry by use of alkyne modified nucleobases became 
the center of interest for a post-synthetic functionalization of artificial oligonucleotide 
strands.[181] 
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2.4 Photocontrol of oligonucleotide duplex hybridization 
Introduction of D-threoninol as a synthetic base surrogate into the backbone of DNA afforded 
an implementation of photoresponsive moieties into oligonucleotides. First established by the 
working group of H. Asanuma, the successful implementation of D-threoninol linked 
azobenzene residues into oligonucleotides could be achieved and led to the efficient 
photoinduced hybridization control of DNA duplexes.[182-191] Incorporation of D-threoninol 
moieties into the phosphate backbone of DNA leads to a distortion of the helical structure which 
is overcompensated by additional π-stacking interactions through intercalation of trans 
azobenzene between the stacked base pairs (fig. 20). The overall stabilizing effect on the DNA 
duplex can be observed by an increase in melting temperatures. 
              
Fig. 20: Azobenzene attached to D-threoninol can be introduced into the backbone of DNA strands 
(left). Intercalation of azobenzene moieties between the base pairs of a DNA double strand (right). 
Additional π-stacking stabilization of intercalated trans azobenzene (red) stacked with the surrounding 
base pairs overcompensates a disruption of the DNA backbone caused by D-threoninol. The figure 
shows an adapted version of the figure found in reference[192]. 
Isomerization of azobenzene from trans to cis conformation upon irradiation with UV light 
removes the additional π-stacking interactions and induces a local or total duplex dissociation, 
depending on the number and positions of introduced moieties (fig. 21). As a general 
observation, introduction of multiple azobenzenes into a duplex leads to a more efficient 
decrease in melting temperature.[187] Depending on the number and positions of the moieties, 
a full duplex dissociation can only be achieved with a minimum number of one azobenzene 
moiety per two base pairs, but still an efficient duplex dissociation can only be achieved using 
elevated irradiation temperatures close to the melting temperature of the native duplex. 
Furthermore, a GC-content of 50 % or lower is required to achieve a full duplex dissociation. 
Azobenzene can be introduced into a double strand in different motifs (fig. 22). The use of 
one azobenzene moiety per two base pairs is the so called wedged motif, where two 
nucleotides are separated by one azobenzene moiety in the same strand. This motif represents 
the optimal compromise between duplex stabilization through additional π-stacking 
interactions and disruption of the B-form helix through D-threoninol when hybridized with a non- 
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Fig. 21: Photocontrol of DNA hybridization upon irradiation with UV and visible light (left).[192] UV light 
irradiation leads to a destabilization and dissociation of the azobenzene-modified DNA duplex. 
Irradiation with visible light reverst the effect and leads to duplex formation by an additional π-stacking 
stabilization as proven by melting curves (right). The figure shows an adapted version of the figure 
found in reference[176]  
modified complementary strand. The wedged motif achieves a duplex dissociation of 80 % 
when irradiated with UV light at 37 °C or higher temperatures.[193-194]  
A maximum number of two azobenzenes per base pair can be introduced into DNA duplexes 
to remain photoswitchable. In this so-called dimer-motif, the two azobenzene moieties are 
located in opposite strands and are separated by one flanking base pair on each side. In both 
the interstrand wedged motif and the dimer motif complete dehybridization of the duplex is only 
possible at high irradiation temperatures of 60°C and above.[193]  
          
Fig. 22: Different azobenzene substitution motifs into DNA double strands (left): wedged motif (top), 
interstrand wedged motif (middle) and dimer motif (bottom) all contain different azobenzene numbers 
and positions, resulting in different duplex dissociation efficiencies.[194] Temperature dependency of 
DMAB isomerization to cis in ODN duplexes upon irradiation.[193] The figures show adapted versions 
of the figures found in references[193] and [194]. 
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Overloading the duplex with azobenzene moieties increases the π-stacking stabilization to 
an extent that photoinduced dehybridization becomes impossible.As stated before, the 
wedged motif is the best compromise between the two stabilizing and destabilizing 
tendencies.Introduction of ortho methyl residues on azobenzene's peripheral phenyl moiety 
led to a drastic stabilization of the cis state, increasing the half-life of azobenzene from 50 
hours up to 200 hours at room temperature.[195-197] Additional sterical hindrance through the 
methyl residues hampers a thermal back-isomerization from cis to trans conformation which 
leads to the increased thermal stability of the cis state. Unfortunately, the mandatory use of 
UV light to achieve formation of the cis state still persists. To circumvent this problem, the 
development of a 4'-methylthio substituted 2',6'-dimethylazobenzene was designed, further 
shifting the cis response wavelength into near-UV range.[198-199] A complete shift of response 
wavelengths into visible light range could not be achieved by methyl substitution. Further 
attempts of optimizing azobenzene’s photophysical properties within DNA duplexes through 
additional substitutents have not been performed yet.  
Despite the successful establishment of azobenzene and its derivatives as DNA 
photoswitches, the method is still to be improved. The main problems associated with 
azobenzenes is the incomplete conversion between the cis and trans state in both 
isomerization directions and the increased duplex stabilization, both causing mandatory high 
irradiation temperatures and high synthetic loads. This inherent problem was further tried to 
be obliterated by replacing the D-threoninol linkage for other diol linkers. An azobenzene C-
nucleoside[200-201] and an R-glycerol linker[202] as base surrogates both led to a stronger 
destabilization of the oligonucleotide duplex (fig. 23). Introduction of azobenzene into 
oligonucleotides via a C-nucleoside surrogate was designed to avoid backbone disruption 
caused by D-threoninol and therefore avoid azobenzene possibly flipping out of the stack upon 
isomerization.  
 
Fig. 23: An azobenzene C-nucleoside[200] (left) and azobenzene attached to an R-glycerol linker[202] 
(right) were developed as phosphoramidites and introduced into DNA backbones to facilitate room 
temperature photoconversion of modified DNA duplexes. Both modifications result in an efficient room 
temperature photocontrol of oligonucleotide duplexes. 
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Leading to 90 % cis isomer formation, room temperature switching could be achieved by 
attaching azobenzene to a C-nucleoside but only in RNA with high AU-content and a high 
synthetic load. An R-glycerol linker was designed to ensure more space in the base stack for 
isomerization which is limited when introducing azobenzene with D-threoninol. Only 80 % 
formation of the cis isomer could be achieved at room temperature irradiation but almost 
quantitative duplex dissociation at 37 °C.  
Nevertheless, all attempts towards quantitative DNA duplex dissociation at room 
temperature still require low GC-contents and high synthetic loads. The inherent stabilizing 
effect of azobenzene on the DNA duplex and incomplete formation of both isomers in both 
isomerization directions could not be abolished by all previously described approaches. An 
efficient room temperature switching of DNA duplex hybridization with lower synthetic loads 
even in systems with high GC-content are yet to be established. 
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2.5 Application of azobenzene-functionalized DNA nanosystems in vitro 
and in vivo 
2.5.1 From photoresponsive DNA nanoarchitectures to photon-fueled DNA 
nanomachines 
Reversible photocontrol of oligonucleotide duplex formation brought up a multitude of 
innovations for applications in vitro and in vivo.[203-205] Complementary pattern recognition in 
DNA sequences facilitated the construction of complex three-dimensional nanostructures and 
nanotechnical devices which, including azobenzene moieties, can be reversibly converted 
between different states by light irradiation. DNA based nanoarchitectures have emerged 
ranging from three-dimensional tetra-hedra,[206] capsules[207-208] and even larger DNA origami 
structures[209] composed of double stranded DNA. Introduction of photoresponsive moieties 
permits dynamic reversible structural changes inside these constructs upon irradiation with UV 
and visible light. A photocontrolled double-stranded DNA nanotweezer can be reversibly 
opened and closed by irradiating an azobenzene modified closing strand (fig. 24).[210] In trans 
conformation, the closing strand hybridizes to both single stranded ends of the tweezer 
construct leading to a closed state. UV irradiation isomerizes azobenzene moieties to cis, 
leading to a dehybridization of the closing strand and results in tweezer opening. Both opening 
and closing states could be reversibly interconverted over several cycles without fatigue or 
disintegration of the system. 
Sophisticated design of complementary patterns emerged even more complex three-
dimensional DNA structures with a size up to several hundred nanometres. Introduction of 
azobenzenes into these structures permits a macromolecular dynamic photocontrol of shape, 
motion and functionality. A macromolecular DNA tetrahedron modified with azobenzene  
 
Fig. 24: A photocontrolled DNA nanotweezer containing azobenzene modified complementary 
sequences. Irradiation of the system with either UV or visible light leads to a hybridization or 
dissociation of the closing strand F to B and C, inducing an opening or closing mechanism of the 
whole nanotweezer. The figure shows an adapted version of the figure found in reference[210]. 
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Fig. 25: Three-dimensional DNA capsules have been reported with an included photoresponsive 
opening and closing mechanism. The azobenzene-modified edges dissociate upon irradiation to cis, 
thus resulting in an opening of the nanocapsule. The figure shows an adapted version of the figure 
found in reference[207]. 
moieties in one flanking strand exhibited a structural change upon irradiation with UV and 
blue light as observed in AFM images.[206] A similar DNA nanocapsule was designed as a 
container with inbuilt photoresponsive open-close meachnism by means of azobenzene 
moieties (fig. 25).[207] The capsule top is thereby connected to the bottom part over one capsule 
edge and permits a flexibile rotatory motion around this axis in the open form with azobenzene 
moieties in cis conformation. The capsule could be opened and closed reversibly over several 
irradiation cycles. 
Beyond photocontrol of structural motifs, generating functionality and controlled 
unidirectional motion are ongoing challenges in recent DNA nanotechnology. Most DNA 
nanoconstructs and devices create motion by interconversion between stalled states while 
permitting a diffusion of single strands or structural components between the states. A basic 
example for a reversible photocontrolled structural motion is an azobenzene modified DNA 
hairpin which exhibits a diffusion motion upon reversible opening and closing of the stem 
region. The stem region is hereby modified with several azobenzene moieties where alterna- 
 
Fig. 26: A photoresponsive DNA hairpin carrying azobenzene modifications in the stem region can be 
reversibly opened and closed upon alternate irradiation with UV and visible light, resulting in the 
uncontrolled diffusion-like motion of the whole hairpin system. The figure shows an adapted version of 
the figure found in reference[211]. 
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Fig. 27: A supramolecular dsDNA origami structure connected to an azobenzene modified linker 
facilitates the measurement of plasmonic resonance upon irradiation with UV or visible light. The 
structure can undergo free rotational motion around the central rotation axis through azobenzene 
isomerization from trans to cis ,resulting in reversible switching between a stalled (left) and a free 
rotational state (right). The figure shows an adapted version of the figure found in reference[212]. 
ting irradiation with UV or visible light leads to opening and closing of the hairpin resulting in 
an uncontrolled diffusion-like motion of the  whole system (fig. 26).[211]An even larger DNA 
origami structure including azobenzenes was designed to provide detectable physical 
functionality in nanoscale.[212] Two origami tubes connected via a rotational dsDNA axis permit 
the direct measurement of plasmonic resonance of the system after irradiation with UV or 
visible light (fig. 27). The nanostructure translates photoisomerization of azobenzenes into 
reversible chiroptical motion depending on the hybridization state. In trans conformation, 
rotatory motion is suppressed by a hybridizing azobenzene modified connecting oligomer while 
in cis state the oligomer dehybridizes and permits a rotational degree of freedom around the 
connection axis. 
Interlocked DNA nanosystems represent another approach to dynamic photon-fueled 
functional nanotechnology and permit higher degrees of freedom. Mechanically interlocked 
compartments of these systems can be stalled and liberated reversibly upon irradiation of 
azobenzene moieties to enable or disable a diffusive motion of the compartment. Photon 
fueled double-stranded DNA rotaxanes were the first examples to show DNA-based 
photocontrolled logic gating systems which can be reversibly forced from stalled states into 
interlocked states, wheras the structures facilitate free motion of single compartments within  
 
Fig. 28: A two-state dsDNA rotaxane shuttle attached to a ring stopper construct on one end and a 
spherical stopper construct on the other end of the central double strand. Irradiation at 365 nm results 
in a ring release and blocking of the second gap through an azobenzene modified release oligomer at 
the same time, allowing the ring to move freely into the second gap. Irradiation with 450nm reverts this 
process to the initial state. The figure shows an adapted version of the figure found in reference[213]. 
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Fig. 29: A photocontrolled DNA seesaw system containing two different azobenzene photochromes 
azobenzene (AB) and 2',6'-dimethyl-4'-methylthioazobenzene (S-DMAB). While irradiation at 450 nm 
hybridizes both strands (state a), irradiation at 340 nm or 390 nm selectively dehybridizes one or the 
other strand (state b and state c) and irradiation at 370 nm results in dehybridization of both strands 
(state d). The system permits an orthogonal photocontrol of two different strands with 50 % efficiency 
upon alternate irradiation at 45 °C. Switching efficiencies were determined by fluorophore quencher 
measurements. The figure shows an adapted version of the figures found in reference[198]. 
an interlocked range (fig. 28).[213-214] A double-stranded DNA ring is threaded over a central 
rod while bulky stopper constructs on both ends prevent dethreading. The ring can move 
unhindered from one single-stranded position on the rod over an interlocked state to another 
single-stranded gap by relieving or blocking azobenzene-modified gaps or gaps with 
azobenzene-modified toehold oligomers. Irradiation of the system with UV or visible light 
permits reversible positional changes of the ring in different positions. This system provides a 
starting point for further functiona-lized DNA nanosystems which necessitate activation and 
inactivation of functions for larger logic gating devices. A DNA daisy chain as a further 
development step beyond DNA rotaxane systems mimics the contraction and relaxation 
motion of muscle cells.[215] 
All these systems mark evolutionary steps to even more complex DNA systems with 
additional functionalities. An ambitious goal still is the development of artificial photon driven 
motor systems with autonomous propulsion for the development of nanomachines. 
Furthermore, origami-templated nanofactories and assembly lines based on multi-state DNA 
systems could enable light-induced control of chemical reactions or directed assembly of 
macromolecules. The more individual states a complex system requires, the higher is the 
mandatory amount of photoswitches which can be individually addressed. Expansion of the 
hitherto established two-way photocontrol of azobenzene based DNA systems, which only use 
the cis and trans isomerization of a single photoswitch, was developed by a series of 
substituted azobenzenes in DNA.  
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A combination of multiple photoswitches with coherent or independent isomerization 
properties facilitates addressing of multiple states by more than two wavelengths of light. 
Orthogonal photoswitching could be achieved using azobenzene and a 2',6'-dimethyl-4'-
methylthioazobenzene derivative (S-DMAB) in a DNA seesaw system (fig. 29).[198] 
Fluorescence quenching experiments showed a 50 % orthogonal switching efficiency upon 
irradiation of both photochromes with different wavelengths of UV and visible light at 47.5 °C. 
Unfortunately, orthogonal photoswitching is strongly decreased by a significant spectral 
overlap of response wavelengths within this system, thus leading to photostationary states with 
mixed compositions of all stereoisomers for both azobenzene derivatives. Further red-shifting 
and better separation of response wavelengths could drastically improve the photoswitching 
behaviour, but has not been established in DNA yet. 
A further example for orthogonal and independent photoswitching outside DNA applications 
was developed by the interaction of azobenzene derivatives with donor-acceptor Stenhouse 
adducts as reported by the working group of B. Feringa.[216] Efficient orthogonal photoswitching 
could be achieved within this small molecule approach in cyclodextrins, but a translation of 
further efficient orthogonally photoswitchable systems into DNA has not been achieved yet. 
Still, the potential range of applications in DNA nanotechnology and the development of more 
complex systems is strongly hampered by a lack of available photoswitches within DNA. An 
expansion of the photoswitch repertoire readily available in DNA strongly increases the usable 
wavelength range and fosters the development of new complex multi-state DNA nanodevices 
and DNA nanomachines. 
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2.5.2 Photopharmacology - photoactivated drug design for control of biological 
functions 
DNA as a key regulator in metabolic functions controls key cellular processes. Introduction 
of visible light responsive azobenzene into DNA backbones possibly leads to a successful 
development of phototherapeutics. Azobenzene in DNA yet yielded a series of technical 
applications in vitro, but translation into living organisms to achieve photocontrol of biological 
and metabolic functions is still limited due to the mandatory use of UV light.[217-219] 
Azobenzene modified oligonucleotides have recently only been established in vitro while 
further development of visible light responsive azobenzenes has not passed beyond the 
molecular level. Translation of these newly developed photoswitches towards in vivo systems 
still remains a highly ambitious goal to achieve phototherapeutics. One application of 
azobenzenes in vivo has been reported by A. A. Beharry et al. by introduction of azobenzene-
modified coiled-coil fluorescence reporter proteins into zebrafish embryos (fig. 30).[220-221] 
Irradiation of these photoresponsive fluorescence reporters could be observed within two days 
of zebrafish growth without influencing the development of the embryo or showing any 
undesired systemic toxicity. However, electron withdrawing azobenzenes are accompanied by 
a high tendency to reduction by glutathione. 
 
Fig. 30: Introduction of photoresponsive fluorescence reporter proteins into zebrafish embryos 
showed photoswitching properties and fluorescence response for more than two days without inherent 
side-effects. This experiment reveald the in vivo applicability of therapeutic oligonucleotides modified 
with azobenzene residues. The figure shows an adapted version of the figure found in reference[220]. 
A more convenient approach to photoresponsive therapeutics and theranostics has been 
postulated by D. Trauner[222] and B. L. Feringa.[223] Existing biologically active prodrugs and 
therapeutics including azobenzene or stilbene backbones exhibit photoresponsive  
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Fig. 31: The molecule acrylamide-azobenzene-quarternary ammonium (AAQ) leads to an activation of 
inactive retinal ganglion cells in cis conformation and restores vision when injected into blind mice. 
The figure shows an adapted version of the figure found in reference[228]. 
isomerization properties. In case of therapeutics with a stilbene backbione, these molecules 
can be chemically modified to result in photoresponsive therapeutics. Substitution of the 
central stilbene double bond by an azo linkage results in azobenzene prodrugs. If biological 
activity is retained within the newly designed azo-prodrugs, biological activity can be turned on 
and off reversibly by light irradiation. The potency of this approach was proven in a variety of 
in vitro applications to achieve photoreversiblebinding to insulin receptors,[224-225] sodium 
channels[226] and photoinduced proliferation of cancer cells.[227] 
Translation of in vitro applications into living organisms was proven through injection of the 
molecule acrylamide-azobenzene-quarternary ammonium (AAQ) into mice (fig 31).[228] This 
photo-active prodrug was initially proven to block potassium channels in the nervous system 
in trans conformation and permits sodium exchange in cis conformation, whereby this effect 
could be turned on and off reversibly by irradiation with 380 nm or 500 nm light. Interestingly, 
the molecule showed another significant biological activity when injected into the eyes of blind 
mice. AAQ bears the potential of restoring light sensitivity of rods and cones in retinal ganglion 
cells in cis conformation after irradiation with 380 nm. The effect was suppressed after 
irradiation with 500 nm, converting the molecule back into the inactive trans conformation. The 
further optimized molecule DENAQ containing a reduced thermal stability of the cis state 
mimics the isomerization of opsins in photoreceptor cells of the human eye.[229-230] The 
molecule showed an increased visual restoration potential and a quick thermal back-relaxation 
in the dark, but was only tested in in vitro models. 
Further potent photoresponsive receptor agonists[231] and bioactive prodrugs[232] showed 
high potentials as possible phototherapeutics, but yet did not overcome the barrier between in 
vitro and in vivo application. A highly promising photoactive anticancer drug has been deve- 
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loped as a photoactive combretastatin analogon,[227] which in cis conformation revealed 
reduction of negative systemic side effects as often associated with anticancer drugs. The 
agent could be activated by isomerization into trans conformation and still retained 
antiproliferate activity. 
Photoactivation and deactivation of therapeutic drugs provides a powerful tool for a broad 
application range in targeted disease phototherapy. Unfortunately, the method is still limited to 
small molecules and has not been transferred towards DNA or RNA based therapeutic 
applications. The mandatory use of UV light, high synthetic loads and elevated irradiation 
temperatures thereby present the strongest limitations of the approach. Photoswitches with 
trans and cis converting wavelengths in visible light range accompanied with near-quantitative 
conversion efficiencies and high thermal cis-stabilities could provide ideal candidates to 
improve the applicability of new photoactive therapeutics. 
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2.6 Motivation and outline 
Azobenzene and its derivatives have proven to be versatile tools for the reversible 
photocontrol over DNA duplex hybridization. The four reported D-threninol linked molecules 
azobenzene (AB), 2’,6’-dimethylazobenzene (DMAB), 4’-methylthioazobenzene (S-AB) and 
2’,6’-dimethyl-4’-methylthio-azobenzene (S-DMAB) have successfully been introduced into 
oligonucleotide duplexes and permit a reversible duplex photocontrol as shown in diverse DNA 
nanosystems in vitro. The photoswitching potential of the described molecules has been 
demonstrated in vitro in functional DNA nanostructures and devices, photon-fueled DNA 
nanotechnology, photocontrol of cellular functions and photoactivated therapeutic molecules. 
Unfortunately, duplex hybridization control through the reported azobenzenes is highly limited 
to in vitro applications due to the mandatory use of UV and near-UV light and its associated 
negative side effects on biomolecules and living tissue, the mandatory use of elevated 
irradiation temperatures close to native duplex melting point and a high synthetic load 
associated with these molecules. Overcompensation of DNA backbone disruption by additional 
π-stacking of azobenzene with DNA base pairs as well as the incomplete conversion from 
trans to cis and vice versa are the main drawbacks which strongly limit feasibility in vivo. 
The recently reported ortho substituted azobenzene and arylazopyrazole molecules state 
promising candidates for a potential improvement of photoinduced oligonucleotide duplex 
hybridization. Increased thermal cis stabilities and near-quantitative reversible conversion 
efficiencies between the trans and cis state accompanied by highly red-shifted response 
wavelengths match the three criteria for potent photoswitches and provide suitable properties 
for in vivo applications. An optimal photoswitch thereby matches three main criteria, which 
have to be fulfilled for improved DNA photoswitching: First, reversible interconversion between 
trans and cis in visible light range has to be established to minimize negative side effects on 
biological systems. Furthermore, near-quantitative conversion efficiencies in both 
isomerization directions are mandatory to reduce the synthetic load in oligonucleo-tides. 
Especially in DNA-nanotechnology, high switching efficiencies at low irradiation temperatures 
possibly minimize the synthetic load required for efficient photoswitching, thus decreasing 
structural disruptions. Last but not least, a high thermal stability of the cis state needs to be 
retained to ensure long-term applications in DNA nanotechnology and living systems. 
The central goal of this project is the systematic synthetic development of substituted 
azobenzene and arylazopyrazole molecules for a general improvement of photophysical 
properties followed by the introduction of new photoswitches into oligonucleotide strands and 
duplexes via DMT-protected phosphoramidites. A series of newly designed molecules have to 
be investigated via spectroscopic methods towards their photophysical properties. Based on  
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the recently reported azobenzenes and arylazopyrazoles, a synthetic toolbox of D-threoninol 
linked photoswitches has to be synthesized and investigated by UV/Vis spectroscopy and 
reversed-phase HPLC quantifications. A selection of suitable candidates is further developed 
synthetically to achieve DMT-protected phosphoramidites. The synthetically accessible 
photoswitches with the most promising photophysical properties are further introduced into 
oligonucleotides via solid phase phosphoramidite synthesis. 
Once successfully introduced into oligonucleotides, a systematic study of different synthetic 
loads, positional effects and irradiation conditions in DNA duplexes with different length and 
GC-content are performed to investigate a translation of photophysical properties from free 
molecules into oligonucleotide strands. The reported DNA photoswitches thereby serve as a 
reference under the same experimental conditions in a direct comparison. Duplex photocontrol 
efficiency is investigated by melting curve experiments as well as hybridization experiments in 
a double-stranded 168bp DNA ring system. Application of the newly developed photoswitches 
is established in competitive environments in DNA based hairpin systems as release oligomers 
to demonstrate photocontrol feasibility.  
Successful development of multiple new photoswitches might bring up a whole toolbox of 
 
Fig. 32: A) Different potential applications of newly designed photoswitches ranging from visible light 
switching for biomedical applications over independent addressing of two different photochromes up to 
orthogonal photoswitching of two different azobenzenes for applications in DNA nanotechnology. 
B) Absorption spectra of two independently addressable photoswitches ideally do not show 
overlapping of absorption maxima, thus resulting in orthogonal controllability of modified DNA 
systems. C) Sterical hindrance of bulky ortho substituents possibly prevent the formation of a planar 
trans conformation which might distort the base pair stacking in DNA duplexes upon intercalation and 
consequently prevent duplex hybridization. 
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molecules with cooperative and independent photoswitching properties for introduction into 
multi-state DNA nanotechnology systems. Depending on the nature of the introduced 
photoswitches, systems with multiple photocontrolled states are thinkable which can be 
addressed independently (fig. 32). Yet, the number of possible different states for a 
combination of multiple photoswitches is strongly limited by the accessible irradiation 
wavelength range for the already available molecules established in DNA strands.  
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3. Development of new azobenzene and arylazopyrazole 
phosphoramidites for improved photocontrol of oligonucleotide 
duplex hybridization 
3.1 Synthesis and spectroscopic investigation of substituted azo 
compounds 
3.1 1 General spectroscopic investigation of ortho substituted azobenzenes 
Since the first report of photocontrol over DNA hybridization through introduction of 
azobenzene residues into the backbone of DNA, a series of azobenzene derivatives have been 
developed and successfully implemented into oligonucleotide strands. Three of the four 
reported D-threoninol linked photoswitches azobenzene (AB), 2’,6’-dimethylazobenzene 
(DMAB) and 4’-methylthio-2’,6’-dimethylazobenzene (S-DMAB) were synthesized following 
pathways previously reported[192,198] (fig. 33) and serve as reference systems during the 
development of new photoswitches. D-threoninol as a base surrogate and linkage between the 
phosphate backbone and the photochromes is well studied and represents the most commonly 
used linkage for introduction of azobenzene into DNA. Photochromes bound to D-threoninol 
represent the switching moiety which is later introduced into oligonucleotides. 
 
Fig. 33: Azobenzene (AB), 2’,6’-dimethylazobenzene (DMAB) and 4’-methylthio-2’,6’-
dimethylazobenzene (S-DMAB) represent the three D-threoninol bound photochromes previously 
reported and established in DNA.[192,198].These molecules were synthesized and used as a reference 
for all newly synthesized and developed photoswitches. 
The three azobenzene moieties AB, DMAB and S-DMAB were irradiated with a set of high 
power LEDs covering the main light-range between 320 nm (UV light) and 630 nm (red light), 
which were used in all further irradiation experiments (see chapter 7.1). The used LEDs permit 
irradiation within a low bandwidth range and, contraryt to commonly used white light in 
combination with cutoff filters, provide high irradiation intensities to foster the formation of 
photostationary states (PSS) within short irradiation times. The relative change in UV/Vis 
absorption intensity thereby correlates to the change in trans and cis composition. Empirical 
investigation of UV/Vis absorbance spectra after consecutive irradiation with all available LEDs  
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permits the profiling of wavelength-dependent photostationary states to determine 
absorption maxima and maximum response wavelengths. Every wavelength-dependent 
photostationary state is characteristic for each photochrome and strongly depends on the 
overlap of absorption bands for the pure trans and cis iomers. Empirical determination of a set 
of photostationary states further enables determination of wavelength-dependent fractions of 
trans and cis isomers within each PSS. The maximum trans- and cis-converting irradiation  
 
 
      
Fig. 34: UV/Vis absorption spectra of D-threoninol bound photochromes azobenzene (AB), 2‘,6‘-
dimethylazobenzene (DMAB) and 2‘,6‘-dimethyl-4‘-methylthioazobenzene (S-DMAB). All spectra were 
recorded using a 50 µM photochrome solution in a 1:1 mixture of acetonitrile and water after 5 minutes 
irradiation with all available LEDs from the newly built LED irradiation source. The absorption values 
were normalized on the respective maximum absorption values at the absorption maxima. 
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Azobenzene WL trans WL trans ref. WL cis WL cis ref. 
AB 405 nm >400 nm 340 nm 340 nm 
DMAB 420 nm >400 nm 350 nm 340 nm 
S-DMAB 450 nm 450 nm 385 nm 400 nm 
Tab. 1: Comparison of empirically determined maximum excitation wavelengths for AB, DMAB and S-
DMAB with the previously reported excitation wavelengths reveal a high similarity with the reported 
wavelengths when using the newly designed LED irradiation machine.[198,199] Comparable irradiation 
wavelengths are a main prerequisite for reproducibility of results when using the irradiation machine. 
wavelengths as well as each wavelength-dependent PSS for a combination of multiple 
photoswitches allows a prediction of coherent switching properties for a combination of multiple 
photoswitches. The resulting empirical data set represents a spectroscopic “fingerprint” for 
each compound. Since azobenzenes do not emit radiation and only exhibit marginal 
photobleaching, the empirical excitation scan can be used for a qualitative investigation of the 
maximum trans and cis converting wavelengths and thus the separation of n->π* and π->π* 
transition bands for both stereo isomers. A high separation of absorption bands, especially in 
visible light range, is one of the main prerequisites for efficient and independent addressing of 
both states. Exact quantification of a UV/Vis spectrum is problematic due to the overlap of cis 
and trans absorption bands in the same spectrum and necessitates complex mathematical 
models to approach the composition of both isomers. The qualitative determination of 
absorbance intensity differences in UV/Vis spectra permits a qualitative characterization to 
determine the maximum trans- and cis-converting wavelengths and thus facilitates the pre-
selection of suitable candidates for further implementation into oligonucleotides.The three 
molecules AB, DMAB and S-DMAB bound to D-threoninol were dissolved in a 1:1-mixture of 
acetonitrile and water and irradiated for 5 minutes at room temperature with all available LEDs 
immediately followed by recording UV/Vis absorption spectra (fig. 34). In agreement with 
literature,[198,199] all three compounds show a significant change in absorption intensity upon 
irradiation with the wavelengths given in table 1, but the maximum irradiation wavelengths 
reveal a slight hypsochromic shift compared to the reported ones, possibly caused by broader 
irradiation bandwidths by the used LEDs. Despite this observation, all maximum trans- and 
cis-converting irradiation wave-lengths are close to the reported ones. 
Azobenzene (AB) exhibits the lowest absorption maximum when irradiated with 340 nm and 
the highest absorption maximum upon irradiation with 405 nm light. DMAB shows slightly red-
shifted excitation wavelengths with 350 nm irradiation for the lowest and 420 nm for the highest 
measured absorbance while S-DMAB reveals 385 nm and 450 nm as the wavelengths with 
the maximum change in intensity. The previously reported wavelengths were determined after  
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irradiation with white light in combination with cutoff filters as stated before. High power LEDs 
possibly permit a lower irradiation bandwidth and a higher light output so the irradiation maxima 
are marginally shifted. The established method proved to be valid by confirming the maximum 
trans and cis switching irradiation wavelengths of the reported azobenzenes. This empirical 
method entails one major drawback: Determination of maximum response wavelengths is only 
possible for azobenzenes with thermal stabilities significantly higher than the irradiation and 
measurement times, usually within a magnitude of several hours. Azobenzenes with low 
thermal stabilities within seconds or minutes rapidly transform back thermally from cis to trans 
conformation, thus potentially changing the ratio of both isomers during the measurement. 
Since most of the investigated photochromes retain thermal stabilities of the cis state within a 
range of several hours to days, fast back-switching is not considered as a severe problem but 
has to be taken into account as a possible error source. 
A distinct quantification of trans and cis composition for each photostationary state can be 
obtained by separating both stereo isomers via reversed-phase HPLC and integration of the 
corresponding peaks in the recordedcchromatograms. This method is later described in 
chapter 3.2.1. 
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3.1.2 Synthesis and spectroscopic investigation of an azobenzene toolbox 
The first criterium for the development of new photoswitches with improved photophysical 
properties is a shift of response wavelengths into the red range of visible light. Substitution of 
azobenzenes in all four ortho positions has been reported to result in red-shifted response 
wavelengths and a separation of both a n->π* transition bands for the trans to cis isomerization 
and vice versa while maintaining high thermal stabilities of the cis state (see chapter 2.2.5). To 
confirm this observation and normalize all irradiation conditions to a newly developed high 
output LED irradiation machine, a series of differently ortho substituted azobenzenes was 
synthesized as a readily available “azobenzene toolbox” for pre-selection of possible 
molecules to be further implemented into oligonucleotides. 
Azobenzenes with four equal substituents in all four ortho positions were synthesized by 
oxidative dimerization involving the corresponding anilines in dichloromethane utilizing a 1:1 
mixture of potassium permanganate and copper(II)-sulfate (fig. 35).[81] The synthetic yields 
strongly depend on the electronic properties of substituted anilines and a possible sterical 
hindrance of the amine moiety throught the substituents. Asymmetric azobenzenes containing 
two differently ortho substituted rings carrying equal substituents on the same ring were 
synthesized by a Mills reaction, which involves an aniline and a nitroso compound in a glacial 
acetic acid mediated condensation. This type of reaction allows the selective synthesis of 
asymmetric azobenzenes while minimizing the formation of undesired by-products, a 
prerequisite for the successful introduction of a linker moiety (fig. 35). 
 
Fig. 35: Synthesis of symmetrically ortho substituted azobenzenes is performed by oxidative 
dimerization using strong oxidation agents (A) and asymmetrically ortho substituted azobenzenes are 
synthesized via Mills reaction from nitrosobenzenes and anilines involving glacial acetic acid (B).[91] 
A pre-selection of suitable photochromes was performed using the molecules which were 
synthesized for the azobenzene-toolbox (fig. 36). Part of these molecules have previously 
been reported and serve as reference compounds for spectroscopic measurements and 
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Fig. 36: Newly synthesized azobenzene toolbox containing azobenzenes with different ortho 
substituents. Aside unmodified azobenzene (20), azobenzenes carrying either two substituents on the 
same ring in ortho position in molecules (21)-(24), four equal substituents in all four ortho positons in 
molecules (25)-(29) or two different ortho substituent types on opposite rings in molecules (30) and 
(31) were synthesized. 
irradiation conditions. Not only the response-wavelengths are of great interest, but also the 
synthetic accessibility of the molecules. Synthetic yields exhibit s strong variance between 1 % 
and 61 % while most reactions yielded azobenzenes below 20 %. A Mills reaction involving 
anilines with two activating ortho groups on the same ring shows the best yields among all 
reactions as observed for compounds (21) and (24), possibly leading to an increase 
nucleophilicity of the amine residue. 
A Mills reaction involving nitrosobenzene and 2,6-dichloroaniline yielded only 1 % of the 
target compound (23), potentially due to sterical hindrance of the amine group through the 
bulky chlorine-substituents. All other Mills reactions exhibited yields between 14 % and 27 %. 
Symmetrically substituted ortho azobenzenes were accessible in moderate yields through 
oxidative dimerizations using the corresponding anilines and did not show a significant 
influence of the substituents on the reaction yields, which lie between 15 % and 19 %. 
Spectroscopic investigation of the newly designed azobenzenes was performed after 5 
minutes irradiation with all available LEDs and consecutive recording of UV/Vis spectra. The 
resulting set of absorption spectra yields irradiation wavelengths for the maximum decrease 
and increase in absorbance at the absorption maxima and permits a qualitative determination 
of the maximum trans- and cis-converting wavelengths as well as the relative n->π* and π->π* 
transitions.  
Ortho substituents were reported to strongly red-shift response wavelengths while 
maintaining high thermal stabilities of the cis state. Azobenzenes with two ortho substituents 
on the same ring revealed a marginal shift in maximum response wavelengths compared to  
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Sample 
Abs. max. 
t1 
Abs. max. 
t2 
Abs. max. 
c1 
Abs. max. 
c2 
max. trans-
WL 
max. cis-
WL 
(20) 319 nm 431 nm 288 nm 422 nm 405 nm 350 nm 
(21) 312 nm 438 nm 278 nm 428 nm 405 nm 340 nm 
(22) 315 nm 412 nm 300 nm 403 nm 385 nm 350 nm 
(23) 299 nm 425 nm 282 nm 416 nm 405 nm 340 nm 
(24) 325 nm 446 nm 280 nm 426 nm 405 nm 350 nm 
(25) 305 nm 450 nm 290 nm 445 nm 405 nm 340 nm 
(26) 306 nm 445 nm 284 nm 412 nm 385 nm 340 nm 
(27) 290 nm 435 nm N/A N/A N/A N/A 
(28) 304 nm N/A 304 nm N/A 320 nm 630 nm 
(29) 310 nm 450 nm 301 nm 430 nm 405 nm 590 nm 
(30) 313 nm 407 nm 282 nm 415 nm 405 nm 340 nm 
(31) 321 nm 440 nm 289 nm 423 nm 405 nm 590 nm 
Tab. 2: Absorption maxima and maximum irradiation wavelengths for all synthesized ortho substituted 
azobenzenes. Absorption maxima t1 and c1 correspond to both π->π*-transitions and absorption 
maxima t2 and c2 correspond to both n->π*-transitions. 
 
 
Fig. 37: Azobenzenes carrying two ortho substituents on the same ring were synthesized and 
investigated via UV/Vis spectroscopy after irradiation with different LED wavelengths. All ortho 
substituted azobenzenes exhibit a significant drop in absorption intensity after irradiation with UV light, 
indicating a successful cis isomerization. The same effect can be observed for irradiation with visible 
light wavelengths, where the intensity drop is slightly lower compared to UV irradiation. 
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Fig. 38: Azobenzenes with substituents in all four ortho positions were investigated via UV/Vis 
spectroscopy, absorption spectra after irradiation with the maximum trans and cis converting 
wavelengths are depicted. All molecules (25)-(29) show a significant drop in absorption intensity when 
irradiated with visible light wavelengths beyond 500 nm. 
unmodified azobenzene. 2,6-Dimethylazobenzene (21) and 2,6-difluoroazobenzene (22) 
exhibit a significant decrease in absorbance upon irradiation with λ = 530 nm, but no complete 
drop to the same absorbance intensity when irradiated with λ = 340 nm and λ = 350 nm 
(fig. 37). As stated before,[132,133] ortho fluorinated azobenzenes exhibit this effect for two and  
four ortho substituents. Two chloro (23) and two methoxy moieties in ortho position (24) on 
the same ring result in the same effect similar to ortho fluorinated azobenzenes as observed 
in a significant absorbance intensity drop at the absorption maximum when irradiated with 
λ = 530 nm. Both molecules exhibit a stronger decrease in intensity compared to ortho 
methylated and ortho fluorinated azobenzenes to an extent comparable to irradiation with 
λ = 340 nm and λ = 350 nm. Reversible switching in visible light range seems to be possible 
with high conversion efficiencies for both molecules, matching the first criterium for visible light 
responsive DNA photoswitches.The strongest separation of both n->π* transition bands are 
observed in 2,6-dimethoxyazobenzene (24) with both absorption maxima separated by 20 nm, 
while all other azobenzenes containing one substituted ring only show separated absorption 
maxima of 10 nm and lower (tab. 2).  
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Fig. 39: Azobenzenes-with two differently ortho substituted opposite phenyl rings exhibit strongly red-
shifted absorption bands and high conversion efficiencies in visible light range. While azobenzene (30) 
shows a similar drop in absorption intensity using UV and visible light irradiation, (31) reveals even a 
higher intensity drop when irradiating the molecule with 590 nm light compared to UV irradiation. 
Azobenzenes with four ortho substituents result in stronger red-shifted absorption 
wavelengths compared to two ortho substituents (fig. 38). Four ortho methyl moieties (25) 
already decrease the intensity of the absorption maximum when irradiated with λ = 340 nm 
and λ = 590 nm although the separation of both n->π*-transitions are only separated by 5 nm. 
One isomerization direction seems to be strongly favored at this irradiation wavelength 
resulting in the observed effect. The same is observed in case of four ortho fluorine 
substituents (26) where both n->π*-transition maxima are separated by 33 nm. Irradiation with 
λ = 340 nm and λ = 530 nm light result in the same decrease in absorbance, indicating high 
conversion efficiencies between the trans and cis state in visible light range. In case of four 
chlorine (27) and bromine atoms (28) all electronic transitions significantly seem to overlap, 
resulting in a low decrease in absorbance. Four ortho bromine substituents indicate a decrease 
in absorbance, but as previously reported for these molecules,[129] long irradiation times of 30 
mintes are mandatory to achieve a successful isomerization to cis using red light. The 
observed change in absorbance intensity could be enhanced by longer irradiation times, which 
is not intended in the workframe of this project. As stated before,[129] azobenzenes with bulky 
ortho substituents demand longer irradiation times up to 30 minutes for cis isomerization, 
excluding them as possible candidates for use in DNA applications. Furthermore, the four bulky 
ortho substituents possibly distort the planar trans conformation, thus possibly hampering 
successful intercalation between the nucleobases in double-stranded DNA. Tetra ortho 
methoxy azobenzene (29) reveals an even stronger decrease in absorbance when irradiated 
with λ = 590 nm compared to irradiation with UV light. As mentioned before, the four methoxy 
moieties potentially disrupt the mandatory planar trans conformation but might be useful for 
other non DNA-based applications. 
Azobenzenes containing two different types of ortho substituents on both rings were also 
investigated in this study. Two electron withdrawing ortho fluorine atoms on one ring in  
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combination with two electron donating ortho methyl (30) or methoxy moieties (31) on the 
opposite ring both result in highly red-shifted absorption bands (fig. 39). (30) exhibits nearly 
the same decrease in absorbance when irradiated with λ = 340 nm or λ = 530 nm while in case 
of (31), the decrease in absorbance becomes even stronger when irradiated with λ = 590 nm 
compared to UV irradiation. In direct comparison to azobenzenes with one modified ring, 
electronic influences of substituents seem to superimpose and lead to higher conversion 
efficiencies in near-infrared range of light. The formation of an ortho push-pull system possibly 
leads to a decrease in thermal stability of the cis state as previously reported for para push-
pull systems.[111]  
Based on the combined spectroscopic observations, a series of azobenzenes was selected 
to be further modified with a D-threoninol linkage for consecutive incorporation into 
oligonucleotide backbones. The most promising isomerization efficiencies even in visible light 
could be observed for azobenzenes carrying two or four ortho fluorine atoms and two ortho 
methoxy moieties on the same ring. Also an azobenzene carrying two chlorine atoms on the 
same phenyl ring could successfully be converted to cis with high efficiency in visible light 
range. Therefore compounds (22), (23), (24), (26) and (30) were chosen to be further modified 
with D-threoninol for DNA implementation. Despite the very promising spectroscopic properties 
of (30) and (31), using an ortho push-pull system possibly entails a decreased thermal stability 
as previously reported for para push-pull systems.[111] Thus, both molecules could be more 
suitable for short-time applications, but DNA-based applications rather demand a high thermal 
stability of the cis  state. 
When interpreting the relative change in absorption intensity after irradiation, it has to be kept 
in mind that different irradiation times might be mandatory to fully reach the photostationary 
state. This possibly error source can falsify the results for slowly isomerizing azobenzenes. 
Nevertheless, the spectroscopic investigations provide a good starting point for any further 
azobenzene development. 
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3.1.3 Synthesis and spectroscopic investigation of an arylazopyrazole toolbox 
Beyond azobenzenes, arylazopyrazoles were reported showing near-quantitative 
conversion efficien-cies between the trans and cis state accompanied by red-shifted response 
wavelengths and thermal stabilities of the cis state of up to 1000 days at room temperature.[136] 
Unfortunately the molecules reported with the highest thermal stabilities do not achieve 
quantitative conversion efficiencies and vice versa,[136,140] but nevertheless arylazopyrazoles 
prove promising candidates for photocontrolled DNA applications in vitro. Furthermore, 
contrary to azobenzenes, arylazopyrazoles can be obtained synthetically in high total yields. 
Diazotation of anilines followed by addition to 2,4-pentadione and consecutive condensation 
with substituted hydrazines leads to arylazopyrazoles in near-quantitative yields (fig. 40). 
 
Fig. 40: General synthetic route for arylazopyrazole molecules carrying ortho substituents on the 
peripheral benzene ring for further spectroscopic investigation and optimization of response 
wavelengths. Diazotation of substituted anilines and consecutive addition of 2,4-pentadione followed 
by condensation with substituted hydrazines yields the ortho substituted arylazopyrazoles. 
In analogy to ortho substituted azobenzenes, ortho substitution of arylazopyrazole's phenyl 
residue potentially results in a further red-shifted response wavelengths and further enhances 
thermal stability of the cis state. Therefore, a series of arylazopyrazoles has been synthesized 
carrying different substituents on the phenyl moiety as well as further functional modalities on 
the pyrazole ring. The resulting “arylazopyrazole toolbox” was examined towards the maximum 
response wavelengths and absorption maxima after irradiation through consecutive UV/Vis 
spectra as described before (fig. 41). 
Arylazopyrazoles carrying three methyl moieties on the peripheral pyrazole ring were 
reported to achieve near-quantitative conversion efficiencies between the trans and cis state. 
The same effect could be observed under the irradiation conditions used in this study by means 
of high output LEDs. When irradiating (79) with UV and orange light respectively (fig. 42), the 
strong absorption maximum at λ = 341 nm corresponding to the π->π*-transition reaches its 
maximum upon irradiation with λ = 590 nm and almost drops to zero upon irradiation with 
λ = 365 nm. This implies a high conversion efficiency between both isomers as previously 
reported in literature. Further substitution of the phenyl residue in both ortho positions with  
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Fig. 41: Arylazopyrazole toolbox consisting of synthesized ortho substituted arylazopyrazole 
molecules (79)-(91) for optical tuning of response wavelengths into visible light range. All molecules 
carry two ortho substituents on the phenyl residue while molecules (79)-(82) contain an N-methyl 
moiety, molecules (83)-(86) contain an N-phenyl residue, molecules (87)-(90) containg a N-(4-
nitrophenyl) residue and molecule (91) contains an N-(4-aminophenyl) residue. 
Sample 
Abs. max. 
t1 
Abs. max. 
t2 
Abs. max. 
c1 
Abs. max. 
c2 
max. trans-
WL 
max. cis-
WL 
(79) 341 nm 435 nm 299 nm 440 nm 590 nm 365 nm 
(80) 315 nm 418 nm 294 nm 420 nm 405 nm 350 nm 
(81) 313 nm 412 nm 298 nm 416 nm 405 nm 340 nm 
(82) 323 nm 419 nm 295 nm 421 nm 420 nm 350 nm 
(83) 335 nm 425 nm 296 nm 435 nm 530 nm 365 nm 
(84) 320 nm 425 nm 293 nm 425 nm 420 nm 350 nm 
(85) 315 nm 417 nm 299 nm 418 nm 420 nm 350 nm 
(86) 326 nm 420 nm 297 nm 422 nm 590 nm 350 nm 
(87) 343 nm 435 nm 332 nm 435 nm 590 nm 365 nm 
(88) 331 nm N/A 318 nm N/A 590 nm 365 nm 
(89) 340 nm 394 nm 320 nm 405 nm 530 nm 385 nm 
(90) 337 nm 425 nm 325 nm 425 nm 590 nm 365 nm 
(91) 343 nm 440 nm 292 nm 436 nm 530 nm 365 nm 
Tab. 3: Absorption maxima and maximum irradiation wavelengths for all synthesized arylazopyrazole 
molecules given in fig. 41. Absorption maxima t1 (trans) and c1 (cis) correspond to π->π*-transitions 
in UV range and absorption maxima t2 (trans) and c2 (cis) correspond to n->π*-transitions in visible 
light range. 
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Fig. 42: UV/Vis absorption spectra of arylazopyrazole photochromes carrying an N-methyl group and 
different substituents in both phenyl ortho positions. UV/Vis absoption spectra after irradiation with the 
maximum trans- and cis-converting response wavelengths are shown. Substituents on both phenyl 
ortho positions appear to blue-shift the maximum trans converting excitation wavelengths. 
methyl (80), chloro (81) or fluoro substituents (82) results in significantly blue-shifted absorp-
tion bands and response wavelengths, shifting the maximum trans converting wavelengths 
into near-UV light range similar to the absorption properties of azobenzene. Also the maximum  
      
Fig. 43: UV/Vis absorption spectra of arylazopyrazole photochromes carrying an N-phenyl group and 
different substituents in both phenyl ortho positions. UV/Vis absoption spectra after irradiation with the 
maximum trans- and cis-converting response wavelengths exhibit a different photoswitching behaviour 
compared to N-methyl arylazopyrazoles as observed in UV/Vis spectra. Two methyl and chloro 
substituents in molecules (84) and (85) appear to blue-shift the maximum trans converting excitation 
wavelengths while two fluorine atoms in (86) apparently retain a near-IR photoswitching. 
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Fig. 44: UV/Vis spectra of arylazopyrazoles carrying an N-(4-nitrophenyl) residue in molecules (87)-
(90) and an N-(4-aminophenyl) residue in (91) in combination with different substituents in both phenyl 
ortho positions. UV/Vis absorption spectra reveal a high overlap of absorption maxima after irradiation 
with different excitation wavelengths. The cis converting excitation wavelengths are slightly red-shifted 
while conversion to trans occurs at different visible light excitation wavelengths. (90) carrying two 
fluorine moieties shows a strong blue shift for the maximum trans converting excitation wavelength. 
cis converting wavelengths are significantly blue-shifted, indicating an increased energy 
difference between the trans and cis state. Substituting the secondary pyrazole nitrogen atom 
with a phenyl residue (83) shows an absorption maximum at λ = 335 nm and also reaches its 
maximum under λ = 530 nm irradiation and its minimum upon irradiation with λ = 365 nm, 
similar to the N-methyl substituted arylazopyrazole (79) (fig. 42). Introduction of the phenyl 
residue leads to an expanded π-system, thus resulting in a possible influence the thermal half-
life of the cis state. Also, it may have an influence on the base pair stacking when the moiety 
in intercalated into DNA duplexes.Further derivatization in both phenyl ortho positions reveals 
for the compounds (83) ,(84) ,(85) and (86) (fig. 43) the same tendency as observed for ortho 
substituted N-methyl arylazopyrazoles. All absorption maxima are blue-shifted and the 
maximum response-wavelengths for cis to trans conversion lie in the blue range of visible light. 
Only in case of ortho fluoro substituents the maximum trans switching response wavelength is 
red-shifted to λ = 590 nm. All maximum trans to cis converting response wavelengths are blue-
shifted and lie in a range similar to the response wavelengths of unsubstituted azobenzene. 
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Introduction of a strong electron withdrawing nitro moiety in para position of the 
arylazopyrazole N-phenyl residue (87) leads to a strong overlap of absorption bands both in 
trans and cis conformation. Despite this, the maximum empirical response wavelengths could 
be determined as λ = 365 nm and λ = 590 nm, illustrating photoswitching in near-infrared 
range. Further derivatization by ortho methyl moieties (88) did not result in any significant 
effect, but led to blue-shifted response wavelenghts for fluorine residues (90) (fig. 44). In case 
of ortho chlorine atoms (89), the π->π*-transition is strongly red-shifted above 400 nm resulting 
in a strong overlap of all absorption bands. Nevertheless, a maximum conversion efficiency 
could be observed when irradiated with λ = 385 nm and λ = 530 nm LEDs. Exchanging the 
nitro moiety for an electron donating amino residue (91) in the N-phenyl para position reveals 
a better separation of all absorption bands and a similar switching behaviour as observed for 
N-phenyl arylazopyrazole (fig. 44), but does not appear to achieve near-quantitative 
conversion efficiencies. 
As a concluding remark, the spectroscopic determination of absorption maxima and 
maximum response wavelengths does not include the thermal stability of the cis state as an 
important factor. Fast back-relaxation as a possible error source might decrease the observed 
conversion efficiencies through back-switching during the measurement. This factor is further 
investigated using D-threoninol linked photoswitches (chapter 3.2.2). Ortho substitution of the 
azo phenyl moiety led to an undesired blue-shift of response wavelengths excluding these 
synthesized molecules from being introduced into oligo-nucleotides. Also the introduction of 
para substituents on the pyrazole N-phenyl residue did not significantly improve the absorption 
behaviour further into the desired red light range. The non ortho modified arylazopyrazoles 
(79), (83) and (87) revealed the most promising spectroscopic properties and were therefore 
selected to be further derivatized with D-threoninol for further consecutive implementation into 
oligonucleotide strands. 
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3.1.4 Synthesis of D-threoninol linked azobenzenes for introduction into DNA 
strands 
Based on the previous spectroscopic investigation of ortho substituted azobenzene and 
arylazo-pyrazole chromophores, a series of these molecules has been selected for further 
implementation into oligonucleotide strands. In analogy to the previously reported 
azobenzenes established in DNA, all molecules necessitate a D-threoninol linkage in para 
position through a peptide bond on one peripheral phenyl ring. Tetra ortho fluoroazobenzene 
(26) thereby revealed the highest conversion efficiencies in visible light range from trans to cis 
and vice versa (see chapter 3.1.2) and was therefore selected for implementation into 
oligonucleotide strands. 
The synthetic pathway starts with the oxidation of 2,6-difluoroaniline to 2,6-difluoronitroso-
benzene (19) using MCPBA in dichloromethane, which represents one part of the 
photochrome formed in a consecutive Mills reaction to yield the photochromic part of the 
asymmetrically substi-tuted tetrafluoroazobenzene backbone. The phenyl moiety containing 
the D-threoninol moiety was synthesized by para bromination of 2,6-difluoroaniline with N-
bromosuccinimide in acetonitrile followed by catalytic substitution of bromine with 
copper(I)cyanide in DMF to form 4-cyano-2,6-difluoroaniline (33) (fig. 45). The following Mills 
reaction in glacial acetic acid involving 2,6-difluoro-nitrosobenzene (19) and 4-cyano-2,6-
difluoroaniline (33) yielded a substituted tetrafluoroazobenzene carrying a cyano residue in 
para position on one peripheral phenyl ring (34). The Mills reaction yield represents the 
bottleneck of the whole synthetic pathway, reaching a maximum yield of 10 %. The strongly 
electron withdrawing fluorines possibly hamper a nucleophilic attack of the nitrogen lone pair, 
resulting in the low reaction yield. Refluxing the resulting 4-cyano-2,2',6,6'-
tetrafluoroazobenzene (34) in 1 M aqueous NaOH led to a 2,2’,6,6’-tetrafluoroazobenzene 
carboxylic acid (35). Consecutive D-threoninol coupling to the carboxylic acid as the required 
base surrogate part for DNA implement-tation could not be achieved. Using a series of peptide 
coupling reagents as HBTU, DCC in combination with OxymaPure, diethylcyanophosphonate 
and a direct formation of the carboxylic acid chloride followed by addition of D-threoninol did 
not show any formation of the desired product. Most reactions returned the unconverted 
starting material. The high electron deficiency involving all four fluorines appears to drastically 
stabilize the non-protonated form of the carboxylic acid which prevents a successful coupling 
to D-threoninol in these reactions. Using harsh reaction conditions possibly results in a 
favoured ipso-substitution of all fluorine residues instead of a peptide coupling. 
A further attempt involved the attachment of D-threoninol to 4-carboxy-2,6-difluoroaniline 
(36) followed by D-threoninol protection using 2,2-dimethoxypropane in acetone (38) (fig. 46).  
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Fig. 45: Synthetic pathway for a 2,2’,6,6’-tetrafluoroazobenzene phosphoramidite based on Mills 
reaction types. A successful coupling of D-threoninol to the 2,2',6,6'-tetrafluoroazobenzene carboxylic 
acid could not be achieved when using a series of different coupling conditions. 
The consecutive Mills reaction involving (38) and 2,6-difluoronitrosobenzene (19) did not 
show any formation of the desired product but gave a series of non-identified by-products. This 
second pathway was therefore also considered to be not appropriate. 
Beyond the two reaction pathways based on a Mills reaction to form the asymmetric 
tetrafluoroazobenzene, synthesis of the 2,2',6,6'-tetrafluoroazobenzene-D-threoninol molecule 
was attempted via a third pathway by coupling the protected 4-carboxy-2,6-difluoroaniline-D-
threoninol (38) to 2,6-difluoroaniline in an asymmetric oxidative dimerization.  
 
Fig. 46: Alternative synthetic pathway to achieve a 2,2’,6,6’-tetrafluoroazobenzene phosphoramidite 
using either a Mills reaction with different starting materials (upper pathway) or an oxidative hetero 
dimerization pathway involving tBuOCl (lower pathway). Efficient coupling of a D-threoninol bound 2,6-
difluoroaniline to 2,6-difluoroaniline could not be achieved by boh reaction pathways. 
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tert-Butylhypochlorite was reported to selectively favour hetero-substituted azobenzene 
products in oxidative dimerizations of two anilines at low temperatures, thereby minimizing 
formation of the undesired homo coupling by-products.[98] Successful oxidative dimerization 
could not be achieved using a series of oxidation agents, namely KMnO4 in a 1:1 mixture with 
a copper(II)sulfate support in dichloromethane[81] as well as the mentioned oxidation involving 
t-BuOCl at low temperatures did not yield the desired product. Synthesis of 2,2’,6,6’-
tetrafluoroazobenzene-D-threoninol was stopped at this point and considered synthetically not 
accessible. Further attempts to achieve the target product have not been performed.Since a 
tetra ortho fluoroazobenzene could not be successfully obtained, the focus was put on further 
ortho fluorinated azobenzenes. 2,6-Difluoroazobenzene carrying two fluorine atoms in ortho 
position on the same phenyl ring as well as further ortho fluorinated derivatives were reported 
to exhibit strongly red-shifted response wavelengths while maintaining high conversion 
efficiencies between both conformations and high thermal stabilities of the cis state.[132,133] 
Also, the previous spectroscopic investigation of 2,6-difluoroazobenzene (22) revealed high 
conversion efficiencies between trans and cis in visible light range, although the conversion 
efficiencies were slightly lower than observed for 2,2',6,6'-tetrafluoroazobenzene (26). A 
reduced number of two fluorine atoms attached to the aromatic system decreases the electron 
deficiency compared to four fluorines, thus possibly exhibiting a lower tendency of fluorine ipso 
substitution in reactions involving nucleophiles. Beyond the scope of synthesis, the tendency 
of fluorine to be prone to ipso-substitution by nucleophilic reactants possibly causes side 
reactions in DNA or cellular environments since a variety of nucleophilic moieties are present 
under these conditions. 
2',6'-difluoroazobenzene-D-threoninol (42) was synthesized following the reported synthetic 
route for azobenzene and 2’,6’-dimethylazobenzene phosphoramidites (fig, 47).[192] A Mills  
 
Fig. 47: Synthetic pathway for 2’,6’-difluoroazobenzene coupled to D-threoninol (DFAB) and further 
derivatives carrying fluorine (DFAB-F), chlorine (DFAB-Cl) or bromine atoms (DFAB-Br) in para 
position. (42) could be obtained in moderate yields while the three other derivatives showed only low 
synthetic yields. The Mills azo formation still remains the bottleneck of the reaction pathways leading 
to highly decreased yields of intermediates. 
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reaction between 2,6-difluoroaniline and ethyl-4-carboxynitrosobenzoate (1) in glacial acetic 
acid yielded 67 % of the target compound (42). Ester hydrolysis and consecutive coupling of 
D-threoninol to the carboxylic acid moiety using HBTU in DMF yielded the product in moderate 
yields.  
Introduction of further electron donating or withdrawing moieties in para position of the 
peripheral fluorinated ring may have an improving effect on the photphysical properties and 
serves as a coupling site for further derivatization of the molecules. As previously reported, 
introduction of electron with-drawing substitutents in para position leads to a more efficient 
separation of both n->π* bands, thus facilitating reversible photoconversion in visible light 
range.[132,133] In respect to oligonucleotide strands, bulky substituents bear the potential of 
additionally disrupting base stacking of nucleobases, thereby decreasing the overall DNA 
duplex stability and relieving efficient photocontrol of duplex hybridi-zation. A series of para 
substituents were introduced on the peripheral 2’,6’-difluoro-azobenzene ring to investigate 
synthetic feasibility and spectroscopic properties of further substituted derivatives. Following 
the same synthetic pathway, a 4’-fluoro (47) and a 4’-chloro derivative (51) were both 
accessible in low yields compared to 2',6'-difluoroazobenzene, possibly caused by additional 
electronic deactivation through the substituents. A derivative carrying bromine in para position 
(56) as well as a 4’-acetamido derivative (59) were synthetically accessible (fig. 48), but pure 
products could not be isolated. Furthermore, both molecules highly tended to para and fluoro 
substitution when trying to attach D-threoninol to the free carboxylic acid moiety. Fluorine 
substitution could be observed by shifted signals in 19F-NMR towards lower ppm values (see 
appendix). Also, mass spectrometry revealed substituted by-products and decomposition of 
the target compounds. 
Further derivatization of 2,6-difluoroazobenzene on the opposite ring carrying the carboxylic 
acid moiety by introduction of two methyl substituents in both ortho positions was performed 
 
Fig. 48: Further derivatisation of DFAB by a para acetamide moiety was synthesized for optical tuning 
of response wavelengths. Using a 4'-bromo-2',6'-difluoroazobenzene derivative, the acetamide moiety 
is introduced by a Palladium catalysed reaction. Consecutive ester hydrolysis and coupling to D-
threoninol yields the target product in high yields. 
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Fig. 49: Synthetic route to achieve a 2’,6’-difluoro-2,6-dimethylazobenzene photoswitch coupled to D-
threoninol in para position. Introduction of a cyano moiety by Zn(CN)2 and consecutive transformation 
to form a carboxylic acid provides a coupling site for D-threoninol. 
to investigate additional stabilization as observed for 2’,6’-dimethylazobenzene (fig. 49). The 
target compound could be obtained by coupling 2,6-dimethyl-4-iodoaniline (60) to 2,6-
difluoronitrosobenzene (19) in a Mills reaction. Catalytic introduction of a nitrile residue by 
zinc(II)cyanide mediated by Pd(PPh3)4 followed by nitrile hydrolysis yielded the photochrome 
including the carboxylic acid moiety (63), which was consecutively linked to D-threoninol. The 
amount of additional necessary reaction steps to obtain the target 2',6'-difluoro-2,6-
dimethylazobenzene-D-threoninol (64) lowered the overall yield significantly. Also, couling to 
D-threoninol could only be achieved in a very low yield. 
Beyond the scope of ortho fluoroazobenzenes, further functional moieties in ortho position 
revealed promising spectroscopic properties in the UV/Vis irradiation scans performed before 
(see chapter 3.2.1). Azobenzenes carrying four chloro and methoxy substituents in all ortho 
positions have been reported to show highly red-shifted response wavelengths into visible light 
range.[128,129] Four sterically challenging substituents in ortho position possibly distort the planar 
aromatic system and consequently might prevent a successful intercalation between DNA 
base stacks, therefore azobenzenes with two substituents on the same ring in ortho position 
were selected. 
2',6'-Dichloroazobenzene attached to D-threoninol (67) was synthesized following the same 
synthetic route as used before (fig. 50). The ethyl-4-carboxy-2',6'-dichloroazobenzene 
precursor (65) was synthesized in one step from 2,6-dichloroaniline and ethyl-4-carboxy 
nitrosobenzene (1) in a Mills reaction containing 1:1 glacial acetic acid and trifluoroacetic acid. 
Since (65) could not be obtained in a purified form, the synthetic pathway was continued with 
the non-purified crude product. Contrary to previous reactions, no product formation could be  
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observed in glacial acetic acid at room tempera-ture, possibly due to the strong sterical 
hindrance of the aromatic amine by both chlorine substituents, thus preventing a nucleophilic 
attack of the amine moiety. Reaction conditions had to be adjusted to a 1:1 mixture of glacial 
acetic acid and trifluoroacetic acid and elevated reaction temperatures (40 °C) to achieve the 
product. These harsh reaction conditions still yielded low impure amounts of the desired 
product. Ester hydrolysis and coupling to D-threoninol was performed analogous to the 
reactions before (fig. 50). Since a product mixture was used for consecutive reactions, the final 
product had to be purified by preparative HPLC to yield the pure product. Since synthesis and 
purification of the target compound and intermediate steps proved difficult, the molecule (67) 
was not further consi-dered for introduction into DNA, but was further used for spectroscopic 
investigations. 
A 2',6'-dimethoxyazobenzene derivative coupled to D-threoninol (72) could be synthesized 
straight forward in high yields, although the 2,6-dimethoxyaniline precursor (69) had to be 
synthesized separately (fig. 51). Starting from 2-nitroresorcinol, methylation of both hydroxy 
moieties by dime-thylsulfate in acetone yielded 2,6-dimethoxynitrobenzene (68) in near-  
 
Fig. 50: Synthetic pathway for a 2’,6’-dichloroazobenzene linked to D-threoninol in para position. The 
previously used Mills reaction conditions had to be adjusted to a 1:1 acetic acid:TFA mixture to 
achieve the target product (67). 
 
Fig. 51: Synthetic route for a 2’,6’-dimethoxyazobenzene coupled to D-threoninol in para position. The 
required starting material 2,6-dimethoxyaniline (69) was prepared in two high-yielded steps. All 
following reactions were executed in analogy to the previously described reaction pathways to achieve 
successful formation of the product (72). 
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quantitative yield, which was further reduced to the corresponding aniline using iron powder 
in combination with hydrochloric acid in a water ethanol mixture in high yield. A Mills reaction 
involving 2,6-dimethoxyaniline (69) and ethyl-4-nitrosobenzoate (1) led to the target molecule 
ethyl-4-carboxy-2',6'-dimethoxyazobenzene (70) in 20 % yield. Follow-up ester hydrolysis and 
coupling to D-threoninol using DCC and OxymaPure in DMF achieved the target D-threoninol 
coupled 2',6'-dimethoxyazobenzene (72) in high yield (fig. 51). 
All synthetically accessible azobenzenes coupled to D-threoninol were selected for further 
intro-duction into oligonucleotide strands. The synthetically non accessible molecules 2,2',6,6'-
tetrafluoro-azobenzene-D-threoninol and 2',6'-dichloroazobenzene-D-threoninol (67) were 
excluded from any other synthetic development since the synthesis of both target molecules 
failed or only yielded the desired product in very low amounts. All synthesized target molecules 
were further investigated towards their photophysical properties as described in chapter 3.2.1. 
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3.1.5 Synthesis of D-threoninol linked arylazopyrazoles for introduction into DNA 
strands 
The pre-selection of suitable photochromes for DNA implementation from the previously 
synthe-sized arylazopyrazole toolbox (chapter 3.1.3) originated three main candidates with 
promising spectroscopic properties to be further synthetically developed for introduction into 
DNA. All three molecules contain an unmodified phenyl ring and a substituted secondary 
nitrogen on the pyrazole residue. The molecules N-methylarylazopyrazole (AAP1) (95), N-
phenylarylazopyrazole (AAP2) (100) and N-4-nitrophenylarylazopyrazole (AAP3) (105) could 
be synthesized successfully by attaching a carboxylic acid moiety in para position to the 
peripheral phenyl moieties to be further coupled to D-threoninol via a pathway similar to the 
reported synthesis routes (fig. 52).[192] 
 
Fig. 52: Modified arylazopyrazoles for improved photocontrol of oligonucleotide duplex hybridization. 
AAP1 (left) was reported in literature without D-threoninol linkage,[136] AAP2 (middle) and AAP3 (right) 
represent newly synthesized modified derivatives of this reported arylazopyrazole. 
The synthetic pathway started from diazotation of ethyl-4-aminobenzoate instead of aniline, 
followed by a diazotation involving 2,4-pentadione and condensation with the respective 
hydrazines carrying either a methyl, phenyl or 4-nitrophenyl residue to form the heterocyclic 
photochromes (fig. 53). Compared to azobenzenes, the total synthesis of all three 
arylazopyrazole carboxylic acids (94), (99) and (104) reveals high-yielded steps, a major 
advantage concerning an economical use of materials. The previously discussed Mills reaction 
used for the synthesis of asymmetrically substituted azobenzenes represents the bottleneck 
in azobenzene synthesis and deteriorates the total synthetic yields of differently substituted 
azobenzenes. Since a Mills reaction is not required for accessing arylazopyrazoles, the total 
synthetic yield increases significantly. 
Coupling to D-threoninol could be achieved successfully for AAP1 and AAP2 in moderate 
yields to form (95) and (100), but coupling of D-threoninol to AAP3 proved difficult. A highly  
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Fig. 53: Synthetic route for D-threoninol linked arylazopyrazoles AAP1, AAP2 and AAP3. All three 
molecules were synthesized following the same synthetic pathway. All single reactions are high-
yielded, only an efficient coupling of D-threoninol to (104) could not be achieved. 
decreased solubility of AAP3 carboxylic acid (104) as observed in a wide range of tested 
organic and inorganic solvents possibly prevents a successful reaction of AAP3 carboxylic acid 
to D-threoninol. The reduced solubility impedes further conversion of the compound and makes 
it synthetically not accessible as a DMT-protected phosphoramidite. AAP3 was 
consequentially not considered any further for a synthetic development and introduction into 
oligonucleotides. 
High total synthetic yields of AAP1-D-threoninol (95) and AAP2-D-threoninol (100) provide 
two promising candidates for introduction into oligonucleotide strands and a possible 
improvement of photocontrol over DNA duplex hybridization. As stated before (chapter 3.1.3), 
the small molecules without D-threoninol linkage already exhibited high reversible conversion 
efficiencies between the trans and cis state upon irradiation with UV and orange light. If these 
properties sustain within DNA or RNA strands, both arylazopyrazoles possibly implicate an 
improvement of oligonucleotide duplex hybridization photocontrol. 
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3.2 Photophysical properties of D-threoninol linked photoswitches 
3.2.1 UV/Vis investigation and conversion efficiencies of D-threoninol bound 
photochromes 
The combination of synthetic accessibility and spectroscopic properties emerged a series of 
chromophores for an introduction into oligonucleotide strands. This final “photoswitch toolbox” 
consisting of D-threoninol bound photochromes constitutes a selection of molecules with 
promising photophysical properties for an improvement of photocontrol over oligonucleotide 
hybridization (fig. 54). All synthetically accessible D-threoninol linked azobenzenes and 
arylazopyrazoles described in chapter 3.1.4 and 3.1.5 represent potential candidates for 
introduction into oligonucleotides.  
Since the introduction of D-threoninol bound to a carboxylic acid moiety in para position 
possibly influences the spectroscopic properties of each previously investigated photochrome. 
A further determination of maximum response wavelengths and switching efficiencies has to 
be performed. All molecules have to match the three criteria of a suitable photoswitch, wheras 
the first criterium, the synthetic accessibility is already fulfilled by the molecules selected. 
The second criterium, high switching efficiencies of the photochromes and a shift of response 
wavelengths into visible light range, is investigated by quantifying the composition of trans and 
cis isomers after irradiation with each available LED via reversed-phase HPLC. In contrast to 
the previous investigations, UV/Vis spectroscopy after irradiation with every available 
wavelength is now used to determine the absorption maxima and isosbestic points of the  
 
Fig. 54: Synthesis of a “photoswitch toolbox” containing a series of D-threoninol bound photochromes. 
The synthetically accessible photochromes described in chapters 3.1.4 and 3.1.5 were further 
investigated vie UV/Vis spectroscopy to select a series of potent photoswitches for further 
development of photochrome phosphoramidites and introduction into DNA strands. 
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molecules. The isosbestic point is a characteristic for all azobenzene and arylazopyrazole 
photochromes and constitutes the point in a set of absorption spectra where the total 
absorbance intensity does not change, independent from the present composition of trans and 
cis isomers. Detection of the isosbestic point is used for a distinct quantification of the trans 
and cis fraction within a photostationary state for each photochrome after irradiation with a 
specified LED wavelength. In analogy to all previous investigations, UV/Vis absorption spectra 
were recorded after irradiation with every available wavelength. The D-threoninol bound small 
molecules were dissolved in a 19:1 water:acetonitrile mixture to approximate the aqueous 
conditions used in DNA experiments. All UV/Vis irradiations and absorption scans bring out 
the isosbestic point by overlaying all recorded curves. Quantifying the cis to trans ratio of 
azobenzene mixtures implies the problem of a changing absorbance intensity after each 
irradiation step, significantly impeding an exact quantification. Detection of the absorption at 
the isosbestic point circumvents this problem since the total intensity does not change. All 
determined isosbestic points are used as detection wavelengths in consecutive reversed-
phase HPLC quantifications using a Nucleodur pentafluorophenylpropyl (PFP) column. The 
column material facilitates separation of trans and cis isomers while detection at the isosbestic 
point minimizes absorption errors through different compositions of trans and cis isomers. 
Integration of all recorded signals permits the calculation of trans and cis isomer fractions for 
every applied irradiation wavelength (fig. 55). 
UV/Vis spectroscopy of D-threoninol bound photochromes after irradiation with every 
available LED wavelength revealed a similar photoswitching behaviour as observed before. 
DFAB (42) exhibits a strong change in absorbance upon irradiation with 350 nm or 385 nm 
 
Fig. 55: UV/Vis spectra of all available photochromes after irradiation with every available LED 
wavelength permits a comprehensive determination of maximum trans and cis converting irradiation 
wavelengths and isosbestic points (left). Separation of both stereo isomers via reversed-phase HPLC 
while detecting the absorption at the isosbestic point permits a disctinct quantification of wavelength-
dependent trans and cis fractions through integration of both peak areas (right). 
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Fig. 56: Empirical UV/Vis spectra of D-threoninol bound azobenzenes and arylazopyrazoles after 
irradiation with all available LED wavelengths reveal the maximum change in absorbance at the 
absorption maxima, thus indicating the maximum trans and cis converting irradiation wavelengths in 
UV and visible light range.  
light and a lower drop in absorbance upon irradiation with 530 nm (fig. 56, tab. 4). As 
observed before, DFAB shows a significant but incomplete cis photoswitching upon 530 nm 
irradiation. Introduction of a fluorine (47) or chlorine residue (51) in para position does not 
enhance visible light photoswitching. While chlorine in para position does not exhibit any 
change in absorption behaviour, the additional fluorine atom shifts the trans response 
wavelength from 385 nm to 420 nm, but visible light switching at 530 nm is significantly 
decreased as observed by a lower drop in absorbance after irradiation. 
DCAB (67) and DOAB (72) both yield a stronger visible light switching compared to ortho 
fluoroazobenzenes (fig. 56, tab. 4). The maximum change in absorbance as observed for UV 
light irradiation could also be observed by a strong decrease in absorbance upon irradiation 
with 530 nm light in case of DCAB and 590 nm irradiation in case of DOAB. The same change 
in absorbance could be observed for both small molecules without D-threoninol linkage as well, 
but the maximum cis converting irradiation wavelength of DOAB is even stronger red-shifted 
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Sample max. trans WL max. cis WL 
max. cis WL 
vis 
Isosbestic 
point 
AB 405 nm 350 nm N/A 282 nm 
DMAB 420 nm 350 nm 590 nm 277 nm 
S-DMAB 440 nm 385 nm N/A 288 nm 
DFAB 385 nm 350 nm 530 nm 274 nm 
DFAB-F 420 nm 365 nm 530 nm 292 nm 
DFAB-Cl 385 nm 350 nm 530 nm 278 nm 
DCAB 385 nm 340 nm 530 nm 268 nm 
DOAB 420 nm 350 nm 590 nm 279 nm 
AAP1 590 nm 365 nm N/A 301 nm 
AAP2 590 nm 365 nm N/A 301 nm 
Tab. 4: Maximum empirical trans and cis converting irradiation wavelengths in UV and visible light 
range as well as isosbestic points determined from UV/Vis absorption spectra after irradiation with 
different LED wavelengths for 5 minutes at room temperature. The full spectra for each irradiation and 
absorbance scan can be found in chapter 7.3.3. 
than in non D-threoninol modified DOAB. Both arylazopyrazoles AAP1 (95) and AAP2 (100) 
on the other hand to not reveal any visible light cis switching, but a strong absorbance 
dropupon 365 nm irradiation indicates the same near-quantitative switching efficiency as 
observed for the molecules without D-threoninol. Absorption wavelengths of AAP2 are further 
red-shifted from 350 to 365 nm and even 385 nm irradiation reveals a decrease in absorbance 
almost as strong as observed for 365 nm irradiation. Both molecules exhibit the strongest 
increase in absorbance at 590 nm irradiation which is close to the infrared range. 
To distinctly quantify the amount of trans and cis isomer in every PSS formed after irradiation 
with different wavelengths, a reversed-phase HPLC assay way performed. After irradiation, an 
aliquot of the sample solution was injected into HPLC and both stereo isomers were 
successfully separated for all photochromes. Detection at the respective isosbestic points (tab. 
4) and consecutive integration of the corresponding signals in the resulting chromatograms 
permit a distinct determination of the trans and cis composition for every wavelength 
dependent PSS (tab. 5). 
As a reference, the cis to trans ratios for all three reported azobenzenes AB (4), DMAB (9) 
and S-DMAB (15) reveal isomerization efficiencies in good agreement with the efficiencies 
reported by Asanuma et al.[198] Azobenzene AB with a maximum trans conversion efficiency of 
81 % at 405 or 420 nm irradiation can be isomerized to cis with a maximum efficiency of 86 % 
at 340 nm irradiation. DMAB shows a maximum trans conversion of 86 % at 405 or 420 nm 
irradiation and a maximum cis conversion of 77 % at 340 nm irradiation. The further red-shifted 
S-DMAB was reported to achieve formation of the cis isomer at 385 nm irradiation and shows 
3. Development of new azobenzene and arylazopyrazole phosphoramidites 
72 
Fig. 57: Overlaid empirical cis-fraction results from multiple HPLC quantifications for all D-threoninol 
bound small molecules after irradiation with all available LED wavelengths facilitates a direct cis-trans 
ratio comparison across the whole visible light range. Details are given in table 5. 
the highest cis conversion with 66 % at this wavelength. The maximum trans conversion 
efficiency can be achieved by means of a 450 nm LED irradiation with 73 % efficiency. The 
maximum irradiation wavelengths represent only one of many possible irradiation 
wavelengths, each forming an individual PSS. The excitation wavelength range often covers 
the whole spectral range in which the photochromes can be isomerized with different 
conversion efficiencies from one isomer to the other an vice versa. This plays a key role for 
the combination of two or more photochrome when used in the same system. 
Tab. 5: Empirical cis percentage values determined for each photostationary state by integration of 
both trans and cis peak areas for all D-threoninol bound small molecules after irradiation with all 
available LED wavelengths. 
cis % dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
AB 3.6 12.9 85.9 85.3 73.4 25.1 19.3 19.1 22.3 23.1 25.8 30.2 30.5 32.1 13.4 11.9 
DMAB 6.5 14.8 76.6 74.9 63.4 20.2 15.8 16.4 21.1 22.7 26.9 35.9 37.2 42.8 38.6 19.9 
S-
DMAB 
15.4 27.1 48.6 54.8 62.9 65.9 40.4 37.1 27.1 26.8 28.4 30.3 34.3 34.8 33.1 29.0 
DFAB 24.7 34.4 85.9 85.6 53.5 18.2 20.9 22.5 33.3 35.9 42.9 54.5 56.0 60.6 39.3 32.1 
DFAB-
F 
25.8 45.7 82.4 87.2 90.1 75.5 41.5 40.5 38.5 39.5 42.1 46.1 46.3 47.8 34.1 36.3 
DFAB-
Cl 
8.8 18.8 65.7 65.2 53.9 15.2 14.4 14.9 21.3 22.8 27.4 35.2 36.3 40.5 25.4 17.9 
DCAB 23.6 29.6 70.9 62.2 28.1 11.4 13.0 15.1 26.1 28.8 37.1 52.4 54.3 61.8 48.0 33.4 
DOAB 48.9 56.2 80.7 82.8 80.4 62.6 35.8 34.8 40.2 42.7 49.3 60.1 61.3 66.4 70.5 60.7 
AAP1 6.8 42.5 77.0 84.1 80.7 62.3 30.9 28.8 19.8 18.9 16.3 13.6 13.3 11.2 5.5 6.0 
AAP2 7.9 49.5 84.3 87.8 90.7 75.7 38.4 35.7 25.1 24.4 22.2 18.4 17.7 15.0 5.3 12.1 
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The newly synthesized photochromic molecules can be directly compared to the reported 
ones by using the same irradiation method with the available LEDs (fig. 57, tab.5). DFAB can 
be isomerized into cis conformation upon irradiation with 340 or 350 nm light achieveing 86 % 
conversion efficiency, while the trans state is formed with 82 % at 385 nm irradiation. 
Isomerization upon 530 nm irradiation only achieves 60 % of the cis state. Introduction of para 
chlorine in case of DFAB-Cl (51) further reduces the conversion efficiencies of DFAB 
significantly. A para fluorine substituent slightly red-shifts the maximum response wavelengths 
and enhances formation of the cis state to 90 % upon 365 nm irradiation. Unfortunately, 
isomerization to trans is significantly reduced, yielding only 61 % of the trans isomer when 
irradiated with 440 nm light. Formation of photostationary states with a mixed composition of 
both trans and cis isomers possibly disturbs proper hybridization of oligonucleotide duplexes 
when introduced into DNA backbones. Therefore, DFAB-F and DFAB-Cl were not further taken 
into account for translation into oligonuleotides. 
DCAB and DOAB on the other hand yield the highest cis fraction when irradiated in visible 
light range. Trans DCAB is formed in 89 % efficiency when irradiated with 385 nm light and the 
cis isomer with 71 % at 340 nm, compared to 62 % cis at 530 nm irradiation. Cis conversion 
efficiency under visible light irradiation of 62 % in combination with the sterically challenging 
chlorine substitutents possibly destabilize DNA duplexes to an extent that efficient 
dehybridization becomes possible upon irradiation in visible light range. Further introduction 
into DNA strands was, as stated before, not considered due to the low synthetic yield of DCAB. 
DOAB on the other hand provides the highest cis content upon visible light irradiation with 
71 % using 590 nm LED. This high cis content might be able to efficiently break up DNA duplex 
hybridization. DOAB's trans isomer is formed with 65 % at 420 nm irradiation but heating the 
sample possibly yields a higher trans content. 
Both arylazopyrazoles AAP1 (95) and AAP2 (100) reveal near-quantitative conversion 
efficiencies but unfortunately formation of the cis isomer can not be achieved with irradiation 
in visible light range. The trans isomer is formed with 95 % efficiency upon irradiation with 590 
nm for AAP1 and AAP2 while the cis isomer is formed in 84 % yield using 350 nm for AAP1 
and 91 % yield in case of AAP2 using 365 nm light. These high conversion efficiencies 
correlate well to the significant increase and decrease in absorbance upon alternate irradiation. 
Through their high conversion efficiencies, both arylazopyrazole molecules are of great interest 
for possible applications in DNA nanotechnology. 
Introduction of the D-threoninol moiety as an electron withdrawing functionality only 
marginally influences the maximum response wavelengths. Not only the maximum trans and 
cis converting wavelengths are of great interest, but also the trans and cis fractions within the 
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photostationary states formed after irradiation with every available LED wavelength. The 
resulting values given in table 5 permit a direct comparison of each cis composition when 
combining two or more photochromes in a single DNA system. The wavelength-dependent 
scan permits a possible prediction for the combination of two or more photochromes to achieve 
coherent or independent photoswitching. By wisely selecting two or more photochromes from 
the designed photoswitch toolbox and directly comparing the empirical values, cooperative 
switching effects can possibly be predicted within limits. 
For example, the previously reported combination of the two azobenzenes AB and S-DMAB 
used for orthogonally photoswitching a DNA seesaw system is based on the superposition of 
response wavelengths depending on the isomers of both photochromes. As reported before, 
      
Fig. 58: Cooperative switching of AB, DMAB and S-DMAB as derived from multiple small molecule 
HPLC quantifications. Both photochrome combinations show a similar coherent photoswitching 
behaviour. At 340 nm irradiation, AB and DMAB are converted to cis, while S-DMAB forms a 50:50 
trans to cis equilibrium. At 385 nm irradiation, S-DMAB converts to cis while AB and DMAB remain in 
trans conformation. Irradiation with wavelengths above 400 nm leads to formation of trans isomers for 
all three photochromes. 
Tab. 6: Direct comparison of empirical cis percentage values between AB and S-DMAB photo-
chromes for each photostationary state after irradiation with all LED irradiation wavelengths. 
Tab. 7: Direct comparison of empirical cis percentage values between DMAB and S-DMAB photo-
chromes for each photostationary state after irradiation with all LED irradiation wavelengths. 
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both photoswitches are converted to trans when irradiated with 450 nm light and to cis using 
370 nm light, while AB switches to cis and S-DMAB to trans when using 340 nm light and vice 
versa upon irradiation with 390 nm light. Similar irradiation wavelengths can be deduced 
empirically from the photoswitch toolbox as well, giving the same results and similar conversion 
efficiencies. At 340 nm irradiation, AB forms 86 % cis isomer while S-DMAB remains in a 50:50 
state between trans and cis. 385 nm irradiation turns S-DMAB into 66 % cis conformation while 
AB merely remains in the trans state (fig. 58, tab. 6). These two orthogonal irradiation 
wavelengths directly confirm the reported irradiation scheme. Also, the independently 
switching wavelengths are close to the reported values with 365 nm for cis conversion and 
440 nm or 450 nm for turning boh photochromes to trans. A combination of DMAB and S-
DMAB reveals the same tendency using the same irradiation wavelengths but since the 
conversion efficiency of DMAB into cis is significantly reduced, an orthogonal switching 
efficiency may be lowered within DNA (fig. 58, tab. 7). As reported by Asanuma et al., the 
combination of AB and S-DMAB proved most efficiently for an orthogonally photocontrolled 
DNA system. Validation of the photoswitch prediction can be assumed as observed in the 
proximity of empirical irradiation wavelengths and efficiencies compared to the reported ones. 
However, the difference in conversion efficiency for the reported system is decreased with a 
maximum conversion difference of 50 %, resulting from a maximum orthogonal switching 
efficiency of this photoswitch combination of 50 %. The incomplete conversion from trans to 
cis and vice versa possibly plays a key role in this context. 
Translating the empirical results to all newly designed photochromes results in completely 
different options when bringing the new molecules into play. A combination of DFAB and S-
DMAB reveals similar orthogonal switching properties when using 340 nm and 385 nm light 
irradiation with a conversion efficiency difference of about 50 % in both cases (fig. 59, tab. 8). 
Additionally, an orthogonal switching with 25 % conversion efficiency difference is observed at 
530 nm irradiation. These conversion efficiencies might be used when translating the switching 
properties into DNA.  
A combination of DOAB and AAP2 shows an example for a consecutive switching system 
(fig. 59, tab. 9). Both photochromes convert to cis when irradiated with 350 nm or 365 nm light 
and back to trans using 405 nm irradiation. At 590 nm irradiation DOAB converts to cis while 
AAP2 turns to trans conformation. This difference in switching efficiencies can be used to 
design consecutively switching logic gating systems. Starting from trans, DOAB can first be 
converted to cis while AAP2 remains in trans upon 590 nm irradiation and both photochromes 
can be switched to cis using 365 nm irradiation. In the opposite direction, both photochromes 
can be converted to cis using 365 nm light and AAP2 can be turned back to trans using 590 nm  
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Fig. 59: Potential cooperative switching properties for a combination of DFAB and S-DMAB as well as 
DOAB and AAP2 photochromes derived from the complete small molecule HPLC quantification. While 
the combination of DFAB and S-DMAB shows a similar behaviour as the combination of AB and S-
DMAB, the combination of DOAB and AAP2 shows a possible consecutive switching. While both 
photochromes can be converted to cis at 350 or 365 nm irradiation, DOAB can be selectively 
converted to trans upon 590 nm irradiation. At 420 nm irradiation, both photochromes are converted to 
the trans state. 
Tab. 8: Direct comparison of empirical cis percentage values between S-DMAB and DFAB photo- 
chromes for each photostationary state after irradiation with all LED irradiation wavelengths. 
Tab. 9: Direct comparison of empirical cis percentage values between DOAB and AAP2 photo- 
chromes for each photostationary state after irradiation with all LED irradiation wavelengths. 
irradiation while DOAB remains in cis conformation. 
Sophisticated design of more photochromes with different response wavelengths permits the 
prediction of more photoswitch combinations and facilitates the design of logic gating systems 
with three or more photoswitches. The development of such a toolbox facilitates the selection 
of photoswitch pairs for complex DNA or RNA applications. Selection of photoswitch pairs and 
system design can be used to construct complex photoswitchable DNA systems. However, it 
has to be considered that the theoretically unlimited toolbox of photochromes only considers 
free molecules. Interactions with nucleotides possibly further stabilize or destabilize DNA 
duplexes and have to be tested separately. 
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3.2.2 Determination of thermal stabilities and half-life times 
The third criterium characterizing a potential photoswitch for improving DNA photoswitching 
is the thermal stability of the cis state which is usually given by half-life time. After converting 
a photo-switch into cis conformation, a thermal back-relaxation to trans occurs over time. The 
temperature dependent back-relaxation can be determined by monitoring the relative change 
in absorbance of the cis state at the absorption maximum over time. Half-life is defined as the 
time span during which half of the total number of photoswitches in cis conformation convert 
back into trans conformation. 
Thermal stabilities of all D-threoninol bound photoswitches were determined in a 1:19 mixture 
of acetonitrile and water via UV/Vis spectroscopy. All photochromes were irradiated with the 
maximum cis converting LED wavelengths as determined before and an initial UV/Vis 
spectrum was recorded. The samples were kept in the dark at a given temperature and aliquots 
were taken after defined time intervals for measuring UV/Vis spectra. If the samples were kept 
at elevated temperatures, the aliquots were cooled down to room temperature before 
measurement to avoid a rapid back-relaxation of the photochromes during the measurements. 
Plotting the intensities at the absorption maxima against time results in an exponential curve 
converging towards an equilibrium absorbance A (fig. 60). All half-life times were calculated 
from the resulting curves using exponential fitting (fig. 60, tab. 10). 
A comparison of all calculated half-life times facilitates a direct comparison of relative thermal 
stabilities of the cis state for all D-threoninol bound photochromes. Azobenzene’s half-life time 
of 42.9 hours at room temperature serves as an empirical reference value which lies close to 
the reported value of around 50 hours at room temperature (tab. 10).[196-197] DMAB, which is 
reported to have a highly stable cis state, shows an empirical half-life of 87.5 hours at 60°C.  
 
Fig. 60: Time-dependent UV/Vis absorption spectra for AB-D-threoninol (left). Plotting the change in 
absorption maximum against time shows an exponential decay of the cis state, which permits 
calculation of the half-life time (right). 
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Sample Irr. wavelength t1/2 20 °C t1/2 40 °C t1/2 60 °C 
AB 340 nm N/A 42.9 hours N/A 
DMAB 350 nm N/A N/A 87.5 hours 
S-DMAB 385 nm N/A N/A 4.1 hours 
DFAB 340 nm N/A N/A 36.7 hours 
DFAB-F 365 nm N/A N/A 47.1 hours 
DFAB-Cl 350 nm N/A 85.0 hours N/A 
DCAB 340 nm N/A N/A 143.0 hours 
DOAB 350 nm N/A 96.1 hours 13.4 hours 
AAP1 365 nm 14.0 hours 4.2 hours N/A 
AAP2 365 nm 108.8 hours 22.0 hours N/A 
Tab. 10: Measured and calculated half-life times for all D-threoninol bound photoswitches after 
irradiation with the maximum cis converting irradiation wavelengths. All thermal stabilities were 
measured at different temperatures in which the absorbance decay could be determined in an 
optimum time range. 
Only the half-life of DCAB is even 1.5-fold higher which possibly results from the sterical 
hindrance of the bulky chlorine atoms in both ortho positions on the peripheral ring, thus 
sterically obstructing a back-switching from cis to trans. 
Ortho fluorinated azobenzenes exhibit high thermal stabilities in agreement with the reported 
fluoroazobenzenes.[132,133] Introduction of a further fluorine substitutent in para position 
additionally enhances the thermal stability through a para pull-pull system in good agreement 
with literature.[133] 
Para chlorination of DFAB reveals the opposite effect as observed by a decreased thermal 
half-life, although the stability remains 2-fold higher than azobenzene's half-life. Unexpectedly, 
DOAB exhibits a half-life of 96.1 hours at 40°C. Both electron donating ortho methoxy moieties 
do not seem to form a push-pull system with the opposite ring containing the peptide moiety. 
As reported for aminoazo-benzenes, both electronic effects seem to superimpose in a positive 
manner due to their different positions on the ring. S-DMAB on the other hand exhibits a 20-
fold decreased thermal stability in direct comparison to DMAB, possibly due to formation of a 
para push-pull system between the elec-tron withdrawing carboxy moiety of D-threoninol and 
the electron donating methylthio residue. 
Both arylazopyrazoles AAP1 and AAP2 exhibit the lowest thermal stabilities of all 
synthesized photochromes. AAP1 with a half-life of 14 hours at room temperature remains the 
least stable photochrome, while introduction of a phenyl residue in AAP2 significantly 
enhances the thermal stability of the cis state to 109 hours at room temperature and makes it  
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at least stable four about one day at 40 °C. Compared to the reported stability of around 10 
hours at room temperature for AAP1 without D-threoninol linkage,[136] the half-life times are 
increased 1.5-fold for AAP1 and more than 10-fold in case of AAP2. Seemingly a 
disadvantage, these results have to be considered in the context of possible applications. DNA 
applications do not necessitate a high thermal half-life of the cis state by default and the rapid 
thermal back-relaxation of AAP1 could even be an advantage, opening the door for thermally 
controlled nanosystems. Different back-switching velocities can be considered as one further 
degree of freedom for the control of DNA nanosystems. Nevertheless, the high conversion 
efficiencies of AAP1 and AAP2 provide promising tools for DNA-based in vitro applications. 
To further investigate the thermal relaxation pertaining to the range of applicability for both 
arylazopyrazoles, melting curves of the D-threoninol bound small molecules were performed. 
Both molecules AAP1 and AAP2 were irradiated to cis conformation and directly submitted to 
melting curve measurements (fig. 61). Therefore, both molecules were dissolved in a 1:19 
mixture of acetonitrile and water and irradiated at 365 nm for 5 minutes at room temperature 
to maximally convert both molecules into cis conformation. The samples were left in the dark 
and a thermal gradient of 1 °C per minute was applied in a range between 20 °C and 80 °C 
while detecting the absorption maximum at λ = 341 nm. Constantly increasing the temperature 
reveals the thermal back-switching rate and serves as a qualitative demonstration of 
applicability within a defined temperature range. While AAP1 shows a constant increase in 
absorbance even at lower temperatures and an increasing absorbance within a higher 
temperature range, AAP2 exhibits no significant change in absorbance below 60 °C. Above 
60 °C absorbance of AAP2 increases, indicating a thermal back-relaxation to trans. In good 
agreement with the observed thermal stabilities for both molecules, the rather low thermal 
stability of cis AAP1 results in a rapid back-switching to trans when applying increased 
temperatures. This property prevents AAP1 from being used in long-term applications, while 
AAP2 on the other hand proves to be a benefitial candidate for long-term DNA applications  
Fig. 61: Small molecule melting curves of 
AAP1 and AAP2 in a temperature range 
between 20 °C and 80 °C. While AAP1 
shows a constant increase in absorbance 
under the applied thermal gradient, AAP2 
does not indicate any thermal back-
relaxation before reaching 50 °C. Thus the 
use of AAP2 appears to be more suitable 
for long-term applications. 
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due to its near-quantitative conversion efficiencies while maintaining a 2-fold half-life 
compared to azobenzene. Also the very low back-switching rate below 60 °C constitutes an 
advantage for DNA nanotechnology applications. 
As observed in this study, thermal half-lives as the third criterium play a key role when 
translating the new photochromes into oligonucleotides. Not only the absorption wavelengths 
and conversion efficiencies are of great interest, but also the thermal relaxation behaviour of 
the cis state. Yet, only photo-reversible systems have been developed within higher order DNA 
nanosystems. A photo- and thermoreversible system at the same time opens the door for more 
degrees of freedom as required in for example complex logic gating systems. For all 
synthesized azobenzenes the electronic properties of para substituents potentially stronger 
influence the thermal cis stability while sterical hindrance of ortho substituents appears to be 
subordinated. Sophisticated substitution of azobenzenes possibly further enhances thermal 
stabilities of the cis state. 
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3.3 Introduction of newly developed photoswitches into DNA strands 
3.3.1 Synthesis of phosphoramidites and introduction of new photoswitches into 
DNA strands 
Introduction of photochromic moieties into oligonucleotide strands via solid phase DNA 
synthesis requires a DMT protection of the primary D-threoninol hydroxy group in analogy to 
the 5'-hyroxy group in natural nucleotides, and a phosphoramidite moiety on the secondary 
hydroxy group which corresponds to the 3'-end of nucleotides. DMT protection of all selected 
D-threoninol bound photoswitches was performed in most cases by a slight excess of DMT-
chloride in a 1:1 mixture of dichloromethane and pyridine including 4-DMAP in catalytic 
amounts. Using this procedure, the three reported azobenzenes AB, DMAB and S-DMAB as 
well as DFAB and its derivatives could be obtained in good yields (fig. 62, chapter 7.2). DMT 
protection of DOAB required the use of pure pyridine instead of a 1:1 dichloromethane pyridine 
mixture to obtain the DMT-protected product. 
DMT protection of both arylazopyrazoles AAP1 and AAP2 required the use of different 
reaction conditions (fig. 63). Using DMT-chloride in a mixture of dichloromethane and pyridine 
as well as in pure pyridine strongly favoured the formation of double DMT-protected products. 
These reaction conditions only yielded small amounts of the desired single-protected product 
containing DMT on the primary D-threoninol hydroxy moiety. Consequentially, reaction 
conditions had to be adjusted by testing a series of organic amine bases in dichloromethane 
and acetonitrile. In both cases, DMT-chloride was first added dropwise to the solution at 0 °C, 
followed by slow addition of the amine base. In case of AAP1, N-methylmorpholine in 
dichloromethane proved best and exclusively yielded the single-DMT protected product in 
moderate yields when added in single portions. Contrary to AAP1, AAP2 yielded the single 
protected target product by means of N-methylpyrrolidine in dry acetonitrile when added very 
slowly dropwise to the reaction solution at 0 °C. 
Synthesis of the respective phosphoramidites in the final reaction steps also necessitated 
different reaction conditions depending on the photochromic backbone.  
 
Fig. 62: General synthetic pathway to achieve a series of 2',6'-substituted azobenzene 
phosphoramidites coupled to D-threoninol. For all synthesized azobenzene phosphoramidites, similar 
experimental conditions were used. 
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Fig. 63: Synthetic pathway used for the synthesis for arylazopyrazole phosphoramidites: N-
methylarylazopyrazole phosphoramidite (AAP1) and N-phenylarylazopyrazole phosphoramidite 
(AAP2) could successfully be obtained under similar reaction conditions. 
While phosphoramidites of AB, DMAB, S-DMAB, DFAB and DOAB could be obtained in high 
yields using DiPEA in dry dichloromethane followed by addition of 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite at 0 °C under argon atmosphere, synthesis of AAP1 and 
AAP2 phosphoramidites proved more difficult. 
Using the same reaction conditions as used in case of azobenzene phosphoramidite leads 
to an oxidation of the phosphorous for both arylazopyrazole phosphoramidites as observed on 
TLC and in 31P-NMR. The reaction conditions were adjust to very short reaction times at 0 °C 
and immediate addition of the phosphitylation agent after adding the respective amine base. 
AAP1 phosphoramidite could be obtained using dry diethyl ether as solvent and AAP2 
phosphoramidte using dry acetonitrile (fig. 63). Changing DiPEA for different amine bases did 
not result in any improvement. All synthesized phosphoramidtes were characterized by NMR 
and high resolution MS (see appendix). 
Introduction of the newly designed photochrome phosphoramidites into DNA strands was 
perfor-med via solid phase phosphoramidite synthesis using an ABI 3400 DNA synthesizer 
and 200 nmol CPG solid supports. All phosphoramidites were irradiated into trans 
conformation and pre-dried in high vacuum for 24 hours prior to coupling. All compounds were 
diluted in DNA grade acetonitrile to yield 0.2 M solutions. In comparison to the standard DNA 
phosphoramidites dA, dG, dC and dT, higher concentrations of the custom phosphoramidites 
had to be used since the sterically more challenging cis states possibly prevent a successful 
phosphoramidite coupling to the deprotected 5’-end of the oligonucleotides. As observed 
empirically, photostationary states containing high amounts of the cis isomer thus decrease 
the coupling yield significantly.  
As two different basic constructs the 8-mer DNA sequence 5’-GAATGGTG-3’ and the 12-
mer DNA-sequence 5’-CACCATTCCGGT-3’ were designed and modified with 
photoresponsive residues in different amounts and positions (fig. 64). According to Asanuma 
et al., the number and position of azobenzene residues strongly determines an efficient 
photocontrol of DNA duplexes.[187] Therefore, different numbers and positions of modifications 
were investigated following the scheme below:  
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Fig. 64: A series of modified 8-mer and 12-mer DNA strands carrying modifications in their backbones 
were synthesized via solid phase phosphoramidite synthesis (left). Custom photochrome 
phosphoramidites were implemented via custom phosphoramidite synthesis cycles (X = modified 
azobenzene or arylazopyrazole). Reversible switching of all introduced modifications was proven by 
UV/Vis spectroscopy after alternating irradiation with the maximum trans and cis converting 
wavelengths prior to recording the UV/Vis spectra. 
1) One central single photoswitch:  
5’-GAATXGGTG-3’ and 5’-CACCATXTCCGGT-3’. 
2) Two independently incorporated photoswitches:  
5’-GAXATGGXTG-3’ and 5’-CACXCATTCCXGGT-3’. 
3) Three consecutive photoswitches separated by two or three nucleobases:  
5’-GAXATXGGXTG-3’ and 5’-CACXCATXTCCXGGT-3’. 
All DNA oligonucleotides were used in combination with their double stranded DNA using 
the complementary sequences 5'-CACCATTC-3‘ as 8-mer and 5'-ACCGGAATGGTG-3' as 12-
mer antisense strands. Successful synthesis of all photochrome modified DNA strands was 
proven by ESI LCMS and reversible switching of the implemented modifications (fig. 64). All 
modified strands were dissolved in water and repeatedly irradiated with the maximum trans 
and cis response wavelengths followed by recording UV/Vis absorption spectra. The resulting 
spectra revealed two absorption maxima in near-UV und visible light range belonging to the 
modifications in proximity to the native DNA absorption at λ = 260 nm. Reversible change in 
absorbance could be observed for each modification in respect to the corresponding irradiation 
wavelengths (full spectra see chapter 7.4.3). 
Unfortunately, not all synthesized phosphoramidites could be successfully introduced into 
DNA strands. Sequences containing DFAB or DOAB moieties could only be isolated with one 
single introduced modification. Two or more implementations per strand did not yield any target 
mass for the designed sequences. Possibly the phosphoramidite coupling conditions lead to a 
partial disass-embly of the modifications or overlapping of the stereo-isomers prevents a 
proper HPLC purification. Unfortunately, DFAB and DOAB are promising molecules for DNA  
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photoswitching with visible light. On the other hand, a variety of strands with single and 
multiple AAP1 and AAP2 introductions could be obtained using a standard phosphoramidite 
coupling protocol. The series of modified DNA strands described above could be successfully 
synthesized including AB, DMAB, S-DMAB, AAP1 and AAP2 modifications. DFAB and DOAB 
could only be introduced a single time per DNA strand. The available set of modified 
oligonucleotides was used as a starting point for all further investigations. A comprehensive 
overview of synthetic accessibility and DNA introduction is given in table 12.  
Despite the unsuccessful introduction of multiple DFAB and DOAB moieties into single DNA 
sequences, DNA photoswitching properties of single modified strands as well as the influence 
of a single modification on the DNA duplex stability was investigated by reversed-phase HPLC 
and melting curve experiments (chapter 3.3.2 and 3.3.3). 
The concentration of modified oligonucleotide strands had to be adjusted for custom 
modifications since all photochromes exhibit a strong absorption at λ = 260 nm. Since both 
isomers have a different absorbance at λ = 260 nm, the total absorbance at λ = 260 nm 
depends on the composition of the cis and trans state within a photostationary state. The 
absorbance of the dark adapted samples corresponds most accurately to the ratio of both 
isomers formed within a photostationary equilibrium. Every absorbance correction for each  
Modification 
Synthetic 
feasibility 
Phosphoramidite 
synthesis 
DNA 
introduction 
Multiple DNA 
introductions 
AB √ √ √ √ 
DMAB √ √ √ √ 
S-DMAB √ √ √ √ 
TFAB X X X X 
DFAB √ √ √ X 
DFAB-F √ X X X 
DFAB-Cl √ X X X 
DFAB-Br X X X X 
DFAB-Pep X X X X 
DMDFAB X X X X 
DCAB X X X X 
DOAB √ √ √ X 
AAP1 √ √ √ √ 
AAP2 √ √ √ √ 
Tab. 11: Complete and comprehensive overview of synthetic accessibility, possible DNA intro-
duction and multiple DNA introductions for all newly synthesized photoswitches. While DFAB and 
DOAB could only be introduced into DNA once into a strand, only AAP1 and AAP2 phosphoramidites 
could reliably and successfully be introduced multiple times into DNA sequences. 
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dark adapted sample was determined by measuring the absorbance at 260 nm after leaving 
the sample in the dark in a 1:19 acetonitrile water mixture and calculating each extinction 
coefficient via the Lambert-Beer law (tab. 13). The concentrations were corrected according to 
the additional extinction coefficients for every modified DNA sample. 
Sample Concentration Abs. (260 nm) Extinction coeff. 
AB 50 µM 0.182 3640 
DMAB 50 µM 0.405 8100 
S-DMAB 50 µM 0.181 3620 
DFAB 50 µM 0.278 5560 
DOAB 50 µM 0.487 9740 
AAP1 25 µM 0.095 3800 
AAP2 25 µM 0.234 9360 
Tab. 12: Extinction coefficients determined for concentration measurements and calculations for 
solutions containing modified oligonucleotide strands. 
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3.3.2 Thermodynamic properties of modified single-stranded oligonucleotides 
While double-stranded DNA preferably exists in a helical structure with all nucleobases 
stacked in the inner helix axis, single-stranded DNA can exist in a random coil state with no 
stacked nucleobases or a stacked conformation containing a distinct persistence length. 
Introduction of azobenzene stabilizes base stacking in single- and double-stranded DNA 
through an additional π-stacking along the stacking direction. Azobenzene photoisomerization 
in single-stranded DNA disrupts the stacked conformation upon conversion from trans to cis 
(fig. 65). Both DNA conformations carrying trans or cis azobenzene can be separated using 
reversed-phase HPLC while detecting the native DNA UV absorbance at λ = 260 nm. 
Separation and detection of both isomers of the single-modified 8-mer sequence 5’-
GAATXGGTG-3’ affords the distinct quantification of cis and trans conversion efficiencies of 
photochrome modified single-stranded DNA. Contrary to the quantification of cis and trans 
isomerization using the free molecules, a determination of an isos-bestic point is not required. 
The total absorbance of single-stranded DNA at λ = 260 nm is significantly higher compared 
to the absorbance of the photochrome, thus minimizing detection errors (fig. 65). 
 
Fig. 65: Reversed-phase HPLC separation of trans and cis isomers using the modified 8-mer DNA 
strand 5’-GAATXGGTG-3’ carrying a central photochrome permits a quantification of switching 
efficiencies in DNA through integration of the corresponding peak areas. 
Additional or lacking π-stacking between the base pairs and the implemented photochromic 
modifications lead to a total gain or loss in additional stacking energy, thus facilitating or 
impeding photoswitching of inbuilt photochromes. A strong duplex stabilization decreases 
conversion efficiencies whereby weak or destabilizing effects support efficient photoswitching. 
Quantive values for all photochromes are achieved by integration of the corresponding trans 
and cis signals for all availablke irradiation wavelengths. The resulting wavelength-dependent 
excitation table analogous to the small molecules quantification (fig. 66, tab. 14) reveals slightly 
different quantification values compared to the small molecules conversion efficiencies. 
The reported azobenzenes AB, DMAB and S-DMAB exhibit decreased switching efficiencies 
in DNA strands compared to the native molecules indicating an additional stabilizing effect on 
the base stack. Intercalation of azobenzene photochromes overcompensates disruption of the  
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Fig. 66: Empirical cis percentage results from multiple HPLC quantifications for all single-modified 
DNA strands 5’-GAATXGGTG-3’ after irradiation with every available LED wavelength. 
Tab. 13: Empirical cis percentage values for all photostationary states as determined by HPLC 
separation and integration of both trans and cis isomer peak areas. The 8-mer DNA strand 5’-
GAATXGGTG-3’ was used for calculation after irradiation with every available LED wavelength. 
backbone caused by D-threoninol, thus leading to a total stabilization of the DNA stack.[176] In 
good agreement with literature, the resulting decreased isomerization rates require high 
synthetic loads and elevated irradiation temperatures to achieve efficient photocontrol over 
DNA duplex hybridization. 
The newly introduced azobenzene chromophores reveal the same tendency. DFAB in DNA 
shows a 16 % reduced isomerization efficiency upon 340 nm irradiation and 530 nm irradiation 
yields an even 23 % reduced switching efficiency. DOAB introduced into DNA also yields 
reduced conversion efficiencies, but to a lower extent compared to DFAB, possibly due to the 
bulky methoxy moieties possibly distorting the DNA stacked bases. Nevertheless, visible light 
DNA photoswitching is possible with 67 % efficiency upon irradiation with 590 nm light. Using 
420 nm irradiation results in the formation of 74 % trans isomer (fig. 67). Both isomerization 
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DOAB 35.1 38.7 70.7 73.6 74.7 57.2 27.6 25.8 28.2 30.9 36.7 47.4 49.9 56.2 66.7 49.3 
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Fig. 67: Direct comparison of empirical cis percentage results from multiple HPLC quantifications for 
newly synthesized free D-threoninol bound photochrome molecules and modified 8-mer DNA strands. 
DFAB and DOAB (top left and top right) reveal reduced switching efficiencies in DNA while 
arylazopyrazoles AAP1 and AAP2 retain high switching efficiencies in DNA duplexes (bottom left and 
bottom right). 
efficiencies lie in the same magnitude as azobenzene. Depending on the duplex stabilization 
or destabilization through intercalation of DOAB moieties, visible light DNA photoswitching can 
be achieved. Stabilization of the DNA stack seems to be significantly stronger in case of DFAB 
compared to DOAB. 
In contrast to substituted azobenzenes, arylazopyrazoles exhibit even higher conversion 
efficiencies compared to the native molecules (fig. 67). Especially in visible light range, 
formation of the trans isomer appears to be favoured wheras the trans conformation can be 
achieved with 96 % efficiency.in case of AAP1 and 97 % efficiency in case of AAP2. The cis 
isomer is formed with about 2 % higher efficiency when irradiated with 365 nm light compared 
to the free molecule, 90 % for AAP1 and 91 % for AAP2, and irradiation with 385 nm light even 
leads to the formation of 77 % and 81 % cis isomer respectively. Retaining high conversion 
efficiencies upon translation into DNA is one main prerequisite for an improved duplex 
hybridization control. Near-quantitative isomerization efficien-cies in both isomerization 
directions proves arylazopyrazoles to be promising candidates for achieving an improved DNA 
duplex photocontrol efficiency.  
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In conclusion, a straight comparison of DNA single strands modified with a single reported 
and newly available photochrome with their D-threoninol bound native states results in reduced 
isomerizations for azobenzene based photoswitches while arylazopyrazoles appear to retain 
high conversion efficiencies when translated into the backbone of DNA. An additional 
stabilization is observed throughout all substituted azobenzene photochromes and possibly 
also hampers efficient photocontrol of DNA duplexes. Arylazopyrazoles on the other hand 
exhibit near-quantitative isomerization efficiencies in DNA in both isomerization directions 
without showing any fatigue during photoconversion. Further translation of the photoswitching 
properties into DNA duplexes has to be examined by additional melting curve experiments. 
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3.3.3 Duplex control efficiency of modified oligonucleotide duplexes 
Introduction of newly designed photochromes into DNA strands proved successful for a 
series of molecules in different numbers and positions. Beyond conversion efficiencies 
between the trans and cis isomers in single-stranded DNA, the influence of the photochromes 
on DNA duplex stability plays a key role for the photoinduced dissociation and re-association 
of DNA duplexes. The influence of implemented modifications on the formation and 
dissociation of dsDNA upon photoisomerization was investigated by melting curve 
experiments. The sequences ds8 5’-GAATGGTG-3’ and ds12 5’-CACCATTCCGGT-3’ (see 
chapter 3.5.1) containing different numbers and positions of photo-chromes were used in 
combination with the unmodified complementary strands. 
Melting curves present the method of choice for a determination of DNA duplex dissociation. 
As previously reported, introduction of azobenzenes into DNA duplexes leads to an overall 
dsDNA stabilization with azobenzenes in trans conformation due to additional π-stacking  
 
Fig. 68: Melting curves of the modified 8-mer duplexes 5’-GAATXGGTG-3’ and their complementary 
sequence containing one central modification in trans conformation. Compared to the unmodified 
duplex, all azobenzene-based modifications exhibit higher melting temperatures while both 
arylazopyrazoles show a reduction in melting temperatures Tm. 
Modification Tm trans Tm cis RT ΔTm trans ΔTm cis RT 
AB 35.3 °C 28.0 °C +1.4 °C -5.9 °C 
DMAB 40.3 °C 40.3 °C +6.4 °C +6.4 °C 
S-DMAB 38.3 °C 38.5 °C +4.4 °C +4.6 °C 
DFAB 36.8 °C 32.1 °C +2.9 °C -1.8 °C 
DOAB 28.4 °C 16.4 °C -5.5 °C -17.5 °C 
AAP1 30.3 °C 21.7 °C -3.6 °C -12.2 °C 
AAP2 26.9 °C 22.1 °C -7.0 °C -11.8 °C 
Tab. 14: Relative change in melting temperature Tm compared to the native DNA duplex melting 
temperature Tm = 33.9 °C using 3 µM single-modified ODN duplexes in trans and cis conformation. 
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stabilization between azobenzene and the stacked nucleobases. Compared to the native 
unmodified DNA duplex an increase or decrease in melting temperature permits a 
determination of duplex stabilization or destabilization or even a complete dissociation of the 
duplex. A single modification within the short DNA strand 5’-GAATXGGTG-3’ with X as the 
modification in hybridized to the complementary strand 5’-CACCATTC-3’ was used in 0.5 M 
NaCl to investigate a general influence of the introduced modifications on DNA duplex stability. 
Melting curves of the native 8-mer duplex exhibit a melting temperature of 33.92 °C for ds8 
under these conditions. Since irradiation temperatures are crucial for photoinduced duplex 
dissociation, all modified DNA duplexes were irradiatied to cis conformation at room 
temperature and 40 °C for 5 minutes before each measurement.  
While a single azobenzene modification in trans conformation does not alter the melting 
temperature of the ds8 duplex significantly, DMAB and S-DMAB in trans lead to an increased 
melting temperature by 6.4 °C and 4.4 °C using DNA with a single modification (fig. 68, tab. 15). 
A DNA duplex stabilization has previously been reported and requires high synthetic loads and 
elevated irradiation temperatures to achieve complete duplex dissociation.[176,198] Irradiation 
into cis conformation at room temperature does not show any melting temperature difference 
for DMAB and S-DMAB, while the azobenzene modified duplex reveals a reduction of 5.9 °C 
in cis. DMAB and S-DMAB in good agreement with literature stabilize the DNA duplex to an 
extent that only unstable duplexes with low GC-contents can be photodissociated efficiently. 
The newly designed photochromes in DNA reveal a different behaviour compared to the 
reported azobenzenes. DFAB increases the native melting temperature in trans conformation 
by 2.9 °C and reduces the melting temperature by 1.8 °C in cis conformation (tab. 15). The 
temperature difference is not as significant as observed for a single DMAB or S-DMAB moiety. 
A single DOAB moiety in the ds8 duplex shows a higher destabilizing effect even in trans 
conformation as observed by a decrease in melting temperature of 5.5 °C. The two methoxy 
moieties possibly destabilize the DNA duplex stacking significantly or the trans isomer is not 
completely intercalated. Also, DOAB exists as a cis-trans mixture within the DNA duplex, 
possibly leading to a statistical distribution of trans and cis isomers whereby the cis isomers 
locally disrupt the DNA duplex. Irradiation to cis shows a melting temperature reduction down 
to 16.4 °C, thus revealing the strongest destabilizing effect on the DNA duplex by a single 
modification among all tested photochromes. 
Both arylazopyrazoles AAP1 and AAP2 significantly decrease the native melting temperature 
in trans conformation, where AAP1 shows a lower decrease in melting temperature with 3.6 °C 
compared to AAP2 with a reduction of 7.0 °C (tab. 15). The strong duplex destabilization may 
have a series of causes. As reported for azobenzene, DMAB and S-DMAB, disruption of the  
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phosphate backbone through D-threoninol is overcompensated by additional π-stacking 
stabilization through the intercalated photochromes. While DFAB shows an effect similar to 
azobenzene, the position and nature of substituents strongly affects π-stacking of the 
nucleobases. Sterically more challenging substituents like methoxy in DOAB possibly stretch 
the nucleobase stack leading to a total duplex destabilization. This effect also seems to 
facilitate isomerization of the moiety which, in case of the reported azobenzenes, is stabilized 
in a way that conversion to cis is hampered. As stated before, this effect was tried to be 
circumvented by use of different diol linkers.[200] Both arylazopyrazole molecules appear to 
disrupt the nucleobase stacking thus resulting in decreased melting temperatures even in trans 
conformation. Isomerization to cis at room temperature is also alleviated as observed in strong-
ly reduced melting temperatures even with a single modification. The increased or decreased  
 
Fig. 69: Melting curves of 8-mer ODN-duplexes modified with two azobenzene moieties upon irradiation 
into trans and cis conformation at different irradiation temperatures. As previously stated, elevated 
irradiation temperatures are required to achieve an efficient reduction in melting temperature.[176,198] 
Modifications Tm trans Tm cis RT ΔTm cis RT Tm cis 40 °C ΔTm cis 40°C 
1 x AB 35.3 °C 28.0 °C -7.3 °C 22.9 °C -12.4 °C 
2 x AB 38.9 °C 32.7 °C -6.2 °C 18.8 °C -20.1 °C 
3 x AB 32.7 °C 21.0 °C -11.7 °C 18.3 °C -14.4 °C 
1 x DMAB 40.3 °C 40.3 °C -0.0 °C 40.8 °C +0.5 °C 
2 x DMAB 47.1 °C 48.6 °C +1.5 °C 47.8 °C +0.7 °C 
3 x DMAB 46.5 °C 44.9 °C -1.6 °C N/A N/A 
1 x S-DMAB 38.3 °C 38.5 °C -0.2 °C 37.6 °C -0.7 °C 
2 x S-DMAB 39.1 °C 38.5 °C -0.6 °C 36.1 °C -3.0 °C 
3 x S-DMAB 39.8 °C 16.9 °C -22.7 °C 17.1 °C -22.7 °C 
Tab. 15: Melting temperatures Tm of AB, DMAB and S-DMAB modified 8-mer duplexes upon 
irradiation with the maximum trans and cis converting wavelengths at room temperature and 40 °C 
irradiation. The change in Tm becomes more significant with an increasing number of modifications. 
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stability of modified duplexes strongly depends on the local base sequence, GC-content, 
relative numbers and positions of photochromes and irradiation temperatures. In this study, 
the main focus is put on determination of the minimum amount of modifications required to 
achieve complete duplex dissociation. Unfortunately, DFAB and DOAB could only be 
introduced a single time into DNA sequences. Therefore, a systematic study involving 
arylazopyrazoles and reported azobenzenes was performed. 
A systematic study with multiple modifications into the ds8 duplex according to the 
sequences given in chapter 3.3.1 reveals a tendency of stabilizing and destabilizing effects. 
While multiple AB moieties in trans do not alter the native duplex melting point significantly, 
multiple DMAB and S-DMAB moie-ties in trans increase the duplex melting temperature 
significantly (fig. 69, tab. 16). Azobenzene reveals an increasing melting temperature reduction 
with an increasing synthetic load and elevated irradiation temperatures. Using three 
modifications at room temperature irradiation or two modifications at 40 °C irradiation result in  
 
Fig. 70: Reversible melting curves of 2 x AAP1 in the 8-mer duplex sequence 5’-GAXATGGXTG-3’ 
and its complement already reveals a reversible decrease and increase in melting temperature. Also 
the relative change in absorbance at λ = 260 nm is significantly reduced when AAP1 is isomerized into 
cis conformation. 
Modifications Tm trans 1st Tm cis RT 1st Tm trans 2nd Tm cis RT 2nd 
1 x AAP1 30.5 °C 22.0 °C 30.9 °C 22.5 °C 
2 x AAP1 25.2 °C 18.3 °C 26.8 °C 16.2 °C 
3 x AAP1 18.5 °C N/A 20.7 °C N/A 
1 x AAP2 27.6 °C 20.8 °C 27.0 °C 19.5 °C 
2 x AAP2 17.5 °C 17.7 °C 17.8 °C 16.8 °C 
3 x AAP2 N/A N/A N/A N/A 
Tab. 16: Melting temperatures Tm for reversible melting curves of multiple AAP1- and AAP2-
modifications in the 8-mer duplex ds8 upon irradiation with the maximum trans and cis switching 
wavelengths at room temperature and 40 °C irradiation. 
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Modifications Tm trans Tm cis RT Tm cis 40 °C 
1 x AB 65.3 °C 65.0 °C 64.7 °C 
2 x AB 65.3 °C 64.5 °C 63.1 °C 
3 x AB 66.5 °C 64.7 °C 58.7 °C 
1 x DMAB 66.5 °C 66.7 °C 67.1 °C 
2 x DMAB 70.0 °C 68.0 °C 67.9 °C 
3 x DMAB 72.1 °C 72.6 °C 64.6 °C 
1 x S-DMAB 64.7 °C 66.3 °C 66.6 °C 
2 x S-DMAB 64.7 °C 60.6 °C 59.6 °C 
3 x S-DMAB 59.2 °C 59.8 °C 61.6 °C 
Tab. 17: Melting temperatures Tm for multiple azobenzene modifications in the 12-mer duplex ds12 
upon irradiation with the maximum trans and cis converting irradiation wavelengths at room 
temperature and 40 °C. The native melting temperature of ds12 was determined as 59.4 °C. 
a full duplex dissociation since no melting point could be obswerved. Two and three AB 
modifications in cis upon 40 °C irradiation alter the melting temperature to room temperature 
and below, which leads to a partial or complete dissociation of the duplex. DMAB and S-DMAB 
only exhibit a compellingly decreased melting temperature using three modifications where S-
DMAB exhibits a full duplex dissociation at room temperature irradiation and DMAB on the 
other hand necessitates 40°C irradiation to achieve complete duplex dissociation.  
Multiple arylazopyrazole moieties in ds8 continue the destabilizing effect in trans as 
observed for a single photochrome. While two and three AAP1 moieties in trans lower the 
melting temperature of the ds8 duplex to 25.2 °C and 18.5 °C, incorporation of AAP2 already 
decreases the melting temperature below room temperature for two modifications in trans 
(tab. 17). Ds8 containing three AAP2 moieties in trans does not show any clear melting point 
at all. Four consecutive melting curves were recorded after alternatingly irradiating the 
duplexes with 590 nm and 365 nm at room temperature. All melting temperatures could be 
reproduced and showed a significant decrease and increase in melting tempe-rature even with 
a low number of modifications (fig. 70, tab. 17). In comparison to azobenzenes, the reported 
NNX motif does not seem to be mandatory to achieve an efficient duplex dissociation. 
The short 8-mer duplex ds8 containing 50 % GC-content constitutes a rather unstable DNA 
duplex. Consequentially, melting curves using the 12-mer DNA duplex ds12 with 58 % GC-
content were investigated with modifications in different numbers and positions. All 12-mer 
duplexes were modified with one, two or three photochromes up to one modification per three 
base pairs (see chapter 3.3.1). As observed before, a full duplex dissociation of the modified 
ds12 duplex should not be possible using reported azobenzenes at room temperature 
irradiation in an NNNX motif in strands with high GC-content. The observed melting tempera- 
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tures reveal a strong duplex stabilization for the reported azobenzenes. No significant 
decrease in melting temperature from 59.4 °C for the native duplex could be observed for a 
series of differently modified ds12 duplexes containing either one, two or three AB, DMAB or 
S-DMAB moieties (tab. 18). Only azobenzene exhibits a slight decrease in melting temperature 
of 7.8 °C upon irradiation to cis at 40 °C. This stabilization prevents all three azobenzenes from 
achieving duplex dissociation in DNA systems with high GC-contents and low synthetic loads. 
Introduction of AAP1 and AAP2 into the 12-mer duplex ds12 on the other hand clearly 
indicates an increased duplex dissociation effiency even when irradiated at room temperature. 
While AAP1 does not significantly alter the native melting temperature of the ds12 duplex in 
trans conformation, irradiation with 365 nm at room temperature already significantly 
decreases the melting temperature by 12.5 °C using two moieties (tab. 19). The two different 
12-mer sequences 2xAAP1 (5’-CACXCAT TCCXGGT-3’) and 2xAAP1sh (5’-CAC CXAT 
TCXC GGT-3’) with different positions of the AAP1 modifications clearly indicate that careful 
design of modified oligonucleotides is mandatory to achieve a maximum switching efficiency. 
While the sequence 2xAAP1 exhibits a strong melting temperature reduction of 12.5 °C, the 
sequence 2xAAP1sh does not seem to decrease the melting temperature at all when 
converted to cis at room temperature. Introduction of AAP2 moieties into ds12 results in a 
significant decrease in melting temperature even in trans conformation, while the 
destabilization significantly increases with an increasing number of modifications. A single 
modification already reduces the native melting temperature by 1.6 °C while two modifications 
lead to a reduction of 9.0 °C and three modifications to a reduction of 14.6 °C (tab. 19). 
Irradiation to cis at room temperature leads to a more significant decrease in melting 
temperature leading to a duplex dissociation using three modifications within ds12. Shifting 
both AAP2 moieties from 2xAAP2 with six base pairs in between the modifications to an 
NNNNX-motif where each photochrome is separated by four nucleobases in 2xAAP2sh 
significantly reduces the melting temperature of ds12 even in trans conformation by 28.5 °C. 
This result is consistent with the effects observed for AAP1 modified ds12 and underlines the 
necessity for a careful and sophisticated design of modified DNA sequences. 
To further investigate the destabilizing effect of AAP1 and AAP2 on DNA duplexes, two more 
modified 12-mer DNA duplexes were investigated. The strands 12mer50 (5’-
CACXCATXTCCXAGT-3’) and 12mer50sh (5’-CAC CXATTCXCGGT-3’) containing 50 % GC-
content and different numbers and positions of AAP1 and AAP2 modifications compared to the 
strand 168ROo (5’-TCCXCCAXGCAXTCG-3’) containing 66 % GC-content and three 
modifications in an NNNX motif were investigated. In agreement with the previous obser-
vations, two trans AAP1 moie-ties in 12mer50 do not significantly alter the native melting 
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Modifications Tm trans 1st Tm cis RT 1st Tm trans 2nd Tm cis RT 2nd 
1 x AAP1 61.6 °C 60.4 °C 62.6 °C 58.9 °C 
2 x AAP1 61.7 °C 49.2 °C 62.8 °C 48.2 °C 
2 x AAP1sh 55.3 °C 59.1 °C 57.6 °C 60.6 °C 
3 x AAP1 58.0 °C 25.9 °C 62.7 °C 31.7 °C 
1 x AAP2 57.8 °C 53.1 °C 58.1 °C 52.6 °C 
2 x AAP2 50.4 °C 44.7 °C 49.8 °C 44.2 °C 
2 x AAP2sh 36.9 °C 31.1 °C 38.7 °C 34.4 °C 
3 x AAP2 44.8 °C 24.5 °C 42.1 °C N/A 
Tab. 18: Melting temperatures Tm of AAP1- and AAP2-modified 12-mer duplexes upon irradiation with 
the maximum trans and cis converting wavelengths at room temperature and 40°C irradiation. 
temperature of 54.6 °C but also do not result in a decreased melting temperature upon 
irradiation to cis even at 40 °C (tab. 20). Introduction of three AAP1 moieties decrease the 
native melting temperature in trans by 6.2 °C which is further lowered close to room 
temperature with a melting point of 26.8 °C upon irradiation to cis at room temperature. Two 
AAP2 moieties in trans already reduce the native melting temperature by 16.5°C but no 
significant change upon irradiation to cis could be observed. Three AAP2 moieties do not show 
any clear melting point, a duplex formation does not seem to take place. A GC-content of 50 % 
appears to be too unstable for AAP2 modifications which consequentially prevent a duplex 
formation. 
Modifications Tm trans Tm cis RT 
2 x AAP1sh 54.7 °C 58.2 °C 
3 x AAP1 48.4 °C 26.8 °C 
2 x AAP2sh 38.1 °C 35.5 °C 
3 x AAP2 N/A N/A 
Tab. 19: Melting temperatures Tm observed for AAP1 and AAP2 modified 12-mer50 duplexes with the 
sequence 5’-CACXCATXTCCXAGT-3’ and complement exhibiting 50 % GC-content upon irradiation 
with the maximum trans and cis converting wavelengths at room temperature. 
Modifications Tm trans Tm cis RT Tm cis 40 °C 
3 x AB 74.3 °C 73.4 °C 64.3 °C 
3 x DMAB 82.2 °C 79.2 °C 56.4 °C 
3 x S-DMAB 71.1 °C 68.4 °C 67.9 °C 
Tab. 20: Melting temperatures Tm of AB, DMAB and S-DMAB modified 168ROo DNA duplexes with 
the sequence 5’-TCCXCCAXGCAXTCG-3’ and complement upon irradiation with the maximum trans 
and cis converting wavelengths after room temperature and 40 °C irradiation. The native melting 
temperature of the 168ROo duplex was determined as Tm = 63.8 °C.  
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Fig. 71: Multiple repeating melting curve cycles for AAP1 and AAP2 modified 168ROo duplexes upon 
alternating irradiation with 590 nm and 365 nm at room temperature. While AAP1 modified duplexes 
reveal an association behaviour in cis (left), AAP2 modified duplexes show a significant reduction in 
melting temperature when irradiated to cis. 
Modifications Tm trans 1st Tm cis RT 1st Tm trans 2nd Tm cis RT 2nd 
3 x AAP1 68.2 °C 62.6 °C 66.8 °C 66.7 °C 
3 x AAP2 71.0 °C 30.6 °C 61.8 °C 33.2 °C 
Tab. 21: Melting temperatures Tm determined for modified 168ROo duplexes upon irradiation with the 
maximum trans and cis switching wavelengths at room temperature and 40 °C irradiation. 
The sequence 168ROo 5’-CACXCATXTCCXGGT-3’ containing 66 % GC-content and three 
modifications in an NNNX motif reveals a significant increase in melting temperature when 
modified with AB, DMAB or S-DMAB in trans conformation. Melting temperatures for duplexes 
with all three modifications are significantly increased for all moieties in trans conformation. 
Only irradiation at 40 °C results in a melting temperature reduction of 10.0 °C for AB, 24.8 °C 
for DMAB and 3.2 °C for S-DMAB, which still remains too low to achieve a full duplex 
dissociation (tab. 21).  
Three AAP1 and AAP2 modifications slightly increase the native melting temperature of 
168ROo by 4.2 °C for AAP1 and 7.2 °C for AAP2 (tab. 22). AAP1 isomerization to cis does not 
significantly alter the trans melting temperature, but the shape of the recorded melting curves 
implies an association behaviour prior to the melting point in the dissociation part of the melting 
curve (fig. 71). The duplex seemingly dissociates upon irradiation and reassociates with 
increasing temperatures. Since a strong thermal back switching of AAP1-D-threoninol moieties 
could be observed when measuring small molecule melting curves, the result indicates a 
strong thermal hybridization of the duplex in three steps. Starting from the photoinduced duplex 
dissociation at room temperature, thermal AAP1 back-relaxation leads to an association of the 
duplex with elevated temperatures as observed in the shape of the melting curve. The duplex 
dissociates thermally when the temperature reaches beyond the melting point of 68.2 °C. In  
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sequences with high GC-content, trans AAP2 also does not show any significant decrease 
in melting temperature, but reduces the melting temperature down to 30.6 °C upon 
photoisomerization using 365 nm irradiation at room temperature. These results were 
reproducible even after four consecutive melting curve cycles when cooling down the samples 
back to room temperature after each measurement and starting the next irradiation and melting 
curve cycle. In addition to 12-mer melting curves, two further 10-mer sequences 126ROo and 
126ROp were designed. The strands 126ROo with the sequence 5’-CCXGATXGCTXGT-3’ 
and 60 % GC-content and 126ROp with the sequence 5’-GGXAATXGGTXGA-3’ and 50 % 
GC-content contain three modifications per strand. AB- and DMAB-modified sequences exhibit 
a duplex stabilization of about 10 °C and above with all modifications in trans conformation 
(tab. 23). Converting AB-modified sequences to cis reduces the melting temperatures back 
close to the native melting temperatures while DMAB-modified sequences in cis do not reveal 
a change at all. Trans S-DMAB in the same sequences does not alter the native melting 
temperaturessignificantly but also shows no melting temperature reduction even when 
irradiated to cis at 40°C. A high synthetic load in combination with the duplex stabilizing 
properties of all three azobenzene derivatives apparently stabilize the two sequences to an 
extent that photoinduced duplex dissociation is not observed. 
Since the duplex destabilization of AAP2 already shows no clear melting point in 12mer50 
sequences and increasing numbers of AAP2 moieties additionally destabilize the DNA 
duplexes, only AAP1-modified strands were used for melting analysis of 126ROo and 
126ROp. Both AAP1-modified strands 126ROo and 126ROp reveal complete duplex 
dissociation in cis conformation and interestingly the shape of all melting curves again indicates 
an associative behaviour followed by a thermal duplex dissociation (fig. 72). An association 
point of the cis irradiated duplexes can be observed in both cases, followed by a dissociation 
point at higher temperatures. Both association points lie in the same magnitude of about 35 °C,  
Modifications Tm trans Tm cis RT Tm cis 40 °C 
3 x AB 126ROo 62.2 °C 56.5 °C 53.4 °C 
3 x AB 126ROp 52.2 °C 45.5 °C 43.6 °C 
3 x DMAB 126ROo 65.0 °C 66.9 °C 64.3 °C 
3 x DMAB 126ROp 59.6 °C 63.1 °C 53.3 °C 
3 x S-DMAB 126ROo 54.5 °C 47.3 °C 51.5 °C 
3 x S-DMAB 126ROp 41.4 °C 41.5 °C 44.4 °C 
Tab. 22: Melting temperatures Tm determined for modified 126ROo duplexes upon irradiation with the 
maximum trans and cis converting wavelengths upon room temperature and 40 °C irradiation. The 
melting temperatures of both native DNA duplexes are Tm = 53.9 °C for 126ROo and Tm = 44.3 °C for 
126ROp. 
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Fig. 72: Melting curve cycles of AAP1 modified 126ROo and 126ROp DNA duplexes upon alternating 
irradiation with 365 nm and 590 nm light at room temperature. All melting curves of modified strands 
show association curve behaviour after irradiation into cis conformation. 
Modifications Tm trans 1st Tm cis RT 1st Tm trans 2nd Tm cis RT 2nd 
3 x AAP1 126ROo 53.0 °C 56.7 °C 56.2 °C 58.7 °C 
3 x AAP1 126ROp 47.0 °C N/A 43.5 °C N/A 
Tab. 23: Melting temperatures Tm measured for AAP1 modified 126ROo and 126ROp duplexes 
upon alternate irradiation with the maximum trans and cis converting irradiation wavelengths at room 
temperature. Multiple repeated melting curve cycles indicate a reversible change in melting 
temperature as observed by reproducible melting temperatures. 
only the thermal dissociation points are shifted relatively towards the melting points observed 
for modified 126ROo and 126ROp duplexes in trans. The appearance of association points in 
DNA melting curves is a novel observation and has not been reported for azobenzene modified 
DNA before. A repetition of melting curves with consecutively trans and cis irradiated AAP1 
duplexes states the reproducibility of these results. A combination of AAP1 thermal back-
relaxation with a complete duplex dissociation upon irradiation to cis possibly causes this 
effect.  
In conclusion, both arylazopyrazoles AAP1 and AAP2 show a highly efficient duplex 
destabilization in trans and photoinduced dissociation upon irradiation into cis using UV light 
at room temperature. As a clear advantage in direct comparison to the reported azobenzenes, 
an efficient photoinduced duplex dissociation at room temperature as observed for both 
arylazopyrazoles could not be achieved with AB, DMAB or S-DMAB in the same DNA 
duplexes. The reported azobenzenes did not reveal any efficient decrease in melting 
temperature when using one modification per three base pairs and GC-contents of 50 % and 
above. While all of the investigated azobenzenes require elevated irradiation temperatures and 
high synthetic loads to achieve an efficient duplex dissociation, both arylazopyrazoles exhibit 
a significant decrease in melting temperature when irradiated with 365 nm light at room  
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temperature. Thereby, AAP1 does not affect the native DNA duplex melting point significantly 
in trans conformation. Unexpectedly, introduction of AAP2 on the other hand resulted in a 
significant duplex destabilization even in trans conformation which becomes less significant 
with increasing GC-contents of 66 % and above. When isomerizing AAP2 to cis conformation, 
the melting temperature reduces significantly in a DNA strand with 66 % GC-content. These 
highly stable DNA duplexes could not be photocontrolled efficiently using azobenzene moities 
due to their stabilizing effect on the double strand. A slight or significant destabilization of native 
DNA duplexes using arylazopyrazoles AAP1 and AAP2 in trans conformation implies a 
facilitated cis isomerization of the duplexes as observed by significantly decreased melting 
temperatures. To sum it up, not only a selection of the photochromic moiety is of vital 
importance to achieve an efficient photoinduced DNA duplex dissociation, but also the careful 
and sophisticated design of DNA sequences considering numbers and positions of 
modifications, GC-content and synthetic load at the same time. Stabilizing photoswitches like 
azobenzenes can enhance the stability of short DNA sequences with low GC-contents while 
destabilizing arylazopyrazole moieties are potentially capable of photoswitching highly stable 
long sequences with GC-contents above 50 %. Also a reduced synthetic load is a great 
advantage compared to the reported azobenzene derivatives, reducing the necessary NNX 
motif where each modification is separated by two base pairs to an NNNX motif with three 
base pairs separating each modification. The commonly used NNX-motif yet required for 
azobenzenes to achieve full duplex dissociation entails a disruption of DNA's B-form and 
possibly influences local sequences in higher order DNA applications. Using an NNNX motif 
with a reduced number of modifications possibly minimizes structural duplex disruptions 
leading to a reduced influence on the native melting temperature. 
To further demonstrate the complexity of modification, position and sequence design, a 
series of DNA applications was designed to demonstrate a feasibility of the newly designed 
photochromes. 
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3.3.4 Investigation of duplex hybridization control efficiency in a 168 bp dsDNA 
ring system 
To further confirm the previously monitored melting curve results in a qualitative manner, a 
circular 168 bp dsDNA construct containing a double-stranded 20 bp overhang and two 
asymmetric single-stranded gaps was designed and assembled. The ring design, which is 
based on a previously developed functional design for a 168 bp ring,[215] was redesigned and 
extended appropriately (fig. 73). Complementary strand hybridization to close the ortho and 
para single-stranded gaps revealed a significant difference in electrophoretic migration 
behaviour on a 6 % PAGE gel. This empirical observation, which possibly results from the 
relative position of both gaps in respect to the AT-track thus distorting the rings secondary 
structure if the complementary strands are hybridized or not, was used in combination with 
modified complementary release oligomers (ROs) to qualitatively confirm photoinduced 
hybridization and dehybridization of modified oligonucleotides to one or both gaps upon 
irradiation into trans or cis. 
 
Fig. 73: Design of a circular 168 bp dsDNA system. The system contains two single-stranded gaps 
(ortho and para) and shows a difference in electrophoretic migration behaviour upon addition of 
release oligomers (ROs) complementary to both gaps. Both hybridization-sequences are highlighted in 
green. 
While the single-stranded 12-mer ortho gap sequence exhibits 66 % GC-content, the 12-mer 
para gap sequence was designed with only 58 % GC-content. Both gaps were designed to 
hybridize to the previously synthesized strands ds12 and 168ROo as complementary ODNs. 
The previously designed sequences containing the same photoswitch modification patterns as 
described before (chapter 3.3.1) were used within this study, whereby each modification is 
separated by three consecutive base pairs (NNNX-motif). The ring system was incubated with 
two equivalents of the complementary ortho or para sequences for 30 minutes at room 
temperature to ensure complete hybridization of the oligomers. Subsequent irradiation with the 
corresponding trans or cis converting wavelengths for 5 minutes at the given temperature and  
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Fig. 74: Relative electrophoretic migration of the circular 168bp dsDNA system upon addition of AB, 
DMAB and S-DMAB modified ortho and para release oligomers complementary to the respective 
gaps. As a reference, the 168 bp dsDNA ring system without release oligomers was used. The ring 
system was incubated with the release oligomers and converted to trans (lanes 1 and 3) and to cis 
(lanes 2 and 4) consecutively (6 % PAGE, 200 V, 90 min, 4 °C). The used ladder (100 bp ladder) and 
corresponding gel bands are the same for all gel pictures. 
subjection to PAGE gel chromatography results in qualitative bands, indicating hybridization 
or dehybridization to both single-stranded gaps. 
An azobenzene modified ortho complementary oligomer shows an efficient hybridization as 
observed by an upper shift of the gel band but does not show any band shift upon irradiation 
at 40 °C (fig. 74). The azobenzene modified complementary sequence seems to hybridize 
strongly to the ortho gap but no photoinduced dehybridization could be observed. DMAB and 
S-DMAB modified complementary ortho sequences exhibit the same strong hybridization upon 
addition to the ring system but no photoinduced dehybridization was observed. Even elevated 
irradiation temperatures did not reveal any significantly shifted gel bands and thus did not 
indicate any dehybridization of the oligomers after irradiation (fig. 74). Furthermore, a DMAB 
modified complementary para oligomer shows the same stabilizing effect and no band shift  
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Fig. 75: Relative migration shift of the circular 168bp dsDNA system upon addition of AAP1 and AAP2 
modified ortho and para release oligomers complementary to both gaps. As a reference, the 168 bp 
dsDNA ring system without release oligomers was used. The ring system was incubated with the 
release oligomers and converted to trans (lanes 1 and 3) and to cis (lanes 2 and 4) consecutively (6 % 
PAGE, 200 V, 90 min, 4 °C). The used ladder (100 bp ladder) and corresponding gel bands are the 
same for all gel pictures. 
after photoirradiation, even when irradiated at 40 °C. In agreement with the previously 
performed melting curve experiments (chapter 3.3.3), DMAB does not indicate any duplex 
dehybridization even at 40 °C, possibly due to a strongly stabilizing intercalation between the 
duplex base pairs. AB and S-DMAB modified complementary para sequences exhibit an 
incomplete hybridization and dehybridization when irradiated to trans or cis. While an AB 
modified para release oligomer reveals a slightly improved hybridization at 40 °C in trans, only 
an incomplete reversible change in gel bands could be observed upon alternative 
photoswitching from trans to cis and vice versa. In agreement with the previously recorded 
melting curves, all gel shifts for the AB modified sequences indicate the same incomplete 
hybridization and dehybridization tendency. S-DMAB modified sequences on the other hand 
show an improved photoswitching behaviour as observed by alternatingly migrated gel bands 
upon alternate irradiation between the trans and cis isomers, whereby 40 °C irradiation further 
increases this effect. The different hybridization behaviour can be deduced from the chemical 
nature of the substitutents attached to each azobenzene derivative. Unsubstituted azobenzene 
slightly stabilizes the duplex hybridization to an extent that efficient photocontrol becomes 
possible at low GC-contents and elevated irradiation temperatures. DMAB shows a stronger 
duplex stabilization which consequentially prevents efficient photocontrol of hybridized  
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modified duplexes, independent from irradiation temperature and GC-content. The bulky 
methylthio residue in S-DMAB potentially counters this stabilizing effect from both ortho methyl 
residues and improves isomerization from trans to cis within the DNA duplex. An S-DMAB 
modified para oligomer is the only example in this study to show a significant but incomplete 
hybridization and dehybridization upon 40 °C irradiation. All observed gel shifts are in good 
agreement with the previously discussed melting curves and point out the necessity and 
limitations for a sophisticated sequence design for the use of photoswitches inside modified 
DNA duplexes. 
In comparison to azobenzene based modified oligomers, both arylazopyrazoles AAP1 and 
AAP2 reveal improved photoswitching properties (fig. 75). An AAP1 modified ortho oligomer 
indicates a complete ortho gap hybridization in trans conformation and a significant but 
incomplete dehybridization upon irradiation with 365 nm at room temperature. The effect 
becomes more significant within a modified para oligomer which shows an even more efficient 
shift in gel bands when isomerized from trans to cis at room temperature, therefore indicating 
a better dehybridization in comparison to the ortho oligomer. Both AAP1 modified ortho and 
para complementary oligomers reveal a more incomplete dehybridization upon irradiation at 
40 °C. A fact which is consistent with the low thermal stability and therefore rapid back-
relaxation of the AAP1 cis isomer at elevated temperatures. Also the gel conditions may play 
a key role since all gels were run for 45 minutes at 4 °C, but local gel warming during the run 
can not be completely excluded.  
AAP2 with a significantly higher thermal half-life shows stronger gel band shifts when 
incorporated into an ortho or para complementary oligomer (fig. 75). For the ortho release 
oligomer, a complete hybridization can be observed by an upper gel shift. Upon irradiation with 
365 nm at room temperature, the reference band reveals a significant downward shift to a 
height comparable to the reference band. Gel band smearing possibly results from a dynamic 
equilibrium formed between the hybridized and non-hybridized complementary oligomers or 
an interaction between the cis modifications of the free oligomers with the construct. Different 
irradiation temperatures do not significantly alter hybridization and photoinduced 
dehybridization of the ortho complementary sequence. For the para oligomer with a decreased 
GC-content, AAP2 in trans reveals an incomplete hybridization as observed by the formation 
of two clearly distinguishable gel bands whereby the upper bands completely disappear upon 
irradiation using 365 nm at room temperature. This observation clearly indicates a complete 
dehybridization of the complementary oligomer even at room temperature irradiation. Using 
40 °C irradiation, hybridization of the AAP2 modified para sequence in trans appears to be 
complete since no further bands are visible in the corresponding gel lanes. Irradiation to cis at  
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40 °C reveals the same down shift for the top gel bands as observed for room temperature 
irradiation. 
Qualitative gel observations using the 168 bp dsDNA construct and its modified 
complementary sequences resemble similar results as observed for all previously measured 
melting curves. The intense duplex destabilizing effect observed for AAP2 modifications in all 
melting curve experiments apparently facilitates photoswitching within the hybridized duplexes 
and leads to a complete duplex dissociation even at room temperature irradiation. The highly 
decreased synthetic load necessary for photoinduced dehybridization of AAP1 and AAP2 
modified complementary sequences could successfully be translated to the presented gel 
study. Incomplete dehybridization of AAP1 modified sequences appear to be decreased, 
possibly due to the low thermal stability of cis AAP1. Long lasting gel run times and potentially 
unavoidable gel warming during the run possibly lead to a thermal back-relaxation of cis AAP1 
during the experiment. 
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3.3.5 Competitive photocontrol of modified oligonucleotides using a DNA hairpin 
Strand displacement is a commonly used technique in DNA nanotechnology to replace 
functional DNA elements in nanosystems through controlled hybridization sites by further 
functional parts or elements to enable or disable functionalities. Opening a DNA hairpin 
structure by strand displacement provides an elementary functional system which can be 
utilized for investigating the photoinduced hybridization of modified strands in a competitive 
environment. The hybridization sequences are split into a short single-stranded four nucleotide 
toehold sequence, which facilitates hybridization of the modified opening oligomers to the 
hairpin stem region, and a hybridization sequence belonging to the hairpin stem (fig. 76). 
Opening oligomers containing photoresponsive moieties permit a reversible opening and 
closing of the hairpin structure upon repeated alternating isomerization into trans or cis 
conformation, thus opening or closing the hairpin through turning on and off hybridization. 
 
Fig. 76: Two DNA hairpins were designed for proof of competitive photoswitching. Both hairpins differ 
in their GC-contents in the hybridization sites. The hairpins were designed to use the same oligomers 
as opening sequences as used for ortho and para gaps in the 168 bp ring (168ROo and 168ROp). 
Two different DNA hairpins were designed and assembled to be examines in combination 
with the previously synthesized modified sequences ds12 and 168ROo towards their 
reversible photocontrolled opening and closing efficiencies. In analogy to the previously 
performed dsDNA ring hybridization experiments, both hairpins were called ortho and para 
hairpin. Both hairpins differ in their relative GC-content inside the hybridizing sequences, 
antisense to the complementary ortho sequence 5’-TCCXCCAXGCAXTCG-3’ (168ROo) with 
66 % GC-content and the complementary para sequence 5’-CACXCATXTCCXGGT-3’ (ds12) 
with 58 % GC-content. Reversible hairpin opening and closing was monitored by a Cy5.5 and 
BHQ3 fluorophore quencher pair. In the closed state, the Cy5.5 fluorescence is quenched by 
a BHQ3 quencher attached to one end of the hybridizing 7-mer stem region. A change in Cy5.5 
fluorescence throughout the irradiation cycles could be monitored upon hybridization of ds12  
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Fig. 77: Fluorescence intensity of DNA hairpin ortho was measured with 2 equivalents of modified 
opening oligomers containing AB, DMAB or S-DMAB in the 12-mer sequence 5’-TCC X CCA X GCA X 
TCG-3’. AB and DMAB modified oligo-mers exhibit an efficient hairpin opening but no closing upon 
irradiation to cis. The S-DMAB modified oligo-mer shows a complete hairpin opening in trans but only 
incomplete closing upon irradiation to cis. 
and 168ROo to their respective single-stranded gaps, consequentially opening the hairpins. 
A free single stranded Cy5.5 modified oligomer served as a reference in all measurements. 
Relative Cy5.5 fluorescence changes indicated the opening and closing efficiencies for both 
hairpins for each modified sequence under different irradiation conditions. 
As a reference, both hairpins were incubated with two equivalents of the unmodified 
complementary sequences in 1x DA buffer and the resulting fluorescence intensity was 
recorded. Using two equivalents of AB, DMAB or S-DMAB modified opening oligomers with 
modifications irradiated to trans all lead to an efficient opening of hairpin ortho as observed in 
increased Cy5.5 fluorescence signals. Incubation at 40 °C results in even increased 
fluorescence intensities, indicating improved opening rates for hairpin ortho at elevated 
temperatures (fig. 77). Upon isomerization to cis using the respective irradiation wavelengths, 
only the S-DMAB modified 168ROo exhibits a significant but incomplete drop in Cy5.5 
fluorescence intensity, indicating a partial dehybridization and closing of hairpin ortho. 
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Fig. 78: Fluorescence intensity of DNA hairpin para was measured with 2 equivalents of modified 
opening oligomers containing AB, DMAB or S-DMAB in the sequence 5’-CAC X CAT X TCC X GGT-
3’. AB and DMAB modified opening oligo-mers exhibit an efficient hairpin opening but no consecutive 
closing upon irradiation to cis. The S-DMAB modified oligomer indicates an incomplete hairpin 
opening in trans and a complete dehybridization in cis. 
AB and DMAB modified 168ROo oligomers did not show any significant decrease in Cy5.5 
fluorescence in hairpin ortho, hereby indicating no photoinduced dehybridization of the 
modified sequences while the same behaviour was observed for room temperature and 40 °C 
irradiation. No efficient reversible opening and closing of hairpin ortho could be observed for 
all three azobenzene modifications upon irradiation at the two temperatures. The equilibrium 
between opened and closed hairpin state strongly seems to favour the opened hairpin where 
this observation is in good agreement with the previous melting curve experiments (chapter 
3.3.3). All three azobenzene based modifications in hairpin para show the same tendency as 
observed for hairpin ortho (fig. 78). AB and DMAB modified opening oligomers exhibit an 
efficient opening of hairpin para upon addition of oligo-mers with modifications in trans, but an 
incomplete dehybridization upon irradiation to cis at room temperature for AB and no 
dehybridization at all could be observed for DMAB. At 40 °C irradiation both modified oligomers 
seemingly open the hairpin efficiently as observed by an increasing Cy5.5 fluorescence signal  
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Fig. 79: Opening of hairpin ortho with AAP1 (top) and AAP2 modified opening oligomers (bottom) 
containing two and three modifications. Efficient hairpin opening and closing upon irradiation is 
observed for two and three AAP1 modifications in the modified opening oligomers. AAP2 modified 
oligomers do not show any hairpin opening at all. 
but do not reveal any decrease in Cy5.5 fluorescence when irradiated into cis conformation. 
S-DMAB on the other hand reveals an incomplete hairpin opening in trans conformation but 
an efficient dehybridization upon irradiation into cis while room temperature and 40 °C 
irradiation do not show any significant difference. The stabilizing effect of AB and DMAB on 
DNA duplex stability apparently strongly shifts the equilibrium between open and closed state 
to the side of the open hairpin as observed by an increased Cy5.5 fluorescence. S-DMAB on 
the contrary favours a closed hairpin state in cis conformation but an incomplete hairpin 
opening in trans conformation. The observed stabilizing effect for AB and DMAB is consistent 
with the previously recorded melting curves and can be successfully transferred to the 
competitive hairpin environment.  
Both arylazopyrazoles AAP1 and AAP2 on the other hand revealed a destabilizing effect on 
the duplex in the previous melting curve experiments (chapter 3.3.3). Therefore, not only 
strands with three AAP1 and AAP2 modifications were used, but also strands containing two 
modifications since the destabilizing properties of AAP1 and AAP2 possibly prevent a  
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successful hybridization of the opening oligomers. The strands 2xAAP1sh and 2xAAP2sh 
with the sequence 5’-TCC CXCA GCXA TCG-3’ for hairpin ortho and 5’-CAC CXAT TCXC 
GGT-3’ for hairpin para exhibit one modification per four nucleobases in an NNNX motif. The 
decreased number of modifications might be mandatory for an efficient hybridization to the 
hairpin stem regions. In a competitive environment, the stabilization of the hybridizing 
oligomers is of higher priority than an efficient duplex dissociation since closing of the hairpin 
is thermodynamically favoured. 
Using two or three AAP1 modifications in an oligomer complementary to the ortho hairpin in 
both cases leads to an increase in Cy5.5 fluorescence with AAP1 in trans conformation and 
irradiation to cis at room temperature leads to a significant drop in Cy5.5 fluorescence (fig. 79). 
The difference in fluorescence intensity indicates efficient photoinduced opening and closing 
for two and three AAP1 modifications. Interestingly, an opening oligomer carrying only two 
modifications separated by four nucleobases was able to successfully open and close the 
 
 
Fig. 80: Opening of hairpin para with AAP1 (top) and AAP2 modified opening oligomers (bottom) 
shows the same tendency as observed for hairpin ortho. Incomplete hairpin opening and closing is 
observed for two and three AAP1 modifications in the modified opening oligomer while AAP2-modified 
oligomers do not show any hairpin opening at all. 
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hairpin to the same extent as observed for three modifications. The additionally hybridizing 
stem region of hairpin ortho apparently facilitates hairpin closing when converting AAP1 to cis. 
Unexpectedly and even more important, hairpin switching seems to improve when using only 
two modifications instead of three.AAP2 modified opening oligomers on the other hand did not 
disclose any increase in fluorescence, neither in trans nor in cis conformation, indicating no 
hairpin ortho opening at all (fig. 79). Thereby the amount of AAP2 modifications within the 
opening oligomer does not show any significant effect. The strongly destabilizing properties of 
AAP2 on the DNA duplex possibly prevent the formation of a stable duplex, thus hampering 
an efficient hairpin opening. Since room temperature irradiation already succeeded in efficient 
hairpin opening and closing for AAP1, elevated irradiation temperatures were not further 
investigated in this respect.  
Photoinduced opening and closing of hairpin para reveals the same tendency for AAP1 and 
AAP2 modified opening oligomers as observed for hairpin ortho. Interestingly, two AAP1 
modifications led to a less efficient increase and decrease in Cy5.5 fluorescence, indicating a 
less efficient opening and closing of hairpin para (fig. 80). AAP2 modified opening oligomers 
did not show any increase in fluorescence in the same matter as observed for hairpin ortho. 
Multiple irradiation cycles with AAP1 modified oligomers in hairpin ortho and hairpin para were 
performed to demonstrate the reversible opening and closing efficiencies (fig. 81). Hairpin 
ortho and para in combination with two equivalents of the corresponding opening oligomers 
including two or three AAP1 modifications were used to reversibly open and close the hairpins  
upon alternating irradiation with 365 nm and 590 nm light at room temperature. In agreement 
with the previous hairpin opening experiments, efficient reversible opening and closing of 
hairpin ortho could be achieved with release oligomers containing two or three AAP1 
modifications (fig. 81). Hereby, modified opening oligomers carrying two and three AAP1 
modifications resulted in en efficient reversible fluorescence intensity drop and recovery upon 
alternate irradiation with 365 nm and 590 nm at room temperature. Reversible irradiation did 
not show any significant fatigue even after 5 alternate irradiation cycles. Using only two AAP1 
modifications in an NNNNX-motif proves efficient reversible photocontrol of the hairpin. This 
proves a reduction of the mandatory synthetic load as commonly used for azobenzenes by 
half compared to the NNX-motif. 
Hairpin para in combination with AAP1 modified opening oligomers carrying two or three 
modifications exhibited an increase and a decrease in Cy5.5 fluorescence upon alternating 
irradiation with 365 nm and 590 nm, but the fluorescence intensities did not reach the minimum 
or maximum reference values. An equilibrium between the open and closed hairpin form 
seems to prevent a complete opening and closing of the para hairpin when using AAP1 modi- 
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Fig. 81: Reversible hairpin ortho and hairpin para opening using AAP1 modified opening oligomers 
including either two or three modifications. While hairpin ortho can be reversibly opened and closed by 
UV and orange light irradiation, hairpin para only shows incomplete opening and closing upon alter-
nate irradiation. Details of the modified sequences are given in the experimental section in chapter 
7.10.3. 
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fied oligomers. Both hairpin conformations could be transformed from the open into the 
closed conformation and vice versa, but the steps were not converted quantitatively. The lower 
GC-content of the stem region in hairpin para probably favours the formation of the closed 
hairpin structure which prevents successful hybridization of the oligomer through the 
additionally introduced destabilizing AAP1 residues. 
To sum it up, both hairpins in combination with opening oligomers modified with one of the 
three azobenzene derivatives showed strong Cy5.5 fluorescence signals but no decrease in 
fluorescence upon irradiation to cis. This clearly indicates a successful opening of both hairpins 
through hybridization of the modified sequences, but no efficient dehybridization from the stem 
regions to close both hairpin structures. The tremendously stabilized hybridization of AB and 
DMAB modified oligomers prohibited a photoinduced dehybridization from the stem region 
once the oligomers were hybridized to the hairpin. S-DMAB modified oligomers could not 
efficiently open both hairpins but indicated a partial dehybridization from the hairpin stem 
regions when transformed into cis as observed by a drop in Cy5.5 fluorescence.  
Arylazopyrazole AAP1 proved to be a superior photochrome for photoregulation in 
competitive hairpin structures. Even a 12-mer opening oligomer containing AAP1 in an NNNNX 
motif exhibited efficient reversible opening and closing of hairpin ortho with minimal fatigue 
upon alternating irradiation at room temperature. Hairpin para could be opened and closed 
reversibly by AAP1 modified complementary oligomers, but only to an inefficient extent since 
no complete drop or recovery of the initial fluorescence signal could be obtained. AAP1 
modified oligomers in competitive environments only appear to work in systems exhibiting high 
GC-contents. This apparent drawback opens the door for photocontrol in highly stable 
duplexes, a range of GC-content which was not accessible yet for azobenzene photoswitches. 
Using AAP2-modified release oligomers did not point out any hybridization to both hairpins, 
possibly due to its strongly destabilizing properties on the DNA duplexes. The strongly 
destabilizing effect of AAP2 prevents this photoswitch from being used in competitive 
environments since no efficient hybridization to any of the two hairpins could be observed for 
AAP2 modified complementary oligomers. 
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4 A photocontrolled two-state dsDNA [2]catenane system 
The following project was designed and executed in cooperation with Johannes Weigandt. 
Part of this work is based on his results and observations.[237] 
 
4.1 Design and assembly strategies for a two-state dsDNA [2]catenane 
system 
DNA catenanes and rotaxanes provide versatile building blocks in DNA nanotechnology 
resulting from pioneering works in macromolecular chemistry[233,234] and DNA 
nanostructures.[235,236] DNA catenanes and rotaxanes both represent complex interlocked DNA 
nanostructures with the potential to serve as molecular transporters and logic gating devices. 
Upon introduction of photoresponsive moieties, such a system can be reversibly controlled by 
light. Hitherto, reversible photocontrol of [2] and [3]rotaxane shuttles has been reported by 
introduction of DMAB moieties into the structure and photoresponsive complementary release 
oligomers.[213,214]  
Resulting from the empirical observations during the design and development of new 
photoswitches and their consecutive introduction into DNA strands, the idea of a reversibly 
photocontrolled two-state DNA [2]catenane emerged. A dsDNA [2]catenane construct was 
designed to prove coherent and independent photoswitching properties when combining 
multiple photochromes in a nanotechnology system. The [2]catenane construct consists of the 
double-stranded 168 bp dsDNA ring described in chapter 3.3.4, which was mechanically 
interlocked with a double-stranded 126 bp dsDNA ring (fig. 82). Both rings contain two 
complementary single stranded functional gaps with different sequences in ortho and para 
position in respect to a double-stranded overhang on the 168 bp ring. Hence, the two inter- 
 
Fig. 82: Design of a functional two-state DNA [2]catenane system reversibly controlled by two different 
photoresponsive release oligomers. A) Hybridization of the ortho toehold oligomer (red) into the ortho 
gap forces the 168 bp ring to hybridize in para position. B) Addition of ortho (red) and para toehold 
oligomers (yellow) block both hybridization sites and force the ring into an interlocked state. C) 
Hybridization of the para toehold oligomer (yellow) blocks the para gap and forces both rings to 
hybridize in ortho position. 
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Fig. 83: Assembly strategy for the [2]catenane system. A) The outer construct 126out is assembled 
separately by combining the three strands 126i1, 126i2 and 126o1 in a 1:1 ratio. B) Starting from the 
assembly and ligation of the 168 bp ring, a toehold oligomer (red) is hybridized into the ortho gap to 
avoid formation of by-products through hybridization of strands into the ortho gap. C) The catenane 
system is assembled via hybridization of 126o2 into the free para gap and consecutive addition of the 
126out construct. Ligation and liberation of the toehold oligomer by a complementary strand forms the 
[2]catenane system. 
locked rings can be stalled in two different hybridization states upon addition of release 
oligomers hybridizing to one of the two single-stranded gaps. 
Addition of either a modified ortho or para release oligomer blocks one of the hybridization 
sites and forces the system via an interlocked transition state to be stalled in the opposite 
conformation. This process can be reversibly photocontrolled by means of photoresponsive 
release oligomers which, upon alternate irradiation into trans or cis conformation, reversibly 
blocks or relieves one of the single-stranded gaps. Release oligomers containing two different 
photoswitches with orthogonal photoswitching properties possibly forces the system from one 
defined state into the other and vice versa. The difference in electrophoretic migration 
behaviour for both [2]catenane states permits the investigation of independent or coherent 
photoswitching properties through distinguishable gel bands when adding release oligomers 
modified with two different photochrome types. Two additional fluorophore quencher pairs  
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Fig. 84: Upper image: 2 % agarose gel (30 min., 200 V, 4 °C) of the [2]catenane assembly and all 
intermediate steps. 1) Outer construct of the 126 bp ring (126out) consisting of the three oligomers 
126i1, 126i2 and 126o1. 2) Completely assembled and ligated 126 bp ring consisting of all four 
oligomers (126-ring). 3) Assembled and ligated 168 bp ring (168-ring). 4) Complete 168 bp ring 
including ortho toehold oligomer (168TH). 5) Assembled [2]catenane system containing the toehold 
oligomer (Catenane-TH). All intermediate steps were purified by weak anionic exchange HPLC.  
Lower image: Strcutrual proof of the [2]catenane system via AFM reveals the three-dimensional 
structure of the catenane. Both interlocked rings are visible as well as the double-stranded overhang. 
The image was recorded by Johannes Weigandt and reworked with Gwyddion image software. 
attached to the terminal ends of each functional gap on both rings supports these 
measurements. The [2]catenane was designed to utilize modified release oligomers instead of 
modifying the functional gaps inside the catenane since the introduction of modifications into 
release oligomers is much more facile than assembling a whole modified [2]catenane for each 
photochrome pair. 
[2]catenane assembly starts from the previously described 168 bp ring (chapter 3.3.4) 
followed by addition of a toehold oligomer to block undesired hybridization to the ortho gap. 
The use of a toehold oligomer for one gap forces the system into one conformation during the 
catenane assembly, thus avoiding the formation of side-products by default. Addition of the 
oligomer 126o2 hybridizing to the free para gap followed by the addition of the pre-formed  
   117 
outer construct of the 126 bp ring consisting of the remaining three oligomers results in the 
formation of the crude [2]catenane which was obtained after purification by weak anionic 
exchange HPLC in about 5 % yield. Assembly progress and formation of all intermediates was 
monitored by agarose gel electrophoresis (fig. 84, left). 
Two different assembly pathways are possible to achieve the [2]catenane, one pathway by 
blocking the ortho gap or the other pathway by blocking the para gap by a toehold oligomer 
and further assembly of the small ring around the free gap. The main focus was put on the 
para assembly pathway in order to guarantee a continuous hybridization of the short toehold 
oligomer in ortho position during the assembly since the ortho gap possesses a higher GC-
content than the para gap. 
Purification of the crude [2]catenane product was performed in two different manners. A 
workup by weak anionic exchange HPLC only yielded very low amounts of the target product, 
whereby a freeze and squeeze agarose gel purification and multiple consecutive freezing and 
centrifugation steps of the cut-out product bands brought up the catenane in up to 5 % yield. 
Also, the ortho toehold oligomer needs to be removed to permit free [2]catenane motion. 
During the freeze and squeeze workup the toehold oligomer gets removed while after weak 
anionic HPLC the toehold oligomer is still attached to the 168 bp ring. The [2]catenane 
structure containing random conformations was proven via AFM in hyperdrive mode (fig. 84, 
right). The double-stranded overhang is clearly visible on AFM as well as the interlocked 
structure with both rings stalled in both ortho and para position. 
Addition of unmodified release oligomers complementary to two of the four free gaps blocks 
the corresponding hybridization sites and forces the ring to be stalled into one conformation. 
Extended toehold sequences permit a release of both unmodified release oligomers upon 
incubation with the complementary sequences to permit a conformational change without light 
irradiation. The change in conformation was proven by a relative gel band migration in a 2 % 
agarose gel and by an additional structural poof via AFM. In addition to both methods, the two 
complementary fluorophore and quencher pairs placed at one terminal end of each gap can 
be used to distinguish between both stalled states and the interlocked state. In both stalled 
states, one of the fluorophores is quenched while in the interlocked state no quenching of both 
fluorophores can be observed. 
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4.2 Proof of catenane switching by unmodified release oligomers 
The purified [2]catenane system contains a total number of four gaps where two times two 
gaps are complementary to each other. Towards testing conformational switching of the 
[2]catenane, unmodified release oligomers with a length of 23 nucleotides containing 12-mer 
hybridization sequences and 11-mer overhangs were used to block one complementary gap 
in the 168 bp ring to force the system into the stalled ortho or para state. An interlocked state 
is achieved by blocking both single-stranded hybridization sites in the same ring. Addition of 
oligomers complementary to the unmodified toehold oligomers followed by addition of a 
second release oligomer complementary to the opposite gap results in a gel band shift. 
Consecutive blocking and relieving cycles for opposite gaps reversibly forces both rings from 
one conformation into the other and vice versa as observed by relatively shifted gel bands in 
a 2 % agarose gel. The up and down shift of the gel bands indicates a reversible transition 
from one conformation over the interlocked state into the second conformation and back 
(fig. 85). 
The [2]catenane without any added release oligomer was used as a reference in the gel. 
Addition of two equivalents of both toehold release oligomers shows a smeary band indicating 
the interlocked catenane state in different dynamic conformations. Addition of two equivalents 
of either the unmodified ortho or the para toehold release oligomer leads to the formation of  
        
Fig. 85: Reversible [2]catenane switching from one stalled state into the other upon consecutive 
addition and release of ortho (red) and para release oligomers (yellow). A shift of gel bands on a 2 % 
agarose gel (200 V, 45 min, 4 °C) indicates the successful transformation between both states. Lanes: 
1) [2]catenane reference without toehold oligomers (structure A). 2) [2]catenane with both unmodified 
toehold oligomers (structure B), 3) [2]catenane system containing the ortho toehold oligomer (C). 4) 
[2]catenane system containing the para toehold oligomer. (D) 5) [2]catenane system containing the 
ortho toehold oligomer. (C) 6) [2]catenane system containing the para toehold oligomer (D). 
Reversible switching was achieved through release of hybridized toehold oligomers by complementary 
sequences before addition of the opposite toehold oligomer. 
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Fig. 86: Structural proof via AFM showing the [2]catenane in ortho (left) and para conformation (right). 
Both pictures were recorded after incubating the [2]catenane with the para toehold oligomer (left) or 
the ortho toehold oligomer (right). The images were recorded by Johannes Weigandt and reworked 
with Gwyddion image software. 
clear bands, indicating the formation of the pseudo-interlocked [2]catenane in ortho or para 
conformation. An upper shift indicates the formation of the ortho pseudo [2]catenane and a 
lower shift the formation of the para pseudo [2]catenane. Further structural proof for both 
conformations was performed via AFM in hyperdrive mode (fig. 86). 
The [2]catenane in ortho conformation merely reveals the double-stranded overhang in close 
proximity to the small ring (fig. 86, left) while the [2]catenane in the pseudo-interlocked para 
state carries the double-stranded overhang in a peripheral para position in respect to the 126 
bp ring (fig. 86, right). Since an interaction of the [2]catenane with the MICA AFM surface 
possibly partially disintegrates the tertiary [2]catenane structure, a structural proof can only be 
seen as an indication and not as a definite proof. Also the adsorption conditions to the surface 
play an important role since polyornithine (PO) was used for the measurements instead of pure 
buffer. Nevertheless, both AFM images indicate a favoured conformation upon addition of the 
complementary release oligomers as observed by relative changes in gel bands. 
Unfortunately, the total catenane yield was too low to perform additional fluorophore 
quencher expreiments and thus give an additional proof to further confirm the dynamic 
interconversion between a [2]catenane in ortho and para conformation. Furthermore, due to 
the missing orthogonal switching properties of possible photochromes and a combination 
thereof after introduction into DNA strands, further development and application of the 
[2]catenane project was stopped at this point and any further development was aborted. 
Nevertheless, reversible interconversion of the [2]catenane could be demonstrated and might 
be useful for future development of additional photochromes to provide a practical system for 
further investigation of photoswitch combinations in DNA nanotechnology. 
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4.3 Structural considerations of asymmetric dsDNA rings and the [2]catenane 
system 
The designed double-stranded 168 bp ring containing two asymmetric single-stranded gaps 
revealed a difference in electrophoretic migration upon addition of the complementary release 
oligomers in ortho and para position. Since the difference in electrophoretic migration may 
have numerous causes, two further dsDNA ring systems were assembled to clarify this 
observation. The relative shift in electrophoretic migration observed for the 168 bp ring (A) as 
well as the assembled [2]catenane upon addition of one or both complementary release  
 
Fig. 87: Two further double-stranded circular 168 bp dsDNA rings were assembled as control systems 
to prove the asymmetry shift of all ring and catenane systems via gel electrophoresis: A) 168 bp 
dsDNA ring with overhang and two asymmetric gaps, B) 168 bp dsDNA ring with overhang and two 
symmetric gaps and C) 168 bp ring with two gaps and no overhang. All three rings exhibit a similar 
electrophoretic migration upon addition of the complementary gap sequences (fig. 88). 
Fig. 88: Relative electrophoretic migration of all three 168 bp dsDNA rings described in fig. 87. A) 
168 bp ring containing non-symmetric gaps and a dsDNA overhang. B) 168 bp ring containing 
symmetric gaps and a dsDNA overhang. C) 168 bp ring containing symmetric gaps and no overhang. 
The gel lanes show each ring system with addition of different release oligomers. 1) Ring systems 
without release oligomers. 2) Ring systems with hybridized ortho release oligomer. 3) Ring systems 
with hybridized para release oligomer. 4) Ring systems with hybridized ortho and para release 
oligomers. A change in relative electrophoretic migration for the rings B and C indicates a shift similar 
to the asymmetric 168 bp dsDNA ring system A on a 6 % PAGE gel (200 V, 30 min, 4 °C). 
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oligomers was assumed to be caused by the asymmetric nature of the 168 bp ring in respect 
to the double-stranded overhang. In addition to the 168 bp ring (A) containing two asymmetric 
gaps, a 168 bp dsDNA ring (B) with two symmetric gaps was assembled as well as a 168 bp 
ring (C) containing two single-stranded gaps but no double-stranded overhang (fig. 87). All 
three ring systems were investigated towards their relative electrophoretic shift upon addition 
of one or both release oligomers. 
Using each of the three 168 bp rings without release oligomers as a reference, addition of 
the ortho and para release oligomers result in a significant upper shift, similar to the shifts 
observed for the non-symmetric 168 bp dsDNA ring system (A) containing the double-stranded 
overhang. Addition of both release oligomers at the same time increases the upper shift similar 
to the 168 bp ring (A). Unexpectedly, this gel band migration behaviour can be observed for 
all three rings (A), (B) and (C). Even the 168 bp ring (C) without overhang exhibits a significant 
gel band difference upon addition of either the ortho or the para release oligomer (fig. 88). 
Initially, it was expected that addition of a release oligomer either in ortho or in para position 
changes the symmetry of the ring in respect to the double-stranded overhang, thus leading to 
the difference in electrophoretic migration. Observing the same effect for all three ring systems 
rather implies a secondary structural change occurring in each ring upon addition of the 
corresponding complementary release oligomers, thus leading to a change in the 
hydrodynamic radius . The possible change in secondary structure can be deduced from the 
respective hybridization sequences inside the 168 bp ring backbone. Both gaps differ in their 
relative extent of overlap concerning the AT-track which is covered by the hybridizing release 
oligomers. The consecutive AT-sequence causes DNA double strand bending and is one of 
the reasons why double-stranded DNA rings are formed. Existing in either a single-stranded 
or double-stranded AT-sequence possibly changes the system's secondary structure, thus 
leading to the significant difference in gel bands. To further investigate this effect, three 
different [2]catenane systems have to be assembled based on the three different 168 bp rings 
and have to be investigated towards their relative shift in electrophoretic migration. The 
assembly and switching proof for three different catenane systems might be mandatory to fully 
clarify the symmetry aspects and secondary structure influences concerning both gaps upon 
addition of ortho and para sequences. 
As demonstrated in these control experiments, further investigation has to be performed to 
fully explain all empirical observations. Since adsorption of the [2]catenane samples on a MICA 
surface in atomic force microscopy possibly distorts the secondary and tertiary structures, cryo 
electron microscopy in solution might be a useful technique to clarifiy the structure of every 
[2]catenane systems in both stalled states. If a change in secondary structure causes the 
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relative shift in gel bands, the introduction of the double-stranded overhang is potentially not 
required for a gel proof and possibly improves the assembly and total yield of future 
[2]catenane systems designed for this purpose. 
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5. A photoresponsive aptamer nanoconstruct including a phototriggered 
release mechanism for active cell targeting and photoinduced drug 
release 
The following project was planned and executed in cooperation with Dr. Deepak Prusty. Part 
of this work is based on his results and observations and has previously been published.[238] 
 
5.1 Design and assembly of photoresponsive micellar hybrid aptameric nano-
constructs 
Targeted delivery of therapeutic agents into diseased cells and tissue has been an ambitious 
goal for the development of versatile drug delivery platforms,[239-242] emerging complex drug 
carrier systems including triggered drug release mechanisms with the aim to increase 
therapeutic efficacy while mini-mizing undesired side-effects. Especially in case of cancer, 
drug delivery systems against solid tumors are of high interest to decrease any inherent 
systemic toxicity.[241-242] Doxorubicin as one of the most commonly applied anticancer agents 
leads to an increased risk of heart failure during treatment, being responsible for 50 % of 
deaths during doxorubicin therapy.[243-244] Several drug delivery platforms have been 
developed to circumvent systemic side-effects by shielding agents until they reach their 
target.[239-242] The potency of these carrier systems strongly depent on stability in human serum, 
drug loading capacity, selective cell targeting and drug release efficiency. One possible way 
of selectively targeting tumor cells is the use of cell receptor targeting aiming for proteins which 
are highly overexpressed on the cell surface. cMet prevails a cell surface protein which is 
widely overexpressed in several tumor models and can be successfully targeted by a DNA 
aptamer cln0003.[245-246] The combination of a cMet binding aptamer combined with a 
doxorubicin carrying moiety facilitates selective cancer cell targeting combined with the 
targeted release of doxoru-bicin inside the cells. To selectively release doxorubicin inside the 
cells after uptake, a phototriggered release mechanism in the system allows a triggered 
liberation of intercalated doxorubicin molecules, thus minimizing systemic side-effects. cMet 
binding aptamers were mediated with doxorubicin carrying moieties via lipid-mediated self 
assembly to form supramolecular micelles. 
These supramolecular hybrid aptamer nanocarriers (HyApNc) consist of a 5’-lipid modified 
cMet targeting aptamer and a GC-rich doxorubicin carrier sequence including 2’,6’-
dimethylazobenzene (DMAB) moieties as phototriggers (fig. 89). Doxorubicin has been 
reported to intercalate between GC-rich DNA duplexes with alternating Guanine and Cytosine 
nucleotides.[247-249] A 5'-lipid modified GC-rich hairpin was designed to serve as a doxorubicin  
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Fig. 89: Design of an aptamer based lipid mediated nanocarrier with an inbuilt phototriggered release 
mechanism for targeted delivery and release of doxorubicin into cMet overexpressing cancer cells. 
The figure shows an adapted version of the figure found in reference[238]. 
carrier, thus shielding the intercalated molecule between the duplex to reduce systemic 
toxicity. The combination of these two motifs leads to supramolecular mixed micelles with 
selective cell targeting properties and a triggered release mechanism for doxorubicin.  
Lipid modifications were synthesized as DMT-protected 5-dodecynyl-2'-deoxyuridine 
phosphoramidites and DMT-protected 2’,6’-dimethylazobenzene phosphoramdite (DMAB) 
were intro-duced into DNA sequences via solid phase phosphoramidite synthesis. Lipid-
modified uridine residues were attached to the 5’-ends of both motifs and DMAB moieties were 
placed into the alternating GC-sequence of the doxorubicin carrier hairpin structure (fig 90). 
The cMet targeting moiety is based on the reported cMet targeting aptamer trcln0003, which 
contains two G-quadruplex structures,[246] wheras the truncated aptamer sequence was 
modified with 5'-lipid modifications. The newly designed doxorubicin carrier sequence consists 
of a hairpin structure with alternating GC base pairs and a central AT base pair. The sequence 
represents a structural compromise between possible doxorubicin intercalation sites and the 
intercalation of covalently bound DMAB moieties. Since doxorubicin and DMAB compete for 
intercalation sites, the design was optimized to provide a maximum doxorubicin loading 
capacity while maintaining a photoresponsive hairpin opening upon irradiation. Irradiation at 
365 nm isomerizes DMAB into cis conformation and opens the hairpin, thus releasing the 
loaded doxorubicin molecules. 
Doxorubicin loading efficiency was determined by titration using an aqueous solition with a 
fixed 10  µM doxorubicin concentration with multiple equivalents of the carrier sequence 
containing DMAB in trans conformation. Doxorubicin autofluorescence at λ = 480 nm is 
quenched upon intercalaton between the GC base pairs, which is used to calculate a maximum 
loading efficiency of eight doxorubicin molecules per carrier hairpin.[238] As discussed before, 
azobenzene has a stabilizing effect on a DNA duplex which is possibly countered by a 
secondary structure disruption through the additional intercalants. Taking all intercalating  
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Fig. 90: A) Design of the doxorubicin carrier sequence carrying four lipid modifications (C) in the 5’-
end presents a compromise between the duplex opening efficiency of DMAB moieties required for 
efficient dehybridization (D) and a maximum doxorubicin loading efficiency into the duplex (E). B) 
Design of a lipidated cMet targeting aptamer carrying four lipid moieties (C) on the 5’-end. The figure 
shows an adapted version of the figure found in reference[238]. 
moieties together, a disruption of the B-form duplex structure becomes apparent to an extent 
that 40 °C photoswitching of the GC-rich hairpin becomes possible. Contrary to the reported 
required elevated temperatures and the possibility of DMAB to switch only duplexes with low 
GC-contents, a photoswitching of the highly stable GC-rich hairpin only becomes possible 
through the multiple doxorubicin intercalations.  
In addition to the doxorubicin quenching experiment, doxorubicin loading and light-triggered 
release efficiency was further determined by a reversed-phase HPLC assay. The doxorubicin 
carrier sequence was irradiated at 450 nm for 5 minutes to fully convert DMAB into trans 
conformation and was consecutively incubated with 10 equivalents of doxorubicin for 12 hours 
in 1x PBS buffer and  
further purified by phenol chloroform extraction to remove excess doxorubicin. The loaded 
carrier motif was subjected to weak anionic exchange HPLC in a gradient of 1xPBS buffer with 
5 % ACN and 1xPBS buffer including 1 M NaCl with 5 % ACN while detecting the doxorubicin 
fluorescence signal at 480 nm.[238] While the carrier is absorbed to the stationary HPLC phase, 
loaded doxorubicin inside the carrier is washed out and can be detected by the fluorescence 
detector. Irradiating the loaded carrier at 365 nm for 5 minutes at 37 °C and performing the  
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Fig. 91: Left: Doxorubicin autofluorescence revealed a doxorubicin loading and release efficiency 
and showed a 63 % decrease in fluorescence when the doxorubicin loaded carrier sequence is 
irradiated at 365 nm light for 5 minutes at 40 °C. Right: Doxorubicin diffusion out of the loaded carrier 
over time in 1 x PBS buffer. The experiment was performed by Dr. Deepak Prusty. The figure shows 
an adapted version of the figure found in reference[238]. 
same phenol/chloroform workup and HPLC run yields a 63 % fluorescence reduction 
compared to the fluorescence signal of the loaded carrier (fig. 91, left). Assuming 8 doxorubicin 
molecules per carrier as determined before, the decrease in fluorescence intensity 
corresponds to a number of 5 released doxorubicin molecules per carrier sequence upon 
isomerization to cis. Doxorubicin diffusion out of the carrier over time in 1 x PBS buffer showed 
a 20 % decrease in fluorescence intensity when left in the dark at 37 °C for 48 hours (fig. 91, 
right). This result indicates that the majority of doxorubicin molecules remains within the carrier 
sequence in buffer after intercalation and only 20 % of the molecules diffuse out of the structure 
over time. To prove the remaining doxorubicin inside the carrier, irradiation at 365 nm after 48 
hours resulted in a further fluorescence intensity decrease, showing an additional 50 % 
photoinduced doxorubicin release after 48 hours.[238] The fluorescence decay and drop after 
irradiation proves retention of doxorubicin inside the carrier and a photoinduced release even 
after 48 hours, which is one of the main prerequisites for the HyApNc to function in vivo. 
The 5'-lipid modified cMet targeting motif showed no significant decrease in binding affinity 
in direct comparison to the non-lipidated cMet aptamer in a competitive filter retention assay. 
While the lipidated cMet motif retained a binding affinity for the cMet receptor of IC50 = 46 nM, 
the non-lipidated cMet aptamer shows a binding affinity of IC50 = 56 nM under the same 
conditions.[238] A two-point mutant cMet aptamer did not reveal any target binding at all. These 
observations confirm no reduction in aptamer binding affinity through 5'-lipid tails when 
translated into micelle structures and therefore pave the way for an applicability of the motif 
without loss of target affinity.  
The two moieties, cMet targeting aptamer and doxorubicin carrier motif, were both 
investigated separately tom prove their individual function. A combinatorial function has to be 
proven upon combination of both motifs in lipid-mediated hybrid aptamer nanocarriers. 
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5.2 Assembly and stability of micellar hybrid aptameric nanoconstructs 
Assembly of the hybrid aptameric nanoconstructs was performed by mixing both lipid 
modified motifs in a 1:1 ratio, followed by heating the mixture to 90 °C and slowly cooling down 
to room temperature with a gradient of 1 °C per 5 minutes. Formation and structure of the 
micelles was monitored by STM, AFM and CryoEM. A spherical micellar structure was 
observed in all methods, indicating a successful micelle formation with an average particle size 
between 30 and 35 nm.[238] A FRET based assay using ATTO550 on the cMet aptamer motif 
5'-end and Atto647N attached to the doxorubicin cafrrier 5'-end was utilized to find an optimum 
mixing ratio (fig. 92). Different mixing ratios exhibited a maximum FRET signal when using a 
1:1 mixing ratio. Using this FRET signal for micelles mixed in a 1:1 ratio, dilution of the 
nanoconstructs reveald a disintegration of the particles below a critical micelle concentration 
of 400 nM.[238] Mixing the two motifs in a 1:1 ratio bears the advantage of retaining both core 
functionalities in equal amounts within the nanoconstructs to provide efficient cell targeting and 
a high doxorubicin load per micelle at the same time. 
Successful formation of the hybrid aptamer nanocarriers above the critical micelle 
concentration was used to investigate the overall nuclease stability of the nanocarriers. The 
readily formed hybrid aptamer nanocamrriers HyApNc revealed a high stability against 
nucleases as tested in concentrated human blood serum and BSA.[238] The carriers showed a 
slow disintegration over time in both solutions but even after 12 hours more than 50 % of the  
 
Fig. 92: Both motifs, cMet targeting unit and doxorubicin carrier, both labelled with ATTO550 and 
ATTO647 on each 5'-end, exhibit a maximum FRET efficiency at a mixing ratio of 1:1 or 1:1.5. STM 
and AFM images of the formed mixed micellar nanoconstructs indicate a nearly spherical shape of the 
formed HyApNc nanoconstructs. The experiments were performed by Dr. Deepak Prust. The figure 
shows an adapted version of the figure found in reference[238].  
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nanoconstructs still remained intact. When injected into human systemic blood circulation, 
the inherent dilution during circulation possibly prevents a translation of the system for 
therapeutic applications. 
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5.3 Cell internalization and photoinduced doxorubicin release induce cell death 
Doxorubicin loaded HyApNc nanocarriers were used in combination with H1838 nsclc non 
small cell lung cancer cells to investigate the receptor-mediated cell internalization and 
photoinduced doxo-rubicin release efficiency. H1838 cells were reported to strongly 
overexpress cMet on their cell surface, therefore providing a useful cell line for cMet targeting. 
Introduction of the fluorescently labelled HyApNc including ATTO550 and ATTO647N was 
monitored by confocal microscopy (fig. 93, A).[238] ATTO550 and ATTO647N fluorescence as 
well as the resulting FRET signal of both dyes were monitored to follow position and stability 
of the nanoconstructs around or inside the cells. A FRET signal upon excitation of ATTO550 
could be observed inside the cytosol after cell uptake, manifesting a successful cell uptake of 
the nanocarriers. Execution of the experiments at 4°C showed no cell internalization over time, 
thus indicating an endocytotic cell uptake pathway since endocyctotic cell uptake is not 
possible at low temperatures.[238] 
Phototriggered doxorubicin release from the loaded HyApNc was also monitored by confocal 
microscopy making use of the doxorubicin self fluorescence (fig. 93, B+C). Free doxorubicin 
as a control already shows a diffusion into the cells and collocates inside the nucleus.[238] The  
 
 
Fig. 93: A) Confocal microscopy reveals a cell internalization of the HyApNc construct into H1838 non 
small cell lung cancer cells as observed by fluorescence and FRET signals inside the cytosol. B) + C): 
Doxorubicin fluorescence of the doxorubicin loaded HyApNc inside the cell before (B) and after (C) UV 
irradiation. All confocal images were recorded by Dr. Deepak Prusty. The figure shows an adapted 
version of the figure found in reference[238]. 
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Fig. 94: MTT staining after incubation with doxorubicin loaded HyApNc in different cell amounts with 
and without UV irradiation. Addition of the doxorubicin loaded HyApNc without UV irradiation leads to 
64 % cell survival after 24 hours while the doxorubicin loaded carrier reduces the cell survival rate 
down to 17 % after UV light irradiation. The experiments were performed by Dr. Deepak Prusty. The 
figure shows an adapted version of the figure found in reference[238]. 
doxorubicin loaded HyApNc exhibits a strong fluorescence mainly in the cytosol, indicating 
that doxorubicin is intercalated into to the carrier even inside the cytosol. Irradiation at 365 nm 
changes the doxorubicin fluorescence mainly to the nuclear region, indicating a release of 
doxorubicin and diffusion into the nucleus. This in vitro proof of concept demonstrates a 
general feasibility of doxorubicin loaded delivery into the cells and a phototriggered release of 
the payload within the target. 
To further test a photoinduced cell viability upon release of the payload from the doxorubicin 
loaded HyApNc an MTT cell staining assay was performed.[238] Alive cells thereby express a 
higher MTT signal than dead cells, showing a cell viability in dependency on the observed MTT 
signal. Different cell amounts were grown with and wihout incubation with the doxorubicin 
loaded HyApNc as well as with and without 365 nm irradiation (fig. 94). Cells without HyApNc 
and doxorubicin only irradiated with UV light and cells with HyApNc irradiated with UV light in 
absence of doxorubicin showed cell survival rates comparable to the native untreated cells. 
Cells treated with doxorubicin loaded HyApNc in absence of UV light shows a drop in cell 
survival down to 64 % which might be caused by a partial doxorubicin diffusion from the 
nanoconstruct into the cycoplasm or partial disintegration of the construct inside the cell. UV 
exposure of these cells further decreases the cell survival rate down to 17 %, indicating an 
efficient photoinduced cell death. After 48 hours, cell viability significantly increases when 
using a doxorubicin loaded HyApNc without UV irradiation, showing a disintegration of the 
construct or a doxorubicin diffusion out of the carrier over time. While the unloaded carrier and 
pure UV irradiation do not reveal any significant effect on cell viability, the combination of 
doxorubicin and HyApNc proves an efficient photoinduced cell viability. 
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Although the doxorubicin delivery approach using HyApNc nanocarriers showed a 
successful doxorubicin deliver into cancer cells and a photoinduced cell viability in vitro in 
H1838 nsclc cells, a translation into mouse models or the use as a therapeutic system is highly 
limited through the overall micelle stability. Systemic dilution of the micelles possibly leads to 
a disintegration of the HyApNc, thus peventing an efficient delivery of doxorubicin into the cells. 
This issue could be improved by covalent crosslinking of the lipid chains within both motifs in 
the core structure to provide a higher HyApNc stability. 
6. Conclusion and Outlook 
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6. Conclusion and outlook 
6.1 Summary and conclusions 
The three main criteria for an ideal DNA photoswitch for use in long-term applications remain 
high conversion efficiencies between both stereo isomers, reversible photoswitching in visible 
light range while maintaining a high thermal cis state stability. Based on these three criteria, 
the systematic synthetic and spectroscopic development of new azobenzene and 
arylazopyrazole photochromes emerged a series of D-threoninol bound molecules with 
improved photophysical properties compared to the reported azobenzene series. While a tetra 
ortho fluorinated azobenzene phosphoramidite (TFAB) could not be obtained synthetically, 
azobenzenes with two ortho substituents in 2'- and 6'-position on the peripheral ring could be 
successfully synthesized and revealed visible light photoconversion from trans to cis and vice 
versa accompanied by retaining high thermal cis stabilities. Further synthetic development 
resulted in two azobenzene derivatives, 2’,6’-difluoroazobenzene (DFAB) and 2’,6’-
dimethoxyazobenzene (DOAB), which could successfully be obtained as DMT-protected 
phosphoramidites and were consecutively implemented into a series of DNA strands. Beyond 
azobenzenes, two arylazopyrazole photochromes, N-methylarylazopyrazole (AAP1) and N-
phenylarylazopyrazole (AAP2), could both be synthesized successfully as DMT-protected 
phosphoramidites and were also introduced into the same set of DNA strands with different 
lengths and positions. 
All newly designed D-threoninol coupled photochromes revealed red-shifted response 
wavelengths further into visible light range compared to azobenzene as observed in empirical 
reversed-phase HPLC quantifications involving all D-threoninol bound photochromes as well 
as single modified 8-mer DNA strands. Determination of thermal stabilities showed half-life 
times between ten and several hundred hours at room temperature. Unfortunately, the most 
stable photochrome 2',6'-dichloroazobenzene (DCAB) could not be obtained successfully as a 
DMT-protected phosphoramidite.  
Both arylazopyrazole photochromes AAP1 and AAP2 on the other hand revealed near-
quantitative two-way isomerization between the trans and cis state. These two photochromes 
could be synthesized in high overall yields and successfully be translated from D-threoninol 
bound small molecules into a series of DNA strands with different lengths and GC-contents. In 
contrast to the DNA duplex stabilization observed for all azobenzene photochromes, 
arylazopyrazoles resulted in a duplex destabilization. While AAP1 does not significantly alter 
the native DNA duplex melting temperatures in trans, AAP2 showed a severe duplex 
destabilizing effect. AAP1 isomerization to cis significantly decreased the duplex melting  
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temperatures even at room temperature irradiation. The stabilizing effect of azobenzene and 
its derivatives upon DNA duplex introduction which yet resulted in the mandatory use of 
elevated irradiation temperatures could successfully be eliminated by the destabilizing effect 
of both arylazopyrazoles on DNA duplexes. Furthermore, the minimum synthetic load could be 
reduced significantly from one photoswitch per two base pairs (NNX-motif) to one photoswitch 
per three base pairs (NNNX-motif) while retaining room temperature photoswitching and 
offering a successful photoinduced duplex dissociation in strands with GC-contents above 
50 %. The superior photoswitch-ing properties of AAP1 and AAP2 could further be proven in 
a series of melting curve and duplex hybridization experiments involving DNA hairpins and 
macromolecular double-stranded DNA nanoconstructs. Even DNA strands with GC-contents 
of 66 % could successfully decrease the melting temperature upon room temperature 
irradiation when modified with AAP1 or AAP2 moieties. Interestingly, using competitive strand 
displacement in DNA hairpins revealed a successful reversible hairpin opening and closing 
even when using an AAP1 NNNNX-motif with one photoswitch per four base pairs. 
Azobenzene modified release oligomers within the same systems did not result in any 
reversible hairpin opening and closing, possibly due to an increased duplex stabilization upon 
azobenzene intercalation. Cooperativity between the hybridizing hairpin stem regions in 
combination with photoswitch-modified opening oligomers revealed the complexity which 
requires a sophisticated design for introduction of photoswitches into complex DNA 
nanosystems. 
Unfortunately, a successful translation of all newly designed photoswitches into higher order 
DNA systems could not be established. A macromolecular dsDNA [2]catenane system was 
designed to provide a prototype for investigating coherent and independent photoswitching 
properties using differently modified complementary sequences for a series of photochrome 
combinations. Structural investigations via AFM proved the successful structural assembly 
and, in combination with additional gel experiments, revealed a systemic interconversion 
between two different stalled states using non-modified complementary release oligomers. 
Photoswitch-modified release oligomers could not be tested within the system due to the 
described synthetic limitations. 
All experiments proved that a sophisticated design of modified DNA sequences in 
combination with the chemical nature of photochromes, their amount and positions as well as 
the wise selection of photochrome combinations are absolutely required to achieve efficient 
photocontrolled DNA hybridizaion in macromolecular systems and cooperative effects when 
using a series of different photochrome types. Empirical development of photochromes 
facilitated the prediction of maximum response wave-lengths when translating a combination 
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of two or more small molecule photochromes into the same DNA system as resulted from 
multiple HPLC quantifications. Unfortunately, combina-torial photoswitching of multiple 
photochromes could not be investigated within the course of this thesis. 
Further synthetic effort has to be performed to finally achieve coherently and independently 
addressable photochromes for multi-state DNA photoswitching systems. On the long road 
towards reaching this ultimate goal, arylazopyrazoles AAP1 and AAP2 prove valuable and 
versatile molecules, expanding the yet available toolbox of DNA photoswitches. 
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6.2 Future perspectives 
Synthetic design and development of new azobenzene and arylazopyrazole based 
phosphoramidites constitutes a straight forward project with practically unlimited possibilities 
for introducing functional azobenzene and arylazopyrazole moieties into DNA backbones in 
different positional and numerous combinations. Further multicyclic and heterocyclic 
photochrome molecules beyond arylazopyrazoles have been reported during the time course 
of this project, potentially offering more versatile and promising candidates for the improvement 
of photocontrol over oligonucleotide duplexes.[261] Especially the development of 
photochromes with high conversion efficiencies back and forth in visible or even infrared light 
range still remains a highly ambitious goal, possibly offering deeper light penetration into living 
tissue. Heterocyclic molecules became the center of attention in this context as potent 
photochromes beyond azobenzenes. Future developments may target more towards the 
development of heterocyclic photochromes rather than using azobenzene based 
photochromes. 
As proven in this abstract, sophisticated design and substitution of photochromic molecules 
in combination with oligonucleotide sequences facilitates the development of photoresponsive 
multi-state systems. Including UV-responsive photochromes, DNA nanotechnology 
applications switching between a multitude of different states become possible. This prevails 
one main prerequisite for the development of multi-state nano assembly lines, factories, data 
storage devices or nanomachines which are controlled by light. The vast complexity of such 
projects requires a multitude of orthogonal and independent photoswitches, thus enabling 
consecutive, orthogonal and independent photoswitching of multiple photochromes within the 
same system. A long road to success which still has to be gone. Since the accessible light 
range can be used from UV to visible light, also the development of Stenhouse adducts and 
other structurally different photoswitches might bring projects in this field along. 
The ultimate goal still remains reversible light addressation of oligonucleotide duplex 
hybridization inside cells and living organisms for phototherapeutic applications. One of the 
main discoveries and developments in this field is the photocontrolled gene knockdown by 
photoresponsive antisense oligonucleotides,[262] the so-called antagomiRs, offering a photo-
controlled gene regulation through the systematic introduction of photochromes. Also 
photoresponsive siRNAs could be of great interest. Furthermore, the use of photoresponsive 
aptamers in vivo affords a reversible photocontrol of receptor inhibition, thus potentially turning 
on and off signal cascades of special cellular receptors. This plays a key role in many disease 
models where receptor activities and signal cascades are suppressed or overexpressed. 
Optical control of receptors and metabolic  
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pathways has successfully been proven by D. Trauner by vision restoration in blind mice.[228] 
Further optically accessible receptors provide useful targets for future therapeutic projects. The 
developed lipid-mediated hybrid aptameric nanocarrier system presents a versatile tool for 
future developments using phototriggered lipid nanoparticles in combination with additional 
targeting moieties and further transporting systems instead of a doxorubicin carrier and anti 
cMet aptamers.  
The possible combination of photochromes and functionalized oligonucleotides is virtually 
unlimited and even more than two functional motifs within a single photoresponsive micellar 
nanoconstruct are thinkable. Beyond the described phototriggered doxorubicin carrier, other 
physical triggers can be used to release molecules within a cell. Cancer cells usually exhibit 
lower pH values than non-diseased cells, facilitating a pH-triggered release mechanism for 
agents in acidic cellular environments. I-motif structures constitue pH-dependent triggerable 
secondary structures which can be used as inherent triggers to release molecules within cells 
with a low pH trigger. A pH triggered release mechanism inside cells does not necessitate any 
external stimulus and potentially only triggers in cells with low pH, preferably cancer cells. A 
hybrid lipid nanocarrier containing a targeting functionality combined with a pH trigger would 
include an automatic trigger for payload release inside cancer cells. 
The use of light, despite all the discussed advantages, has its limitations concerning 
applicability in living systems and therapeutic areas since its penetration depth is highly limited 
and light cannot reach targets deep inside the human body without bringing light sources 
deeply into the body. Therefore, non light triggers have to be used to fully reach targets all over 
the human body. Heat and time triggered delivery systems or antisense oligonucleotides 
possibly lead to a time dependent back-relaxation of photochromes inside the oligonucleotides 
while circulating through the human body and might unfold its potency over time at the site of 
interest. As demonstrated by AAP1, a thermal back-relaxation by switching AAP1 modified 
oligomers into cis conformation in combination with a further functionality which is activated 
through AAP1 in trans conformation can be used to achieve different effects over time.  
Another physical trigger which can penetrate the whole human body is electricity. Electricity 
can be used in antisense oligonucleotides in combination with electrochemically responsive 
moieties, thus leading to an electro-triggered DNA duplex formation or dissociation to control 
cellular and metabolic functions. Phenazines have been reported in this context to isomerize 
from an all over planar aromatic structure to a reduced non-planar structure containing two 
separated aromatic rings.[263-264] Both rings are connected by two amine moieties, thus leading 
to a bending of the molecular structure. The electric potential for a reversible electrochemical 
reduction of phenazines is rather low with +0.2 V and can easily be applied in the human body.  
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Theoretically, the planar aromatic phenazine and its derivatives attached to D-threoninol 
possibly intercalate between the stacked DNA base pairs analogous to azobenzene and lead 
to a duplex destabilization in its reduced form. Also, further molecules could be investigated in 
this context in future developments. 
All described possibilities may be of high interest in future developments but any limitations 
for each described method have to be considered when developing systems including new 
triggers. 
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7. Experimental section 
7.1 Materials and methods 
Chemicals and devices 
All chemical reactions were performed on air at room temperature with reagent grade purity 
chemicals ordered from ABCR, ACROS, Alfa Aesar, Fluorochem UK, Merck Millipore, Sigma 
Aldrich, TCI Chemicals and VWR. Special reaction conditions are stated in the corresponding 
procedures. Thin layer chromatography (TLC) was performed on aluminium coated silica gel 
plates. Purification of small molecule compounds via column chromatography was performed 
on an automated Interchim PuriFlash 430 flash chromatography column with a pressure of 10 
bar. Pre-packed silica gel columns from Interchim and Grace were used with a particle size of 
50 µm and 40 µm respectively and column sizes of 12 g, 25 g, 40 g and 80 g high purity silica. 
All compounds were dried after isolation by a high vacuum pump with a maximum pressure 
up to 1∙10-2 millibar. NMR-spectra were measured on Bruker Advance 300 MHz, 400 MHz and 
500 MHz NMR machines in deuterated solvents from ALFA or Sigma Aldrich at room 
temperature. The corresponding measurement frequencies for all NMR spectra are given in 
each synthesis procedure. Mass-spectra were measured on by the mass spectrometry 
department of the chemical institutes of the Univeristy of Bonn. 
 
Preparative High Performance Liquid Chromatography (HPLC) 
Purification of small molecules by preparative HPLC was done on an Agilent 1200 Series 
system by Agilent Technologies with a Gemini Preparative C18 column 30 x 75 mm 5 μm. 
HPLC-grade acetonitrile and Millipore water with 0.1 % formic acid were used as eluents. 
 
Analytical High Performance Liquid Chromatography (HPLC) 
Analysis and purification of small molecules and oligonucleotide-strands was performed on 
a semi-preparative Agilent 1100 Series HPLC system by Agilent Technologies. DNA and RNA 
analysis and workup were done with an Agilent Eclipse XDB-C18 column 4.5 x 150 mm and a 
particle size of 5 μm. Small molecule quantifications were done on a Nucleodur 
pentafluorophenylpropyl (PFP) column 150x2 mm with a particle size of 5 μm. Weak anionic 
exchange chromatography was performed on a TOSOH DNA-NPR column 4.5 x 75 mm with 
a particle size of 5 μm. 
All buffers were prepared in Millipore water and HPLC grade solvents. Buffers were filtered 
through a 0.2 μm Nylon membrane filter and degassed in vacuo using an ultrasonic bath for 
10 minutes before usage. 
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DNA synthesis and workup 
If not further specified, all modified and unmodified DNA strands were synthesized either by 
Microsynth AG, Schützenstrasse 34, Balgach, Switzerland or in the Famulok group lab on an 
ABI Applied Biosystems 3400 DNA synthesizer on CPG (controlled pore glass) solid supports 
in 0.2 μmol scale. Further details are given in section 5.3.3. 
 
UV/Vis-spectroscopy and melting curve analysis 
All UV/Vis measurements and melting curves were performed on a JASCO V630 Bio 
Spectrophotometer with an automated 6-slot cuvette changer including a thermostat and 
Hellma Analytics ultra micro cuvettes 105.202_QS 10 mm with a minimum volume of 50 μL. 
Small molecule samples for UV/Vis spectroscopy were diluted by Millipore purity water and 
HPLC-grade acetonitrile. Standard scan range for all UV/Vis absorption measurements ranged 
from 220 nm to 650 nm. DNA samples were diluted in Millipore purity water and measured in 
the same wavelength range. 
DNA melting curves were performed with the same technical equipment, but all 
oligonucleotide strands were diluted in 0.5 M NaCl solution. Melting curves were measured 
between 10 °C and 60 °C for 8-mer duplexes and between 20 °C and 80 °C for all other DNA 
strands. Melting temperatures were determined by use of the JASCO melting temperature 
software provided with the device. 
 
Fluorescence Measurements 
Fluorescence measurements were performed on an EnSpire Multimode Plate Reader by 
Perkin Elmer Inc. in flat-bottom 96 well OptiPlates or flat bottom 364 well ProxyPlates. Sample 
volumes, excitation wavelengths and emission wavelength ranges are given in the 
corresponding experimental procedures. 
 
LCMS-measurements 
Liquid chromatography mass spectrometry (LCMS) was performed on an esquire HCT series 
ESI mass spectrometer by Bruker Daltonics connected to an Agilent 1100 series HPLC 
system. All samples were separated on an Agilent Zorbax SB-C18 column 2.1x50mm with a 
flow rate of 0.4 mL/minute. 
For separation and measurement of small molecules, a solution of 0.1 mg/mL of each sample 
was dissolved in 95/5 Millipore purity water and acetonitrile and filtered through a 0.2 μm PTFE 
filter membrane. All samples were separated by a gradient of 95/5 -> 0/100 acetonitrile and 
Millipore water containing 0.1 % formic acid. Oligonucleotide strands were diluted in Millipore  
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water in a concentration between 5 and 10 μM and separated by a gradient of 100/0 -> 80/20 
TAE buffer containing 1 % hexafluoroisopropanol (HFIP) and acetonitrile. 
 
Gel electrophoresis 
Agarose gel chromatography was performed with High Resolution Agarose from Carl Roth 
GmbH (Germany) in horizontal gel electrophoresis chambers by Bio-Rad Laboratories GmbH 
(Germany) attached to an external power supply.  
Polyacrylamide gel chromatography (PAGE) was performed using a Rotiphorese 
Sequenziergel 30 solution by Carl Roth GmbH containing 30% acrylamide in water. The PAGE 
gels were run in Mini Protean Tetra Cell Systems gel chambers by Bio-Rad Laboratories GmbH 
in Mini Protean Spacer Cells 10.1x8.2 cm. 
 
Buffers and solvents 
All buffers were mixed in Millipore purity water and filtered through a 0.2 μm cellulose sterile 
filter membrane before usage. Buffers for HPLC-purification- and quantification-runs were 
degassed for 10 minutes under reduced pressure after sterile filtration. The following buffers 
were used for all experiments and purifications: 
Melting curves buffer:  0.5 M NaCl, pH = 7.0. 
TAE-buffer:    40 mM Tris, 20 mM acetic acid, 1 mM EDTA, pH = 8.3. 
TBE-buffer:    89 mM Tris, 89 mM boric acid, 2 mM EDTA, pH = 7.6. 
TEAAc-buffer:   100 mM glacial acetic acid, 100 mM trimethylamine, pH = 7.0. 
DA-buffer:    10 mM Tris, 50 mM NaCl, 10 mM MgCl2, pH = 7.5. 
WaxA-buffer:   20 mM Tris, pH = 9.0. 
WaxB-buffer:   20 mM Tris, 1 M NaCl, pH = 9.0. 
 
Atomic Force Microscopy 
Atomic Force Microscopy was performed on a Nanowizard 3 instrument by JPK instruments 
on mica surfaces in intermittend contact mode in air (AC-mode) and liquid (Hyperdrive mode). 
All buffers, solvents and sample solutions were filtered through a 0.2 μm PTFE-filter before 
usage.  
In AC-mode, the samples were immobilized in a marked area on a freshly cleaved mica-
surface, which was obtained by removal of the top layer on the mica surface by a tape strip. 
Each sample in a concentration between 1 and 5 nM in 1xDA-buffer was incubated for 1 minute 
on the surface, followed by rinsing of the surface area three times with Millipore water and 
drying in an air flow. Samples were directly taken after this procedure. 
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LED-irradiation-machine 
For all irradiation procedures, an irradiation machine specially designed for the working 
group Famulok by the electrical department of the University Bonn was used (fig. 95). The 
irradiation machine consists of several LEDs with a high light output and narrow bandwidths 
for irradiation of all samples with a distinct wavelength range. The technical details including 
wavelength (WL), bandwidth (BW) and other technical details for all LEDs are given below. 
 
Fig. 95: LED irradiation machine used for all irradiation experiments. Complete closed apparatus (left) 
and open apparatus showing all slots for irradiation vials (right). Technical details for all irradiation 
LEDs are given in table 24 below. 
Slot LED WL BW max. I max. U Output 
1 UVTOP320-TO18-FW 325nm 10nm 20mA 6,2 V 180 mW 
2 NICHIA NCSU033B 365nm 10nm 500mA 3,8 V 450 mW 
3 NICHIA NCSU034B 385nm 10nm 500mA 3,7 V 540 mW 
4 VL400-Emitter 400nm 10nm 500mA 3,6 V 350 mW 
5 APG2C1-420 420nm 20nm 350mA 3,5 V 130 mW 
6 VL440-Emitter 440nm 10nm 350mA 3,2 V 350 mW 
7 Edixeon S Series royal blue 450nm 10nm 700mA 3,5 V 81 mW 
8 APG2C3-470 470nm 10nm 700mA 4,0 V 30 lm 
9 APG2C1-490 490nm 35nm 350mA 3,3 V 130 mW 
10 APG2C1-505 505nm 35nm 350mA 3,5 V 130 mW 
11 APG2C3-530 530nm 20nm 700mA 4,0 V 120 lm 
12 APG2C3-590 590nm 20nm 700mA 2,8 V 36 lm 
13 ELJ-630-628 630nm 20nm 350mA 2,5 V 70 mW 
14 2 x UVTOP335-FW-SMD 340nm 10 nm 30mA 6,2 V 400 mW 
15 2 x UVTOP345-FW-SMD 350nm 10 nm 30mA 6,2 V 400 mW 
Tab. 24: Technical details for all irradiation LEDs built into the irradiation machine. LED type, output 
wavelengths (WL), bandwidth (BW) and maximum current and voltage are given for each implemented 
LED. The respective maximum light output is given in lumen (lm). 
7. Experimental section 
142 
The LEDs were installed with digital time-, current- and temperature controlling devices. 
Temperature-control ranges from 20 °C to 100 °C and time-control between 1 millisecond and 
9000 seconds. All wavelengths and bandwidths were chosen to cover the whole range of the 
visible light spectrum without large wavelength-gaps. 
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7.2 Synthetic procedures for all synthesized small molecules 
7.2.1 Synthesis of azobenzene phosphoramidite[192] 
 
 
Ethyl-4-nitrosobenzoate (1)[250] 
Ethyl-4-nitrobenzoate (100 g, 512 mmol) was dissolved in 1.25 L 2-methoxyethanol and 
mixed with NH4Cl (54.6 g, 1.02 mol) dissolved in 250 mL distilled water. The resulting mixture 
was stirred for 15 minutes at room temperature, then cooled to 0 °C. Zinc-powder (100 g, 1.53 
mol) was added slowly over 30 minutes at 0 °C and the reaction mixture was stirred at 0 °C for 
1 hour, then warmed up to room temperature and stirring was continued for 24 hours. All solid 
residues were filtered off and rinsed twice with 50 ml of 2-methoxyethanol. A solution of 
FeCl3∙6H2O (375 g, 1.37 mol) in 2 L water and 350 mL ethanol was prepared and cooled to 
0 °C. The filtrate was added slowly to the prepared solution at 0 °C over 30 minutes and the 
resulting mixture was stirred for 1 hour at 0 °C. 500 mL ice cold water was added and the 
yellow precipitate was collected by filtration. The product was isolated by recrystallization from 
a 2:1 mixture of water and ethanol as a bright yellow solid (yield: 57.0 g, 62 %).  
1H-NMR (300 MHz, CDCl3) δ [ppm] = 8.29 (dt, 2 H, 3J6,5 = 8.5 Hz, 4J6,6’ = 1.8 
Hz, H6), 7.98 (dt, 2 H, 3J5,6 = 8.5 Hz, 4J5,5’ = 1.8 Hz, H5), 4.36 (q, 2 H, 3J2,1 = 7.1 
Hz, H2), 1.36 (t, 3 H, 3J1,2 = 7.1 Hz, H1). 
 13C-NMR (75 MHz, CDCl3) δ [ppm] = 164.9 (C3), 164.1 (C7), 135.2 (C5), 130.6 
(C6), 120.0 (C4), 61.5 (C2), 13.9 (C1). 
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MS (ESI, positive) m/z (%) 179.1 (100) [M]+, 149.0 (14) [M-NO]+, 124.1 (54) [C7H8O2]+. 
HRMS (ESI, positive) m/z calculated for C9H9NO3: 179.0582, found: 179.0577. 
 
Ethyl-4-carboxyazobenzene (2)[192] 
Ethyl-4-nitrosobenzoate (1) (5.50 g, 30.7 mmol) and aniline (3.43 g, 3.4 mL, 36.8 mmol) were 
dissolved in 250 mL glacial acetic acid and the reaction mixture was stirred for 48 hours at 
room temperature. 150 mL water were added and the resulting mixture was neutralized with 
sodium bicarbonate. The resulting mixture was extracted twice with 250 mL ethyl acetate, the 
organic layer was washed subsequently with 300 mL water, 500 mL saturated sodium 
bicarbonate solution and 300 mL brine. The organic layer was dried over MgSO4 and all 
solvents were removed in vacuo. The product was isolated by column chromatography (silica, 
eluent: cyclohexane) as a red solid (yield: 5.46 g, 70 %). 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.20 (dd, 2 H, 3J5,6 = 8.7 Hz, 4J5,5’ = 
2.1 Hz, H5), 7.95 (m, 4 H, H6+H9), 7.53 (m, 3 H, H10+H11), 4.44 (q, 2 H, 3J2,1 = 7.1 
Hz, H2), 1.44 (t, 3 H, , 3J1,2 = 7.1 Hz, H1). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 166.0 (C3), 155.0 (C4), 152.5 (C7), 
131.6 (C8), 130.5 (C11), 129.2 (C5), 123.4 (C9), 123.1 (C10), 122.6 (C6), 61.2 (C2), 
14.3 (C1). 
MS (ESI, negative) m/z (%) 255.1 (100) [M+H]+. 
HRMS (EI, 70 eV) m/z calculated for C15H15N2O2: 255.1128, found: 255.1133. 
 
4-Carboxyazobenzene (3)[192] 
Ethyl-4-carboxyazobenzene (2) (5.0 g, 19.7 mmol) was dissolved in 200 mL ethanol and 60 
mL 2 M aqueous NaOH was added. The reaction mixture was stirred for 6 hours at room 
temperature, then 150 mL hydrochloric acid (1 M) was added. The reaction mixture was 
extracted two times with 250 mL ethyl acetate each, the combined organic layers were washed 
twice with 250 mL water and 250 mL brine and the organic layer was dried over MgSO4. All 
solvents were removed in vacuo to yield a red solid (yield: 4.42 g, quant.). 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 13.31 (s, 1 H, H1), 8.18 (m, 2 H, H4), 
7.97 (m, 4 H, H5+H8), 7.63 (m, 3 H, H9+H10).  
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 166.7 (C2), 154.3 (C3), 151.9 (C6), 
132.9 (C7), 130.6 (C10), 129.6 (C4), 123.7 (C8), 122.8 (C9), 122.5 (C5). 
MS (ESI, negative) m/z (%) 225.0 (100) [M-H]-. 
HRMS (EI, 70 eV) m/z calculated for C13H9N2O2: 225.0659, found: 225.0652. 
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4-Carboxyazobenzene-D-threoninol (“AB”) (4)[192] 
4-Carboxyazobenzene (3) (10.0 g, 44.2 mmol), DCC (10.9 g, 53.0 mmol), OxymaPure (6.91 
g, 48.6 mmol) and D-threoninol (5.11 g, 48.6 mmol) were mixed in 400 mL dry DMF under 
argon atmosphere. The reaction mixture was stirred for 24 hours under argon atmosphere at 
room temperature. All solids were filtered off and DMF was removed in vacuo. The product 
was isolated by column chromatography (silica, eluent: chloroform/methanol = 95/5) as a red 
solid (yield: 11.8 g, 85 %). 
TLC (SiO2, eluent: chloroform/methanol = 10:1) Rf = 0.32. 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 8.09-8.06 (m, 2 H, 
H10), 7.95-7.91 (m, 5 H, H11+H14+H16),7.63-7.58 (m, 3 H, 
H15+H7), 4.63-4.59 (m, 2 H, H1+H3), 3.96-3.91 (m, 2 H, H4), 3.63-
3.61 (m, 1 H, H2), 3.53-3.51 (m, 1 H, H5), 1.09 (d, 3 H, 3J6,2 = 6.2 Hz, H6). 
13C-NMR (125 MHz, DMSO-d6) δ [ppm] = 166.0 (C8), 153.4 (C12), 152.1 (C13), 137.2 (C16), 
132.1 (C15), 129.7 (C10), 128.8 (C14), 122.9 (C11), 122.4 (C9), 65.1 (C2), 60.7 (C3), 57.1 (C4), 
20.4 (C6). 
MS (ESI, positive) m/z (%) 649.3 (14) [2M+Na]+, 336.1 (100%) [M+Na]+, 247.2 (18 %) [M-
C4H9O2+Na]+∙. 
HRMS (ESI, positive) m/z calculated for C17H19N3O3Na: 336.1319 [M+Na]+, found: 
336.1316 [M+Na]+.  
 
DMT-protected 4-carboxyazobenzene-D-threoninol (5)[192] 
4-Carboxyazobenzene-D-threoninol (4) (1.0 g, 3.19 mmol) and 4-DMAP (19.6 mg, 0.16 
mmol) were mixed in 20 mL dry pyridine under argon atmosphere and cooled to 0 °C. 4,4’-
dimethoxytritylchloride (1.19 g, 3.51 mmol) was dissolved in 15 mL dry dichloromethane and 
added dropwise to the reaction mixture at 0 °C under argon atmosphere. The reaction mixture 
was warmed up to room temperature and stirred under argon atmosphere for 24 hours. All 
solvents were removed in vacuo and the product was isolated column chromatography (silica, 
eluent: cyclohexane/ethyl acetate = 1/1 with 3 % triethylamine) as a red foamy solid (yield: 
0.84 g, 43%). 
1H-NMR (400 MHz, CDCl3) δ [ppm] = 8.50-8.47 (m, 2 H, H9), 7.91-7.85 (m, 2 H, H18), 7.60-
7.55 (m, 1 H, H15), 7.60-7.41 (m, 2 H, H10), 7.34-7.08 (m, 11 H, H13+H14+H19+H20+H22), 6.86-
6.68 (m, 4 H, H23), 4.19-4.06 (m, 1 H, H6), 3.70-3.65 (m, 6 H, H25), 3.51-3.30 (m, 2 H, H1+H3), 
1.85-1.81 (m, 2 H, H4), 1.62-1.48 (m, 1 H, H2), 1.28-0.96 (m, 3 H, H5). 
13C-NMR (100 MHz, CDCl3) δ [ppm] = 167.0 (C7), 158.5 (C24), 154.3 (C11), 152.5 (C12), 149.7 
(C17), 147.5 (C21), 144.3 (C14), 139.6 (C19), 136.0 (C9), 131.6 (C22), 129.9 (C20), 129.1 (C18),  
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127.8 (C15), 127.0 (C10), 123.7 (C8), 123.1 (C13), 113.1 (C23), 86.9 (C16), 68.6 (C4), 65.3 (C2), 
55.2 (C25), 54.1 (C3), 20.1 (C5). 
MS (ESI, positive) m/z (%) 638.3 (73) [M+Na]+, 303.1 (100) [DMT]+. 
HRMS (ESI, positive) m/z calculated for C38H37N3O5Na: 638.2625, found: 638.2622. 
 
 
DMT-protected 4-carboxyazobenzene-D-threoninol phosphoramidite (6)[192] 
DMT-protected 4-carboxyazobenzene-D-threoninol (5) (0.50 g, 0.81 mmol) was dissolved in 
10 mL extra dry dichloromethane under argon atmosphere and the solution was cooled to 0 °C. 
DiPEA (0.15 mL, 0.89 mmol) was added dropwise to the solution and the reaction mixture was 
stirred for 10 minutes at 0 °C. 2-Cyanoethyl-N,N-diisopropylchlorophosophoramidite (0.20 mL, 
0.89 mmol) was added dropwise to the reaction mixture at 0 °C under argon atmosphere and 
the reaction mixture was stirred for 10 minutes at 0 °C, then warmed up to room temperature 
and stirred for 2.5 hours. All solvents were removed in vacuo. The product was isolated via 
column chromatography (silica, eluent: cyclohexane/ethyl acetate = 1/1 with 3 % triethylamine) 
as a red foamy solid (yield: 0.41 g, 62 %). 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 7.96-7.88 (m, 3 H, H8+H14), 7.52-7.40 (m, 3 H, 
H17+H19), 7.33-7.13 (m, 10 H, H9+H12+H13+H21), 6.81-6.76 (m, 6 H, H18+H22), 4.48-4.36 (m, 1 
H, H5), 3.75-3.74 (m, 9 H, H24+H28+H3), 3.57-3.48 (m, 2 H, H4), 3.34-3.32 (m, 1 H, H6), 3.04-
2.98 (m, 1 H, H6’), 2.86 (s, br, 1 H, H2), 2.62-2.31 (m, 2 H, H29), 1.34-0.96 (m, 15 H, H1+H27). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 166.4 
(C6), 158.6 (C23), 154.2 (C10), 152.5 (C11), 147.4 
(C20), 144.8 (C16), 139.5 (C13), 135.9 (C19), 131.5 
(C8) 130.1 (C21), 129.1 (C18), 128.2 (C17), 128.0 
(C14), 127.8 (C9), 127.0 (C10), 123.1 (C12), 117.7 
(C30), 113.1 (C22), 86.1 (C15), 81.4 (C2), 69.2 (C4), 
62.7 (C28), 55.2 (C3), 51.8 (C24), 43.1 (C26), 39.1 
(C29), 24.6 (C27), 20.6 (C1). 
31P-NMR: (162 MHz, CDCl3) δ [ppm] = 148.7.  
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MS (ESI, positive) m/z (%) 838.4 (10) [M+Na]+, 130.2 (100) [C6H7N2+Na]+.  
HRMS (ESI, positive) m/z calculated for C47H54N5O6PNa: 838.3704, found: 838.3698. 
 
 
7.2.2 Synthesis of 2’,6’-dimethylazobenzene phosphoramidite[192] 
 
 
Ethyl-4-carboxy-2’,6’-dimethylazobenzene (7)[192] 
Ethyl-4-nitrosobenzoate (1) (40.41 g, 226 mmol) and 2,6-dimethylaniline (35.20 g, 36.0 mL, 
290 mmol) were dissolved in 2 L glacial acetic acid. The reaction mixture was stirred for 48 
hours at room temperature, then 500 mL water were added and the resulting mixture was 
neutralized with sodium carbonate. The mixture was extracted twice with 2 L ethyl acetate and 
the organic layer was washed subsequently with 2 L water, 2 L saturated sodium bicarbonate 
solution and 1 L brine. The organic layer was dried over MgSO4 and all solvents were removed 
in vacuo. The product was isolated by column chromatography (silica, eluent: cyclohexane) as 
a red solid (yield: 46.0 g, 72 %). 
1H-NMR (400 MHz, CDCl3) δ [ppm] = 8.23 (m, 2 H, H5), 7.93 (m, 2 H, H6), 
7.21 (m, 3 H, H10+H11), 4.46 (q, 2 H, 3J2,1 = 7.1 Hz, H2), 2.41 (s, 6 H, H12), 1.46 
(t, 3 H, 3J1,2 = 7.1 Hz, H1). 
13C-NMR (100 MHz, CDCl3) δ [ppm] = 166.0 (C3), 155.2 (C7), 150.9 (C8), 
132.2 (C4), 131.4 (C5), 130.6 (C10), 129.3 (C9), 128.9 (C11), 122.2 (C6), 61.2 
(C2), 19.1 (C12), 14.3 (C1). 
MS (ESI, positive) m/z (%) 283.1 [M+H]+, 194.1 [C11H11N2+Na]+. 
HRMS (ESI, positive) m/z calculated for C17H19N2O2: 283.1441, found: 283.1449. 
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4-Carboxy-2’,6’-dimethylazobenzene (8)[192] 
Ethyl-4-carboxy-2’,6’-dimethylazobenzene (7) (3.69 g, 13.1 mmol) was dissolved in 130 mL 
ethanol. 40 mL 2 M aqueous NaOH solution was added and the reaction mixture was stirred 
for 6 hours at room temperature, then 90 mL 1 M hydrochloric acid was added. The reaction 
mixture was extracted two times with 150 mL ethyl acetate each, the combined organic layers 
were washed twice with 150 mL water and 150 mL brine and dried over MgSO4. All solvents 
were removed in vacuo to yield the product as a red solid (yield: 3.28 g, 98 %). 
1H-NMR (400 MHz, DMSO-d6) δ [ppm] = 13.07 (s, br, 1 H, H1), 8.15-8.12 (m, 
2 H, H4), 7.91-7.88 (m, 2 H, H5), 7.24-7.15 (m, 3 H, H9+H10), 2.31 (s, 6 H, H11). 
13C-NMR (100 MHz, DMSO-d6) δ [ppm] = 165.9 (C2), 153.8 (C6), 149.5 (C7), 
132.0 (C3), 130.0 (C4), 129.8 (C9), 128.5 (C8), 128.3 (C10), 121.3 (C5), 17.9 
(C11). 
MS (ESI, negative) m/z (%) 253.1 (100) [M-H]-. 
HRMS (ESI, negative) m/z calculated for C15H13N2O2: 253.0972, found: 
253.0974. 
 
4-Carboxy-2’,6’-dimethylazobenzene-D-threoninol (“DMAB”) (9)[192] 
4-Carboxy-2’,6’-dimethylazobenzene (8) (10.0 g, 39.3 mmol) and D-threoninol (4.96 g, 47.2 
mmol) were dissolved in 250 mL extra dry DMF under argon atmosphere. HBTU (17.9 g, 47.2 
mmol) was dissolved in 150 mL extra dry DMF and added dropwise to the reaction mixture. 
The resulting solution was stirred for 24 hours at room temperature under argon atmosphere, 
followed by filtering off all solids and removal of DMF in vacuo. The product was isolated by 
column chromatography (silica, eluent: CHCl3/MeOH = 95/5) as a red solid (yield: 12.5 g, 
93 %). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.30. 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.10-8.08 (m, 2 H, 
H10), 7.94-7.89 (m, 3 H, H7+H11), 7.21-7.16 (m, 3 H, H15+H16), 
4.66 (s, br, 2 H, H1+H3), 3.96 (m, 2 H, H4), 3.63-3.61 (m, 1 H, 
H2), 3.55-3.52 (m, 1 H, H5) 2.34 (s, 6 H, H17), 1.10 (s, 3 H, H6). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 165.9 (C8), 153.6 (C12), 150.4 (C13), 137.0 (C16), 
130.6 (C15), 129.2 (C10), 128.9 (C14), 128.7 (C9), 121.9 (C11), 64.9 (C2), 60.5 (C3), 56.9 (C4), 
20.3 (C6), 18.6 (C17).  
MS (ESI, positive) m/z (%) 364.2 (100%) [M+Na]+. 
HRMS (ESI, positive) m/z calculated for C19H23N3O3Na: 364.1632 [M+Na]+, found: 364.1635 
[M+Na]+.  
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DMT-protected 4-carboxy-2’,6’-dimethylazobenzene-D-threoninol (10)[192] 
4-Carboxy-2’,6’-dimethylazobenzene-D-threoninol (9) (3.60 g, 10.54 mmol) and 4-DMAP (65 
mg, 0.53 mmol) were mixed in 80 mL dry pyridine under argon atmosphere and cooled to 0 °C. 
4,4’-dimethoxytritylchloride (3.93 g, 11.6 mmol) was dissolved in 60 mL dry dichloromethane 
and added dropwise to the reaction mixture at 0 °C under argon atmosphere. The mixture was 
warmed up to room temperature and stirred under argon atmosphere for 24 hours. All solvents 
were removed in vacuo and the product was isolated by column chromatography (silica, eluent: 
cyclohexane/ethyl acetate = 1/1 with 3 % triethylamine) as a red foamy solid (yield: 5.37 g, 
79 %). 
1H-NMR (400 MHz, CDCl3) δ [ppm] = 7.91-7.96 (m, 4 H, H9+H19), 7.11-7.40 (m, 9 H, 
H9+H10+H21+H23), 6.91-6.89 (m, 1 H, H15), 6.77-6.81 (m, 6 H, H14+H24), 4.19-4.25 (m, 1 H, H4), 
4.12-4.15 (m, 1 H, H4’), 3.74 (s, 6 H, H26), 3.57-3.61 (m, 1 H, H6), 3.46-3.16 (m, 3 H, H1+H2+H3), 
2.39 (s, 6 H, H16), 1.17-1.22 (m, 3 H, H5).  
13C-NMR (100 MHz, CDCl3) δ [ppm] = 166.8 (C7), 158.4 (C25), 154.3 (C11), 150.8 (C12), 144.1 
(C18), 135.9 (C14), 135.2 (C20), 131.1 (C9), 129.7 (C23), 129.1 (C21), 128.9 (C19), 128.7 (C15), 
127.8 (C10), 127.6 (C8), 126.8 (C22), 122.4 (C13), 113.1 (C24), 86.7 (C17), 68.6 (C4), 65.2 (C2), 
55.0 (C26), 53.9 (C3), 19.9 (C5), 18.9 (C16). 
MS (ESI, positive) m/z (%) 666.3 (5) [M+Na]+, 512.4 (14) [C32H34NO5]+, 449.4 (50) 
[C26H24N3O3Na]+, 328.3 (100) [C23H20O2]+, 303.1 (52) [DMT]+,  
HRMS (ESI, positive) m/z calculated for C40H41N3O5Na: 666.2938, found: 666.2971. 
 
 
DMT-protected 4-carboxy-2’,6’-dimethylazobenzene-D-threoninol phosphoramidite 
(11)[192] 
DMT-protected 4-carboxy-2’,6’-dimethylazobenzene-D-threoninol (10) (1.00 g, 1.55 mmol) 
was dissolved in 15 mL dry dichloromethane under argon atmosphere and the solution was 
cooled to 0 °C. DiPEA (0.29 mL, 1.70 mmol) was added dropwise to the solution and the 
reaction mixture was stirred for 10 minutes at 0 °C under argon atmosphere. 2-Cyanoethyl-
N,N-diisopropylchloro-phosophoramidite (0.38 mL, 0.17 mmol) was added dropwise to the  
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reaction mixture at 0 °C and the reaction mixture was stirred for 10 minutes at 0 °C, then 
warmed up to room temperature and stirred for 2.5 hours under argon atmosphere. All solvents 
were removed in vacuo and the product was isolated via column chromatography (silica, 
eluent: cyclohexane/ethyl acetate = 1/1 with 3 % triethylamine) as a red foamy solid (yield: 
1.06 g, 81 %). 
1H-NMR (400 MHz, CD2Cl2) δ [ppm] = 7.94-7.89 (m, 2 H, H8), 7.65-7.39 (m, 2 H, H18), 7.35-
7.14 (m, 10 H, H9+H13+H19+H22), 7.03-6.91 (m, 1 H, H20), 6.85-6.78 (m, 4 H, H23), 6.60-6.41 
(m, 1 H, H14), 4.48-4.34 (m, 1 H, H5), 3.87-3.67 (m, 7 H, H25+H2), 3.59-3.54 (m, 3 H, H4), 3.38-
3.20 (m, 2 H, H27), 3.02-2.99 (m, 1 H, H3), 2.62-2.38 (m, 6 H, H15), 1.95-.1.93 (m, 1 H, H29), 
1.58 (s, 1 H, H29’), 1.34-1.26 (m, 2 H, H30), 1.24-0.94 (m, 15 H, H1+H28). 
31P-NMR: (100 MHz, CD2Cl2) δ [ppm] = 148.5. 
MS (ESI, positive) m/z (%) 866.4 (100) [M+Na]+, 303.1 (92) [DMT]+. 
HRMS (ESI, positive) m/z calculated for C49H58N5O6PNa: 866.4017 [M+Na]+, found: 
866.4011 [M+Na]+. 
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7.2.3 Synthesis of 2’,6’-dimethyl-4’-methylthioazobenzene phosphoramidite[198] 
 
2,6-Dimethyl-4-methylthioaniline (12)[198] 
2,6-Dimethylaniline (20.0 g, 165 mmol) and dry aluminium chloride (1.46 g, 10.9 mmol) were 
mixed and heated to 150 °C for 30 minutes. The reaction mixture was cooled to 100 °C and 
dimethyl-disulfide (15.5 g, 165 mmol) was added dropwise to the solution. The reaction mixture 
was refluxed for 16 hours, then cooled down to room temperature. The reaction mixture was 
quenched with 200 mL 1 M aqueous NaOH solution and extracted twice with 500 mL ethyl 
acetate. The combined organic layers were washed with 1 L brine and dried over MgSO4. The 
product was isolated by column chromatography (silica, eluent: cyclohexane/ethyl acetate = 
19/1) as a yellowish oil (yield: 12.85 g, 47 %). 
1H-NMR (400 MHz, CDCl3) δ [ppm] = 7.00 (s, 2H, H3), 3.66 (s, br, 2 H, H1), 
2.42 (s, 3 H, H5), 2,17 (s, 6 H, H6). 
13C-NMR (100 MHz, CDCl3) δ [ppm] = 141.3 (C1), 129.8 (C4), 124.7 (C3), 
122.3 (C2), 18.8 (C6), 17.4 (C5).  
MS (ESI, positive) m/z (%) 168.1 (100) [M+H]+. 
HRMS (ESI, positive) m/z calculated for C9H14NS: 168.0841, found: 168.0841.  
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Ethyl-4-carboy-2’,6’-dimethyl-4’-methylthioazobenzene (13)[198] 
Ethyl-4-nitrosobenzoate (1) (12.9 g, 71.7 mmol) and 2,6-dimethyl-4-methylthioaniline (12) 
(10.0 g, 59.8 mmol) were mixed in 350 mL glacial acetic acid and the reaction mixture was 
stirred for 24 hours at room temperature. 200 mL water was added and the resulting mixture 
was neutralized with sodium carbonate. The resulting crude mixture was extracted twice with 
500 mL ethyl acetate, the combined organic layers were washed subsequently with 500 mL 
water, 500 mL saturated sodium bicarbonate solution and 500 mL brine. The organic layer was 
dried over MgSO4 and all solvents were removed in vacuo. The product was isolated by column 
chromatography (silica, eluent: cyclohexane) as a red solid (yield: 10.0 g, 42 %). 
1H-NMR (400 MHz, CDCl3) δ [ppm] = 8.20 (m, 2 H, H5), 7.87 (m, 2 H, H6), 
6.98 (s, 2 H, H10), 4.43 (q, 2 H, 3J2,1 = 7.1 Hz, H2), 2.51 (s, 3 H, H13), 2.46 (s, 6 
H, H12), 1.44 (t, 3 H, 3J1,2 = 7.1 Hz, H1). 
13C-NMR (100 MHz, CDCl3) δ [ppm] = 165.8 (C3), 155.3 (C7), 147.2 (C8), 
140.5 (C4), 133.3 (C5), 130.3 (C10), 126.1 (C9), 123.2 (C11), 121.9 (C6), 61.0 
(C2), 19.8 (C12), 15.0 (C1), 14.1 (C13). 
MS (ESI, positive) m/z (%) 329.1 (100) [M+H]+. 
HRMS (ESI, positive) m/z calculated for C18H21N2O2S: 329.1318, found: 329.1310. 
 
4-Carboxy-2’,6’-dimethyl-4’-methylthioazobenzene (14)[198] 
Ethyl-4-carboxy-2’,6’-dimethyl-4’-methylthioazobenzene (13) (9.90 g, 30.1 mmol) was 
dissolved in 750 mL ethanol and 100 mL 2 M aqueous NaOH solution was added. The reaction 
mixture was stirred for 6 hours at room temperature, then 220 mL hydrochloric acid (1 M) was 
added. The reaction mixture was extracted twice with 300 mL ethyl acetate, the combined 
organic layers were washed twice with 100 mL water and 100 mL brine. The organic layer was 
dried over MgSO4 and all solvents were  
removed in vacuo to yield the product as a red solid (yield: 8.54 g, 94 %). 
1H-NMR (400 MHz, DMSO-d6) δ [ppm] = 13.29 (s, br, 1 H, H1), 8.16 (m, 2 H, 
H4), 7.88 (m, 2 H, H5), 7.06 (s, 2 H, H9), 2.51 (s, 3 H, H12), 2.40 (s, 6 H, H11). 
13C-NMR (100 MHz, DMSO-d6) δ [ppm] = 166.1 (C2), 154.2 (C6), 146.0 (C7), 
140.3 (C3), 132.5 (C4), 130.0 (C9), 125.2 (C8), 123.1 (C10), 121.4 (C5), 18.9 (C11), 
13.5 (C12). 
MS (ESI, negative) m/z (%) 299.1 (38) [M-H]-, 166.0 (100) [C9H12NS]-. 
HRMS (ESI, negative) m/z calculated for C16H15N2O2S: 299.0849, found: 299.0855. 
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4-Carboxy-2’,6’-dimethyl-4’-methylthioazobenzene-D-threoninol (“S-DMAB”) (15)[198] 
4-Carboxy-2’,6’-dimethyl-4’-methylthioazobenzene (14) (1.74 g, 5.78 mmol), D-
threoninol∙HCl (0.90 g, 6.36 mmol) and NEt3 (0.96 mL, 6.93 mmol) were dissolved in 35 mL 
dry DMF under argon atmosphere. HBTU (2.63 g, 6.93 mmol) was dissolved in 25 mL dry DMF 
and added dropwise to the reaction mixture. The resulting solution was stirred for 24 hours 
under argon atmosphere at room temperature, all solids were filtered off followed by removal 
of DMF in vacuo. The product was isolated by column chromatography (silica, eluent: 
CHCl3/MeOH = 95/5) as a red solid (yield: 2.21 g, 99 %). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.28. 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.30-8.28 (m, 1 
H, H10), 8.15-8.05 (m, 3 H, H10+H11), 7.94-7.86 (m, 2 H, H15), 
4.67 (s, br, 2 H, H3+H7), 3.96-3.91 (m, 2 H, H4), 3.50-3.65 (m, 
2 H, H5), 3.34 (s, br, 1 H, H1), 2.52 (s, 3 H, H18), 2.40 (s, 6 H, 
H17), 1.09 (t, 3 H, 3J6,2 = 6.4 Hz, H6). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 165.9 (C8), 153.9 (C12), 146.7 (C13), 140.5 (C16), 
136.6 (C14), 132.9 (C10), 128.6 (C15), 125.8 (C11), 121.7 (C9), 64.9 (C4), 60.5 (C2), 56.9 (C3), 
20.3 (C17), 19.5 (C6), 14.2 (C18). 
MS (ESI, positive) m/z (%) 388.2 (15) [M+Na]+. 
HRMS (ESI, positive) m/z calculated for C20H25N3O3SH: 388.1689 [M+H]+, found: 388.1681 
[M+H]+.  
 
DMT-protected 4-carboxy-2’,6’-dimethyl-4’-methylthioazobenzene-D-threoninol (16)[198] 
4-Carboxy-2’,6’-dimethyl-4’-methylthioazobenzene-D-threoninol (15) (1.97 g, 5.08 mmol) 
and 4-DMAP (30 mg, 0.26 mmol) were dissolved in 30 mL dry pyridine under argon 
atmosphere and cooled to 0 °C. 4,4’-dimethoxytritylchloride (1.89 g, 5.59 mmol) was dissolved 
in 15 mL dry dichloromethane and the resulting solution was added dropwise to the reaction 
mixture at 0 °C under argon atmosphere. The reaction mixture was warmed up to room 
temperature and stirred under argon atmosphere for 24 hours. All solvents were removed in 
vacuo and the product was isolated by silica gel chromatography (eluent: cyclohexane/ethyl 
acetate = 1/1 with 3 % triethylamine) as a red foamy solid (yield: 2.23 g, 64 %). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 8.57-7.62 (m, 4 H, H9+H20), 7.38-7.34 (m, 2 H, H21), 
7.28-7.13 (m, 6 H, H10+H24), 6.97 (s, 1 H, H22), 6.89-6.74 (m, 6 H, H14+H25), 4.23-4.11 (m, 2 H, 
H4), 3.75-3.72 (m, 9 H, H17+H27), 3.59-3.51 (m, 1 H, H6), 3.42-3.36 (m, 1 H, H3), 3.25-3.11 (m, 
1 H, H1), 2.49-2.37 (m, 6 H, H16), 2.01-1.77 (m, 1 H, H2), 1.21-1.18 (m, 3 H, H5).  
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13C-NMR (125 MHz, CDCl3) δ [ppm] = 167.0 (C7), 165.6 (C26), 158.7 (C23), 154.8 (C19), 149.7 
(C11), 147.5 (C12), 144.3 (C15), 140.5 (C22), 135.3 (C9), 133.4 (C24), 129.9 (C21), 129.1 (C20), 
128.0 (C13), 126.4 (C14), 123.8 (C10), 122.5 (C8), 113.3 (C25), 86.9 (C18), 68.7 (C4), 65.4 (C27), 
56.2 (C2), 54.0 (C3), 20.1 (C16), 19.9 (C5), 15.2 (C17). 
 
 
DMT-protected 4-carboxy-2’,6’-dimethyl-4’-methylthioazobenzene-D-threoninol phos-
phoramidite (17)[198] 
DMT-protected 4-carboxy-2’,6’-dimethyl-4’-methylthioazobenzene-D-threoninol (16) (1.00 g, 
1.45 mmol) was dissolved in 15 mL dry dichloromethane under argon atmosphere and the 
solution was cooled to 0 °C. DiPEA (0.28 mL, 1.60 mmol) was added dropwise to the solution 
and the reaction mixture was stirred for 10 minutes at 0 °C. 2-Cyanoethyl-N,N-
diisopropylchlorophosophoramidite (0.36 mL, 1.60 mmol) was added dropwise to the reaction 
mixture at 0 °C and stirring was continued for 10 minutes at 0 °C, then warmed up to room 
temperature and stirred for 2.5 hours under argon atmosphere. All volatiles were removed in 
vacuo and the product was isolated via column chromatography (silica, eluent: 
cyclohexane/ethyl acetate = 1/1 with 3 % triethylamine) as a red foamy solid (yield: 0.91 g, 
69 %). 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.30-7.80 (m, 3 H, H8+H21), 7.69-7.15 (m, 10 H, 
H9+H19+H20+H23), 7.02-6.64 (m, 6 H, H13+H24), 4.48-4.38 (m, 2 H, H4), 3.81-3.75 (m, 7 H, 
H5+H26), 3.59-3.47 (m, 3 H, H16), 3.35-2.95 (m, 2 H, H27), 2.71-2.35 (m, 7 H, H15+H3), 1.95-1.92 
(m, 1 H, H2), 1.58-0.94 (m, 19 H, H1+H28+H29+H30). 
31P-NMR: (162 MHz, CDCl3) δ [ppm] = 149.0, 148.7. 
MS (ESI, positive) m/z (%) 912.4 (26) [M+Na]+, 866.4 (10) [M-CH2S+Na]+, 303.1 (100) 
[DMT]+. 
HRMS (ESI, positive) m/z calculated for C50H60N5O6PSNa: 912.3894 [M+Na]+, found: 
912.3878 [M+Na]+.  
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7.2.4 Synthesis of ortho-substituted azobenzenes (“azobenzene-library”) 
 
 
Nitrosobenzene (18)[251] 
Aniline (100 g, 1.07 mol), 35 % H2O2 (146.15 g, 4.29 mol) and MoO3 (15.46 g, 107 mmol) 
were mixed with a 108 mL 1 M aqueous KOH-solution, 300 mL methanol and 400 mL water. 
The reaction mixture was cooled to 4 °C and stirred for 20 hours, then extracted two times with 
1 L ethyl acetate each. The combined organic layers were washed with 1 L water and 1 L brine. 
All solvents were removed under reduced pressure to yield the product as a brownish white 
solid (yield: 63.92 g, 56 %). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 7.91-7.89 (m, 2 H, H2), 7.72-7.69 (m, 1 H, H4),  
7.64-7.61 (m, 2 H, H3). 
13C-NMR (125 MHz, CDCl3) δ [ppm] = 165.8 (C1), 135.5 (C4), 129.3 (C3), 120.9 (C2). 
MS (EI, 70 eV) m/z (%) 107.0 (63) [M]+∙, 77.0 (100) [C6H5]+. 
 
2,6-Difluoro-nitrosobenzene (19)[252] 
To a solution of 2,6-difluoroaniline (10.0 g, 77.4 mmol) in 400 mL dichloromethane a solution 
of MCPBA (38.19 g, 155 mmol) in 350 mL dichloromethane was added dropwise at 0 °C over 
1.5 hours. The reaction mixture was continued stirring and warmed up slowly to room 
temperature over 2 hours. 300 mL dichloromethane was added and the reaction mixture was 
washed subsequently with two times 500 mL 2 % Na2S2O3 solution, four times 500 mL 
saturated NaHCO3 solution and twice with 300 mL water. All solids were filtered off and all  
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solvents were removed in vacuo to yield the product as a brownish white solid (yield: 10.31 
g, 93 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.68-7.58 (m, 1 H, H4), 7.16-7.08 (m, 2 H, H3). 
19F-NMR (100 MHz, CDCl3) δ [ppm] = -130.5 (F5). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 151.4 (C2), 137.0 (C1), 129.0 (C4), 112.8 
(C3). 
MS (EI, 70 eV) m/z (%) 143.1 (100) [M]+∙, 113.1 (65) [C6H3F2]+, 63.1 (31) 
[C5H3]+. 
HRMS (EI, 70 eV) m/z calculated for C6H3F2NO: 143.0183, found: 143.0183. 
 
Azobenzene (20)[81] 
Aniline (0.37 g, 4.0 mmol) was mixed with 2 g KMnO4 and 2 g CuSO4 in 40 mL 
dichloromethane and the reaction mixture was stirred for 24 hours at room temperature. All 
solids were filtered off and rinsed twice with 10 mL dichloromethane. Dichloromethane was 
removed under reduced pressure and the product was isolated via column chromatography 
(silica, eluent: cyclohexane) as a red solid (yield: 0.11 g, 15 %). 
1H-NMR (400.1 MHz, CDCl3) δ [ppm] = 7.84 (d, 2 H, 3J2,3 = 6.8 Hz, 
H2), 7.43-7.34 (m, 3 H, H3+H4). 
13C-NMR (100.6 MHz, CDCl3) δ [ppm] = 152.7 (C1), 131.0 (C4), 129.1 
(C3), 122.9 (C2). 
 
2,6-Dimethylazobenzene (21) 
2,6-Dimethylaniline (1.36 g, 11.2 mmol) and nitrosobenzene (18) (1.0 g, 9.34 mmol) were 
dissolved in 80 mL glacial acetic acid and the reaction mixture was stirred for 24 hours at room 
temperature. 50 mL water were added and the mixture was neutralized with sodium 
bicarbonate. The crude reaction mixture was extracted twice with 100 mL ethyl acetate, the 
combined organic layers were collected and washed subsequently with 100 mL water, 200 mL 
saturated sodium bicarbonate solution and 100 mL brine, followed by drying over MgSO4. All 
solvents were removed under reduced pressure and the product was isolated by column 
chromatography (silica, eluent: cyclohexane) as a red solid (yield: 1.20 g, 61 %). 
1H-NMR (400.1 MHz, CDCl3) δ [ppm] = 7.82-7.79 (m, 2 H, H7), 7.44-
7.37 (m, 3 H, H8+H9), 7.04-7.01 (m, 3 H, H3+H4), 2.25 (s, 6H, H5). 
13C-NMR (100.6 MHz, CDCl3) δ [ppm] = 152.8 (C6), 151.5 (C1), 131.0 
(C9), 130.6 (C3), 129.1 (C8), 129.1 (C4), 128.1 (C2), 122.5 (C7), 18.8 
(C5). 
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MS (EI, 70 eV) m/z (%) 210.1 (72) [M]+∙, 105.1 (100) [C6H5N2]+, 77.0 (52) [C6H5]+. 
HRMS (EI, 70 eV) m/z (%) calculated for C14H13N2 [M-H]+: 209.1079, found: 209.1078. 
 
2,6-Difluoroazobenzene (22) 
Nitrosobenzene (18) (1.50 g, 14.0 mmol) and 2,6-difluoroaniline (2.17 g, 16.8 mmol) were 
dissolved in 150 mL glacial acetic acid and the reaction mixture was stirred for 24 hours at 
room temperature. 100 mL water was added, the mixture was neutralized with sodium 
bicarbonate and extracted twice with 100 mL ethyl acetate. The combined organic layers were 
washed subsequently with 150 mL water, 250 mL saturated bicarbonate solution and 150 mL 
brine. The remaining organic layer was dried over MgSO4 and all solvents were removed under 
reduced pressure. The product was isolated by column chromatography (silica, eluent: 
cyclohexane) as a red oil (yield: 0.71 g, 19 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 8.22-8.06 (m, 1 H, H4), 7.86-7.82 (m, 1 H, H9), 7.45-
7.36 (m, 3 H, H7+H8), 7.22-7.15 (m, 1 H, H8), 6.97-6.89 (m, 2 H, H3). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 156.7 (C2), 153.2 (C6), 131.9 
(C1), 130.2 (C9), 129.1 (C8), 125.5 (C7), 122.9 (C4), 112.6 (C3). 
19F-NMR (100 MHz, CDCl3) δ [ppm] = -121.75 (F5).  
MS (EI, 70 eV) m/z (%) 218.0 (47) [M]+∙, 198.1 (24) [M-HF] +∙, 141.0 (16) [C6H3F2N2]+, 105.0 
(37) [C6H5N2]+, 77.0 (100) [C6H5]+. 
HRMS (EI, 70 eV) m/z calculated for C12H8F2N2: 218.0655, found: 218.0656.  
 
2,6-Dichloroazobenzene (23) 
2,6-Dichloroaniline (2.50 g, 14.20 mmol) and nitrosobenzene (18) (1.59 g, 17.05 mmol) were 
dissolved in a mixture of 130 mL glacial acetic acid and 13 mL trifluoroacetic acid and the 
reaction mixture was stirred for 24 hours at room temperature. 100 mL water was added and 
the mixture was neutralized with sodium bicarbonate, then extracted twice with 150 mL ethyl 
acetate. The combined organic layers were washed subsequently with 250 mL water, 250 mL 
saturated sodium bicarbonate solution, and 150 mL brine. All volatiles were removed under 
reduced pressure and the product was isolated by column chromatography (silica, eluent: 
cyclohexane/ethyl acetate = 19/1) as a red solid (yield: 30 mg, 1 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.91-7.88 (m, 1 H, H7), 7.50-
7.47 (m, 2 H, H7), 7.35 (d, 2 H, 3J3,4 = 8.1 Hz, H3), 7.18-7.11 (m, 3 H, 
H8+H9), 7.00-6.97 (m, 1 H, H4). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 132.0 (C6), 128.9 (C1), 128.7 
(C4), 128.1 (C9), 128.0 (C8), 128.0 (C3), 122.7 (C7), 119.3 (C2). 
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MS (EI, 70 eV) m/z (%) 250.0 (48) [M]+∙, 144.9 (100) [C6H3Cl2]+, 105.0 (142) [C6H5N2]+, 77.0 
(100) [C6H5]+. 
HRMS (EI, 70 eV) m/z calculated for C12H8Cl2N2: 250.0065, found: 250.0067. 
 
2,6-Dimethoxyazobenzene (24) 
2,6-Dimethoxyaniline (69) (2.57 g, 16.81 mmol) and nitrosobenzene (18) (1.50 g, 14.00 
mmol) were dissolved in 150 mL glacial acetic acid and the reaction mixture was stirred for 24 
hours at room temperature. 100 mL water was added, the mixture was neutralized with sodium 
carbonate and extracted twice with 150 mL ethyl acetate. The combined organic layers were 
washed subsequently with 150 mL water, 250 mL saturated sodium bicarbonate solution and 
150 mL brine. The organic layer was dried over MgSO4 and all solvents were removed under 
reduced pressure. The product was isolated by column chromatography (silica, eluent: 
cyclohexane) as a red solid (yield: 1.78 g, 52 %). 
1H-NMR (400.1 MHz, CDCl3) δ [ppm] = 7.82-7.80 (m, 2 H, H7), 7.43-7.36 (m, 3 H, H8+H9), 
7.17 (t, 1 H, 3J4,3 = 8.4 Hz, H4), 6.59 (d, 2 H, 3J3,4 = 8.5 Hz, H3), 3.73 (s, 
6 H, H5). 
13C-NMR (100.6 MHz, CDCl3) δ [ppm] = 153.3 (C6), 152.3 (C2), 133.8 
(C1), 130.8 (C9), 129.5 (C8), 128.9 (C7), 122.6 (C4), 105.1 (C3), 56.4 (C5). 
MS (EI) m/z (%) 242.1 (88) [M]+·, 165.0 (100) [M-C6H5]+, 122.0 (62) [C7H6O2]+, 107.0 (69) 
[C7H7O]+. 
HRMS (EI) m/z (%) calculated for C14H14N2O2: 242.1055, found: 242.1057. 
 
2,2’,6,6’-Tetramethylazobenzene (25)[81] 
2,6-Dimethylaniline (0.49 g, 4.0 mmol) was mixed with 2 g KMnO4 and 2 g CuSO4 in 40 mL 
dichloromethane. The reaction mixture was stirred for 24 hours at room temperature, followed 
by filtering off all solids and rinsing twice with 10 mL dichloromethane. All volatiles were 
removed under reduced pressure and the product was isolated by column chromatography 
(silica, eluent: cyclohexane) as a red solid (yield: 0.14 g, 15 %). 
1H-NMR (400.1 MHz, CDCl3) δ [ppm] = 7.09-7.03 (m, 6 H, H3+H4), 2.33 
(s, 12 H, H5). 
13C-NMR (100.6 MHz, CDCl3) δ [ppm] = 151.4 (C1), 131.3 (C3), 129.4 
(C2), 128.4 (C4), 19.8 (C5). 
MS (EI, 70 eV) m/z (%) 238.0 (24) [M]+∙, 104.9 (100) [C8H9]+. 
HRMS (EI, 70 eV) m/z calculated for C16H18N2: 238.1470, found: 238.1464. 
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2,2’,6,6’-Tetrafluoroazobenzene (26)[253] 
2,6-Difluoroaniline (1.0 g, 7.75 mmol), K3Fe(CN)6 (10.2 g, 30.98 mmol) and KOH (0.87 g, 
15.5 mmol) were mixed in 25 mL water and 25 mL ethanol and refluxed for 24 hours. All solids 
were filtered off and the reaction mixture was extracted twice with 50 mL ethyl acetate. The 
combined organic layers were washed with 50 mL water and all solvents were removed in 
vacuo. The product was isolated by column chromatography (silica, eluent: cyclohexane) as a 
red solid (yield: 0.18 g, 18 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.42-7.33 (m, 2 H, H4), 7.10-7.02 
(m, 4 H, H3). 
19F-NMR (100 MHz, CDCl3) δ [ppm] = -119.8 (F5), -121.5 (F5’). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 157.0 (C2), 153.5 (C1), 131.3 (C4), 112.4 (C3). 
MS (EI, 70 eV) m/z (%) 254.0 (52) [M]+∙, 140.9 (73) [C6H3F2N2]+, 112.9 (100) [C6H3F2]+.  
HRMS (EI, 70 eV) m/z calculated for C12H6F4N2: 254.0467, found: 254.0466. 
 
2,2’,6,6’-Tetrachloroazobenzene (27)[81] 
2,6-Dichloroaniline (0.56 g, 4.0 mmol) was mixed with 2 g KMnO4 and 2 g CuSO4 in 40 mL 
dichloromethane. The reaction mixture was stirred for 24 hours at room temperature. All solids 
were filtered off and rinsed twice with 10 mL dichloromethane, followed by removal of 
dichloromethane under reduced pressure. The product was isolated by column 
chromatography (silica, eluent: cyclohexane) to yield a red solid (yield: 0.22 g, 17 %). 
1H-NMR (400 MHz, CDCl3) δ [ppm] = 7.41-7.32 (m, 2 H, H4), 7.22-7.06 
(m, 4 H, H3). 
13C-NMR (100 MHz, CDCl3) δ [ppm] =129.6 (C1), 129.4 (C3), 129.1 (C4), 
127.3 (C2). 
MS (EI, 70 eV) m/z (%) 317.9 (30) [M]+∙, 251.0 (20) [M-Cl2]+, 173.0 (93) [C6H3Cl2N2]+, 145.0 
(100) [C6H3Cl2]+, 109.0 (32) [C6H2Cl]+. 
HRMS (EI, 70 eV) m/z calculated for C12H6Cl4N2: 317.9285, found: 317.9284. 
 
2,2’,6,6’-Tetrabromoazobenzene (28)[81] 
2,6-Dibromoaniline (1.0 g, 4.0 mmol) was mixed with 2 g KMnO4 and 2 g CuSO4 in 40 mL 
dichloromethane. The reaction mixture was stirred for 48 hours at room temperature. All solids 
were filtered off and rinsed with 10 mL dichloromethane, then dichloromethane was removed 
under reduced pressure. The product was isolated by column chromatography (silica, eluent: 
cyclohexane) to yield a red solid (yield: 0.38 g, 19 %). 
1H-NMR (600 MHz, CDCl3) δ [ppm] = 7.59-7.62 (m, 4 H, H3), 6.93-6.95 (m, 2 H, H4).  
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13C-NMR (150 MHz, CDCl3) δ [ppm] = 146.2 (C1), 132.2 (C3), 126.8 (C4), 
113.3 (C2). 
MS (EI, 70 eV) m/z (%) 493.7 (43) [M]+∙, 260.8 (100) [C6H3Br2N2]+, 232.8 
(82) [C6H3Br2]+, 153.9 (20) [C6H3Br]+, 75.0 (32) [C6H3]+. 
HRMS (EI, 70 eV) m/z (%) calculated for C12H6Br4N2: 493.7264, found: 493.7262. 
 
2,2’,6,6’-Tetramethoxyazobenzene (29)[81] 
2,6-Dimethoxyaniline (69) (0.31 g, 2.0 mmol) was mixed with 1 g KMnO4 and 1 g CuSO4 in 
20 mL dichloromethane. The reaction mixture was stirred for 24 hours at room temperature. 
All solids were filtered off and rinsed with 10 mL dichloromethane followed by removal of all 
solvents under reduced pressure. The product was isolated by column chromatography (silica, 
eluent: cyclohexane) as a red solid (yield: 0.11 g, 18 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.20-7.09 (m, 2 H, H4), 6.64-6.62 
(m, 4 H, H3), 3.85 (s, 3 H, H5), 3.81 (s, 3 H, H5’), 3.77 (s, 6 H, H5’’). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 154.3 (C2), 152.3 (C2’), 149.9 (C1), 
129.2 (C4), 104.5 (C3), 100.1 (C3’), 56.5 (C5), 56.5 (C5’). 
MS (ESI, positive) m/z (%) 326.1 (73) [M+Na]+, 303.1 (100) [M+H]+. 
HRMS (ESI, positive) m/z calculated for C16H18N2O4H: 303.1339, found: 303.1341. 
 
2,6-Difluoro-2’,6’-dimethylazobenzene (30) 
2,6-Difluoro-nitrosobenzene (19) (2.0 g, 13.98 mmol) and 2,6-dimethylaniline (2.03 g, 
16.77 mmol) were dissolved in 150 mL glacial acetic acid. The reaction mixture was stirred for 
24 hours at room temperature, then 100 mL water was added and the mixture was neutralized 
with sodium bicarbonate. The crude mixture was extracted twice with 150 mL ethyl acetate 
and the combined organic layers were washed subsequently with 150 mL water, 250 mL 
saturated bicarbonate solution and 150 mL brine. The organic layer was dried over MgSO4 
and all solvents were removed under reduced pressure. The product was isolated by column 
chromatography (silica, eluent: cyclohexane) as a red solid (yield: 470 mg, 14 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.23-7.17 (m, 1 H, H4), 7.10-7.02 (m, 3 H, H3+H9), 6.98-
6.90 (m, 2 H, H8), 2.32 (s, 6 H, H10). 
19F-NMR (100 MHz, CDCl3) δ [ppm] = -116.9 (F5), -122.9 (F5’). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 156.8 (C2), 153.4 (C1), 151.4 (C6), 
131.1 (C8), 129.6 (C7), 128.9 (C9), 127.9 (C4), 112.2 (C3), 18.7 (C10). 
MS (EI, 70 eV) m/z (%) 246.1 (60) [M]+∙, 105.0 (100) [C6H5N2]+. 
HRMS (EI, 70 eV) m/z (%) calculated for C14H11F2N2 [M-H]+: 245.0890, found: 245.0890. 
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2,6-Difluoro-2’,6’-dimethoxyazobenzene (31) 
2,6-Difluoro-nitrosobenzene (19) (1.50 g, 10.48 mmol) and 2,6-dimethoxyaniline (69) (1.93 
g, 12.58 mmol) were dissolved in 120 mL glacial acetic acid and the reaction mixture was 
stirred for 24 hours at room temperature. 100 mL water was added and the reaction mixture 
was neutralized with sodium bicarbonate. The crude mixture was extracted twice with 100 mL 
ethyl acetate and the combined organic layers were washed subsequently with 100 mL water, 
200 mL saturated sodium bicarbonate solution and 150 mL brine. The organic layer was dried 
over MgSO4 and all solvents were removed under reduced pressure. The product was isolated 
by column chromatography (silica, eluent: cyclohexane) as a red solid (yield: 0.80 g, 27 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.22-7.15 (m, 2 H, H4+H9), 6.95 (d, 2 H, 3J3,4 = 8.4 Hz, 
H3), 6.60 (d, 2 H, 3J8,9 = 8.4 Hz, H8), 3.77 (s, 6 H, H10). 
19F-NMR (100 MHz, CDCl3) δ [ppm] = -120.5 (F5), -123.1 (F5’). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 156.6 (C2), 153.2 (C7), 152.4 (C1), 
133.6 (C6), 130.7 (C9), 129.4 (C4), 112.2 (C3), 104.8 (C8), 56.2 (C10).  
MS (EI, 70 eV) m/z (%) 278.0 (100) [M]+∙, 165.0 (20) [C8H9N2O2]+, 142.0 (93) [C6H4F2N2]+, 
122.0 (74) [C7H6O2]+, 107.0 (80) [C7H7O]+, 77.0 (34) [C6H5]+. 
HRMS (EI, 70 eV) m/z calculated for C14H12F2N2O2: 278.0867, found: 278.0866. 
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7.2.5 Attempted synthesis of 2,2’,6,6’-tetrafluoroazobenzene phosphoramidite 
First synthesis pathway] 
 
 
4-Bromo-2,6-difluoroaniline (32)[132] 
2,6-Difluoroaniline (5.0 g, 38.7 mmol) and N-bromosuccinimide (7.58 g, 42.6 mmol) were 
dissolved in 100 mL acetonitrile and the reaction mixture was stirred for 24 hours at room 
temperature. 100 mL water and 100 mL cyclohexane were added, the organic layer was 
separated and dried over MgSO4. All solvents were evaporated and the product was isolated 
by column chromatography (silica, eluent: dichloromethane/cyclohexane = 1/1) as a white 
brownish solid (yield: 7.26 g, 90 %). 
1H-NMR (400 MHz, CDCl3) δ [ppm] = 6.92-6.90 (m, 2 H, H4), 3.62 (s, br, H1). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 149.8 (C3), 123.1 (C2), 114.6 (C4), 106.9 
(C5). 
19F-NMR: (162 MHz, CDCl3) δ [ppm] = 130.9 (F6). 
MS (ESI, positive) m/z (%) 208.0 (100) [M+H]+. 
HRMS (ESI, positive) m/z calculated for C6H5BrF2N: 207.9568,  found: 
207.9562. 
 
4-Cyano-2,6-difluoroaniline (33)[132] 
4-Bromo-2,6-difluoroaniline (32) (28.5 g, 137 mmol) and CuCN (36.8 g, 411 mmol) were 
mixed in 300 mL DMF and refluxed for 16 hours, then cooled down to room temperature and 
purged into 300 mL 12% aqueous ammonia. The crude mixture was extracted twice with 300 
mL ethyl acetate, the combined organic layers were dried over MgSO4 followed by evaporation 
of all solvents. The product was isolated by column chromatography (silica, eluent:  
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dichloromethane/cyclohexane = 1/1) as a white solid (yield: 13.4 g, 63 %). 
1H-NMR (400 MHz, CDCl3) δ [ppm] = 7.08-7.05 (m, 2 H, H4), 4.22 (s, br, 2H, 
H1). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 151.8 (C3), 148.6 (C2), 129.5 (C6), 115.3 
(C5), 97.9 (C4). 
19F-NMR (162 MHz, CDCl3) δ [ppm] = -131.9 (F7). 
MS (ESI, positive) m/z (%) 155.0 (1) [M+H]+, 111.0 (100) [M-HCN-2HF+Na]+. 
HRMS (ESI, positive) m/z (%) calculated for C7H5F2N2: 155.0415, found: 155.0422. 
 
4-Cyano-2,2’,6,6’-tetrafluoroazobenzene (34) 
4-Cyano-2,6-difluoroaniline (33) (17.45 g, 122 mmol) and 2,6-difluoronitrosobenzene (18) 
(9.40 g, 61 mmol) were dissolved in 1.0 L glacial acetic acid and the reaction mixture was 
stirred for 48 hours at room temperature. 1.0 L water was added and the crude mixture was 
neutralized with sodium carbonate, followed by extraction with two times 1.0 L ethyl acetate. 
The combined organic layers were washed subsequently with 1.0 L water, 1.0 L saturated 
sodium hydrogen carbonate solution and 500 mL water. The organic phase was dried over 
MgSO4, all solvents were removed under reduced pressure and the product was isolated by 
column chromatography (silica, eluent: cyclohexane/ethyl acetate = 9/1) as a yellow solid 
(yield: 3.42 g, 10 %). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 7.66-7.44 (m, 1 H, H3), 7.38-
7.28 (m, 1 H, H3’), 7.17-7.00 (m, 3 H, H8+H9). 
19F-NMR: (125 MHz, CDCl3) δ [ppm] = -113.8, -120.8. 
MS (EI, 70 eV) m/z (%) 279.1 (100) [M]+∙, 166.1 (12) [C7H2F2N3]+, 
141.1 (34) [C6H3F2N2]+, 138.0 (19) [C7H2F2N]+, 113.0 (32) [C6H3F2]+. 
 
4-Carboxy-2,2’,6,6’-tetrafluoroazobenzene (35) 
4-Cyano-2,2’,6,6’-tetrafluoroazobenzene (34) (1.0 g, 3.58 mmol) was suspended in 40 mL 1 
M aqueous NaOH and refluxed for 20 hours. The reaction mixture was cooled to room 
temperature, acidified with 45 mL 1 M hydrochloric acid and extracted with 200 mL ethyl 
acetate. The organic layer was washed with 100 mL water, dried over MgSO4 and all volatiles 
were removed under reduced pressure. The product was isolated by column chromatography 
(silica, eluent: cyclohexane/ethyl acetate = 1/1) as a yellow solid (yield: 1.06 g, quant.). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 11.21 (s, br, 1 H, H1), 7.81-7.75 (m, 1 H, H10), 7.58-
7.50 (m, 2 H, H4), 7.43-6.90 (m, 2 H, H9).  
13C-NMR (500 MHz, DMSO-d6) δ [ppm] = 155.5 (C2), 153.5 (C5), 153.5 (C8), 133.9 (C6), 131.3  
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(C7), 127.0 (C10), 120.7 (C3), 114.0 (C4), 113.1 (C9). 
19F-NMR (500 MHz, CDCl3) δ [ppm] = -115.4, -123.0. 
MS (EI, 70 eV) m/z (%) 298.0 (3) [M]+∙, 270.0 (50) [M-CO]+, 157.0 
(18) [C7H3F2O2]+, 141.0 (50) [C6H3F2N2]+, 127.0 (100) [C6H3F2N]+, 
113.0 (64) [C6H3F2]+, 100 (30) [C5H2F2]+. 
Second synthesis pathway 
 
 
4-Carboxy-2,6-difluoroaniline (36)[132] 
4-Cyano-2,6-difluoroaniline (33) (8.0 g, 51.9 mmol) was suspended in 300 mL 1 M aqueous 
NaOH solution and refluxed for 16 hours. 320 mL 1 M aqueous hydrochloric acid was added 
to form a white precipitate and the crude mixture was extracted with 500 mL ethyl acetate. The 
organic layer was separated, dried over MgSO4 and all solvents were removed in vacuo to 
yield a white solid as the product (yield: 9.43 g, quant.). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 12.63 (s, br, 1 H, H7), 7.40 (m, 2 H, 
H4), 6.05 (s, br, 2 H, H1). 
13C-NMR (125 MHz, DMSO-d6) δ [ppm] = 166.5 (C6), 151.2 (C3), 131.1 (C4), 
116.1 (C2), 112.8 (C5). 
19F-NMR: (500 MHz, DMSO-d6) δ [ppm] = -131.6 (F8).  
MS (ESI, negative) m/z (%) 172.0 (100) [M-H]-, 128.0 (36) [M-CO2H]-, 108.0 [C6H3FN]-. 
HRMS (ESI, negative) m/z (%) calculated for C7H4F2NO2: 172.0216, found: 172.0226. 
 
4-Carboxy-2,6-difluoroaniline-D-threoninol (37) 
4-Carboxy-2’,6’-difluoroaniline (36) (2.26 g, 13.0 mmol), D-threoninol (1.51 g, 14.3 mmol) 
and HBTU (5.44 g, 14.3 mmol) were dissolved in 150 mL DMF and the reaction mixture was 
stirred for 24 hours at room temperature under argon atmosphere. All solid residues were 
filtered off and rinsed with DMF followed by evaporation of DMF under reduced pressure. The 
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crude product was purified by column chromatography (silica, eluent: chloroform/methanol = 
98/2) to yield a brownish white solid (yield: 3.01 g, 89 %). 
1H-NMR (500 MHz, DMF-d7) δ [ppm] = 7.57-7.50 (m, 1 H, H7), 7.50-
7.47 (m, 2 H, H10), 5.74 (s, 2 H, H13), 4.56-4.50 (m, 2 H, H3+H5), 3.86-
3.83 (m, 2 H, H4), 3.57-3.55 (m, 1 H, H1), 3.45-3.43 (m, 1 H, H2), 1.02 
(d, 3 H, 3J6,2 = 5.8 Hz, H6). 
13C-NMR (125 MHz, DMF-d7) δ [ppm] = 165.4 (C8), 151.9 (C11), 129.5 (C9), 121.0 (C12), 111.4 
(C10), 65.8 (C2), 61.3 (C4), 57.6 (C3), 21.0 (C6). 
19F-NMR: (500 MHz, DMSO-D6) δ [ppm] = -131.5. 
MS (EI, 70eV) m/z (%) 260.2 (10) [M]+∙, 258.2 (14) [M-H2]+∙, 198.1 (16) [C9H8F2N2O]+, 156.1 
(100) [C7H4F2NO]+, 114.1 (40) [C6H4F2]+. 
HRMS (EI, 70eV) m/z calculated for C11H14F2N2O3: 260.0972, found: 260.0976. 
 
Dimethylacetyl-4-carboxy-2,6-difluoroaniline-D-threoninol (38)[254] 
4-Carboxy-2’,6’-difluoroaniline-D-threoninol (37) (1.0 g, 3.48 mmol) and p-toluenesulfonic 
acid (75 mg, 0.1 eq) were dissolved in 40 mL acetone. 2,2-Dimethoxypropane (4.0 g, 34.8 
mmol) was added dropwise to the solution and the reaction mixture was stirred for 24 hours at 
room temperature. Acetone was removed under reduced pressure and the crude product was 
purified by column chromatography (silica, eluent: cyclohexane/ethyl acetate = 1/1) to yield a 
white solid (yield: 0.68 g, 65 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.38-7.31 (m, 2 H, H10), 
6.66-6.63 (m, 1 H, H7), 4.27-3.68 (m, 6 H, H2+H3+H4+H13), 1.52-1.40 
(m, 6 H, H6), 1.16-1.11 (d, 3 H, 3J1,2 = 6.3 Hz, H1). 
19F-NMR: (125 MHz, CDCl3) δ [ppm] = -132.2. 
MS (ESI, positive) m/z (%) 300.1 (4) [M]+∙, 285.1 (10) [M-CH3]+, 
198.0 (30) [C9H8F2N2O]+, 156.0 (100) [C7H4F2NO]+. 
HRMS (ESI, positive) m/z calculated for C14H18F2N2O3: 300.1285, found: 300.1289. 
 
tert-butylhypochlorite (39)[98] 
The following reaction was performed under exclusion of light and moisture! tert-Butanol 
(41.5 mL, 32.4 g, 437 mmol) and glacial acetic acid (25.0 mL, 26.25 g, 437 mmol) were mixed 
in a 1 L flask and cooled down to 0 °C. A 25 % aqueous NaOCl solution containing 12 % active 
chlorine (300 mL, 1.0 mol) was added in one portion and the resulting mixture was stirred 
vigorously for 15 minutes at 0 °C. The organic layer was separated and washed with 100 mL 
10% aqueous NaHCO3 solution and 100 mL water. The resulting colourless oily liquid was  
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collected as the pure product (42 g, 88 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 1.26 (s, 9H, Me-H). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 83.5, 26.4. 
 
 
7.2.6 Synthesis of 2’,6’-difluoroazobenzene phosphoramidite 
 
 
Ethyl-4-carboxy-2‘,6‘-difluoroazobenzene (40) 
Ethyl-4-nitrosobenzoate (1) (10.0 g, 55.8 mmol) and 2,6-difluoroaniline (14.4 g, 112 mmol) 
were dissolved in 400 mL glacial acetic acid and the reaction mixture was stirred for 24 hours 
at room temperature. 300 mL water was added and the resulting mixture was neutralized with 
sodium carbonate. The crude mixture was extracted twice with 500 mL ethyl acetate, the 
combined organic layers were washed subsequently with 500 mL water, 500 mL saturated 
sodium bicarbonate solution and 250 mL brine. The organic layer was dried over MgSO4 and 
all solvents were removed in vacuo. The product was isolated by silica gel chromatography 
(eluent: cyclohexane) as a red solid (yield: 10.9 g, 67 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 8.18-8.21 (m, 2 H, H5), 7.94-7.96 (m, 
2 H, H6), 7.32-7.38 (m, 1 H, H11), 7.03-7.07 (m, 2 H, H10), 4.44 (q, 2 H, 3J2,1 = 
7.1 Hz, H2), 1.44 (t, 3 H, 3J1,2 = 7.1 Hz, H1). 
19F-NMR: (162 MHz, CDCl3) δ [ppm] = -121.0, -132.9. 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 165.8 (C3), 156.9 (C7), 155.4 (C9), 132.9 
(C8), 131.1 (C5), 130.5 (C6), 122.6 (C4), 118.2 (C10), 112.7 (C11), 61.3 (C2), 14.2 
(C1). 
MS (ESI, positive) m/z (%) 291.1 (100) [M+H]+. 
HRMS (ESI, positive) m/z (%) calculated for C15H13F2N2O2: 291.0940, found: 291.0940. 
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4-Carboxy-2‘,6‘-difluoroazobenzene (41) 
Ethyl-4-carboxy-2’,6’-difluoroazobenzene (40) (10.0 g, 34.5 mmol) was dissolved in 350 mL 
ethanol and 86 mL 1 M aqueous sodium hydroxide solution and the reaction mixture was 
stirred for 8 hours at room temperature. The mixture was acidified with 90 mL 1 M hydrochloric 
acid and extracted two times with 250 mL ethyl acetate. The combined organic layers were 
washed subsequently with 200 mL water and 100 mL brine, dried over MgSO4 and all volatiles 
were removed under reduced pressure to yield the product as a red solid (yield: 6.62 g, 73 %). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 13.28 (s, 1 H, H1), 8.16-8.13 (m, 2 
H, H5), 7.94-7.91 (m, 2 H, H4), 7.62-7.56 (m, 1 H, H10), 7.35-7.31 (m, 2 H, H9). 
13C-NMR (125 MHz, DMSO-d6) δ [ppm] = 167.0 (C2), 156.5 (C6), 155.1 (C8), 
134.2 (C7), 133.1 (C3), 131.2 (C4), 123.0 (C5), 118.8 (C10), 113.7 (C9). 
19F-NMR: (162 MHz, DMSO-d6) δ [ppm] = -120.1 (F11), -121.5 (F11’). 
MS (ESI, negative) m/z (%) 261.0 (100) [M-H]-. 
HRMS (ESI, negative) m/z calculated for C13H7F2N2O2: 261.0470, found: 
261.0476. 
 
4-Carboxy-2‘,6‘-difluoroazobenzene-D-threoninol (“DFAB”) (42) 
4-Carboxy-2’,6’-difluoroazobenzene (41) (1.0 g, 3.81 mmol), D-threoninol (0.44 g, 4.20 
mmol) and HBTU (1.59 g, 4.20 mmol) were mixed in 40 mL DMF and the reaction mixture was 
stirred for 24 hours at room temperature under argon atmosphere. All solids were filtered off, 
DMF was removed under reduced pressure and the crude mixture was purified by column 
chromatography (silica, eluent: chloroform/methanol = 98/2) to yield a red solid (yield: 0.90 g, 
69 %). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.28. 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.31-8.08 (m, 3 H, 
H10+H16), 8.01-7.92 (m, 2 H, H11), 7.70-7.28 (m, 3 H, H7+H15),  
4.53 (s, br, 2 H, H1+H5), 3.97-3.93 (m, 2 H, H4), 3.67-3.49 (m, 
2 H, H2+H3), 1.10-1.03 (m, 3 H, H6). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 165.8 (C8), 162.3 (C12), 153.7 (C14), 137.9 (C13), 
128.8 (C10), 127.1 (C16), 124.4 (C16’), 123.3 (C11), 122.3 (C11’), 119.0 (C9), 109.7 (C15), 65.0 
(C2), 60.5 (C4), 57.0 (C3), 20.2 (C6). 
19F-NMR: (162 MHz, CDCl3) δ [ppm] = -120.0, -121.5.  
MS (ESI, positive) m/z (%) 721.2 (88) [2M+Na]+, 372.1 (100) [M+Na]+, 350.1 (86) [M+H]+. 
HRMS (ESI, positive) m/z (%) calculated for C17H17F2N3O3Na:372.1130, found: 372.1135. 
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DMT-protected 4-carboxy-2‘,6‘-difluoroazobenzene-D-threoninol (43) 
4-Carboxy-2’,6’-difluoroazobenzene-D-threoninol (42) (0.33 g, 0.95 mmol) and 4-DMAP (6 
mg, 0.05 mmol) were dissolved in 8 mL dry pyridine under argon atmosphere and cooled to 
0 °C. 4,4’-dimethoxytritylchloride (0.36 g, 1.05 mmol) was dissolved in 7 mL dry dichloro-
methane and added dropwise to the reaction mixture at 0 °C. The reaction mixture was warmed 
up to room temperature and stirred under argon atmosphere for 24 hours. All volatiles were 
removed in vacuo and the product was isolated by silica gel chromatography (eluent: 
cyclohexane/ethyl acetate = 1/1 with 3 % triethylamine) as a red foamy solid (yield: 0.42 g, 
66 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 8.47 (s, br, 1 H, H9), 8.17-8.07 (m, 1 H, H9’), 7.89-7.54 
(m, 3 H, H19+H21), 7.33-6.65 (m, 15 H, H10+H14+H15+H20+H23+H24), 4.32-3.97 (m, 4 H, 
H3+H4+H6), 3.69-3.64 (m, 6 H, H26), 3.49-3.30 (m, 2 H, H1+H2), 1.29-1.06 (m, 3 H, H5). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 165.4 (C7), 158.9 (C25), 158.3 (C11), 149.2 (C12), 148.7 
(C18), 144.0 (C22), 139.6 (C20), 139.2 (C13), 136.4 (C21), 135.1 (C9), 130.5 (C23), 129.6 (C19), 
128.8 (C14), 127.9 (C15), 126.7 (C10), 123.4 (C8),  
113.0 (C24), 86.5 (C17), 67.7 (C4), 64.4 (C2), 62.8 (C3), 54.8 (C26), 19.9 (C5). 
19F-NMR: (162 MHz, CDCl3) δ [ppm] = -119.4, -121.0. 
MS (ESI, positive) m/z (%) 1325.5 (46) [2M+Na]+, 674.3 (100) [M+Na]+, 303.1 (60) [DMT]+. 
HRMS (ESI, positive) m/z calculated for C38H35F2N3O5Na: 674.2437, found: 674.2441. 
 
 
DMT-protected 4-carboxy-2‘,6‘-difluoroazobenzene-D-threoninol phosphoramidite (44) 
DMT-protected 4-carboxy-2’,6’-difluoroazobenzene-D-threoninol (43) (0.97 g, 1.49 mmol) 
was dissolved in 15 mL dry dichloromethane under argon atmosphere and the solution was 
cooled to 0 °C. DiPEA (0.28 mL, 1.64 mmol) was added dropwise to the solution and the 
reaction mixture was stirred for 10 minutes at 0 °C. 2-Cyanoethyl-N,N-
diisopropylchlorophosophoramidite (0.40 mL, 1.78 mmol) was added dropwise at 0 °C and the 
reaction mixture was stirred for 10 minutes at 0 °C, then warmed up to room temperature and 
stirred for 2.5 hours. All solvents were removed in vacuo and the product was isolated via  
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column chromatography (silica, eluent: cyclohexane/ethyl acetate = 1/1 with 3 % 
triethylamine) as a red foamy solid (yield: 0.75 g, 58 %). 
1H-NMR (500 MHz, CD2Cl2) δ [ppm] = 8.33-8.16 (m, 1 H, H8), 8.02-7.93 (m, 1 H, H8’), 7.50-
7.00 (m, 13 H, H5+H9+H13+H14+H18+H20+H22), 6.89-6.67 (m, 6 H, H19+H23),  
4.50-4.36 (m, 1 H, H3), 3.85-3.79 (m, 9 H, H2+H4+H25), 3.62-3.54 (m, 2 H, H29), 3.39-3.05 (m, 
2 H, H30), 2.64-2.43 (m, 2 H, H27), 1.48 (s, 3 H, H1), 1.39-1.01 (m, 12 H, H28). 
19F-NMR (500 MHz, CD2Cl2) δ [ppm] = -115.1, -120.2, -121.7, -127.2. 
31P-NMR (500 MHz, CD2Cl2) δ [ppm] = 148.2. 
MS (ESI, positive) m/z (%) 874.3 (100) [M+Na]+, 303.1 (95) [DMT]+. 
HRMS (ESI, positive) m/z calculated for C47H52F2N5O6PNa: 874.3515, found: 874.3478. 
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7.2.7 Synthesis of 2’,4’,6’-trifluoroazobenzene-D-threoninol 
 
 
Ethyl-4-carboxy-2‘,4‘,6‘-trifluoroazobenzene (45) 
Ethyl-4-nitrosobenzoate (1) (3.05 g, 17.0 mmol) and 2,4,6-trifluoroaniline (3.0 g, 20.4 mmol) 
were dissolved in 150 mL glacial acetic acid and the reaction mixture was stirred for 24 hours 
at room temperature. 100 mL water was added, the resulting mixture was neutralized with 
sodium carbonate and extracted twice with 250 mL ethyl acetate. The combined organic layers 
were washed subsequently with 500 mL water, 500 mL saturated sodium bicarbonate solution 
and 100 mL brine. The organic layer was dried over MgSO4 and all solvents were removed in 
vacuo. The product was isolated by column chromatography (silica, eluent: cyclohexane) as a 
red solid (yield: 1.80 g, 34 %). 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.24-7.87 (m, 4 H, H5+H6), 7.45-7.39 
(m, 1 H, H10’), 6.96-6.90 (m, 1 H, H10), 4.38-4.29 (m, 2 H, H2), 1.35 (t, 3 H, 
3J1,2 = 7.1 Hz, H1). 
19F-NMR: (100 MHz, DMSO-d6) δ [ppm] = -102.41 (F12) -116.6 (F12'), -126.77 
(F13), -128.8 (F13'),  
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 164.9 (C3), 154.8 (C7), 135.4 (C11), 
132.5 (C9), 130.9 (C8), 130.5 (C4), 122.5 (C5), 120.6 (C6), 100.1 (C10), 61.2 (C2), 
14.0 (C1). 
MS (ESI, positive) m/z (%) 309.1 (12) [M+H]+, 210.0 (50) [C10H5F3N2]+ ,168.1 (100) 
[C6H3F2N+Na]+. 
HRMS (ESI, positive) m/z calculated for C16H12F3N2O2: 309.0845, found: 309.0844. 
 
4-Carboxy-2‘,4‘,6‘-trifluoroazobenzene (46) 
Ethyl-4-carboxy-2’,4’,6’-trifluoroazobenzene (45) (1.70 g, 5.51 mmol) was dissolved in 50 mL 
ethanol and 27.6 mL 1 M aqueous sodium hydroxide and the mixture was stirred for 16 hours 
at room temperature. The reaction mixture was acidified with 30 mL 1 M hydrochloric acid and 
extracted two times with 100 mL ethyl acetate. The combined organic layers were washed 
subsequently with 100 mL water and 50 mL brine, dried over MgSO4 and all volatiles were  
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removed under reduced pressure to remain a red solid as the product (yield: 1.05 g, 68 %). 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 13.06 (s, br, 1 H, H1), 8.34-7.80 (m, 4 H, H4+H5), 
7.44-6.85 (m, 2 H, H9). 
19F-NMR: (100 MHz, DMSO-d6) δ [ppm] = -117.2 (F11), -120.5 (F12). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 166.7 (C2), 155.1 (C6), 132.7 (C8), 
130.6 (C10), 124.9 (C8), 123.7 (C3) , 122.4 (C4), 122.1 (C5), 99.9 (C9). 
MS (EI, 70 eV) m/z (%) 280.1 (45) [M]+∙, 121.1 (100) [C7H5O2]+, 65.1 (78) 
[C6H5]+. 
HRMS (EI, 70 eV) m/z calculated for C13H7F3N2O2: 280.0460, found: 
280.0460. 
 
 
4-Carboxy-2‘,4‘,6‘-trifluoroazobenzene-D-threoninol (“DFAB-F”) (47) 
4-Carboxy-2’,4’,6’-trifluoroazobenzene (46) (0.50 g, 1.78 mmol), D-threoninol (0.21 g, 1.96 
mmol), DCC (0.37 g, 1.78 mmol) and OxymaPure (0.25 g, 1.78 mmol) were mixed in 18 mL 
dry DMF and stirred for 20 hours at room temperature under argon atmosphere. All solids were 
filtered off and rinsed with DMF, then DMF was removed under reduced pressure. The product 
was isolated by column chromatography (silica, eluent: chloroform/methanol = 98/2) to yield a 
red solid (yield: 0.55 g, 72 %). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.28. 
1H-NMR (600 MHz, DMSO-d6) δ [ppm] = 8.34-8.04 (m, 2 H, 
H10), 7.95-7.80 (m, 2 H, H11), 7.49-6.72 (m, 2 H, H15), 4.62-
4.50 (m, 1 H, H7), 4.32-4.15 (m, 2 H, H4), 4.03-3.83 (m, 2 H, 
H2+H5), 3.61-3.43 (m, 2 H, H1+H3), 1.36-1.22 (m, 3 H, H6). 
19F-NMR: (162 MHz, DMSO-d6) δ [ppm] = -103.0, -117.1, -117.5, -118.0. 
13C-NMR (150 MHz, DMSO-d6) δ [ppm] = 165.9 (C8), 158.7 (C16), 154.3 (C14), 128.8 (C12), 
125.9 (C12’), 122.4 (C10), 118.5 (C11), 109.1 (C9), 102.4 (C15), 100.1 (C15’), 65.1 (C2), 62.6 (C2‘), 
60.7 (C4), 57.1 (C3), 20.4 (C6), 14.0 (C6’). 
MS (ESI, positive) m/z (%) 390.1 (12) [M+Na]+, 247.2 (100) [M-2HF-H2O+Na]+. 
HRMS (ESI, positive) m/z calculated for C17H16N3F3O3Na: 390.1036, found: 390.1037. 
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7.2.8 Synthesis of 4’-chloro-2’,6’-difluoroazobenzene phosphoramidite 
 
 
4-Chloro-2,6-difluoroaniline (48)[255] 
2,6-Difluoroaniline (15.0 g, 116 mmol) and N-chlorosuccinimide (17.6 g, 128 mmol) were 
dissolved in 120 mL acetonitrile. The reaction mixture was refluxed for 20 hours, then poured 
into 300 mL 2 % aequous Na2SO3 solution. The aqueous mixture was extracted twice with 250 
mL diethyl ether, the combined oranic layers were washed with 200 mL water and 200 mL 
brine and dried over MgSO4. Diethyl ether was removed under reduced pressure and the 
product was isolated by column chromatography (silica, eluent: cyclohexane/ethyl acetate = 
1/1) as a white solid (yield: 19.77 g, quant.). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 6.75-6.73 (m, 2 H, H4), 3.65 (s, br, 2 H, 
H1). 
19F-NMR: (100 MHz, CDCl3) δ [ppm] = -131.0. 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 152.9 (C3), 149.6 (C5), 122.8 (C2), 111.8 
(C4). 
 
Ethyl-4-carboxy-4‘-chloro-2‘,6‘-difluoroazobenzene (49) 
Ethyl-4-nitrosobenzoate (1) (2.0 g, 11.2 mmol) and 4-chloro-2,6-difluoroaniline (48) (2.08 g, 
13.4 mmol) were dissolved in 100 mL glacial acetic acid. The reaction mixture was stirred for 
24 hours at room temperature, followed by addition of 100 mL water. The resulting mixture 
was neutralized with sodium carbonate and extracted twice with 150 mL ethyl acetate. The 
combined organic layers were washed subsequently with 200 mL water, 300 mL saturated 
sodium bicarbonate solution and 100 mL brine. The organic layer was dried over MgSO4 and 
all solvents were removed in vacuo. The product was isolated by column chromatography 
(silica, eluent: cyclohexane) as a red solid (yield: 0.55 g, 15 %). 
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1H-NMR (300 MHz, CDCl3) δ [ppm] = 8.21-8.17 (m, 2 H, H5), 7.96-7.92 (m, 2 
H, H6), 7.13-6.83 (m, 2 H, H10), 4.45 (q, 2 H, 3J2,1 = 7.1 Hz, H2), 1.45 (t, 3 H, 3J1,2 
= 7.1 Hz, H1). 
19F-NMR (100 MHz, CDCl3) δ [ppm] = -111.9, -118.5. 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 165.4 (C3), 157.3 (C7), 155.0 (C9), 153.8 
(C8), 136.1 (C11), 132.8 (C5), 130.2 (C6), 122.3 (C4), 113.6 (C10), 61.0 (C2), 13.9 
(C1). 
 
4-Carboxy-4‘-chloro-2‘,6‘-difluoroazobenzene (50) 
Ethyl-4-carboxy-4’-chloro-2’,6’-difluoroazobenzene (49) (0.41 g, 1.26 mmol) was mixed with 
12 mL ethanol and 7.5 mL 1 M aqueous sodium hydroxide and the reaction mixture was stirred 
for 20 hours at room temperature followed by addition of 15 mL 1 M hydrochloric acid. The 
mixture was extracted two times with 200 mL ethyl acetate, the combined organic layers were 
washed subsequently with 300 mL water and 100 mL brine, dried over MgSO4 and all volatiles 
were removed under reduced pressure to remain a red solid as the product (yield: 0.35 g, 
quant.). 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 13.30 (s, br, 1 H, H1), 8.37-8.10 (m, 
2 H, H4), 7.95-7.84 (m, 2 H, H5), 7.66-7.59 (m, 1 H, H9), 7.48-6.87 (m, 1 H, 
H9’). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 166.5 (C2), 154.8 (C6), 154.7 (C8), 
133.8 (C7), 133.2 (C10), 130.7 (C4), 122.6 (C3), 122.3 (C5), 114.5 (C9). 
19F-NMR: (100 MHz, CDCl3) δ [ppm] = -118.8, -122.9. 
MS (ESI, negative) m/z (%) 311.0 (100) [M+O-H]-, 295.0 (54) [M-H]-. 
HRMS (ESI, negative) m/z calculated for C13H6ClF2N2O2: 295.0091, found: 
295.0077. 
 
4-Carboxy-4‘-chloro-2‘,6‘-difluoroazobenzene-D-threoninol (“DFAB-Cl”) (51) 
4-Carboxy-4’-chloro-2’,6’-difluoroazobenzene (50) (0.30 g, 1.01 mmol), D-threoninol (0.13 g, 
1.21 mmol) and HBTU (0.46 g, 1.21 mmol) were mixed in 15 mL DMF and the reaction mixture 
was stirred for 24 hours at room temperature under argon atmosphere. All solid residuals were 
filtered off and DMF was removed under reduced pressure. The product was isolated by 
column chromatography (silica, eluent: chloroform/methanol = 98/2) to yield a red solid (yield: 
0.42 g, quant.). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.28. 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.35-7.84 (m, 4 H, H10+H11), 7.71-6.93 (m, 3 H,  
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H7+H15), 4.63 (s, br, 1 H, H5), 4.20-3.91 (m, 2 H, H1+H3), 3.66-3.49 (m, 3 H, H2+H4), 1.33-
1.02 (m, 3 H, H6). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 165.7 (C8), 162.3 (C12), 153.7 (C14),  
138.1 (C13), 130.7 (C16), 128.8 (C16’), 127.2 (C10), 124.4 (C11), 122.6 (C11’), 119.1 (C9), 109.6 
(C15), 64.9 (C2), 60.5 (C4), 57.0 (C3), 20.2 (C6). 
19F-NMR: (100 MHz, DMSO-d6) δ [ppm] = -119.0, -123.2. 
MS (ESI, positive) m/z (%) 789.2 (77) [2M+Na]+, 406.1 (87) [M+Na]+, 384.1 (100) [M+H]+. 
HRMS (ESI, positive) m/z calculated for C17H16ClF2N3O3H: 384.0921, found: 384.0911. 
 
DMT-protected 4-carboxy-4‘-chloro-2‘,6‘-difluoroazobenzene-D-threoninol (52) 
4-Carboxy-4’-chloro-2’,6’-difluoroazobenzene-D-threoninol (51) (2.50 g, 6.51 mmol) and 4-
DMAP (0.08 g, 0.6 mmol) were dissolved in 30 mL dry pyridine under argon atmosphere. The 
reaction mixture was cooled to 0 °C and 4,4’-dimethoxytritylchloride (2.43 g, 7.17 mmol) 
dissolved in 30 mL dry dichloromethane was added dropwise to the mixture. The reaction was 
warmed up to room temperature and stirred under argon atmosphere for 24 hours. All volatiles 
were removed in vacuo and the product was isolated by column chromatography (silica, eluent: 
cyclohexane/ethyl acetate = 1/1 with 3 % triethylamine) as a red foamy solid (yield: 1.80 g, 
39 %). 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.37-7.83 (m, 7 H, H10+H14+H19+H21), 7.68-7.60 (m, 
2 H, H9), 7.45-7.17 (m, 5 H, H23), 7.08-6.81 (m, 5 H, H6+H24), 4.24-4.17 (m, 1 H, H3), 4.01-3.90 
(m, 2 H, H4), 3.72 (s, 6 H, H26), 3.59-3.35 (m, 2 H, H1+H2), 1.34-1.21 (m, 3 H, H5). 
19F-NMR: (100 MHz, DMSO-d6) δ [ppm] = -112.49, -117.48, -118.80, -120.53, -122.96. 
MS (ESI, positive) m/z (%) 734.2 (42) [M-H+2Na]+, 
708.2 (42) [M+Na]+, 406.1 (100) [M-DMT+Na]+. 
HRMS (ESI, positive) m/z calculated for 
C38H34ClF2N3O5Na: 708.2047, found: 708.2042. 
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DMT-protected 4-carboxy-4‘-chloro-2‘,6‘-difluoroazobenzene-D-threoninol phosphor-
amidite (53) 
DMT-protected 4-carboxy-4’-chloro-2’,6’-difluoroazobenzene-D-threoninol (52) (0.25 g, 
0.36 mmol) was dissolved in 5 mL dry dichloromethane under argon atmosphere and the 
solution was cooled to 0 °C. DiPEA (0.08 mL, 0.44 mmol) was added dropwise to the solution 
and the reaction mixture was stirred for 10 minutes at 0 °C. 2-Cyanoethyl-N,N-
diisopropylchlorophosophoramidite (0.10 mL, 0.44 mmol) was added dropwise to the reaction 
mixture at 0 °C and the reaction mixture was stirred for 10 minutes at 0 °C, then warmed up to 
room temperature and stirred for 2.5 hours. All solvents were removed in vacuo, the product 
was isolated via column chromatography (silica, eluent: cyclohexane/ethyl acetate = 1/1 with 
3% triethylamine) as a red foamy solid (yield: 0.30 g, 92 %). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 8.29-8.27 (m, 1 H, H20), 7.95-7.63 (m, 2 H, H9), 7.44-
7.39 (m, 2 H, H13), 7.32-7.10 (m, 9 H, H8+H22+H18+H19), 6.96-6.77 (m, 5 H, H8+H23), 6.66-6.26 
(m, 1 H, H5), 4.48-4.33 (m, 1 H, H3), 3.77 (s, 6 H, H25), 3.55-3.50 (m, 3 H, H2+H4), 3.35-3.23 
(m, 2 H, H27), 1.47-0.95 (m, 19 H, H1+H28+H29+H30). 
19F-NMR (500 MHz, CDCl3) δ [ppm] = -111.75, -118.40, -119.30, -121.84. 
31P-NMR (500 MHz, CDCl3) δ [ppm] = 148.40. 
MS (ESI, positive) m/z (%) 908.3 (4) [M+Na]+, 535.2 (7) [C23H28ClF2N4O3P+Na]+, 372.2 (31) 
[C17H14ClF2N3O+Na]+, 370.2 (100) [C17H12ClF2N3O+Na]+, 303.1 (30) ]DMT}+. 
HRMS (ESI, positive) m/z calculated for C47H51ClF2N5O6PNa: 908.3126, found: 908.3132. 
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7.2.9 Synthesis of 4’-bromo-2’,6’-difluoroazobenzene-D-threoninol 
 
 
Ethyl-4‘-bromo-4-carboxy-2‘,6‘-difluoroazobenzene (54) 
Ethyl-4-nitrosobenzoate (1) (1.0 g, 5.58 mmol) and 4-bromo-2,6-difluoroaniline (32) (1.74 g, 
8.37 mmol) were mixed in 50 mL glacial acetic acid and stirred for 24 hours at room 
temperature. 30 mL water was added, the resulting mixture was neutralized with sodium 
carbonate and extracted with 150 mL ethyl acetate. The organic layer was washed 
subsequently with 200 mL saturated sodium bicarbonate solution and 100 mL brine. The 
organic layer was dried over MgSO4 and all solvents were removed in vacuo. The product was 
isolated by column chromatography (silica, eluent: cyclohexane) as a red solid (yield: 0.65 g, 
32 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 8.11-8.09 (m, 2 H, H5), 7,86-7,83 (m, 2 
H, H6), 7,19-7,15 (m, 2 H, H10), 4,37 (q, 2 H, 3J2,1 = 7.1 Hz, H2), 1,36 (t, 3 H, 3J1,2 
= 7.1 Hz, H1). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 165.4 (C3), 157.2 (C9), 155.0 (C7), 153.7 
(C8), 132.8 (C5), 130.2 (C4), 123.2 (C6), 122.4 (C10), 116.5 (C11), 61.0 (C2), 13.9 
(C1). 
19F-NMR: (100 MHz, CDCl3) δ [ppm] = -118.7 (F12), -111.9 (F12’). 
MS (EI, 70 eV) m/z (%) 368.0 (40) [M]+∙, 323.0 (10) [M-C2H5O]+, 218.9 (22) [M-C9H9O2]+, 
190.9 (20) [C6H2BrF2]+, 149.1 (100) [C9H9O2]+. 
HRMS (EI, 70 eV) m/z calculated for C15H11BrF2N2O2: 367.9972, found: 367.9972. 
 
4-Carboxy-4‘-bromo-2‘,6‘-difluoroazobenzene (55) 
Ethyl-4’-bromo-4-carboxy-2‘,6‘-difluoroazobenzene (54) (2.35 g, 6.37 mmol) was dissolved 
in 70 mL ethanol and 40 mL 1 M aqueous NaOH solution and stirred for 24 hours at room 
temperature, followed by addition of 50 mL 1 M hydrochloric acid. The resulting mixture was 
extracted twice with 200 mL ethyl acetate. The combined organic layers were washed with 
200 mL water and 200 mL brine and all volatiles were removed under reduced pressure. The 
product was isolated by column chromatography (silica, eluent: chloroform/methanol = 98/2) 
to yield a bright red solid (yield: 0.59 g, 27 %). 
7. Experimental section 
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1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 13.19 (s, br, 1 H, H1), 8.39-8.14 (m, 3 H, H4+H5), 
7.97-7.54 (m, 2 H, H5+H9), 7.39-6.97 (m, 1 H, H9). 
13C-NMR (500 MHz, DMSO-d6) δ [ppm] = 166.7 (C2), 155.0 (C8), 133.4 (C6), 
130.8 (C7), 123.8 (C4), 122.4 (C3), 118.3 (C5), 113.7 (C9), 112.4 (C10). 
19F-NMR (100 MHz, DMSO-d6) δ [ppm] = -112.8, -119.2, -121.5, -123.3. 
MS (EI, 70 eV) m/z (%) 339.9 (15) [M]+∙, 262.0 (36) [M-Br]+, 204.9 (56) 
[C6H2BrF2N] +, 167.0 (76) [C6H2BrN]+, 121.0 (100) [C7H5O2]+. 
HRMS (EI, 70 eV) m/z calculated for C13H7BrF2N2O2: 339.9659, found: 
339.9659. 
 
4’-Bromo-4-carboxy-2‘,6‘-difluoroazobenzene-D-threoninol (“DFAB-Br”) (56) 
4’-Bromo-4-carboxy-2’,6’-difluoroazobenzene (55) (0.50 g, 1.47 mmol), D-threoninol (0.19 g, 
1.76 mmol) and HBTU (0.67 g, 1.76 mmol) were mixed in 20 mL dry DMF. The reaction mixture 
was stirred for 24 hours at room temperature under argon atmosphere followed by filtering off 
all solids. DMF was removed under reduced pressure and the product was isolated by column 
chromatography (silica, eluent: chloroform/methanol = 98/2) to yield a red solid (yield: 0.55 g, 
87 %). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.30. 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.32-8.28 (m, 1 H, 
H10), 8.17-7.69 (m, 4 H, H10+H11+H15), 7.56-7.30 (m, 1 H, H15), 
4.63 (s, br, 1 H, H7), 3.95-3.90 (m, 2 H, H4), 3.63-3.23 (m, 3 
H, H1+H3+H5), 2.67-2.55 (m, 1 H, H2), 1.33-1.04 (m, 3 H, H6). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 165.1 (C8), 162.3 (C8’), 148.9 (C14), 140.6 (C12), 
130.7 (C13), 128.9 (C13’), 127.3 (C10), 124.5 (C11), 123.4 (C11’), 122.0 (C9), 119.1 (C15), 109.6 
(C16), 64.9 (C2), 60.4 (C4), 57.2 (C3), 20.2 (C6). 
19F-NMR (100 MHz, DMSO-d6) δ [ppm] = 68.71, 71.22,112.88, 115.97, 119.34, 120.63, 
123.57. 
MS/HRMS (EI, 70 eV): no target mass could be isolated 
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7.2.10 Synthesis of 4’-acetamido-2’,6’-difluoroazobenzene-D-threoninol 
 
 
Ethyl-4’-acetamido-4-carboxy-2‘,6‘-difluoroazobenzene (57)[132] 
Ethyl-4‘-bromo-4-carboxy-2‘,6‘-difluoroazobenzene (54) (5.0 g, 13.5 mmol), acetamide (2.40 
g, 40.6 mmol) and caesium carbonate (8.83 g, 27.1 mmol) were mixed in a flask with 140 mL 
dioxane and set under argon. Pd2dba3 (0.39 g, 0.68 mmol) and XantPhos (1.57 g, 2.71 mmol) 
were added under argon and the resulting reaction mixture was heated at 90 °C for 1 hour. 
After cooling to room temperature, 300 mL ethyl acetate were added and the resulting mixture 
was washed with 400 mL brine. The organic layer was dried over MgSO4, all solids were filtered 
off and all solvents were removed in vacuo. The product was isolated by column 
chromatography (silica, eluent: cyclohexane/ethyl acetate = 9/1) as a red solid 
(yield: 3.20 g, 68 %). 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.16-8.10 (m, 2 H, H5), 7.99-7.87 (m, 
2 H, H6), 7.71-7.48 (m, 2 H, H12), 7.27-7.05 (m, 1 H, H13), 4.38-4.25 (m, 2 H, H2), 
2.12-2.02 (m, 3 H, H15), 1.37-1.26 (m, 3 H, H1). 
19F-NMR (100 MHz, DMSO-d6) δ [ppm] = -117.88, -118.34. 
MS (EI, 70 eV) m/z (%) 347.1 (100) [M]+∙, 302.0 (15) [M-C2H5O]+, 198.0 (62) 
[C8H6F2N3O]+, 170.0 (52) [C8H6F2NO]+, 149.0 (57) [C9H9O2]+, 120.0 (33) 
[C7H4O2]+. 
HRMS (EI, 70 eV) m/z calculated for C17H15F2N3O3: 347.1081, found: 347.1079. 
 
 
4’-Acetamido-4-carboxy-2‘,6‘-difluoroazobenzene (58) 
Ethyl-4'-acetamido-4-carboxy-2’,6’-difluoroazobenzene (57) (0.38 g, 1.10 mmol) was 
dissolved in 5 mL ethanol and 5 mL 1 M aqueous NaOH and stirred for 10 hours at room 
temperature. The reaction mixture was acidified with 10 mL 1 M aqueous hydrochloric acid 
followed by extraction with 100 mL ethyl acetate. The organic layer was washed with 80 mL 
water and 80 mL brine. Evaporation of all solvents yielded the product as a red solid (yield: 
0.35 g, quant.). 
7. Experimental section 
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1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 13.60 (s, br, 1 H, H1), 8.14-7.87 (m, 
2 H, H4), 7.78-7.57 (m, 2 H, H5), 7.54-7.36 (m, 3 H, H9+H12), 2.86-2.12 (m, 3 H, 
H14). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 169.6 (C13), 162.3 (C2), 155.2 (C8), 
142.8 (C6), 130.5 (C7), 127.8 (C10), 127.3 (C4), 124.5 (C5), 119.1 (C3), 109.6 
(C9), 14.1 (C14). 
19F-NMR (100 MHz, DMSO-d6) δ [ppm] = -117.8, -129.3. 
 
 
4’-Acetamido-4-carboxy-2‘,6‘-difluoroazobenzene-D-threoninol (“DFAB-Pep”) (59) 
4’-Acetamido-4-carboxy-2’,6’-difluoroazobenzene (58) (0.35 g, 1.10 mmol), D-threoninol 
hydrochloride (0.19 g,  1.32 mmol), triethylamine (0.13 g, 1.32 mmol) and HBTU (0.46 g, 1.21 
mmol) were mixed in 10 mL dry DMF. The reaction mixture was stirred for 24 hours at room 
temperature under argon atmosphere followed by filtering off all solid residuals. DMF was 
removed under reduced pressure and the product was isolated by column chromatography 
(silica, eluent: chloroform/methanol = 98/2) to yield a red solid (yield: 0.44 g, quant.). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.18. 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 8.08-7.62 (m, 
4 H, H10+H11), 7.54-7.00 (m, 2 H, H15), 6.80-6.32 (m, 1 H, 
H18), 4.61 (s, br, 1 H, H7), 3.95-3.82 (m, 2 H, H4), 3.61-3.50 
(m, 2 H, H3+H5), 3.01-2.68 (m, 3 H, H20), 2.12-1.83 (m, 2 
H, H1+H2), 1.12-0.99 (m, 3 H, H6). 
19F-NMR (100 MHz, DMSO-d6) δ [ppm] = -117.3, -118.3. 
MS (ESI, positive) m/z (%) 429.2 (100) [M+Na]+, 387.1 
(72) [M-CH2O+Na]+. 
HRMS (ESI, positive) m/z calculated for C19H20F2N4O4Na: 429.1345, found: 429.1349. 
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7.2.11 Synthesis of 2’,6’-difluro-2,6-dimethylazobenzene-D-threoninol 
 
 
2,6-Dimethyl-4-iodoaniline (60)[256] 
2,6-Dimethylaniline (20.0 g, 166 mmol) was mixed with NaHCO3 (41.6 g, 248 mmol) and 230 
mL methanol. ICl (29.4 g, 183 mmol) was dissolved in 180 mL dichloromethane and added 
dropwise to the reaction mixture followed by stirring for 16 hours at room temperature. The 
reaction mixture was quenched with 500 mL 2 % aqueous Na2S2O3 solution, the organic layer 
was separated, dried over MgSO4 and concentrated in vacuo. The product was isolated by 
column chromatography (silica, eluent: cyclohexane/ethyl acetate = 9/1) as a dark purple solid 
(yield: 39.78 g, 97 %). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 7.24 (s, 2 H, H4), 4.43 (s, br, 2 H, H1), 2.13 (s, 6 H, H6). 
13C-NMR (125 MHz, CDCl3) δ [ppm] = 141.7 (C2), 136.5 (C4), 128.6 (C3), 
124.6 (C5), 17.3 (C6). 
MS (ESI, positive) m/z (%) 248.0 (100) [M+H]+. 
HRMS (ESI, positive) m/z calculated for C8H11IN: 247.9931, found: 
247.9925. 
 
2‘,6‘-Difluoro-2,6-dimethyl-4-iodoazobenzene (61) 
2,6-Dimethyl-4-iodoaniline (60) (5.0 g, 20.2 mmol) and 2,6-difluoro-4-nitrosobenzene (19) 
(3.48 g, 24.3 mmol) were dissolved in 150 mL glacial acetic acid. The reaction mixture was 
stirred for 24 hours at room temperature, then 250 mL water was added and the mixture was 
neutralized with sodium carbonate. The resulting mixture was extracted twice with 500 mL 
ethyl acetate, the combined organic layers were washed subsequently with 250 mL water, 
300 mL saturated sodium bicarbonate soltion and 200 mL brine. All solvents were removed in 
vacuo and the product was isolated by column chromatography (silica, eluent: 
cyclohexane/ethyl acetate = 19/1) as a red solid (yield: 1.61 g, 22 %). 
7. Experimental section 
182 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.42 (s, 2 H, H2), 7.26-7.16 (m, 1 H, H8), 6.97 (t, 2 H, 
3J7,8 = 8.5 Hz, H7), 2.27 (s, 6H, H10). 
19F-NMR: (100 MHz, CDCl3) δ [ppm] = -116.9 (F9), -122.4 (F9’). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 156.8 (C6), 153.4 (C5), 150.6 (C4), 
137.7 (C2), 133.3 (C3), 130.0 (C8), 112.3 (C7), 95.2 (C1), 18.4 (C10). 
MS (EI, 70 eV) m/z (%) 372.1 (98) [M]+∙, 231.0 (100) [M-CH2I]+, 104.1 (44) 
[C8H8]+. 
HRMS (EI, 70 eV) m/z calculated for C14H10F2N2I [M-H] +∙: 370.9856, found: 
370.9851. 
 
4-Cyano-2‘,6‘-difluoro-2,6-dimethylazobenzene (62)[257] 
2’,6’-Difluoro-2,6-dimethyl-4-iodoazobenzene (61) (1.0 g, 2.69 mmol), Pd(PPh3)4 (0.31 g, 
0.27 mmol) and zinc cyanide (0.38 g, 3.22 mmol) were suspended in 10 mL dry DMF and 
heated at 90 °C for 16 hours. The reaction mixture was cooled to room temperature, poured 
into 20 mL 12 % aqueous ammonia solution and extracted with 150 mL ethyl acetate. The 
organic phase was washed with 50 mL saturated sodium bicarbonate solution and 50 mL brine, 
dried over MgSO4 and all solvents were removed in vacuo. The product was isolated by silica 
gel chromatography (eluent: cyclohexane/ethyl acetate = 4/1) as a red solid (yield: 0.68 g, 
93 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.35-7.28 (m, 3 H, H3+H9), 7.03-6.95 (m, 2 H, H8), 2.25 
(s, 6 H, H11). 
19F-NMR: (100 MHz, CDCl3) δ [ppm] = -116.9 (F10), -122.0 (F10’). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 156.9 (C7), 154.3 (C6), 153.4 (C5), 
132.3 (C3), 131.3 (C4), 131.0 (C9), 118.3 (C1), 112.4 (C8), 111.5 (C2), 18.0 
(C11). 
MS (EI, 70 eV) m/z (%) 271.1 (84) [M]+∙, 251.1 (10) [M-HF]+, 208.1 (8) 
[C14H10N2]+, 183.1 (15) [C11H9N3]+, 158.1 (8) [C9H8N3]+, 141.1 (18) [C6H3F2N2]+, 
130.1 (100) [C9H8N]+, 113.1 (24) [C6H3F2]+, 103.1 (19) [C8H7]+. 
HRMS (EI, 70 eV) m/z calculated for C15H11F2N3: 271.0921, found: 271.0918. 
 
4-Carboxy-2‘,6‘-difluoro-2,6-dimethylazobenzene (63) 
4-Cyano-2‘,6‘-difluoro-2,6-dimethylazobenzene (62) (0.25 g, 0.92 mmol) and potassium 
hydroxide (0.05 g, 0.92 mmol) were dissolved in 3 mL ethanol and the mixture was refluxed 
for 6 hours at 80 °C. The reaction mixture was cooled to room temperature, neutralized with 
1 M aqueous hydrochloric acid and extracted with 50 mL ethyl acetate. The organic layer was  
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washed with 20 mL water and 20 mL brine, followed by evaporation of all solvents. The 
product was isolated by column chromatography (silica, eluent: chloroform/methanol = 19/1) 
as a red solid (yield: 0.32 g, quant.). 
1H-NMR (600 MHz, DMSO-d6) δ [ppm] = 7.11 (s, br, 1 H, H1), 7.75-7.69 (m, 1 H, H10), 7.61-
7.52 (m, 2 H, H9), 2.33 (s, 6 H, H12). 
13C-NMR (125 MHz, DMSO-d6) δ [ppm] = 167.4 (C2), 155.7 (C8), 153.7 (C6), 
153.0 (C7), 134.6 (C3), 132.1 (C4), 130.3 (C5), 128.6 (C10), 113.3 (C9), 18.5 
(C12). 
19F-NMR: (125 MHz, CDCl3) δ [ppm] = -118.7, -122.6, -126.4, 126.9. 
MS (ESI, negative) m/z (%) 289.1 (100) [M-H]-, 265.1 (78) [C13H11F2N2O2]-, 
236.1 (51) [C14H8N2O2]-, 221.1 (42) [C13H5N2O2]-. 
HRMS (ESI, negative) m/z calculated for C15H11F2N2O2: 289.0794, found: 289.0780. 
 
 
4-Carboxy-2‘,6‘-difluoro-2,6-dimethylazobenzene-D-threoninol (“DMDFAB”) (64) 
4-Carboxy-2’,6’-difluoro-2,6-dimethylazobenzene (63) (0.10 g, 0.35 mmol), D-threoninol 
(0.04 g, 0.38 mmol) and HBTU (0.16 g, 0.41 mmol) were mixed in 5 mL DMF. The reaction 
mixture was stirred for 24 hours at room temperature under argon atmosphere followed by 
filtering off all solid residues and evaporation of DMF under reduced pressure. The product 
was isolated by column chromatography (silica, eluent: chloroform/methanol = 98/2) to yield a 
red solid (yield: 0.01 g, 8 %). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.31. 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 7.78-7.67 (m, 2 H, 
H10), 7.60-7.48 (m, 1 H, H15), 7.42-7.33 (m, 1 H, H15’), 7.14-6.89 
(m, 1 H, H16), 4.60-4.51 (m, 2 H, H3+H7), 3.93-3.90 (m, 2 H, H4), 
3.62-3.42 (m, 3 H, H1+H2+H5), 2.35 (s, 4 H, H18), 1.97 (s, 2 H, H18’), 1.07-1.01 (m, 3 H, H6). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 166.0 (C8), 155.7 (C14), 153.7 (C12), 152.8 (C13), 
135.2 (C9), 132.1 (C10), 130.4 (C11), 128.4 (C16), 113.3 (C15), 65.0 (C2), 60.7 (C4), 56.9 (C3), 
20.4 (C6), 18.5 (C18). 
19F-NMR (125 MHz, DMSO-d6) δ [ppm] = -117.8, -122.4, -123.0, -127.0. 
MS (ESI, positive) m/z (%) 378.2 (68) [M+H]+, 400.1 (100) [M+Na]+, 777.3 (64) [2M+Na]+. 
HRMS (ESI, positive) m/z calculated for C19H22F2N3O3: 378.1624, found: 378.1634. 
 
7. Experimental section 
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7.2.12 Synthesis of 2’,6’-dichloroazobenzene-D-threoninol 
 
 
Ethyl-4-carboxy-2‘,6‘-dichloroazobenzene (65) 
Ethyl-4-nitrosobenzoate (1) (2.0 g, 11.2 mmol) and 2,6-dichloroaniline (2.17 g, 13.4 mmol) 
were dissolved in a mixture of 70 mL acetic acid and 50 mL trifluoroacetic acid and stirred for 
24 hours at room temperature. 200 mL water was added, the resulting mixture was neutralized 
with sodium carbonate and extracted twice with 200 mL ethyl acetate. The combined organic 
layers were washed subsequently with 250 mL water, 250 mL saturated sodium bicarbonate 
solution and 200 mL brine. The organic layer was dried over MgSO4 and all solvents were 
removed in vacuo. The product was isolated by column chromatography (silica, eluent: 
cyclohexane) as a red solid (yield: 1.20 g, 33 %). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 8.31-8.69 (m, 2 H, H5), 7.67-8.19 (m, 5 
H, H6+H10+H11). 
13C-NMR (125 MHz, CDCl3) δ [ppm] = 165.6 (C3), 150.7 (C7), 146.8 (C8), 133.5 
(C5), 131.0 (C10), 130.1 (C11), 125.2 (C4), 122.4 (C9), 119.4 (C6), 61.6 (C2), 14.2 
(C1). 
MS (EI, 70 eV) m/z (%) no target mass could be isolated. 
 
4-Carboxy-2‘,6‘-dichloroazobenzene (66) 
Ethyl-4-carboxy-2’,6’-dichloroazobenzene (65) (3.0 g, 9.28 mmol) was dissolved in 45 mL 
ethanol and 45 mL 1 M aqueous NaOH solution and stirred for 20 hours at room temperature. 
The reaction mixture was acidified with 60 mL 1 M aqueous hydrochloric acid and extracted 
twice with 200 mL ethyl acetate. The combined organic layers were washed with 200 mL water 
and 100 mL brine, followed by evaporation of all solvents. Column 
chromatography (silica, eluent: chloroform/methanol = 98/2) was performed  to 
yield a red solid (yield: 0.86 g, 32 %).  
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 13.32 (s, 1 H, H1), 8.21-8.17 (m, 2 
H, H4), 8.01-7.97 (m, 2 H, H5), 7.67-7.65 (m, 2 H, H9), 7.48-7.43 (m, 1 H, H10). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 166.49 (C2), 153.83 (C6), 147.39 (C7), 
134.26 (C4), 130.83 (C9), 130.20 (C10), 129.59 (C3), 125.55 (C8), 122.71 (C5). 
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MS (ESI, positive) m/z (%) 295.0 (5) [M+Na]+, 225.2 (100) [M-Cl2+H]+. 
HRMS (ESI, positive) m/z (%) calculated for C13H8Cl2N2O2: 295.0036, found: 295.0027. 
 
4-Carboxy-2‘,6‘-dichloroazobenzene-D-threoninol (“DCAB”) (67) 
4-Carboxy-2’,6’-dichloroazobenzene (66) (0.10 g, 0.34 mmol), D-threoninol (0.04 g, 0.41 
mmol), DCC (0.08 g, 0.37 mmol) and OxymaPure (0.05 g, 0.37 mmol) were mixed in 3.5 mL 
dry DMF. The reaction mixture was stirred for 24 hours at room temperature under argon 
atmosphere. All solids were filtered off and DMF was removed under reduced pressure. A 
small product fraction was isolated by preparative HPLC chromatography (C18, eluent: 
acetonitrile/water in different gradients) to yield a red solid 
(yield: 0.04 g, 31 %). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.26. 
MS (ESI, positive) m/z (%) 787.1 (20) [2M+Na]+, 404.0 (100) 
[M+Na]+, 306.3 (15) [C16H15N2O3+Na]+. 
HRMS (ESI, positive) m/z calculated for C17H17Cl2N3O3Na: 404.0539, found: 404.0541. 
 
7. Experimental section 
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7.2.13 Synthesis of 2’,6’-dimethoxyazobenzene-D-threoninol phosphoramidite 
 
 
1,3-Dimethoxy-2-nitrobenzene (68)[258] 
2-Nitroresorcinol (10.0 g, 64.5 mmol) and sodium carbonate (34.2 g, 322 mmol) were 
dissolved in 600 mL acetone. Dimethylsulfate (24.4 g, 193 mmol) was added dropwise and the 
reaction mixture was heated to 60 °C for 2.5 hours, then cooled down to room temperature 
and acetone was removed by distillation. The remaining aqueous layer was extracted three 
times with 500 mL dichloromethane. The combined organic layers were dried over MgSO4 
followed by removal of dichloromethane under reduced pressure. The remaining yellowish 
white solid was isolated as the product (yield: 11.58 g, 98 %). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 7.34 (t, 1 H, 3J4,3 = 8.5 Hz, H4), 6.63 
(d, 2 H, 3J3,4 = 8.5 Hz, H3), 3.87 (s, 6 H, H5). 
13C-NMR (166 MHz, CDCl3) δ [ppm] = 151.9 (C2), 131.1 (C4), 131.1 (C1), 
104.5 (C3), 56.5 (C5). 
MS (EI, 70 eV) m/z (%) 183.1 [M]+∙, 136.0 (50) [M-NO2]+, 107.0 (46) [C7H7O]+. 
HRMS (EI, 70 eV) m/z calculated for C8H9NO4: 183.0532, found: 183.0532. 
 
1,3-Dimethoxyaniline (69)[258] 
1,3-Dimethoxy-2-nitrobenzene (68) (7.5 g, 41.0 mmol) was dissolved in 200 mL glacial acetic 
acid, 200 mL ethanol and 100 mL water. Iron powder (13.7 g, 246 mmol) was added in small 
portions and the resulting mixture was heated to 90 °C for 20 hours under argon atmosphere. 
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The reaction mixture was cooled to room temperature, then extracted twice with 250 mL ethyl 
acetate. The combined organic layers were dried over MgSO4, filtered and all volatiles were 
removed in vacuo. The resulting brownish white solid was isolated as the product (yield: 5.77 
g, 92 %). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 6.72-6.69 (m, 1 H, H5), 6.55 (d, 2 H, 
3J4,5 = 8.3 Hz, H4), 3.87 (s, 6 H, H6), 3.84 (s, br, 2 H, H1). 
13C-NMR (166 MHz, CDCl3) δ [ppm] = 147.6 (C3), 125.3 (C2), 117.1 (C5), 
104.1 (C4), 55.9 (C6). 
MS (ESI, positive) m/z (%) 182.1 (63) [M+Na]+, 154.1 (100) [M+H]+. 
HRMS (ESI, positive) m/z calculated for C8H12NO2: 154.0863, found: 154.0871. 
 
Ethyl-4-carboxy-2‘,6‘-dimethoxyazobenzene (70) 
1,3-Dimethoxyaniline (69) (5.0 g, 32.6 mmol) and ethyl-4-nitrosobenzoate (5.85 g, 32.6 
mmol) were dissolved in 300 mL glacial acetic acid. The reaction mixture was stirred for 24 
hours at room temperature, then neutralized with sodium carbonate and extracted two times 
with 300 mL ethyl acetate. The combined organic layers were washed subsequently with 300 
mL water, 300 mL saturated sodium bicarbonate solution and 150 mL brine. The organic layer 
was dried over MgSO4 and all volatiles were removed under reduced pressure. The product 
was isolated by column chromatography (silica, eluent: cyclohexane/ethyl acetate = 95/5) as 
a red solid (yield: 2.08 g, 20 %). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 8.19-8.17 (m, 2 H, H5), 7.92-7.90 (m, 
2 H, H6), 7.31 (t, 1 H, 3J11,10 = 8.5 Hz, H11), 6.70 (d, 2 H, 3J10,11 = 8.4 Hz, H10), 
4.43 (q, 2 H, 3J2,1 = 7.1 Hz, H2), 3.86 (s, 6 H, H12), 1.43 (t, 3 H, 3J1,2 = 7.1 Hz, 
H1). 
13C-NMR (166 MHz, CDCl3) δ [ppm] = 166.1 (C3), 155.7 (C7), 152.9 (C9), 
133.4 (C8), 131.9 (C4), 130.9 (C11), 130.5 (C5), 122.3 (C6), 105.1 (C10), 61.2 
(C2), 56.5 (C12), 14.3 (C1). 
MS (ESI, positive) m/z (%) 337.1 (81) [M+Na]+, 315.1 (100) [M+H]+. 
HRMS (EI, 70 eV) m/z calculated for C17H19N2O4: 315.1339, found: 315.1363.  
 
4-Carboxy-2‘,6‘-dimethoxyazobenzene (71) 
Ethyl-4-carboxy-2’,6’-dimethoxyazobenzene (70) (1.67 g, 5.31 mmol) was dissolved in 25 
mL 1 M aqueous NaOH and 25 mL ethanol. The reaction mixture was stirred for 3 hours at 
room temperature, then 30 mL 1 M aqueous hydrochloric acid was added and the mixture was 
extracted twice with  
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150 mL ethyl acetate. The combined organic layers were washed with 200 mL brine and 
dried over MgSO4. All solvents were removed under reduced pressure to yield the product as 
a red solid (yield: 1.50 g, quant.). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 10.17 (s, br, 1 H, H1), 8.13-8.11 
(m, 2 H, H4), 7.83-7.80 (m, 2 H, H5), 7.36-7.33 (m, 1 H, H10), 6.83-6.80 (m, 
2 H, H9), 3.76 (s, 6 H, H11). 
13C-NMR (125 MHz, DMSO-d6) δ [ppm] = 167.2 (C2), 155.4 (C6), 152.3 
(C8), 133.3  (C7), 133.0 (C3), 131.0 (C10), 130.9 (C4), 122.5 (C5), 105.7 (C9), 
56.7 (C11). 
MS (ESI, positive) m/z (%) 287.1 (100) [M+H]+. 
HRMS (ESI, positive) m/z calculated for C15H15N2O4: 287.1032, found: 287.1032. 
 
4-Carboxy-2‘,6‘-dimethoxyazobenzene-D-threoninol (“DOAB”) (72) 
4-Carboxy-2’,6’-dimethoxyazobenzene (71) (0.70 g, 2.45 mmol), D-threoninol (0.31 g, 2.93 
mmol), DCC (0.55 g, 2.69 mmol) and OxymaPure (0.38 g, 2.69 mmol) were dissolved in 25 
mL dry DMF. The reaction mixture was stirred for 24 hours at room temperature under argon 
atmosphere. All solid residues were filtered off followed by removal of DMF in vacuo. The crude 
product was purified by column chromatography (silica, eluent: chloroform/methanol = 98/2) to 
yield a red solid (yield: 0.81 g, 88 %). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.28. 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 7.90-8.30 (m, 2 H, 
H10), 7.71-7.82 (m, 2 H, H11), 7.06-7.35 (m, 1 H, H16), 6.55-6.85 
(m, 2 H, H15), 4.53-4.66 (m, 1 H, H3), 3.77-3.95 (m, 1 H, H2), 3.75 
(s, 3 H, H1+H5+H7), 3.42-3.65 (m, 2 H, H4), 3.35 (s, 6 H, H17), 
1.01-1.22 (m, 3 H, H6). 
13C-NMR (125 MHz, DMSO-d6) δ [ppm] = 166.4 (C8), 154.3 (C12), 152.2 (C12’), 148.1 (C16), 
137.2 (C14), 133.4 (C14’), 130.6 (C13), 129.0 (C13’), 128.1 (C10), 122.3 (C11), 117.8 (C9), 105.7 
(C15), 104.8 (C15’), 79.6 (C2), 65.4 (C4), 60.9 (C4’), 57.4 (C3), 56.7 (C17), 56.1 (C17’), 20.7 (C6). 
MS (ESI, positive) m/z (%) 769.3 (50) [2M+Na]+, 396.2 (65) [M+Na]+, 374.2 (100) [M+H]+. 
HRMS (ESI, positive) m/z calculated for C19H23N3O5H: 374.1710, found: 374.1697.  
 
DMT-protected 4-carboxy-2‘,6‘-dimethoxyazobenzene-D-threoninol (73) 
4-Carboxy-2’,6’-dimethoxyazobenzene-D-threoninol (72) (3.20 g, 8.57 mmol) and 4-DMAP 
(0.12 g, 0.86 mmol) were dissolved in 60 mL dry pyridine under argon atmosphere and cooled 
to 0 °C. DMT-chloride (3.48 g, 10.3 mmol) was dissolved in 30 mL dry pyridine and added 
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dropwise to the reaction mixture under argon atmosphere. The mixture was warmed up to 
room temperature and stirring was continued for 24 hours under argon atmosphere. All 
solvents were removed in vacuo followed by purification via column chromatography (silica, 
eluent: cyclohexane/ethyl acetate = 1/1 with 3 % triethylamine) to yield the product as a red 
solid (yield: 1.91 g, 32 %). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 8.20-7.58 (m, 4 H, H9+H19), 7.42-7.06 (m, 9 H, 
H10+H20+H21+H23), 6.89-6.80 (m, 6 H, H14+H24), 6.57-6.55 (m, 1 H, H15), 4.62-4.50 (m, 1 H, H6), 
4.20-3.98 (m, 2 H, H4), 3.76 (s, 3 H, H16), 3.71 (s, 6 H, H26), 3.64 (s, 3 H, H16’), 3.27-3.16 (m, 1 
H, Hx), 3.08-2.88 (m, 1 H, Hx), 1.77-1.58 (m, 1 H, Hx), 1.06-0.97 (m, 3 H, Hx). 
13C-NMR (125 MHz, DMSO-d6) δ [ppm] = 171.1 (C7), 163.2 (C25), 159.1 (C11), 156.9 (C13), 
152.8 (C22), 150.3 (C18), 141.9 (C12), 141.1 (C15), 138.5 (C9), 137.2 (C23), 134.9 (C20), 133.8 
(C19), 132.9 (C10), 122.6 (C8), 118.3 (C24), 110.4 (C14), 90.4 (C17), 70.5 (C4), 68.2 (C2), 61.4 
(C16), 60.8 (C16’), 60.2 (C26), 52.7 (C3), 25.6 (C5). 
MS (ESI, positive) m/z (%) 1373.6 (20) [2M+Na]+, 698.3 (56) [M+Na]+. 
HRMS (ESI, positive) m/z calculated for C40H41N3O7Na: 698.2837, found: 698.2820. 
 
 
DMT-protected 4-carboxy-2‘,6‘-dimethoxyazobenzene-D-threoninol phosphoramidite 
(74) 
DMT-protected 4-carboxy-2‘,6‘-dimethoxyazobenzene-D-threoninol (73) (0.50 g, 0.74 mmol) 
was dissolved in 7.5 mL dry dichloromethane under argon atmosphere and cooled to 0 °C. 
DIPEA (0.12 g, 0.89 mmol) was added under argon atmosphere, followed by addition of 2-
cyanoethyl-N,N-diisopropylchlorophosphoramidite (0.21 g, 0.89 mmol). The reaction mixture 
was stirred for 15 minutes at 0 °C, then warmed up to room temperature and stirring was 
continued for 1 hour at room temperature under argon atmosphere. All solvents were removed 
in vacuo and the product was isolated by column chromatography (silica, eluent: 
cyclohexane/ethyl acetate = 1/1 with 3 % triethylamine) as a red foamy solid (yield: 0.50 g, 
77 %). 
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31P-NMR (125 MHz, CD2Cl2) δ [ppm] = 148.6, 147.9, 147.1. 
MS (ESI, positive) m/z (%) 892.4 (1) [M+Na]+, 876.4 (1) [M+H]+, 303.1 (100) [DMT]+. 
HRMS (ESI, positive) m/z calculated for C49H59N5O8P: 876.4096, found: 876.4094. 
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7.2.14 Synthesis of substituted arylazopyrazoles (“arylazopyrazole-library”) 
 
3-(2-Phenylhydrazono)pentane-2,4-dione (75)[136] 
A solution of aniline (3.00 g, 32.2 mmol) in 40 mL glacial acetic acid and 8 mL 12 % aqueous 
hydrochloric acid was prepared. NaNO2 (2.67 g, 38.6 mmol) was dissolved in 12 mL water and 
the solution was added dropwise to the prepared solution at 0 °C and stirred for 1 hour at 0 °C. 
A suspension of 2,4-pentanedione (4.19 g, 41.5 mmol) and NaOAc (7.92 g, 96.6 mmol) in 35 
mL ethanol and 20 mL water was prepared and the reaction mixture was added dropwise to 
the suspension, forming a yellow precipitate. The resulting mixture was stirred for 1 hour at 
room temperature, the yellow precipitate was collected by filtration and rinsed with 20 mL of a 
1:1 mixture of water and ethanol followed by rinsing with 10 mL cyclohexane. All solvents were 
removed in vacuo to yield a bright yellow solid as the product (5.52 g, 84 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 14.63 (s, br, 1 H, H1), 7.32 (m, 4 H, 
H2+H3), 7.12-7.09 (m, 1 H, H4), 2.51 (s, 3 H, H7), 2.39 (s, 3 H, H9). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 197.5 (C6), 196.7 (C8), 141.1 (C1), 132.8 
(C4), 129.3 (C3), 125.5 (C2), 115.9 (C5), 31.3 (C7), 26.2 (C9). 
MS (ESI, positive) m/z (%) 205.1 (100) [M+H]+, 187.1 (27) [C11H11N2O]+, 162.1 
(77) [C9H9N2O+H]+. 
HRMS (ESI, positive) m/z calculated for C11H12N2O2H: 205.0972, found: 205.0965. 
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3-(2-(2,6-Dimethylphenyl)hydrazono)pentane-2,4-dione (76) 
A solution of 2,6-dimethylaniline (3.90 g, 32.2 mmol) in 40 mL glacial acetic acid and 8 mL 
12 % aqueous hydrochloric acid was prepared. NaNO2 (2.67 g, 38.6 mmol) was dissolved in 
12 mL water and added dropwise to the prepared solution at 0 °C, followed by stirring for 1 
hour at 0 °C. A suspension of 2,4-pentanedione (4.19 g, 41.5 mmol) and NaOAc (7.92 g, 96.6 
mmol) in 35 mL ethanol and 20 mL water was prepared and the reaction mixture was added 
dropwise to the suspension, forming a bright red solution. The resulting solution was stirred for 
1 hour at room temperature and extracted twice with 100 mL ethyl acetate. The combined 
organic layers were washed with 100 mL water and 100 mL brine, dried over MgSO4, followed 
by filtering off all solids and removal of ethyl acetate under reduced pressure. The product was 
isolated as a bright yellow solid (5.12 g, 68 %). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 14.96 (s, br, 1 H, H1), 7.12-7.06 (m, 3 
H, H3+H4), 2.62 (s, 3 H, H8), 2.45 (s, 6 H, H5), 2.40 (s, 3 H, H10). 
13C-NMR (125 MHz, CDCl3) δ [ppm] = 197.7 (C7), 197.2 (C9), 138.0 (C1), 
133.6 (C6), 129.8 (C2), 129.7 (C4), 126.4 (C3), 31.6 (C8), 27.0 (C10), 19.5 (C5). 
MS (ESI, positive) m/z (%) 233.1 (100) [M+H]+, 121.1 (39) [C8H11N]+. 
HRMS (EI, 70 eV) m/z calculated for C13H17N2O2: 233.1285, found: 233.1291. 
 
3-(2-(2,6-Dichlorophenyl)hydrazono)pentane-2,4-dione (77) 
A solution of 2,6-dichloroaniline (5.22 g, 32.2 mmol) in 40 mL glacial acetic acid and 8 mL 
12 % aqueous hydrochloric acid was prepared. NaNO2 (2.67 g, 38.6 mmol) was dissolved in 
12 mL water, added dropwise to the prepared solution at 0 °C and stirred for 1 hour at 0 °C. A 
suspension of 2,4-pentanedione (4.19 g, 41.5 mmol) and NaOAc (7.92 g, 96.6 mmol) in 35 mL 
ethanol and 20 mL water was prepared and the reaction mixture was added dropwise to the 
suspension, forming a yellow precipitate. The resulting mixture was stirred for 1 hour at room 
temperature, the yellow precipitate was collected by filtration and rinsed with 20 mL of a 1:1-
mixture of water and ethanol followed by 10 mL cyclohexane. All solvents were removed in 
vacuo to yield a yellow solid (4.84 g, 55 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 14.53 (s, br, 1 H, H1), 7.39 (d, 2 H, 3J3,4 
= 8.1 Hz, H3), 7.12 (m, 1 H, H4), 2.62 (s, 3 H, H7), 2.43 (s, 3 H, H9). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 198.1 (C6), 197.4 (C8), 135.3 (C5), 134.4 
(C1), 129.6 (C3), 127.4 (C4), 126.6 (C2), 31.6 (C7), 26.7 (C9). 
MS (ESI, positive) m/z (%) 301.1 (55) [M+Na]+, 273.1 (43) [M+H]+, 160.9 (100) 
[C6H5Cl2N]+. 
HRMS (ESI, positive) m/z calculated for C11H10Cl2N2O2H: 273.0192, found: 273.0183. 
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3-(2-(2,6-Difluorophenyl)hydrazono)pentane-2,4-dione (78) 
A solution of 2,6-difluoroaniline (4.16 g, 32.2 mmol) in 40 mL glacial acetic acid and 8 mL 
12 % aqueous hydrochloric acid was prepared. NaNO2 (2.67 g, 38.6 mmol) was dissolved in 
12 mL water and the solution was added dropwise to the prepared solution at 0 °C, followed 
by stirring for 1 hour at 0 °C. A suspension of 2,4-pentanedione (4.19 g, 41.5 mmol) and NaOAc 
(7.92 g, 96.6 mmol) in 35 mL ethanol and 20 mL water was prepared and the reaction mixture 
was added dropwise to the suspension, forming a yellow precipitate. The resulti-ng mixture 
was stirred for 1 hour at room temperature, the yellow precipitate was collected by filtration 
and rinsed with 20 mL of a 1:1-mixture of water and ethanol followed by 10 mL cyclohexane. 
All solvents were removed in vacuo to yield a bright orange solid (6.06 g, 78 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 14.34 (s, br, 1 H, H1), 7.07-6.89 (m, 3 
H, H3+H4), 2.53 (s, 3 H, H8), 2.35 (s, 3 H, H10). 
19F-NMR (162 MHz, CDCl3) δ [ppm] = -124.6 (F5). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 197.7 (C7), 197.1 (C9), 155.5 (C6), 
152.1 (C2), 134.7 (C1), 125.1 (C4), 112.3 (C3), 31.2 (C10), 26.0 (C8). 
MS (ESI, positive) m/z (%) 241.1 (79) [M+H]+, 203.9 (51) [C11H12N2O2]+. 
HRMS (ESI, positive) m/z calculated for C11H10F2N2O2H: 241.0783, found: 241.0777. 
 
(E)-1,3,5-Trimethyl-4-(phenyldiazenyl)-1H-pyrazole (79)[136] 
N-Methylhydrazine (1.00 g, 4.90 mmol) was added dropwise to a solution of 3-(2-
phenylhydrazono)pentane-2,4-dione (75) (1.00 g, 4.90 mmol) in 25 mL ethanol. The reaction 
mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all solvents were 
removed in vacuo. The product was isolated as the remaining bright yellow solid (0.93 g, 89 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.80-7.76 (m, 2 H, H3), 7.48-
7.42 (m, 2 H, H2), 7.38-7.33 (m, 1 H, H4), 3.75 (s, 3 H, H10), 2.56 (s, 3 
H, H9), 2.51 (s, 3 H, H7). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 153.2 (C1), 142.0 (C8), 138.4 
(C5), 134.7 (C6), 128.9 (C4), 128.5 (C3), 121.4 (C2), 35.6 (C10), 13.5 
(C9), 9.6 (C7). 
MS (EI, 70 eV) m/z (%) 214.1 (90) [M]+∙, 137.1 (100) [M-C6H5]+, 109.1 (78) [M-C6H5N2]+. 
HRMS (EI, 70 eV) m/z calculated for C12H14N4: 214.1218, found: 214.1223. 
 
(E)-1,3,5-Trimethyl-4-((2,6-dimethylphenyl)diazenyl)-1H-pyrazole (80) 
N-Methylhydrazine (0.26 mL, 5.00 mmol) was added dropwise to a solution of 3-(2-(2,6-
dimethylphenyl)hydrazono)pentane-2,4-dione (76) (1.16 g, 5.00 mmol) in 25 mL ethanol. The 
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reaction mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all 
solvents were removed in vacuo. The product was isolated as the remaining bright yellow solid 
(1.12 g, 93 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.02-6.98 (m, 3 H, H3+H4), 3.69 
(s, 3 H, H11), 2.45 (s, 3 H, H10), 2.39 (s, 3 H, H8), 2.26 (s, 6 H, H5). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 151.5 (C7), 141.3 (C1), 138.4 
(C6), 135.4 (C9), 130.0 (C3), 128.7 (C2), 126.7 (C4), 35.5 (C11), 18.9 (C5), 
13.6 (C10), 9.5 (C8). 
MS (EI, 70 eV) m/z (%) 242.2 (84) [M]+∙, 227.1 (16) [M-CH3]+, 213.1 (37) [M-CH2N] +∙, 199.1 
(34) [M-CH2N2]+, 137.1 (100) [C6H9N4]+, 109.1 (98) [C6H9N2]+. 
HRMS (EI, 70 eV) m/z calculated for C14H18N4: 242.1531, found: 242.1530. 
 
(E)-1,3,5-Trimethyl-4-((2,6-dichlorophenyl)diazenyl)-1H-pyrazole (81) 
N-Methylhydrazine (0.26 mL, 5.00 mmol) was added dropwise to a solution of 3-(2-(2,6-
dichlorophenyl)hydrazono)pentane-2,4-dione (77) (1.37 g, 5.00 mmol) in 25 mL ethanol. The 
reaction mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all solvents 
were removed in vacuo. The product was isolated as the remaining bright yellow solid (0.84 g, 
60 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.22-7.19 (m, 2 H, H3), 6.97-
6.92 (m, 1 H, H4), 3.63 (s, 3 H, H10), 2.40 (s, 3 H, H9), 2.33 (s, 3 H, H7). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 176.1 (C6), 148.3 (C1), 142.4 
(C5), 139.8 (C8), 135.4 (C3), 128.6 (C4), 127.1 (C2), 35.6 (C10), 13.3 
(C9), 9.5 (C7). 
MS (EI, 70 eV) m/z (%) 282.0 (16) [M]+∙, 247.1 (16) [M-Cl]+, 161.0 (100) [C5H3Cl2N2]+, 137.1 
(45) [M-C6H3Cl2]+, 109.1 (30) [C6H9N2]+, 77.1 (73) [C6H5]+. 
HRMS (EI, 70 eV) m/z calculated for C12H12Cl2N4: 282.0439, found: 282.0439. 
 
(E)-1,3,5-Trimethyl-4-((2,6-difluorophenyl)diazenyl)-1H-pyrazole (82) 
N-Methylhydrazine (0.26 mL, 5.00 mmol) was added dropwise to a solution of 3-(2-(2,6-
difluorophenyl)hydrazono)pentane-2,4-dione (78) (1.20 g, 5.00 mmol) in 25 mL ethanol. The 
reaction mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all solvents 
were removed in vacuo. The product was isolated as the remaining bright orange solid (yield: 
0.87 g, 70 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.22-7.11 (m, 1 H, H4), 6.99-6.90 (m, 2 H, H3), 3.74 (s, 
3 H, H11), 2.51 (s, 3 H, H10), 2.45 (s, 3 H, H8). 
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19F-NMR (100 MHz, CDCl3) δ [ppm] = -123.4 (F5). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 157.1 (C2), 153.7 (C7), 142.0 
(C1), 139.4 (C8), 136.2 (C9), 127.9 (C4), 112.0 (C3), 35.6 (C11), 13.4 
(C10), 9.4 (C8). 
MS (EI, 70 eV) m/z (%) 250.1 (100) [M]+∙, 137.1 (72) [M-C6H3F2]+, 109.1 (69) [M-C6H3F2N2]+. 
HRMS (EI, 70 eV) m/z calculated for C12H12F2N4: 250.1030, found: 250.1032. 
 
(E)-1-Phenyl-3,5-dimethyl-4-(phenyldiazenyl)-1H-pyrazole (83) 
N-Phenylhydrazine (0.46 mL, 4.90 mmol) was added dropwise to a solution of 3-(2-
phenylhydrazono)pentane-2,4-dione (75) (1.00 g, 4.90 mmol) in 25 mL ethanol. The reaction 
mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all solvents were 
removed in vacuo. The product was isolated as the remaining bright orange solid (1.31 g, 
97 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.75-7.71 (m, 2 H, H11), 7.42-7.26 
(m, 8 H, H2+H3+H4+H12+H13), 2.55 (s, 3 H, H7), 2.51 (s, 3 H, H9). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 153.2 (C8), 143.5 (C1), 138.7 (C10), 
135.8 (C5), 129.2 (C6), 128.9 (C3), 128.6 (C12), 127.7 (C4+C11), 124.5 (C13), 
121.5 (C2), 13.7 (C9), 11.0 (C7). 
MS (EI, 70 eV) m/z (%) 276.2 (100) [M]+∙, 199.1 (72) [M-C6H5]+, 171.1 (53) 
[M-C6H5N2]+, 108.1 (70) [C5H6N3]+, 77.1 (73) [C6H5]+. 
HRMS (EI, 70 eV) m/z calculated for C17H16N4: 276.1375, found: 276.1375. 
 
(E)-1-Phenyl-3,5-dimethyl-4-((2,6-dimethylphenyl)diazenyl)-1H-pyrazole (84) 
N-Phenylhydrazine (0.49 mL, 5.00 mmol) was added dropwise to a solution of 3-(2-(2,6-
dimethylphenyl)hydrazono)pentane-2,4-dione (76) (1.16 g, 5.00 mmol) in 25 mL ethanol. The 
reaction mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all solvents 
were removed in vacuo. The product was isolated as the remaining bright orange solid (1.42 
g, 93 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.53-7.51 (m, 4 H, H12+H13), 7.46-7.41 (m, 1 H, H4), 
7.15-7.12 (m, 3 H, H3+H14), 2.64 (s, 3 H, H8), 2.60 (s, 3 H, H10), 2.42 (s, 6 H, 
H5). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 151.5 (C9), 142.8 (C1), 138.7 (C11), 
136.4 (C6), 130.2 (C7), 128.9 (C3), 128.8 (C13), 127.8 (C2), 127.0 (C4), 124.6 
(C14), 119.8 (C12), 19.0 (C5), 13.9 (C10), 10.9 (C8). 
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MS (EI, 70 eV) m/z (%) 304.2 (30) [M]+∙, 275.1 (17) [M-C2H5]+, 199.1 (28) [M-C8H9]+, 187.1 
(45) [M-C8H7N]+, 171.1 (44) [M-C8H9N2]+, 137.1 (82) [C6H9N4]+, 108.1 (100) [C5H6N3]+, 105.1 
(52) [C8H9]+, 77.1 (98) [C6H5]+. 
HRMS (EI, 70 eV) m/z calculated for C19H20N4: 304.1688, found: 304.1687. 
 
(E)-1-Phenyl-3,5-dimethyl-4-((2,6-dichlorophenyl)diazenyl)-1H-pyrazole (85) 
N-Phenylhydrazine (0.49 mL, 5.00 mmol) was added dropwise to a solution of 3-(2-(2,6-
dichlorophenyl)hydrazono)pentane-2,4-dione (77) (1.37 g, 5.00 mmol) in 25 mL ethanol. The 
reaction mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all solvents 
were removed in vacuo. The product was isolated as the remaining bright orange solid (1.22 
g, 71 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.40-7.36 (m, 3 H, H4+H11), 7.34-7.29 
(m, 1 H, H13), 7.14-7.07 (m, 1 H, H3), 7.04-6.98 (m, 1 H, H3), 6.80-6.57 (m, 2 
H, H12), 2.52 (s, 2 H, H7), 2.48 (s, 2 H, H9), 1.93 (s, 1 H, H7), 1.90 (s, 1 H, H9). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 148.4 (C8), 143.7 (C1), 140.3 (C10), 
138.4 (C5), 128.9 (C6), 128.7 (C6’), 128.0 (C3), 127.3 (C12), 124.6 (C4), 120.9 
(C13), 114.8 (C11), 113.2 (C2), 112.1 (C2’), 20.5 (C7), 13.6 (C7’), 10.9 (C9). 
MS (EI, 70 eV) m/z (%) 344.1 (4) [M]+∙, 309.1 (6) [M-Cl]+, 199.1 (8) [M-
C6H3Cl2]+, 171.1 (32) [M-C6H3F2N2]+, 108.1 (100) [C5H6N3]+, 92.0 (36) 
[C5H4N2]+, 77.1 (52) [C6H5]+. 
HRMS (EI, 70 eV) m/z calculated for C17H14Cl2N4: 344.0596, found: 344.0597. 
 
(E)-1-Phenyl-3,5-dimethyl-4-((2,6-difluorophenyl)diazenyl)-1H-pyrazole (86) 
N-Phenylhydrazine (0.49 mL, 5.00 mmol) was added dropwise to a solution of 3-(2-(2,6-
difluorophenyl)hydrazono)pentane-2,4-dione (78) in 25 mL ethanol. The reaction mixture was 
refluxed for 3 hours at 80 °C, cooled to room temperature and all solvents were removed in 
vacuo. The product was isolated as the remaining bright orange solid (1.23 
g, 79 %). 
1H-NMR (300 MHz, CDCl3) δ [ppm] = 7.42-7.32 (m, 5 H, H4+H12+H13), 
7.14-7.09 (m, 1 H, H14), 6.93-6.87 (m, 2 H, H3), 2.53 (s, 3 H, H8), 2.43 (s, 3 
H, H10). 
13C-NMR (75 MHz, CDCl3) δ [ppm] = 157.1 (C2), 153.7 (C9), 143.4 (C1), 
139.9 (C11), 138.5 (C6), 137.3 (C7), 128.9 (C13), 128.1 (C14), 127.9 (C12), 
124.5 (C4), 111.8 (C3), 13.7 (C10), 10.9 (C8). 
19F-NMR (100 MHz, CDCl3) δ [ppm] = -123.2 (F5). 
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MS (EI, 70 eV) m/z (%) 312.1 (46) [M]+∙, 205.1 (54) [M-C6H3N2]+, 199.1 (26) [M-C6H3F2]+, 
171.1 (27) [M-C6H3F2N2]+, 148.1 (100) [C7H8N4]+, 108.1 (67) [C5H6N3]+, 92.0 (96) [C5H4N2]+, 
77.1 (76) [C6H5]+. 
HRMS (EI, 70 eV) m/z calculated for C17H14F2N4: 312.1187, found: .312.1187. 
 
 (E)-1-(4-Nitrophenyl)-3,5-dimethyl-4-(phenyldiazenyl)-1H-pyrazole (87) 
N-(4-Nitrophenyl)-hydrazine (0.77 g, 5.00 mmol) was added dropwise to a solution of 3-(2-
phenylhydrazono)pentane-2,4-dione (75) (1.02 g, 5.00 mmol) in 25 mL ethanol. The reaction 
mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all solvents were 
removed in vacuo. The product was isolated as the remaining bright orange solid (1.13 g, 
70 %).  
1H-NMR (600 MHz, CDCl3) δ [ppm] = 8.37-8.39 (m, 2 H, H12), 7.82-7.84 
(m, 2 H, H11), 7.76-7.78 (m, 2 H, H3), 7.48-7.51 (m, 2 H, H2), 7.43-7.45 (m, 1 
H, H4), 2.79 (s, 3 H, H7), 2.60 (s, 3 H, H9). 
13C-NMR (150 MHz, CDCl3) δ [ppm] = 153.3 (C8), 146.2 (C1), 145.1 (C13), 
144.1 (C10), 139.6 (C5), 137.1 (C6), 130.1 (C3), 129.0 (C4), 124.8 (C11), 124.0 
(C2), 122.0 (C12), 14.2 (C9), 11.8 (C7). 
MS (EI, 70 eV) m/z (%) 321.1 (80) [M]+∙, 291.1 (38) [M-NO]+, 274.1 (22) 
[M-HNO2]+, 244.1 (100) [M-C6H5]+, 216.1 (51) [M-C6H5N2]+, 186.1 (28) [C10H10N4]+, 170.1 (38) 
[C11H10N2]+, 151.0 (16) [C6H5N3O2]+, 122.0 (22) [C6H4NO2]+, 92.0 (96) [C5H4N2]+, 77.1 (76) 
[C6H5]+. 
HRMS (EI, 70 eV) m/z calculated for C17H15N5O2: 321.1226, found: 321.1227. 
 
(E)-1-(4-Nitrophenyl)-3,5-dimethyl-4-((2,6-dimethylphenyl)diazenyl)-1H-pyrazole (88) 
N-(4-Nitrophenyl)-hydrazine (0.77 g, 5.00 mmol) was added dropwise to a solution of 3-(2-
(2,6-dimethylphenyl)hydrazono)pentane-2,4-dione (76) (1.16 g, 5.00 mmol) in 25 mL ethanol. 
The reaction mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all 
solvents were removed in vacuo. The product was isolated as the remaining bright orange 
solid (1.28 g, 73 %). 
H-NMR (600 MHz, CDCl3) δ [ppm] = 8.38-8.40 (m, 2 H, H13), 7.77-7.79 (m, 2 H, H12), 7.11-
7.14 (m, 3 H, H3+H4), 2.75 (s, 3 H, H8), 2.58 (s, 3 H, H10), 2.41 (s, 6 H, H5). 
13C-NMR (150 MHz, CDCl3) δ [ppm] = 151.5 (C9), 146.3 (C1), 144.4 (C14), 139.7 (C11), 137.7 
(C6), 136.9 (C7), 130.8 (C3), 129.2 (C2), 127.8 (C4), 124.9 (C12), 124.1 (C13), 19.5 (C5), 14.4 
(C10), 11.6 (C8). 
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MS (EI, 70 eV) m/z (%) 349.1 (6) [M]+∙, 320.1 (4) [M-C2H5]+, 262.1 (7) 
[C16H14N4]+, 232.1 (52) [C11H12N4O2]+, 217.1 (22) [M-C8H8N2]+, 193.1 (100) 
[C11H10N2+Na]+, 120.1 (77) [C8H10N]+. 
HRMS (EI, 70 eV) m/z calculated for C19H19N5O2: 349.1539, found: 
349.1537. 
 
(E)-1-(4-Nitrophenyl)-3,5-dimethyl-4-((2,6-dichlorophenyl)diazenyl)-1H-
pyrazole (89) 
N-(4-Nitrophenyl)-hydrazine (0.77 g, 5.00 mmol) was added dropwise to a solution of 3-(2-
(2,6-dichlorophenyl)hydrazono)pentane-2,4-dione (77) (1.37 g, 5.00 mmol) in 25 mL ethanol. 
The reaction mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all 
solvents were removed in vacuo. The product was isolated as the remaining bright orange 
solid (1.61 g, 83 %). 
1H-NMR (600 MHz, CDCl3) δ [ppm] = 8.39-8.41 (m, 2 H, H12), 7.76-7.78 
(m, 2 H, H3), 7.40-7.42 (m, 2 H, H11), 7.15-7.18 (m, 1 H, H4), 2.77 (s, 3 H, 
H9), 2.59 (s, 3 H, H7). 
13C-NMR (150 MHz, CDCl3) δ [ppm] = 148.4 (C8), 146.5 (C1), 145.2 (C13), 
143.9 (C10), 141.3 (C5), 137.7 (C6), 129.1 (C3), 128.0 (C4), 127.3 (C11), 124.9 
(C2), 124.3 (C12), 14.2 (C9), 11.6 (C7). 
MS (EI, 70 eV) m/z (%) 389.0 (45) [M]+∙, 354.1 (63) [M-Cl]+, 324.1 (6) [M-
ClNO]+, 244.1 (100) [M-C6H3Cl2]+, 216.1 (58) [M-C6H3Cl2N2]+, 170.1 (34) [M-C6H2Cl2N2-NO2]+, 
108.1 (41) [C5H6N3]+. 
HRMS (EI, 70 eV) m/z calculated for C17H13Cl2N5O2: 389.0446, found: 389.0443. 
 
(E)-1-(4-Nitrophenyl)-3,5-dimethyl-4-((2,6-difluorophenyl)diazenyl)-1H-pyrazole (90) 
N-(4-Nitrophenyl)-hydrazine (0.77 g, 5.00 mmol) was added dropwise to a solution of 3-(2-
(2,6-difluorophenyl)hydrazono)pentane-2,4-dione (78) (1.20 g, 5.00 mmol) in 25 mL ethanol. 
The reaction mixture was refluxed for 3 hours at 80 °C, cooled to room temperature and all 
solvents were removed in vacuo. The product was isolated as the remaining bright orange 
solid (1.48 g, 83 %). 
1H-NMR (600 MHz, CDCl3) δ [ppm] = 8.38-8.40 (m, 2 H, H13), 7.76-7.78 (m, 2 H, H12), 7.25-
7.28 (m, 1 H, H4), 7.01-7.04 (m, 2 H, H3), 2.76 (s, 3 H, H10), 2.56 (s, 3 H, H8). 
13C-NMR (150 MHz, CDCl3) δ [ppm] = 156.6 (C2), 154.9 (C9), 146.4 (C1), 144.9 (C14), 144.0 
(C11), 140.8 (C6), 138.5 (C7), 131.8 (C12), 129.1 (C13), 124.9 (C4), 124.2 (C4’), 112.4 (C3), 14.2 
(C10), 11.6 (C8).  
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MS (EI, 70 eV) m/z (%) 357.1 (100) [M]+∙, 337.1 (10) [M-HF]+∙, 327.1 (19) 
[M-NO]+, 244.1 (77) [M-C6H3F2]+, 216.1 (55) [M-C6H3F2N2]+, 170.1 (27) [M-
C6H2F2N2-NO2]+, 122.0 (18) [C6H4NO2]+, 108.1 (12) [C5H6N3]+. 
HRMS (EI, 70 eV) m/z calculated for C17H13F2N5O2: 357.1037, found: 
357.1037. 
 
 
(E)-1-(4-Aminophenyl)-3,5-dimethyl-4-(phenyldiazenyl)-1H-pyrazole (91)[259] 
(E)-1-(4-Nitrophenyl)-3,5-dimethyl-4-(phenyldiazenyl)-1H-pyrazole (87) (0.50 g, 1.56 mmol) 
was dissolved in 30 mL DMF. Na2S∙H2O (0.38 g, 3.90 mmol) was dissolved in 37.5 mL H2O 
and the solution was added dropwise to the first solution. The resulting reaction mixture was 
heated to 90 °C for 5 hours, then cooled to room temperature and diluted with 100 mL water. 
The reaction mixture was extracted twice with 100 mL dichloromethane, the combined organic 
layers were dried over MgSO4 and all solvents were removed in vacuo to yield the product as 
a bright yellow solid (0.41 g, 90 %). 
1H-NMR (600 MHz, CDCl3) δ [ppm] = 7.76-7.82 (m, 2 H, H3), 7.46-7.48 (m, 
2 H, H11), 7.34-7.39 (m, 1 H, H4), 7.22-7.24 (m, 2 H, H2), 6.75-6.76 (m, 2 H, 
H12), 2.57-2.60 (m, 6 H, H7+H9). 
13C-NMR (150 MHz, CDCl3) δ [ppm] = 153.6 (C8), 146.3 (C1), 143.4 (C13), 
139.0 (C10), 135.7 (C5), 130.1 (C6), 129.3 (C3), 128.9 (C4), 126.4 (C12), 121.8 
(C2), 115.1 (C11), 13.9 (C9), 11.2 (C7). 
MS (ESI, positive) m/z (%) 605.3 (66) [2M+Na]+, 314.1 (100) [M+Na]+, 
225.1 (65) [C13H13N4]+. 
HRMS (ESI, positive) m/z calculated for C17H17N5Na: 314.1376, found: 314.1375. 
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7.2.15 Synthesis of N-methyl-arylazopyrazole phosphoramidite 
 
 
Ethyl-4-(2-(2,4-dioxopentan-3-ylidene)hydrazono)benzoate (92) 
A solution of ethyl-4-aminobenzoate (12.2 g, 74.0 mmol) in 100 mL glacial acetic acid and 
17 mL 12 % aqueous hydrochloric acid was prepared. NaNO2 (6.10 g, 88.8 mmol) was 
dissolved in 25 mL water, the solution was added dropwise to the prepared solution at 0 °C 
and the reaction mixture was stirred for 1 hour at 0 °C. A suspension of 2,4-pentanedione (9.80 
mL, 100 mmol) and NaOAc (18.1 g, 220 mmol) in 70 mL ethanol and 40 mL water was 
prepared and the reaction mixture was added dropwise to the suspension. The resulting 
mixture was stirred for 1 hour at room temperature, followed by removal of all solvents in vacuo. 
The product was isolated by column chromatography (silica, eluent: cyclohexane/ethyl acetate 
= 1/1) as a bright yellow solid (yield: 20.4 g, quant.). 
1H-NMR (400 MHz, CDCl3) δ [ppm] = 14.56 (s, br, 1 H, H7), 8.09-8.06 (m, 
2 H, H5), 7.43-7.39 (m, 2 H, H6), 4.40 (q, 2 H, 3J2,1 = 7.1 Hz, H2), 2.60 (s, 3 H, 
H12), 2.49 (s, 3 H, H8), 1.41 (t, 3 H, 3J1,2 = 7.1 Hz, H1). 
13C-NMR (100 MHz, CDCl3) δ [ppm] = 198.3 (C11), 196.9 (C9), 165.8 (C3), 
145.0 (C7), 134.1 (C5), 131.3 (C6), 127.3 (C4), 115.6 (C10), 61.0 (C2), 31.7 
(C12), 26.6 (C8), 14.3 (C1). 
MS (ESI, positive) m/z (%) 299.1 (100) [M+Na]+. 
HRMS (ESI, positive) m/z calculated for C14H16N2O4Na: 299.1002, found: 299.1004.  
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Ethyl-4-((E)-(1,3,5-trimethyl-1H-pyrazol-4-yl)diazenyl)benzoate (93) 
Ethyl-4-(2-(2,4-dioxopentan-3-ylidene)hydrazono)benzoate (92) (1.50 g, 5.43 mmol) was 
dissolved in 30 mL ethanol. N-Methylhydrazine (0.28 mL, 5.43 mmol) was added dropwise to 
the solution at room temperature and the reaction mixture was refluxed for 3 hours. All solvents 
were removed in vacuo and the product was isolated by column chromatography (silica, eluent: 
cyclohexane/ethyl acetate = 1/1) as a bright orange solid (1.55 g, quant.). 
1H-NMR (400 MHz, CDCl3) δ [ppm] = 8.14-8.11 (m, 2 H, H5), 7.81-7.78 (m, 
2 H, H6), 4.43 (q, 2 H, 3J2,1 = 7.1 Hz, H2), 3.78 (s, 3 H, H13), 2.58 (s, 3 H, H11), 
2.51 (s, 3 H, H12), 1.44 (t, 3 H, 3J1,2 = 7.1 Hz, H1). 
13C-NMR (100 MHz, CDCl3) δ [ppm] = 166.2 (C3), 156.2 (C10), 142.6 (C7), 
139.7 (C9), 135.4 (C8), 130.5 (C5), 130.4 (C6), 121.5 (C4), 61.0 (C2), 36.0 
(C13), 14.3 (C1), 13.9 (C11), 9.9 (C12). 
MS (EI, 70 eV) m/z (%) 595.3 (27) [2M+Na]+, 309.1 (100) [M+Na]+. 
HRMS (EI, 70 eV) m/z calculated for C15H18N4O2Na: 309.1322, found: 309.1323. 
 
4-((E)-(1,3,5-Trimethyl-1H-pyrazol-4-yl)diazenyl)benzoic acid (94) 
Ethyl-4-((E)-(1,3,5-trimethyl-1H-pyrazol-4-yl)diazenyl)benzoate (93) (7.50 g, 26.2 mmol) was 
dissolved in 1.2 L ethanol and 130 mL 1 M aqueous NaOH. The reaction mixture was stirred 
for 24 hours at room temperature, acidified with 1 M aqueous hydrochloric acid and extracted 
three times with 500 mL ethyl acetate. The combined organic layers were washed with 1 L 
water and 500 mL brine, dried over MgSO4, filtered and all solvents were removed in vacuo. 
The product was isolated by column chromatography (silica, eluent: chloroform/methanol = 
95/5) as a bright orange solid (6.75 g, quant.). 
1H-NMR (400 MHz, DMSO-d6) δ [ppm] = 13.04 (s, br, 1 H, H1), 8.06-8.03 (m, 
2 H, H4), 7.79-7.76 (m, 2H, H5), 3.73 (s, 3 H, H12), 2.54 (s, 3 H, H10), 2.36 (s, 3 
H, H11). 
13C-NMR (100 MHz, DMSO-d6) δ [ppm] = 166.9 (C2), 155.6 (C9), 140.7 (C6), 
134.8 (C8), 131.0 (C7), 130.5 (C4), 121.4 (C5), 36.0 (C12), 13.8 (C10), 9.5 (C11). 
MS (ESI, negative) m/z (%) 342.1 (23) [M+CHCl2-H]-, 257.1 (100) [M-H]-, 
213.1 (17) [M-CO2H]-. 
HRMS (ESI, negative) m/z calculated for C13H13N4O2: 257.1044, found: 257.1028. 
 
4-((E)-(1,3,5-Trimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-threoninol (“AAP1”) (95) 
4-((E)-(1,3,5-Trimethyl-1H-pyrazol-4-yl)diazenyl)benzoic acid (94) (5.0 g, 19.4 mmol), D-
threoninol (2.44 g, 23.2 mmol), DCC (4.79 g, 23.2 mmol) and OxymaPure (3.30 g, 23.2 mmol)  
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were dissolved in 180 mL dry DMF and the reaction mixture was stirred for 24 hours at room 
temperature under argon atmosphere. All solid residues were filtered off, DMF was removed 
in vacuo and the crude product was purified by column chromatography (silica, eluent: 
chloroform/methanol = 98/2) as a bright orange solid (4.76 g, 71 %). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.30. 
1H-NMR (400 MHz, DMSO-d6) δ [ppm] = 8.01-7.98 (m, 2 H, 
H10), 7.83-7.75 (m, 3 H, H7+H11), 4.64-4.60 (m, 2 H, H3+H5), 
3.95-3.89 (m, 2 H, H4), 3.74 (s, 3 H, H18), 3.64-3.58 (m, 1 H, 
H2), 3.53-3.48 (m, 1 H, H1), 2.56 (s, 3 H, H16), 2.38 (s, 3 H, 
H17), 1.08 (d, 3 H, 3J6,2 = 6.2 Hz, H6). 
13C-NMR (100 MHz, DMSO-d6) δ [ppm] = 166.0 (C8), 154.5 (C15), 140.6 (C12), 140.3 (C13), 
135.1 (C14), 134.7 (C10), 128.5 (C10), 121.1 (C11), 64.9 (C4), 60.5 (C2), 56.9 (C3), 36.0 (C16), 
20.3 (C6), 13.9 (C16), 9.6 (C17). 
MS (ESI, positive) m/z (%) 713.4 (35) [2M+Na]+, 368.2 (45) [M+Na]+, 346.2 [M+H]+. 
HRMS (ESI, positive) m/z calculated for C17H23N5O3H: 346.1874, found: 346.1876. 
 
DMT-protected 4-((E)-(1,3,5-trimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-threoninol 
(96) 
4-((E)-(1,3,5-Trimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-threoninol (95) (0.91 g, 2.64 
mmol) was dissolved in 30 mL dry dichloromethane. DMT-chloride (0.89 g, 2.64 mmol) was 
dissolved in 20 mL dry dichloromethane and added dropwise to the first solution under argon 
atmosphere over 20 minutes. The reaction mixture was stirred for 1 hour under argon 
atmosphere at room temperature, then N-methylmorpholine (0.27 g, 2.64 mmol) was added 
dropwise to the solution under argon atmosphere and stirring was continued for 24 hours at 
room temperature under argon atmosphere. All solvents were removed under reduced 
pressure and the product was isolated by column chromatography (silica, eluent: 
cyclohexane/ethyl acetate = 1/1 with 3 % triethylamine) as a bright orange solid (0.82 g, 47 %). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 7.73-7.81 (m, 4 H, H9+H20), 7.33-7.36 (m, 2 H, H10), 
7.11-7.24 (m, 7 H, H21+H22+H24), 6.72-6.75 (m, 4 H,H25), 5.23 (s, 1 H, H6), 4.12-4.15 (m, 1 H, 
H3), 3.99-4.05 (m, 1 H, H2), 3.66-3.69 (m, 9 H, H17+H27), 3.55-3.57 (m, 1 H, H1), 3.25-3.40 (m, 
2 H, H4), 2.49 (s, 3 H, H15), 2.38 (s, 3 H, H16), 1.11-1.16 (m, 3 H, H5). 
13C-NMR (125 MHz, DMSO-d6) δ [ppm] = 167.3 (C7), 159.1 (C26), 155.9 (C14), 145.1 (C11), 
142.5 (C19), 140.3 (C23), 136.0 (C12), 135.9 (C13), 135.7 (C22), 135.0 (C9), 130.3 (C24), 128.3 
(C21), 128.2 (C20), 127.3 (C10), 122.0 (C8), 113.6 (C25), 87.0 (C18), 68.5 (C4), 65.0(C2), 55.6 (C3), 
54.9 (C27), 36.3 (C17), 20.5 (C5), 14.1 (C15), 10.1 (C16).  
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MS (ESI, positive) m/z (%) 670.3 (100) [M+Na]+, 368.2 (92) [M-DMT+Na]+, 343.1 (61) 
[C17H21N5O3]+, 303.1 (32) [DMT]+. 
HRMS (ESI, positive) m/z calculated for C38H41N5O5Na: 670.3000, found: 670.2998. 
 
 
DMT-protected 4-((E)-(1,3,5-trimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-threoninol 
phosphoramidite (97) 
DMT-protected 4-((E)-(1,3,5-trimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-threoninol (96) 
(1.0 g, 1.54 mmol) was dissolved in 15 mL dry diethyl ether under argon atmosphere and the 
reaction mixture was cooled to 0 °C. DiPEA (0.24 g, 1.85 mmol) was added dropwise at 0 °C 
followed by dropwise addition of 2-cyanoethyl-N,N-diisopropylchlorophosporamidite (0.44 g, 
1.85 mmol). The reaction mixture was stirred for 15 minutes at 0 °C followed by evaporation 
of all solvents. The product was isolated by column chromatography (silica, eluent: 
cyclohexane/ethyl acetate = 1/1) as a bright orange solid (0.92 g, 69 %). 
1H-NMR (300 MHz, DMSO-d6) δ [ppm] = 7.86-7.69 (m, 4 H, H8+H19), 7.46-7.40 (m, 2 H, H9), 
7.32-7.19 (m, 7 H, H20+H21+H23), 6.82-6.78 (m, 4 H, H24), 4.47-4.30 (m, 1 H, H5), 4.18-3.98 (m, 
1 H, H3), 3.79-3.71 (m, 8 H, H26+H30), 3.64-3.45 (m, 5 H, H16+H28), 3.33-3.27 (m, 1 H, H2), 3.04 
(s, br, 2H, H4), 2.56 (s, 3 H, H14), 2.44 (s, 3 H, H15), 1.50-0.96 (m, 17 H, H1+H29+H31). 
31P-NMR (75 MHz, DMSO-d6) δ [ppm] = 148.4, 140.8. 
MS (ESI, positive) m/z (%) 870.4 (18) [M+Na]+, 
459.2 (100) [C22H32N6O3P]+, 441.2 (78) 
[C23H34N6O5P]+.  
HRMS (ESI, positive) m/z calculated for 
C47H58N7O6PNa: 870.4078, found: 870.4081. 
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7.2.16 Synthesis of N-phenyl-arylazopyrazole phosphoramidite 
 
 
Ethyl-4-((E)-(1-Phenyl-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)benzoate (98) 
Ethyl-4-(2-(2,4-dioxopentan-3-ylidene)hydrazono)benzoate (92) (7.50 g, 27.0 mmol) was 
dissolved in 150 mL ethanol. N-Phenylhydrazine (2.31 mL, 27.0 mmol) was added dropwise 
to the solution at room temperature and the reaction mixture was refluxed for 3 hours. The 
reaction mixture was cooled to room temperature and all solvents were removed in vacuo. The 
product was isolated by column chromatography (silica, eluent: cyclohexane/ethyl acetate = 
1/1) as a bright orange solid (9.40 g, quant.). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 8.11-8.09 (m, 2 H, H5), 7.87-7.86 
(m, 2 H, H14), 7.63-7.47 (m, 5 H, H6+H15+H16), 4.36 (q, 2 H, 3J2,1 = 7.1 Hz, 
H2), 2.65 (s, 3 H, H11), 2.49 (s, 3 H, H12), 1.35 (t, 3 H, 3J1,2 = 7.1 Hz, H1). 
13C-NMR (166 MHz, DMSO-d6) δ [ppm] = 165.7 (C3), 156.1 (C10), 142.9 
(C7), 141.5 (C13), 139.0 (C9), 136.4 (C8), 130.9 (C5), 130.8 (C15), 129.8 (C16), 
128.7 (C14), 125.1 (C6), 122.2 (C4), 61.4 (C2), 14.7 (C1), 14.6 (C11), 11.5 (C12). 
MS (EI, 70 eV) m/z (%) 719.3 (55) [2M+Na]+, 371.1 (100) [M-Na]+, 349.2 
(42) [M+H]+. 
HRMS (EI, 70 eV) m/z calculated for C20H20N4O2Na: 371.1478, found: 371.1465.  
 
4-((E)-(1-Phenyl-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)benzoic acid (99) 
Ethyl-4-((E)-(1-Phenyl-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)benzoate (98) (9.20 g, 
26.4 mmol) was dissolved in 120 mL ethanol. 130 mL 1 M aqueous sodium hydroxide was 
added and the reaction mixture was stirred for 24 hours at room temperature, then acidified 
with 1 M hydrochloric acid followed by extraction twice with 250 mL ethyl acetate. The  
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combined organic layers were washed with 250 mL water and dried over MgSO4. All solvents 
were removed in vacuo and the product was isolated by column chromatography (silica, eluent: 
chloroform/methanol = 95/5) as a bright orange solid (7.13 g, 85 %). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 13.09 (s, br, 1 H, H1), 8.11 (d, 2 
H, 3J4,5 = 8.5 Hz, H4), 7.87 (d, 2 H, 3J13,14 = 8.4 Hz, H13), 7.64-7.49 (m, 5 H, 
H5+H14+H15), 2.67 (s, 3 H, H10), 2.50 (s, 3 H, H11). 
13C-NMR (125 MHz, DMSO-d6) δ [ppm] = 167.3 (C2), 155.9 (C9), 142.9 
(C6), 141.3 (C12), 139.0 (C8), 136.4 (C7), 131.8 (C4), 131.0 (C14), 129.8 (C15), 
128.7 (C13), 125.1 (C5), 122.0 (C3), 14.6 (C10), 11.5 (C11). 
MS (ESI, negative) m/z (%) 319.1 (100) [M-H]-. 
HRMS (ESI, negative) m/z calculated for C18H15N4O2: 319.1200, found: 
319.1190. 
 
4-((E)-(1-Phenyl-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-threoninol (“AAP2”) 
(100) 
4-((E)-(1-Phenyl-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)benzoic acid (99) (5.0 g, 15.6 mmol), 
DCC (3.87 g, 18.7 mmol), OxymaPure (2.66 g, 18.7 mmol) and D-threoninol (1.97 g, 18.7 
mmol) were dissolved in 150 mL dry DMF under argon atmosphere and stirred for 24 hours at 
room temperature. All solids were filtered off and rinsed with DMF followed by removal of DMF 
in vacuo. The product was isolated by column chromatography (silica, eluent: 
chloroform/methanol = 98/2) as a bright orange solid (3.81 g, 50 %). 
TLC (SiO2, eluent: chloroform/methanol = 10/1) Rf = 0.38. 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 8.06-8.04 (m, 
2 H, H10), 7.87-7.83 (m, 3 H, H19+H21), 7.64-7.57 (m, 4 
H, H11+H20), 7.51-7.48 (m, 1 H, H7), 4.66-4.63 (m, 2 H, 
H3+H5), 3.97-3.94 (m, 2 H, H4), 3.66-3.62 (m, 1 H, H2), 
3.54-3.52 (m, 1 H, H1), 2.67 (s, 3 H, H16), 2.51 (s, 3 H, 
H17), 1.18-1.09 (m, 3 H, H6). 
13C-NMR (125 MHz, DMSO-d6) δ [ppm] = 166.4 (C8), 154.8 (C15), 142.8 (C12), 141.0 (C18), 
139.0 (C13), 136.2 (C14), 136.0 (C10), 129.8 (C20), 129.0 (C21), 125.0 (C19), 121.7 (C11), 79.6 
(C9), 65.4 (C4), 61.0 (C2), 57.3 (C3), 20.7 (C6), 14.6 (C16), 11.5 (C17). 
MS (ESI, positive) m/z (%) 837.4 (82) [2M+Na]+, 430.2 (100) [M+Na]+, 408.2 (14) [M+H]+. 
HRMS (ESI, positive) m/z calculated for C22H26N5O3: 408.2030, found: 408.2034. 
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DMT-protected 4-((E)-(1-Phenyl-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-threo-
ninol (101) 
4-((E)-(1-Phenyl-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-threoninol (100) (1.0 g, 
2.45 mmol) was dissolved in 20 mL dry dichloromethane under argon atmosphere. DMT-
chloride (0.83 g, 2.45 mmol) was dissolved in 10 mL dry dichloromethane and added dropwise 
to the first solution under argon atmosphere over 30 minutes. The reaction mixture was stirred 
for 30 minutes at room temperature under argon atmosphere. A gentle argon flow was attached 
to the reaction mixture and N-methylpyrrolidine (0.19 mL, 1.96 mmol) was added very slowly 
dropwise to the solution over 30 minutes. The reaction mixture was stirred for 24 hours at room 
temperature under argon atmosphere followed by evaporation of all solvents. The product was 
isolated by column chromatography (silica, eluent: cyclohexane/ethyl acetate/triethylamine = 
50/50/3%) as a bright orange solid (0.45 g, 25%). 
1H-NMR (500 MHz, CDCl3) δ [ppm] = 8.14-8.15 (m, 1 H, H20), 8.06-8.09 (m, 2 H, H9), 7.86-
7.88 (m, 2 H, H23), 7.61-7.63 (m, 2 H, H18), 7.55-7.58 (m, 2 H, H19), 7.46-7.49 (m, 1 H, H25), 
7.40-7.43 (m, 2 H, H10) 7.25-7.28 (m, 6 H, H24+H27), 7.17-7.20 (m, 1 H, H6), 6.82-6.86 (m, 4 H, 
H28), 4.62-4.62 (m, 1 H, H6), 4.16-4.19 (m, 1 H, H3), 4.04-4.08 (m, 1 H, H2), 3.71 (s, 6 H, H30), 
3.25-3.28 (m, 1 H, H4), 3.00-3.03 (m, 1 H, H4’), 2.66 (s, 3 H, H15), 2.50 (s, 3 H, H16), 1.03-1.05 
(m, 3 H, H5). 
13C-NMR (125 MHz, CDCl3) δ [ppm] = 175.5 (C7), 171.2 (C29), 163.2 (C14), 159.7 (C11), 150.4 
(C22), 147.6 (C26), 145.8 (C17), 143.8 (C12), 141.1 (C13), 141.0 (C24), 140.6 (C25), 134.9 (C9), 
134.6 (C27), 134.5 (C23), 133.8 (C19), 132.9 (C18), 131.8 (C10), 129.8 (C20), 126.5 (C8), 118.3 
(C28), 90.4 (C21), 70.5 (C4), 68.3 (C2), 65.0 (C3), 60.2 (C30), 25.6 (C15), 19.3 (C5), 16.2 (C16). 
MS (ESI, positive) m/z (%) 1442.7 (24) [2M+Na]+, 732.4 (100) [M+Na]+.  
HRMS (ESI, positive) m/z calculated for C43H43N5O5Na: 732.3156, found: 732.3142. 
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DMT-protected 4-((E)-(1-phenyl-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-threo-
ninol phosphoramidite (102) 
DMT-protected 4-((E)-(1-Phenyl-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-
threoninol (101) (1.0 g, 1.41 mmol) was dissolved in 14 mL dry acetonitrile under argon 
atmosphere and cooled to 0 °C. DiPEA (0.22 g, 1.69 mmol) was added dropwise followed by 
dropwise addition of 2-cyanoethyl-N,N-diisopropylchlorophosporamidite (0.40 g, 1.69 mmol). 
The reaction mixture was stirred for ten minutes at 0 °C followed by evaporation of all solvents. 
The product was isolated by column chromatography (silica, eluent: cyclohexane/ethyl acetate 
= 1/1) as a bright orange solid (1.08 g, 82 %). 
1H-NMR (300 MHz, CD3CN) δ [ppm] = 7.94-7.85 (m, 4 H, H8+H17), 7.54-7.41 (m, 7 H, 
H19+H22+H27), 7.31-7.18 (m, 8 H, H23+H26), 6.85-6.74 (m, 5 H, H9+H18+H24), 4.41-4.19 (m, 1 H, 
H5), 4.14-4.03 (m, 1 H, H3), 3.72 (s, 6 H, H29), 3.61-3.55 (m, 2 H, H31), 3.39-3.30 (m, 2 H, H2), 
3.25-3.18 (m, 1 H, Hx), 2.62 (s, 3 H, H14), 2.50 (s, 3 H, H15), 1.41.1.07 (m, 17 H, H1+H32+H34). 
31P-NMR (75 MHz, CD3CN) δ [ppm] = 181.8, 148.5, 141.2. 
MS (ESI, positive) m/z (%) 932.4 (10) [M+Na]+, 849.3 (100) [M-CH3+OH]+, 467.2 (48) 
[C20H25N6O4P]+. 
HRMS (ESI, positive) m/z calculated for C52H60N7O6PNa: 932.4235, found: 932.4238. 
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7.2.17 Synthesis of N-(4-nitrophenyl)-arylazopyrazole-D-threoninol (“AAP3”) 
 
 
Ethyl-4-((E)-(1-(4-nitrophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)benzoate (103) 
Ethyl-4-(2-(2,4-dioxopentan-3-ylidene)hydrazono)benzoate (92) (2.0 g, 7.24 mmol) was 
dissolved in 40 mL ethanol. 4-Nitrophenylhydrazine (1.11 g, 7.24 mmol) was added 
portionwise to the solution and the reaction mixture was refluxed for 3 hours. All solvents were 
removed in vacuo and the product was isolated by column chromatography (silica, eluent: 
cyclohexane/ethyl acetate = 1/1) as a bright orange solid (2.30 g, 81 %). 
1H-NMR (600 MHz, C6D6) δ [ppm] = 8.32-8.34 (m, 2 H, H15), 7.87-7.90 (m, 
2 H, H5), 7.74-7.76 (m, 2 H, H14), 7.02-7.04 (m, 2 H, H6), 4.17 (q, 2 H, 3J2,1 = 
7.1 Hz, H2) , 2.67 (s, 3 H, H12) , 2.16 (s, 3 H, H11) , 1.05 (t, 3 H, 3J1,2 = 7.1 Hz, 
H1). 
13C-NMR (150 MHz, C6D6) δ [ppm] = 166.2 (C3), 156.9 (C10), 146.8 (C16), 
145.2 (C13), 144.1 (C7), 141.3 (C9), 138.3 (C8), 132.5 (C5), 131.4 (C14), 128.7 
(C6), 125.0 (C3), 124.0 (C4), 122.6 (C15), 61.5 (C2), 15.1 (C1), 14.7 (C11), 11.8 
(C12). 
MS (ESI, positive) m/z (%) 416.1 (47) [M+Na]+, 381.3 (24) [C19H19N5O4]+, 305.1 (28) 
[C17H15N5O]+, 299.1 (100) [C17H16N4+Na]+. 
HRMS (ESI, positive) m/z calculated for C20H19N5O4Na: 416.1329, found: 416.1336. 
 
4-((E)-(1-(4-Nitrophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)benzoic acid (104) 
Ethyl-4-((E)-(1-(4-nitrophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)benzoate (103) (1.00 
g, 2.54 mmol) was dissolved in 18 mL ethanol and 7 mL 1 M aqueous NaOH solution and the 
reaction mixture was stirred for 24 hours at room temperature. The mixture was acidified with 
1 M aqueous hydrochloric acid and extracted twice with 100 mL ethyl acetate. The combined 
organic layers were washed with 150 mL water and 100 mL brine followed by evaporation of 
all solvents. The product was isolated by column chromatography (silica, eluent: 
chloroform/methanol = 95/5) as a bright orange solid (0.75 g, 81 %). 
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1H-NMR (500 MHz, CDCl3) δ [ppm] = 9.47 (s, br, 1 H, H1), 8.39-8.41 (m, 2 
H, H14), 8.16-8.18 (m, 2 H, H4), 7.85-7.87 (m, 2 H, H5), 7.76-7.79 (m, 2 H, 
H13), 2.81 (s, 3 H, H11), 2.61 (s, 3 H, H10). 
13C-NMR (125 MHz, CDCl3) δ [ppm] = 166.1 (C2), 155.9 (C9), 146.4 (C6), 
145.1 (C15), 143.9 (C12), 140.6 (C6), 137.3 (C7), 131.3 (C4), 130.5 (C3), 124.9 
(C13), 124.2 (C5), 121.8 (C14), 14.3 (C10), 11.8 (C11). 
MS (ESI, negative) m/z (%) 364.1 (100) [M-H]-. 
HRMS (ESI, negative) m/z calculated for C18H14N5O4: 364.1051, found: 
364.1033. 
 
4-((E)-(1-(4-Nitrophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)carboxy-D-threoninol 
(“AAP3”) (105) 
4-((E)-(1-(4-Nitrophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)diazenyl)benzoic acid (104) (0.71 g, 
1.94 mmol), DCC (0.48 g, 2.32 mmol), OxymaPure (0.30 g, 2.13 mmol) and D-threoninol (0.22 
g, 2.13 mmol) were mixed in 20 mL dry DMF under argon atmosphere and stirred for 24 hours. 
All solid residuals were filtered off and rinsed with DMF followed by removal of DMF in vacuo. 
A small product fraction was isolated by preparative HPLC (C18, eluent: acetonitrile and water 
in different gradients) as a bright orange solid (10 mg, 1 %). 
1H-NMR/13C-NMR: not possible. 
MS (ESI, positive) m/z (%) 475.2 (22) [M+Na]+, 431 
(100) [M-NO2+Na]+, 358.1 (44) [C17H15N5O3+Na]+, 
306.3 (32) [C17H16N5O]+. 
HRMS (ESI, positive) m/z calculated for 
C22H24N6O5Na: 475.1700, found: 475.1715. 
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7.2.18 Synthesis of 5-dodecyne-2’-deoxyuridine phosphoramidite (“Lipid”) 
 
 
DMT-protected 5-iodo-2’-deoxyuridine (106)[260] 
5-Iodo-2’-deoxyuridine (5.0 g, 14.1 mmol) and 4-DMAP (85 mg, 0.7 mmol) were dissolved in 
80 mL dry pyridine under argon atmosphere. DMT-chloride (5.74 g, 16.9 mmol) was dissolved 
in dry dichloromethane and the solution was added dropwise to the first solution under argon 
atmosphere at room temperature over 30 minutes. The reaction mixture was stirred for 16 
hours followed by removal of all volatiles under reduced pressure. The product was isolated 
by column chromatography (silica, eluent: cyclohexane/ethyl acetate = 1/1 with 3 % 
triethylamine) as a yellowish white solid (yield: 3.0g, 32 %). 
1H-NMR (500 MHz, CD2Cl2) δ [ppm] = 9.55 (s, br, 1 H, H8), 8.15 (s, 1 H, H11), 7.49-7.47 (m, 
2 H, H14), 7.40-7.26 (m, 7 H, H15+H16+H18), 6.91-6.89 (m, 4 H, H19), 
6.33-6.30 (m, 1 H, H1), 4.14 (q, 2 H, H3+H6), 3.82 (s, 6 H, H21), 
3.40-3.39 (m, 2 H, H5), 2.59-2.49 (m, 2 H, H2), 2.35-2.30 (m, 1 H, 
H4). 
13C-NMR (125 MHz, CD2Cl2) δ [ppm] = 170.9 (C11), 160.3 (C7), 
158.8 (C20), 150.1 (C9), 144.5 (C13), 135.6 (C17), 130.1 (C16), 128.1 
(C18), 127.0 (C19), 113.3 (C14), 86.6 (C4), 85.7 (C1), 72.3 (C21), 68.4 
(C3), 63.6 (C10), 60.3 (C12), 55.3 (C5), 41.3 (C2). 
MS (ESI, positive) m/z (%) 679.1 (48%) [M+Na]+, 303.1 (100%) [DMT]+. 
HRMS (ESI, positive) m/z calculated for C30H29IN2O7Na: 679.0912 [M+Na]+, found: 679.0900 
[M+Na]+. 
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DMT-protected 5-dodecynyl-2’-deoxyuridine (107)[260] 
DMT-protected 5-iodo-2’-deoxyuridine (106) (1.0 g, 1.52 mmol), Pd(PPh3)4 (176 mg, 0.15 
mmol) and CuI (57 mg, 0.30 mmol) were dried for 30 minutes. 12.5 mL dry DMF was added 
under argon atmosphere, followed by Amberlite IRA67 (2.5 g) and 1-dodecyne (0.76 g, 4.56 
mmol). The reaction mixture was stirred for 20 hours at room temperature under argon 
atmosphere. All solids were filtered off and rinsed with 10 mL of a 1:1 methanol 
dichloromethane mixture. All solvents were removed under reduced pressure and the product 
was isolated by column chromatography (silica, eluent: cyclohexane/ethyl acetate = 1/1) as a 
white solid (yield: 0.50 g, 47 %). 
1H-NMR (500 MHz, CD2Cl2) δ [ppm] = 7.94-7.96 (m, 2 H, H26), 7.21-7.48 (m, 8 H, 
H8+H27+H28+H30), 6.84-6.86 (m, 4 H, H31), 6.24-6.30 (m, 1 H, H11), 4.53-4.55 (m, 1 H, H1), 4.06-
4.08 (m, 1 H, H3), 3.78 (s, 6 H, H33), 3.31-3.47 (m, 2 H, H5), 2.56-2.59 (m, 1 H, H2), 2.42-2.48 
(m, 1 H, H2’),2.24-2.29 (m, 1 H, H4), 2.05-2.21 (m, 1 H, H4), 1.18-1.43 (m, 19 H, H15-H23), 0.87-
0.90 (m, 2 H, H14). 
13C-NMR (125 MHz, CD2Cl2) δ [ppm] = 162.1 (C7), 158.7 (C32), 149.5 (C9), 144.7 (C11), 141.7 
(C27), 135.6 (C25), 130.0 (C29), 128.0 (C28), 127.9 (C30), 126.8 (C31), 113.2 (C26), 100.8 (C13), 
95.1 (C12), 86.5 (C4), 85.5 (C1), 72.3 (C33), 70.7 (C3), 63.6 (C24), 57.9 (C10), 55.2 (C5), 45.3 
(C14), 41.3 (C2), 31.9 (C15-23), 29.6 (C15-23), 29.5 (C15-23), 29.3 (C15-23), 29.1 (C15-23), 28.5 (C15-23), 
22.7 (C15-23), 19.4 (C15-23), 13.9 (C15-23). 
MS (ESI, positive) m/z (%) 717.4 (95%) [M+Na]+, 303.1 (100 %) [DMT]+. 
HRMS (ESI, positive) m/z calculated for C42H50N2O7Na: 717.3510 [M+Na]+, found: 717.3500 
[M+Na]+. 
 
 
DMT-protected 5-dodecynyl-2’-deoxyuridine phosphoramidite (108)[260] 
DMT-protected 5-dodecynyl-2’-deoxyuridine (107) (0.5 g, 0.72 mmol) was dissolved in 7 mL 
dry dichloromethane under argon atmosphere and the solution was cooled to 0 °C. DiPEA 
(0.10 g, 0.80 mmol) was added dropwise to the solution and the reaction mixture was stirred 
for 10 minutes at 0 °C. 2-Cyanoethyl-N,N-diisopropylchlorophosophoramidite (0.19 g, 0.80 
mmol) was added dropwise to the reaction mixture at 0 °C and stirring was continued for  
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10 minutes at 0 °C, then the mixture was warmed up to room temperature. Stirring was 
continued for 2.5 hours followed by evaporation of all solvents in vacuo. The product was 
isolated via column chromatography (silica, eluent: cyclohexane/ethyl acetate = 1/1 with 3% 
triethylamine) as a white foamy solid (yield 0.5 g, 78 %). 
1H-NMR (400 MHz, CD2Cl2) δ [ppm] = 8.72 (s, br, 1 H, H7), 7.94-7.98 (m, 1 H, H27), 7.46-7.49 
(m, 2 H, H25), 7.30-7.39 (m, 6 H, H26+H29), 7.22-7.26 (m, 1 H, H3), 6.84-6.88 (m, 4 H, H30), 6.25-
6.29 (m, 1 H, H10), 4.61-4.65 (m, 1 H, H1), 4.16-4.22 (m, 1 H, H36), 3.58-3.79 (m, 9 H, 
H5+H32+H36), 3.33-3.38 (m, 3 H, H37+H3), 2.48-2.65 (m, 3 H, H2+H34), 2.28-2.33 (m, 1 H, H34), 
2.06-2.11 (m, 2 H, H4), 1.17-1.29 (m, 25 H, H14-22+H35), 1.11 (d, 3 H, H35), 0.90 (t, 3 H, H35). 
31P-NMR: (162 MHz, CD2Cl2) δ [ppm] = 149.3 (P33). 
MS (ESI, positive) m/z (%) 917.5 (17) [M+Na]+, 895.5 (29) [M+H]+, 303.1 (100) [DMT]+. 
HRMS (ESI, positive) m/z calculated for C51H67N4O8PH: 895.4769, found: 895.4773. 
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7.3 UV/Vis spectra of all synthesized photochrome molecules 
UV/Vis spectroscopy was performed on a JASCO V630 Bio spectrophotometer in Hellma 
Analytics Suprasil QS precision cuvettes with a sample volume of 100 μL and a concentration 
of c = 25 μM in a mixture of 1:1 acetonitrile and Millipore water. Each sample was irradiated 
for 5 minutes at room temperature at a given wavelength with maximum intensity to fully reach 
the wavelength-dependent photostationary state (PSS). For each set of UV/Vis absorption 
spectra, the relative change of intensity at the absorption maximum was calculated to yield a 
qualitative wavelength-dependent irradiation scan profile. The highest absorption maximum 
was normalized to 1 in each irradiation scan profile, all other values are given in respect to the 
normalized maximum value. 
 
 
7.3.1 UV/Vis spectra of all synthesized azobenzene molecules 
 
Fig. 96: Azobenzene molecules investigated via UV/Vis-spectroscopy to determine the absorption 
maxima as well as the minimum and maximum converting irradiation wavelengths. 
 
7. Experimental section 
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Azobenzene (20) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(318 
nm) 
0.91 0.23 0.20 0.55 1.00 1.00 1.00 0.94 0.93 0.89 0.81 0.80 0.79 0.97 0.95 
 
2,6-Dimethylazobenzene (21) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(308 
nm) 
0.86 0.27 0.30 0.58 0.99 1.00 0.99 0.91 0.89 0.81 0.67 0.65 0.58 0.74 0.76 
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2,6-Difluoroazobenzene (22) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(315 
nm) 
0.69 0.30 0.29 0.83 1.00 0.88 0.86 0.73 0.71 0.62 0.50 0.49 0.45 0.67 0.71 
 
2,6-Dichloroazobenzene (23) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(299 
nm) 
1.00 0.82 0.43 0.60 0.88 0.96 0.97 0.91 0.81 0.78 0.71 0.61 0.56 0.50 0.79 0.89 
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2,6-Dimethoxyazobenzene (24) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(325 
nm) 
0.71 0.28 0.26 0.37 0.83 1.00 0.99 0.80 0.77 0.66 0.49 0.47 0.41 0.56 0.71 
 
 
2,2‘,6,6‘-Tetramethylazobenzene (25) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(305 
nm) 
0.92 0.59 0.61 0.70 0.98 1.00 1.00 0.98 0.98 0.94 0.85 0.83 0.76 0.57 0.79 
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2,2‘,6,6‘-Tetrafluoroazobenzene (26) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(307 
nm) 
0.62 0.24 0.30 0.97 1.00 0.91 0.89 0.66 0.61 0.47 0.29 0.28 0.24 0.48 0.61 
 
 
2,2‘,6,6‘-Tetrachloroazobenzene (27) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(291 
nm) 
1.00 0.94 0.90 0.91 0.88 0.87 0.85 0.80 0.79 0.80 0.81 0.79 0.76 0.75 0.71 0.71 
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2,2’,6,6’-Tetrabromoazobenzene (28) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(304 
nm) 
1.00 0.93 0.91 0.85 0.84 0.83 0.76 0.72 0.67 0.66 0.59 0.53 0.53 0.49 0.42 0.41 
 
 
2,2‘,6,6‘-Tetramethoxyazobenzene (29) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(307 
nm) 
0.95 0.85 0.80 0.82 0.86 0.95 1.00 0.99 0.93 0.91 0.86 0.71 0.69 0.63 0.58 0.73 
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2,6-Dimethyl-2’,6’-difluoroazobenzene (30) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(313 
nm) 
0.84 0.35 0.38 0.68 1.00 1.00 0.99 0.91 0.90 0.79 0.59 0.56 0.42 0.55 0.78 
 
 
2,6-Dimethoxy-2‘,6‘-difluoroazobenzene (31) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(322 
nm) 
0.74 0.49 0.49 0.60 0.89 1.00 0.99 0.86 0.82 0.69 0.46 0.44 0.35 0.33 0.63 
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7.3.2 UV/Vis spectra of all synthesized arylazopyrazole molecules 
 
Fig. 97: Arylazopyrazole molecules investigated via UV/Vis-spectroscopy to determine the absorption 
maxima as well as the minimum and maximum converting irradiation wavelengths. 
Phenyl-AAP1 (79) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(341 
nm) 
0.89 0.18 0.08 0.05 0.04 0.21 0.65 0.69 0.80 0.82 0.84 0.89 0.90 0.94 1.00 0.90 
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2’,6’-Dimethyl-AAP1 (80) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(315 
nm) 
1.00 0.56 0.42 0.42 0.52 0.79 0.87 0.87 0.86 0.85 0.82 0.80 0.80 0.78 0.92 0.93 
 
2’,6’-Dichloro-AAP1 (81) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(313 
nm) 
1.00 0.62 0.51 0.53 0.62 0.81 0.86 0.86 0.85 0.86 0.84 0.82 0.83 0.80 0.86 0.87 
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2’,6’-Difluoro-AAP1 (82) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(324 
nm) 
0.94 0.33 0.24 0.22 0.36 0.86 0.99 1.00 0.98 0.96 0.95 0.91 0.91 0.93 0.97 0.97 
 
Phenyl-AAP2 (83) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(335 
nm) 
0.79 0.22 0.16 0.14 0.13 0.39 0.39 0.74 0.84 0.84 0.93 0.94 0.95 1.00 0.91 0.84 
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2’,6’-Dimethyl-AAP2 (84) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(320 
nm) 
1.00 0.44 0.36 0.32 0.38 0.83 0.96 0.97 0.96 0.94 0.88 0.81 0.80 0.77 0.89 0.91 
 
2’,6’-Dichloro-AAP2 (85) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(315 
nm) 
0.98 0.66 0.59 0.55 0.65 0.92 0.99 1.00 0.97 0.97 0.95 0.90 0.89 0.86 0.94 0.97 
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2’,6’-Difluoro-AAP2 (86) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(326 
nm) 
0.91 0.35 0.27 0.23 0.28 0.71 0.91 0.91 0.89 0.89 0.86 0.81 0.80 0.80 1.00 0.89 
 
Phenyl-AAP3 (87) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(343 
nm) 
0.96 0.65 0.61 0.57 0.50 0.54 0.79 0.81 0.90 0.89 0.92 0.95 0.95 0.98 1.00 0.96 
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2’,6’-Dimethyl-AAP3 (88) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(332 
nm) 
1.00 0.92 0.82 0.92 0.33 0.36 0.45 0.51 0.53 0.55 0.60 0.60 0.55 0.55 0.88 0.87 
 
2’,6’-Dichloro-AAP3 (89) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(393 
nm) 
0.94 0.96 0.93 0.96 0.16 0.11 0.69 0.81 0.93 0.94 0.96 0.96 0.95 1.00 0.96 0.97 
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2’,6’-Difluoro-AAP3 (90) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(337 
nm) 
1.00 0.73 0.67 0.63 0.57 0.71 0.91 0.92 0.90 0.91 0.88 0.83 0.83 0.82 0.98 0.99 
 
Phenyl-Amino-AAP3 (91) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(341 
nm) 
0.86 0.42 0.36 0.30 0.27 0.37 0.68 0.70 0.84 0.85 0.89 0.95 0.97 1.00 0.98 0.88 
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7.3.3 UV/Vis spectra of all synthesized D-threoninol bound photochromes 
 
Fig. 98: D-threoninol bound azobenzene and arylazopyraole molecules investigated via UV/Vis-
spectroscopy to determine the absorption maxima as well as the minimum and maximum converting 
irradiation wavelengths. 
 
Azobenzene-D-threoninol (AB) (4) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(321 
nm) 
0.99 0.42 0.12 0.10 0.28 0.88 0.91 0.91 0.86 0.80 0.81 0.73 0.73 0.69 0.92 1.00 
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2’,6’-Dimethylazobenzene-D-threoninol (DMAB) (9) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(322 
nm) 
1.00 0.55 0.20 0.19 0.34 0.90 0.93 0.93 0.87 0.86 0.80 0.67 0.65 0.57 0.50 0.83 
 
4’-Methylthio-2’,6’-dimethylazobenzene-D-threoninol (S-DMAB) (15) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(371 
nm) 
1.00 0.76 0.53 0.42 0.26 0.25 0.68 0.76 1.00 0.99 0.96 0.87 0.87 0.81 0.74 0.88 
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2’,6’-Difluoroazobenzene-D-threoninol (DFAB) (42) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(319 
nm) 
0.84 0.36 0.16 0.16 0.61 1.00 0.94 0.93 0.78 0.75 0.65 0.50 0.48 0.41 0.61 0.81 
 
2’,4’,6’-Trifluoroazobenzene-D-threoninol (DFAB-F) (47) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(345 
nm) 
0.99 0.34 0.21 0.14 0.12 0.41 0.94 0.95 0.91 0.89 0.83 0.73 0.71 0.68 0.89 1.00 
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4’-Chloro-2’,6’-difluoroazobenzene-D-threoninol (DFAB-Cl) (51) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(326 
nm) 
0.98 0.43 0.20 0.18 0.43 1.00 0.98 0.97 0.84 0.81 0.73 0.58 0.57 0.50 0.67 0.92 
 
4’-Acetamido-2’,6’-difluoroazobenzene-D-threoninol (DFAB-Pep) (59) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(382 
nm) 
1.00 0.64 0.50 0.42 0.26 0.25 0.36 0.42 0.60 0.65 0.72 0.77 0.75 0.82 0.96 1.00 
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2’,6’-Dichloroazobenzene-D-threoninol (DCAB) (67) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(303 
nm) 
0.83 0.63 0.44 0.48 0.87 1.00 0.97 0.97 0.88 0.85 0.77 0.63 0.62 0.55 0.58 0.78 
 
2’,6’-Dimethoxyazobenzene-D-threoninol (DOAB) (72) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(336 
nm) 
0.72 0.41 0.27 0.25 0.29 0.64 0.99 1.00 0.85 0.81 0.69 0.50 0.48 0.40 0.28 0.49 
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Methyl-arylazopyrazole-D-threoninol (AAP1) (95) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(341 
nm) 
0.89 0.18 0.09 0.05 0.04 0.21 0.65 0.69 0.80 0.82 0.84 0.89 0.90 0.94 1.00 0.90 
 
Phenyl-arylazopyrazole-D-threoninol (AAP2) (100) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(341 
nm) 
0.77 0.26 0.17 0.12 0.09 0.20 0.63 0.67 0.81 0.81 0.84 0.88 0.90 0.90 1.00 0.89 
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4’-Nitrophenyl-arylazopyrazole-D-threoninol (AAP3) (105) 
UV/vis absorption spectra after irradiation with each available wavelength (left) and the 
resulting change in absorption intensity at the absorption maximum upon irradiation (right). 
 
Normalized, wavelength dependent absorption intensity values at the absorption maximum: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
I(360 
nm) 
0.93 0.83 0.80 0.75 0.61 0.63 0.80 0.83 0.93 0.92 0.94 0.97 0.95 0.97 1.00 0.96 
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7.3.4 Extinction coefficient calculation for D-threoninol bound photoswitches 
The introduction of photoresponsive moieties into oligonucleotides necessitates a correction 
of each extinction coefficient for the maximum absorbance of oligonucleotides λ = 260 nm. 
Extinction coefficients at λ = 260 nm for all D-threoninol bound photoswitches were determined 
from the recorded UV/Vis spectra to permit a calculation of concentrations for modified 
oligonucleotides. From the absorption value at λ = 260 nm for each dark adapted sample, the 
extinction coefficient was calculated following the Lambert-Beer-law: 
𝐸 = 𝑙𝑔 (
𝐼0
𝐼
) = 𝜀𝑐𝑑 
The ectinction coefficient ε results as: 
𝜀 =
𝐸
𝑐𝑑
 
Using a cuvette length d = 1 cm, the absorption values and extinction coefficients depending 
on the concentrations were determined as given below. 
 
Azobenzene Concentration Abs. (260 nm) ε (260 nm) 
AB 50 µM 0.182 3640 
DMAB 50 µM 0.405 8100 
S-DMAB 50 µM 0.181 3620 
DFAB 50 µM 0.278 5560 
DOAB 50 µM 0.487 9740 
AAP1 25 µM 0.095 3800 
AAP2 25 µM 0.234 9360 
 
The calculated extinction coefficients were used for all concentration calculations of the 
synthesized modified oligonucleotides. 
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7.4 DNA synthesis and purification 
7.4.1 Synthesis and purification of modified DNA strands 
Coupling conditions 
Modified and non-modified DNA strands were synthesized using an ABI Applied Biosystems 
3400 DNA synthesizer with the following settings and chemicals: 
Activator: 5-(Ethylthio)-1H-tetrazole (ETT). 
Cap Mix A: 80 % tetrahydrofuran, 10 % acetic anhydride, 10 % pyridine. 
Cap Mix B: 84 % tetrahydrofuran, 16 % 1-methylimidazole. 
Oxidizer: 0.02 M Iodine in 70 % tetrahydrofuran, 20 % pyridine and 10 % water. 
DNA synthesis grade acetonitrile was used for dissolving custom phosphoramidites to a 
0.2 M solution. The coupling time for all custom phosphoramidites was 600 seconds. The 
terminal DMT group was not cleaved from the 5’-end of each oligonucleotide after each DNA 
synthesis. All synthesized DNA strands were deprotected and released from the solid support 
by heating the solid support in a 25 % aqueous ammonia solution at 55 °C for 16 hours. The 
resulting dispersion was centrifuged for 5 minutes at 15000 rpm, the supernatant was 
separated from the solid residues using spin filtration columns and lyophilised overnight in an 
Eppendorf Concentrator at 40 °C. The remaining crude DNA product was dissolved in 200 µL 
Millipore water and purified via reversed phase HPLC on an Eclipse XDB C18 column with a 
solvent gradient of 0-30% acetonitrile and water. The target fractions were evaporated and 
further worked up by manual 5’-DMT deprotection. 
 
Manual DMT-deprotection of 5*-DMT-groups 
5’-DMT deprotection of all DNA strands was performed with the collected fractions from 
HPLC purification. The following deprotection procedure was used: 
Waters SepPak C18 classic columns were conditioned with 4 mL acetonitrile, followed by 4 
mL 0.1 M TEAAc buffer. The target HPLC fractions were dissolved in 1 mL Millipore water, 
loaded on the column and the loading process was repeated three times. The column was 
flushed with 4mL Millipore water, 4 mL 2 % trifluoroacetic acid and 4 mL Millipore water, 
followed by elution and collection of the DNA with 2 mL acetonitrile and water in a1:1 mixture. 
The collected DNA solution was dried by lyophilisation and further subjected to LCMS analysis 
(see chapter 7.4.2). 
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7.4.2 LCMS results for all modified oligonucleotides 
LCMS analysis for all modified oligonucleotide strands was performed on an Agilent 1100 
Series HPLC system in line with an Esquire HCT ESI-MS system by Bruker Daltonics in 
standard enhanced mode with alternating charge. 5 µL 10 µM sample solution of each 
oligonucleotide dissolved in Millipore water were used for injection and separated on an Agilent 
Zorbax SB-C18 column (2.1x50 mm) with a gradient of 3 % to 20 % LCMS-grade acetonitrile 
in 0.1 M LCMS-grade TEAAc buffer containing 2 % 1,1,1,3,3,3-hexafluoro isopropanol (HFIP). 
The absorbance at λ = 260 nm was detected and a mass spectrum for every detected area 
was processed. The relative masses were determined via deconvolution of the resulting ESI 
mass spectra. 
 
Azobenzene-modified DNA strands 
 
 
Fig. 99: UV absorption trace at 260 nm (top) and the mass spectra corresponding to each absorption 
maxima (bottom) were recorded and deconvoluted to determine each oligonucleotide mass. Full 
chromatograms and mass spectra are given in the attachments (chapter 10.2). 
 
Sequence Modification Mass calculated Mass found 
5’-GAATXGGTG-3’ (A) 
5’-GAXATGGXTG-3’ (B) 
5’-GAXATXGGXTG-3’ (C) 
5’-CACCATXTCCGGT-3’ (D) 
5’-CACXCATTCCXGGT-3’ (E) 
5’-CACXCATXTCCXGGT-3’ (F) 
5‘-TCCXCCAXGCAXTCG-3‘ (I) 
5‘-CCXGATXGCTXGT-3‘ (J) 
5‘-GGXAATXGGTXGA-3‘ (K) 
X = AB 
X = AB 
X = AB 
X = AB 
X = AB 
X = AB 
X = AB 
X = AB 
X = AB 
2864.79 
3239.89 
3614.98 
3956.49 
4331.59 
4706.69 
4691.67 
4144.32 
4257.40 
2864.65 
3239.77 
3614.87 
3956.20 
4331.48 
4706.36 
4691.45 
4144.20 
4257.20 
 
2016_06_01_1AB8_71_01_1381.d: BPC -All MS
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2‘,6‘-Dimethylazobenzene-modified DNA strands 
Sequence Modification Mass calculated Mass found 
5’-GAATXGGTG-3’ (A) 
5’-GAXATGGXTG-3’ (B) 
5’-GAXATXGGXTG-3’ (C) 
5’-CACCATXTCCGGT-3’ (D) 
5’-CACXCATTCCXGGT-3’ (E) 
5’-CACXCATXTCCXGGT-3’ (F) 
5‘-TCCXCCAXGCAXTCG-3‘ (I) 
5‘-CCXGATXGCTXGT-3‘ (J) 
5‘-GGXAATXGGTXGA-3‘ (K) 
X = DMAB 
X = DMAB 
X = DMAB 
X = DMAB 
X = DMAB 
X = DMAB 
X = DMAB 
X = DMAB 
X = DMAB 
2892.82 
3295.94 
3699.07 
3984.52 
4387.65 
4790.77 
4775.76 
4228.40 
4341.49 
2892.67 
3295.75 
3698.87 
3984.25 
4387.14 
4790.65 
4775.44 
4228.41 
4341.58 
 
4‘-Methylthio-2‘,6‘-dimethylazobenzene-modified DNA strands 
Sequence Modification Mass calculated Mass found 
5’-GAATXGGTG-3’ (A) 
5’-GAXATGGXTG-3’ (B) 
5’-GAXATXGGXTG-3’ (C) 
5’-CACCATXTCCGGT-3’ (D) 
5’-CACXCATTCCXGGT-3’ (E) 
5’-CACXCATXTCCXGGT-3’ (F)  
5‘-TCCXCCAXGCAXTCG-3‘ (I) 
5‘-CCXGATXGCTXGT-3‘ (J) 
5‘-GGXAATXGGTXGA-3‘ (K) 
X = S-DMAB 
X = S-DMAB 
X = S-DMAB 
X = S-DMAB 
X = S-DMAB 
X = S-DMAB 
X = S-DMAB 
X = S-DMAB 
X = S-DMAB 
2938.81 
3387.92 
3837.04 
4030.51 
4479.63 
4928.74 
4913.73 
4366.37 
4479.46 
2938.53 
3387.66 
3836.90 
4029.64 
4479.34 
4928.74 
4913.63 
4366.65 
4479.92 
 
2’,6’-Difluoroazobenzene-modified DNA strands 
Sequence Modification Mass calculated Mass found 
5’-GAATXGGTG-3’ (A) 
5’-CACCATXTCCGGT-3’ (D) 
X = DFAB 
X = DFAB 
2900.77 
3992.47 
2900.92 
3992.39 
 
2’,6’-Dimethoxyazobenzene-modified DNA strands 
Sequence Modification Mass calculated Mass found 
5’-GAATXGGTG-3’ (A) 
5’-CACCATXTCCGGT-3’ (D) 
X = DOAB 
X = DOAB 
2924.81 
4016.52 
2924.47 
4015.99 
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N-methyl-arylazopyrazole-modified DNA strands 
Sequence Modification Mass calculated Mass found 
5’-GAATXGGTG-3’ (A) 
5’-GAXATGGXTG-3’ (B) 
5’-GAXATXGGXTG-3’ (C) 
5’-CACCATXTCCGGT-3’ (D) 
5’-CACXCATTCCXGGT-3’ (E) 
5’-CACXCATXTCCXGGT-3’ (F) 
5’-CACCXATTCXCAGT-3’ (G) 
5’-CACXCATXTCCXAGT-3’ (H) 
5‘-TCCXCCAXGCAXTCG-3‘ (I) 
5‘-CCXGATXGCTXGT-3‘ (J) 
5‘-GGXAATXGGTXGA-3‘ (K) 
5‘-TCCCXCAGCXATCG-3‘ (L) 
5’-CACCXATTCXCGGT-3’ (M) 
X = AAP1 
X = AAP1 
X = AAP1 
X = AAP1 
X = AAP1 
X = AAP1 
X = AAP1 
X = AAP1 
X = AAP1 
X = AAP1 
X = AAP1 
X = AAP1 
X = AAP1 
2896.82 
3303.96 
3711.10 
3988.53 
4395.66 
4802.80 
4379.68 
4786.82 
4787.79 
4240.43 
4353.52 
4380.68 
4395.68 
2896.79 
3303.87 
3711.25 
3988.19 
4395.48 
4803.00 
4379.78 
4787.29 
4787.41 
4240.19 
4353.23 
4380.39 
4395.39 
 
N-pheny-arylazopyrazole-modified DNA strands 
Sequence Modification Mass calculated Mass found 
5’-GAATXGGTG-3’ (A) 
5’-GAXATGGXTG-3’ (B) 
5’-GAXATXGGXTG-3’ (C) 
5’-CACCATXTCCGGT-3’ (D) 
5’-CACXCATTCCXGGT-3’ (E) 
5’-CACXCATXTCCXGGT-3’ (F) 
5’-CACCXATTCXCAGT-3’ (G) 
5’-CACXCATXTCCXAGT-3’ (H) 
5‘-TCCXCCAXGCAXTCG-3‘ (I) 
5‘-CCXGATXGCTXGT-3‘ (J) 
5‘-GGXAATXGGTXGA-3‘ (K) 
5‘-TCCCXCAGCXATCG-3‘ (L) 
5’-CACCXATTCXCGGT-3’ (M) 
X = AAP2 
X = AAP2 
X = AAP2 
X = AAP2 
X = AAP2 
X = AAP2 
X = AAP2 
X = AAP2 
X = AAP2 
X = AAP2 
X = AAP2 
X = AAP2 
X = AAP2 
2958.84 
3427.99 
3897.14 
4050.54 
4519.69 
4988.85 
4503.70 
4972.85 
4973.83 
4426.48 
4539.56 
4504.70 
4519.70 
2958.83 
3427.90 
3897.11 
4050.19 
4519.46 
4988.77 
4504.15 
4973.26 
4973.90 
4426.49 
4540.02 
4504.26 
4519.59 
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7.4.3 Proof of reversible isomerization for all modifications in DNA strands 
Introduction of photoresponsive modifications was proven by reversible switching 
measurements. All modified 8-mer DNA strands containing a single modifictions in the 
sequence 5’-GAATXGGTG-3’ (X = AB, DMAB, S-DMAB, DFAB, DOAB, AAP1 or AAP2) were 
diluted in a stem solution of 1 mL with Millipore water to a concentration of 5 µM. The stem 
solutions were alternatingly irradiated with the wavelengths corresponding to the maximum cis 
and trans coverting wavelengths for 5 minutes with maximum intensity at room temperature. 
After each irradiation step, an aliquot of the solution was measured in a JASCO V630 Bio 
UV/Vis spectrometer with a detection range between 220 nm and 650 nm. The resulting 
spectra and corresponding irradiation wavelengths for each individual measurement are given 
below. 
 
Reversible switching of azobenzene-modified 8-mer DNA 
 
UV/Vis-spectra of the sequence 5’-GAATXGGTG-3’ with X = Azobenzene (AB) after 5 
minutes alternating irradiation with the maximum trans- and cis-converting wavelengths at 
room temperature. A UV/Vis-spectrum was recorded after each irradiation step. 
Excitation wavelength trans isomer: 405 nm. 
Excitation wavelength cis isomer: 340 nm. 
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Reversible switching of 2’,6’-dimethylazobenzene-modified 8-mer DNA 
 
UV/Vis-spectra of the sequence 5’-GAATXGGTG-3’ with X = 2’,6’-Dimethylazobenzene 
(DMAB) after 5 minutes alternating irradiation with the maximum trans- and cis-converting 
wavelengths at room temperature. A UV/Vis-spectrum was recorded after each irradiation 
step. 
Excitation wavelength trans isomer: 420 nm. 
Excitation wavelength cis isomer: 350 nm. 
 
Reversible switching of 2’,6’-dimethyl-4’-methylthioazobenzene-modified 8-mer DNA 
 
UV/Vis-spectra of the sequence 5’-GAATXGGTG-3’ with X = 2’,6’-Dimethyl-4’-
methylthioazobenzene (S-DMAB) after 5 minutes alternating irradiation with the maximum 
trans- and cis-converting wavelengths at room temperature. A UV/Vis-spectrum was recorded 
after each irradiation step. 
Excitation wavelength trans isomer: 450 nm. 
Excitation wavelength cis isomer: 385 nm. 
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Reversible switching of 2’,6’-difluoroazobenzene-modified 8-mer DNA 
 
UV/Vis-spectra of the sequence 5’-GAATXGGTG-3’ with X = 2’,6’-Difluoroazobenzene 
(DFAB) after 5 minutes alternating irradiation with the maximum trans- and cis-converting 
wavelengths at room temperature. A UV/Vis-spectrum was recorded after each irradiation 
step. 
Excitation wavelength trans isomer: 405 nm. 
Excitation wavelength cis isomer: 340 nm. 
 
Reversible switching of 2’,6’-dimethoxyazobenzene-modified 8-mer DNA 
 
UV/Vis-spectra of the sequence 5’-GAATXGGTG-3’ with X = 2’,6’-Dimethoxyazobenzene 
(DOAB) after 5 minutes alternating irradiation with the maximum trans- and cis-converting 
wavelengths at room temperature. A UV/Vis-spectrum was recorded after each irradiation 
step. 
Excitation wavelength trans isomer: 420 nm. 
Excitation wavelength cis isomer: 365 nm. 
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Reversible switching of N-methylarylazopyrazole-modified 8-mer DNA 
 
UV/Vis-spectra of the sequence 5’-GAATXGGTG-3’ with X = N-Methylarylazopyrazole 
(AAP1) after 5 minutes alternating irradiation with the maximum trans- and cis-converting 
wavelengths at room temperature. A UV/Vis-spectrum was recorded after each irradiation 
step. 
Excitation wavelength trans isomer: 590 nm. 
Excitation wavelength cis isomer: 365 nm. 
 
Reversible switching of N-phenylarylazopyrazole-modified 8-mer DNA 
 
UV/Vis-spectra of the sequence 5’-GAATXGGTG-3’ with X = N-Phenylarylazopyrazole 
(AAP2) after 5 minutes alternating irradiation with the maximum trans- and cis-converting 
wavelengths at room temperature. A UV/Vis-spectrum was recorded after each irradiation 
step. 
Excitation wavelength trans isomer: 590 nm. 
Excitation wavelength cis isomer: 365 nm. 
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7.5 Determination of conversion efficiencies via HPLC quantification 
7.5.1 Reversed-phase HPLC quantification of D-threoninol coupled photo-
chromes 
Separation of both cis and trans isomer for all D-threoninol bound azobenzene-molecules 
was performed on a Nucleodur PFP (PentaFluorophenylPropyl) 4.6x150 mm column with 
different gradients of acetonitrile and water. The sample of the corresponding azobenzene or 
arylazopyrazole was dissolved in a 1:1 mixture of Millipore water and acetonitrile and irradiated 
for 5 minutes at room temperature with each available wavelength. After irradiation, the 
samples were immediately injected into the HPLC for separation of both cis and trans isomers 
while the absorption of the isosbestic point was measured. Each fraction of cis and trans 
isomer was determined by integration of the corresponding signals in the chromatogram. Each 
measurement was performed in dublets, the calculated standard deviation is given for each 
irradiation wavelength. 
 
Azobenzene-D-threoninol (AB) 
Sample: Azobenzene-D-threoninol, 10 μM, 20 μL injection for each measurement. 
Gradient: ACN/H2O = 40/60 -> 80/20 in 15 minutes, flow-rate: 0.5 mL/min. 
Detection: λ = 282 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
Dark 
 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
3.63 
± 
2.13 
12.87 
± 
7.11 
85.87 
± 
2.42 
85.30 
± 
1.90 
73.43 
± 
0.60 
25.14 
± 
0.16 
19.31 
± 
0.38 
19.13 
± 
0.42 
22.26 
± 
0.15 
23.12 
± 
0.15 
25.77 
± 
0.15 
30.22 
± 
0.14 
30.51 
± 
0.39 
32.06 
± 
0.28 
13.37 
± 
0.88 
11.86 
± 
1.38 
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2’,6’-Dimethylazobenzene-D-threoninol (DMAB) 
Sample: 2’,6’-Dimethylazobenzene-D-threoninol, 10 μM, 20 μL injection for each 
measurement. 
Gradient: ACN/H2O = 40/60 -> 80/20 in 15 minutes, flow-rate: 0.5 mL/min. 
Detection: λ = 277 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
6.52 
± 
2.02 
14.84 
± 
4.42 
76.55 
± 
1.88 
74.86 
± 
1.99 
63.44 
± 
1.02 
20.19 
± 
0.68 
15.79 
± 
0.32 
16.36 
± 
1.08 
21.07 
± 
0.51 
22.72 
± 
0.80 
26.88 
± 
0.46 
35.92 
± 
0.01 
37.21 
± 
0.23 
42.84 
± 
0.73 
38.55 
± 
1.46 
19.87 
± 
1.04 
 
4’-Methylthio-2’,6’-dimethylazobenzene-D-threoninol (S-DMAB) 
Sample: 4’-Methylthio-2’,6’-dimethylazobenzene-D-threoninol, 10 μM, 20 μL injection. 
Gradient: ACN/H2O = 40/60 -> 80/20, flow-rate: 0.5 mL/min. 
Detection: λ = 288 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
15.43 
± 
6.24 
27.12 
± 
1.79 
48.61 
± 
4.21 
54.84 
± 
2.88 
62.90 
± 
3.27 
65.93 
± 
4.49 
40.38 
± 
3.03 
37.05 
± 
2.09 
27.13 
± 
0.22 
26.81 
± 
1.70 
28.43 
± 
0.82 
30.29 
± 
2.32 
34.34 
± 
0.78 
34.83 
± 
0.90 
33.05 
± 
1.72 
29.00 
± 
1.03 
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2’,6’-Difluoroazobenzene-D-threoninol (DFAB) 
Sample: Azobenzene-D-threoninol, 10 μM, 20 μL injection for each measurement. 
Gradient: ACN/H2O = 25/75 -> 45/55 in 15 minutes, flow-rate: 0.5 mL/min. 
Detection: λ = 274 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
24.73 
± 
1.47 
34.40 
± 
1.56 
85.93 
± 
2.60 
85.56 
± 
2.03 
53.48 
± 
0.04 
18.24 
± 
0.34 
20.94 
± 
0.48 
22.52 
± 
0.20 
33.26 
± 
0.31 
35.91 
± 
0.25 
42.92 
± 
0.49 
54.53 
± 
0.65 
55.97 
± 
0.89 
60.55 
± 
1.04 
39.28 
± 
2.86 
32.11 
± 
3.69 
 
2’,4’,6’-Trifluoroazobenzene-D-threoninol (DFAB-F) 
Sample: Azobenzene-D-threoninol, 10 μM, 20 μL injection for each measurement. 
Gradient: ACN/H2O = 25/75 -> 45/55, flow-rate: 0.5 mL/min. 
Detection: λ = 292 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
25.77 
± 
5.50 
45.67 
± 
7.08 
82.42 
± 
1.35 
87.18 
± 
0.39 
90.09 
± 
0.47 
75.45 
± 
1.72 
41.48 
± 
0.40 
40.48 
± 
0.21 
38.53 
± 
0.06 
39.54 
± 
0.17 
42.05 
± 
0.17 
46.05 
± 
0.20 
46.27 
± 
0.04 
47.78 
± 
0.59 
34.09 
± 
0.09 
36.33 
± 
0.16 
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4’-Chloro-2’,6’-difluoroazobenzene-D-threoninol (DFAB-Cl) 
Sample: Azobenzene-D-threoninol, 10 μM, 20 μL injection for each measurement. 
Gradient: ACN/H2O = 25/75 -> 45/55 in 15 minutes, flow-rate: 0.5 mL/min. 
Detection: λ = 278 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
8.75 
± 
0.93 
18.82 
± 
2.27 
65.73 
± 
1.82 
65.22 
± 
1.30 
53.91 
± 
0.76 
15.21 
± 
0.95 
14.42 
± 
0.11 
14.87 
± 
0.28 
21.30 
± 
0.45 
22.76 
± 
0.49 
27.44 
± 
0.77 
35.17 
± 
0.78 
36.34 
± 
0.89 
40.54 
± 
1.14 
25.44 
± 
3.25 
17.86 
± 
4.53 
 
2’,6’-Dichloroazobenzene-D-threoninol (DCAB) 
Sample: Azobenzene-D-threoninol, 10 μM, 20 μL injection for each measurement. 
Gradient: ACN/H2O = 25/75 -> 45/55 in 15 minutes, flow-rate: 0.5 mL/min. 
Detection: λ = 268 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
23.61 
± 
0.64 
29.59 
± 
0.47 
70.87 
± 
0.91 
62.21 
± 
0.42 
28.05 
± 
0.05 
11.42 
± 
0.46 
12.95 
± 
1.08 
15.13 
± 
0.12 
26.07 
± 
0.05 
28.77 
± 
0.08 
37.05 
± 
0.18 
52.37 
± 
0.37 
54.27 
± 
0.64 
61.84 
± 
0.41 
47.96 
± 
1.52 
33.38 
± 
2.79 
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2’,6’-Dimethoxyazobenzene-D-threoninol (DOAB) 
Sample: Azobenzene-D-threoninol, 10 μM, 20 μL injection for each measurement. 
Gradient: ACN/H2O = 15/85 -> 25/75 in 15 minutes, flow-rate: 0.5 mL/min. 
Detection: λ = 279 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
48.90 
± 
0.08 
56.23 
± 
1.47 
80.72 
± 
1.72 
82.75 
± 
0.82 
80.37 
± 
0.92 
62.63 
± 
0.48 
35.75 
± 
0.02 
34.76 
± 
0.55 
40.21 
± 
0.37 
42.67 
± 
0.30 
49.25 
± 
0.19 
60.07 
± 
0.49 
61.28 
± 
0.25 
66.36 
± 
0.14 
70.48 
± 
0.78 
60.74 
± 
4.30 
 
Methylarylazopyrazole-D-threoninol (AAP1) 
Sample: Azobenzene-D-threoninol, 10 μM, 20 μL injection for each measurement. 
Gradient: ACN/H2O = 25/75 -> 45/55 in 15 minutes, flow-rate: 0.5 mL/min. 
Detection: λ = 301 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
6.76 
± 
4.36 
42.50 
± 
3.04 
77.00 
± 
3.45 
84.11 
± 
0.57 
80.73 
± 
3.27 
62.32 
± 
2.38 
30.94 
± 
0.16 
28.83 
± 
0.24 
19.76 
± 
0.64 
18.94 
± 
0.58 
16.30 
± 
0.19 
13.56 
± 
0.69 
13.34 
± 
1.04 
11.21 
± 
0.81 
5.53 
± 
2.06 
6.03 
± 
1.71 
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Phenylarylazopyrazole-D-threoninol (AAP2) 
Sample: Azobenzene-D-threoninol, 10 μM, 20 μL injection for each measurement. 
Gradient: ACN/H2O = 25/75 -> 45/55 in 15 minutes, flow-rate: 0.5 mL/min. 
Detection: λ = 301 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
7.92 
± 
4.04 
49.53 
± 
2.26 
84.31 
± 
0.37 
87.76 
± 
0.40 
90.69 
± 
0.18 
75.67 
± 
1.45 
38.39 
± 
0.21 
35.67 
± 
0.42 
25.09 
± 
0.50 
24.42 
± 
0.74 
22.21 
± 
0.62 
18.40 
± 
0.37 
17.71 
± 
0.79 
15.03 
± 
0.77 
5.29 
± 
1.22 
12.05 
± 
3.18 
 
 
Comparison of wavelength-dependent cis-fraction of all D-threoninol-bound small 
molecules 
Each individual quantification of wavelength dependent cis fractions permits the direct 
comparison of switching properties for all synthesized D-threoninol bound small molecules. All 
cis fractions derived from the individual quantification steps are given below. 
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Cis percentage values calculated for all synthesized D-threoninol bound small molecules: 
WL [nm] AB DMAB S-DMAB DFAB DFAB-F DFAB-Cl AAP1 AAP2 DCAB DOAB 
dark 
3.63 ± 
2.13 
6.52 ± 
2.02 
15.43 ± 
6.24 
24.73 ± 
1.47 
25.77 ± 
5.50 
8.75 ± 
0.93 
6.76 ± 
4.36 
7.92 ± 
4.04 
23.61 ± 
0.64 
48.90 ± 
0.08 
320 nm 
12.87 ± 
7.11 
14.84 ± 
4.42 
27.12 ± 
1.79 
34.40 ± 
1.56 
45.67 ± 
7.08 
18.82 ± 
2.27 
42.50 ± 
3.04 
49.53 ± 
2.26 
29.59 ± 
0.47 
56.23 ± 
1.47 
340 nm 
85.87 ± 
2.42 
76.55 ± 
1.88 
48.61 ± 
4.21 
85.93 ± 
2.60 
82.42 ± 
1.35 
65.73 ± 
1.82 
77.00 ± 
3.45 
84.31 ± 
0.37 
70.87 ± 
0.91 
80.72 ± 
1.72 
350 nm 
85.30 ± 
1.90 
74.86 ± 
1.99 
54.84 ± 
2.88 
85.56 ± 
2.03 
87.18 ± 
0.39 
65.22 ± 
1.30 
84.11 ± 
0.57 
87.76 ± 
0.40 
62.21 ± 
0.42 
82.75 ± 
0.82 
365 nm 
73.43 ± 
0.60 
63.44 ± 
1.02 
62.90 ± 
3.27 
53.48 ± 
0.04 
90.09 ± 
0.47 
53.91 ± 
0.76 
80.73 ± 
3.27 
90.69 ± 
0.18 
28.05 ± 
0.05 
80.37 ± 
0.92 
385 nm 
25.14 ± 
0.16 
20.19 ± 
0.68 
65.93 ± 
4.49 
18.24 ± 
0.34 
75.45 ± 
1.72 
15.21 ± 
0.95 
62.32 ± 
2.38 
75.67 ± 
1.45 
11.42 ± 
0.46 
62.63 ± 
0.48 
405 nm 
19.31 ± 
0.38 
15.79 ± 
0.32 
40.38 ± 
3.03 
20.94 ± 
0.48 
41.48 ± 
0.40 
14.42 ± 
0.11 
30.94 ± 
0.16 
38.39 ± 
0.21 
12.95 ± 
1.08 
35.75 ± 
0.02 
420 nm 
19.13 ± 
0.42 
16.36 ± 
1.08 
37.05 ± 
2.09 
22.52 ± 
0.20 
40.48 ± 
0.21 
14.87 ± 
0.28 
28.83 ± 
0.24 
35.67 ± 
0.42 
15.13 ± 
0.12 
34.76 ± 
0.55 
440 nm 
22.26 ± 
0.15 
21.07 ± 
0.51 
27.13 ± 
0.22 
33.26 ± 
0.31 
38.53 ± 
0.06 
21.30 ± 
0.45 
19.76 ± 
0.64 
25.09 ± 
0.50 
26.07 ± 
0.05 
40.21 ± 
0.37 
450 nm 
23.12 ± 
0.15 
22.72 ± 
0.80 
26.81 ± 
1.70 
35.91 ± 
0.25 
39.54 ± 
0.17 
22.76 ± 
0.49 
18.94 ± 
0.58 
24.42 ± 
0.74 
28.77 ± 
0.08 
42.67 ± 
0.30 
470 nm 
25.77 ± 
0.15 
26.88 ± 
0.46 
28.43 ± 
0.82 
42.92 ± 
0.49 
42.05 ± 
0.17 
27.44 ± 
0.77 
16.30 ± 
0.19 
22.21 ± 
0.62 
37.05 ± 
0.18 
49.25 ± 
0.19 
490 nm 
30.22 ± 
0.14 
35.92 ± 
0.01 
30.29 ± 
2.32 
54.53 ± 
0.65 
46.05 ± 
0.20 
35.17 ± 
0.78 
13.56 ± 
0.69 
18.40 ± 
0.37 
52.37 ± 
0.37 
60.07 ± 
0.49 
505 nm 
30.51 ± 
0.39 
37.21 ± 
0.23 
34.34 ± 
0.78 
55.97 ± 
0.89 
46.27 ± 
0.04 
36.34 ± 
0.89 
13.34 ± 
1.04 
17.71 ± 
0.79 
54.27 ± 
0.64 
61.28 ± 
0.25 
530 nm 
32.06 ± 
0.28 
42.84 ± 
0.73 
34.83 ± 
0.90 
60.55 ± 
1.04 
47.78 ± 
0.59 
40.54 ± 
1.14 
11.21 ± 
0.81 
15.03 ± 
0.77 
61.84 ± 
0.41 
66.36 ± 
0.14 
590 nm 
13.37 ± 
0.88 
38.55 ± 
1.46 
33.05 ± 
1.72 
39.28 ± 
2.86 
34.09 ± 
0.09 
25.44 ± 
3.25 
5.53 ± 
2.06 
5.29 ± 
1.22 
47.96 ± 
1.52 
70.48 ± 
0.78 
630 nm 
11.86 ± 
1.38 
19.87 ± 
1.04 
29.00 ± 
1.03 
32.11 ± 
3.69 
36.33 ± 
0.16 
17.86 ± 
4.53 
6.03 ± 
1.71 
12.05 ± 
3.18 
33.38 ± 
2.79 
60.74 ± 
4.30 
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7.5.2 Reversed-phase HPLC quantification of modified oligonucleotides 
Separation of both cis to trans ratio for modified oligonucleotides was performed on an 
Agilent Eclipse SDB C18 4.6x150 mm reversed phase column with different gradients of 
acetonitrile and 0.1 M TEAAc buffer. All DNA strands were directly injected into the HPLC 
column upon irradiation and both cis and trans isomers were separated. The absorption at 
λ = 260 nm was recorded, integration of the corresponding signalsresults in the corresponding 
fraction of cis and trans isomer. Integral limits and values are given for each chromatogram. 
 
Azobenzene-modified 8-mer DNA (AB) 
Sample: 5’-GAATXGGTG-3’ with X = Azobenzene (AB), 10 μM solution in H2O, 20 μL 
injection for each measurement. 
Gradient: ACN/0.1 M TEAAC = 5/95 -> 25/75 in 20 minutes, flow-rate: 1 mL/min. 
Detection: λ = 260 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
10.49 
± 
0.41 
17.22 
± 
2.49 
72.94 
± 
2.58 
72.76 
± 
5.54 
68.21 
± 
4.05 
18.94 
± 
0.06 
10.75 
± 
0.52 
13.44 
± 
2.12 
12.20 
± 
0.74 
11.91 
± 
0.40 
13.53 
± 
2.78 
13.51 
± 
2.07 
16.75 
± 
1.45 
14.76 
± 
2.18 
10.79 
± 
1.35 
11.62 
± 
0.99 
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2’,6’-Dimethylazobenzene-modified 8-mer DNA (DMAB) 
Sample: 5’-GAATXGGTG-3’ with X = 2’,6’-Dimethylazobenzene (DMAB), 10 μM solution in 
H2O, 20 μL injection for each measurement. 
Gradient: ACN/0.1 M TEAAC = 15/85 -> 25/75 in 20 minutes, flow-rate: 1 mL/min. 
Detection: λ = 260 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
10.51 
± 
1.10 
16.85 
± 
1.56 
68.01 
± 
1.91 
66.08 
± 
1.56 
63.58 
± 
2.52 
17.73 
± 
0.23 
8.43 
± 
0.14 
6.88 
± 
1.54 
11.09 
± 
0.03 
11.43 
± 
1.22 
15.15 
± 
0.33 
22.03 
± 
1.19 
24.73 
± 
0.10 
31.15 
± 
0.07 
45.86 
± 
2.38 
27.83 
± 
4.84 
 
4’-Methylthio-2’,6’-dimethylazobenzene-modified 8-mer DNA (S-DMAB) 
Sample: 5’-GAATXGGTG-3’ with X = 4’-Methylthio-2’,6’-dimethylazobenzene (S-DMAB), 10 
μM solution in H2O, 20 μL injection for each measurement. 
Gradient: ACN/0.1 M TEAAC = 5/95 -> 25/75 in 20 minutes, flow-rate: 1 mL/min. 
Detection: λ = 260 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
24.97 
± 
9.19 
25.37 
± 
6.20 
33.79 
± 
1.06 
47.15 
± 
5.82 
62.87 
± 
3.12 
73.04 
± 
3.46 
44.15 
± 
0.36 
36.56 
± 
1.44 
17.52 
± 
2.11 
19.81 
± 
5.46 
16.08 
± 
1.75 
27.38 
± 
5.98 
19.96 
± 
3.01 
22.66 
± 
3.70 
33.35 
± 
1.81 
27.77 
± 
4.87 
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2’,6’-Difluoroazobenzene-modified 8-mer DNA (DFAB) 
Sample: 5’-GAATXGGTG-3’ with X = 2’,6’-Difluoroazobenzene (DFAB), 10 μM solution in 
H2O, 20 μL injection for each measurement. 
Gradient: ACN/0.1 M TEAAC = 13/87 -> 18/82 in 20 minutes, flow-rate: 1 mL/min. 
Detection: λ = 260 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
23.24 
± 
2.34 
25.39 
± 
2.16 
69.90 
± 
1.92 
62.91 
± 
4.61 
45.12 
± 
3.41 
17.57 
± 
3.16 
16.97 
± 
3.41 
17.29 
± 
1.67 
20.36 
± 
4.03 
21.84 
± 
3.82 
24.64 
± 
4.17 
32.00 
± 
5.19 
33.09 
± 
5.33 
38.34 
± 
4.41 
30.26 
± 
2.77 
24.95 
± 
1.52 
 
2’,6’-Dimethoxyazobenzene-modified 8-mer DNA (DOAB) 
Sample: 5’-GAATXGGTG-3’ with X = 2’,6’-Dimethoxyazobenzene (DOAB), 10 μM solution 
in H2O, 20 μL injection for each measurement. 
Gradient: ACN/0.1 M TEAAC = 10/90 -> 20/80 in 20 minutes, flow-rate: 1 mL/min. 
Detection: λ = 260 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
35.13 
± 
0.64 
38.69 
± 
1.27 
70.73 
± 
0.57 
73.58 
± 
1.07 
74.73 
± 
0.47 
57.18 
± 
0.35 
27.61 
± 
0.23 
25.84 
± 
0.31 
28.22 
± 
0.77 
30.86 
± 
0.52 
36.74 
± 
0.69 
47.43 
± 
1.32 
49.87 
± 
0.06 
56.20 
± 
0.47 
66.65 
± 
0.18 
49.30 
± 
1.38 
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N-Methylarylazopyrazole-modified 8-mer DNA (AAP1) 
Sample: 5’-GAATXGGTG-3’ with X = N-Methylarylazopyrazole (AAP1), 10 μM solution in 
H2O, 20 μL injection for each measurement. 
Gradient: ACN/0.1 M TEAAC = 5/95 -> 25/75 in 20 minutes, flow-rate: 1 mL/min. 
Detection: λ = 260 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
4.53 
± 
4.01 
25.22 
± 
6.29 
81.20 
± 
2.21 
86.65 
± 
1.19 
88.87 
± 
0.77 
77.28 
± 
0.89 
29.05 
± 
0.50 
26.75 
± 
0.11 
16.53 
± 
1.61 
16.26 
± 
0.92 
12.61 
± 
3.89 
8.26 
± 
2.05 
8.83 
± 
4.26 
6.05 
± 
3.39 
3.52 
± 
0.36 
4.55 
± 
0.66 
 
N-Phenylarylazopyrazole-modified 8-mer DNA (AAP2) 
Sample: 5’-GAATXGGTG-3’ with X = N-Phenylarylazopyrazole (AAP2), 10 μM solution in 
H2O, 20 μL injection for each measurement. 
Gradient: ACN/0.1 M TEAAC = 10/90 -> 30/70 in 20 minutes, flow-rate: 1 mL/min. 
Detection: λ = 260 nm. 
 
Wavelength dependent cis-percentage calculated from integrated peak areas: 
Wave-
length 
dark 
320 
nm 
340 
nm 
350 
nm 
365 
nm 
385 
nm 
405 
nm 
420 
nm 
440 
nm 
450 
nm 
470 
nm 
490 
nm 
505 
nm 
530 
nm 
590 
nm 
630 
nm 
cis-
fraction 
[%] 
5.75 
± 
2.33 
25.29 
± 
0.47 
78.00 
± 
1.83 
83.79 
± 
0.39 
90.61 
± 
2.99 
80.57 
± 
3.63 
35.50 
± 
0.88 
29.90 
± 
0.25 
14.37 
± 
1.69 
13.99 
± 
1.50 
11.09 
± 
1.46 
9.31 
± 
1.76 
10.29 
± 
0.07 
8.01 
± 
1.72 
2.52 
± 
1.08 
8.41 
± 
5.93 
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Comparison of wavelength-dependent cis fraction of all modified 8-mer DNA strands 
 
Cis-percentage calculated for all modified 8-mer DNA strands: 
WL [nm] AB DMAB S-DMAB DFAB DOAB AAP1 AAP2 
dark 
10.49 ± 
0.41 
10.51 ± 
1.10 
24.97 ± 
9.19 
23.24 ± 
2.34 
35.13 ± 
0.64 
4.53 ± 
4.01 
5.75 ± 
2.33 
320 nm 
17.22 ± 
2.49 
16.85 ± 
1.56 
25.37 ± 
6.20 
25.39 ± 
2.16 
38.69 ± 
1.27 
25.22 ± 
6.29 
25.29 ± 
0.47 
340 nm 
72.94 ± 
2.58 
68.01 ± 
1.91 
33.79 ± 
1.06 
69.90 ± 
1.92 
70.73 ± 
0.57 
81.20 ± 
2.21 
78.00 ± 
1.83 
350 nm 
72.76 ± 
5.54 
66.08 ± 
1.56 
47.15 ± 
5.82 
62.91 ± 
4.61 
73.58 ± 
1.07 
86.65 ± 
1.19 
83.79 ± 
0.39 
365 nm 
68.21 ± 
4.05 
63.58 ± 
2.52 
62.87 ± 
3.12 
45.12 ± 
3.41 
74.73 ± 
0.47 
88.87 ± 
0.77 
90.61 ± 
2.99 
385 nm 
18.94 ± 
0.06 
17.73 ± 
0.23 
73.04 ± 
3.46 
17.57 ± 
3.16 
57.18 ± 
0.35 
77.28 ± 
0.89 
80.57 ± 
3.63 
405 nm 
10.75 ± 
0.52 
8.43 ± 0.14 
44.15 ± 
0.36 
16.97 ± 
3.41 
27.61 ± 
0.23 
29.05 ± 
0.50 
35.50 ± 
0.88 
420 nm 
13.44 ± 
2.12 
6.88 ± 1.54 
36.56 ± 
1.44 
17.29 ± 
1.67 
25.84 ± 
0.31 
26.75 ± 
0.11 
29.90 ± 
0.25 
440 nm 
12.20 ± 
0.74 
11.09 ± 
0.03 
17.52 ± 
2.11 
20.36 ± 
4.03 
28.22 ± 
0.77 
16.53 ± 
1.61 
14.37 ± 
1.69 
450 nm 
11.91 ± 
0.40 
11.43 ± 
1.22 
19.81 ± 
5.46 
21.84 ± 
3.82 
30.86 ± 
0.52 
16.26 ± 
0.92 
13.99 ± 
1.50 
470 nm 
13.53 ± 
2.78 
15.15 ± 
0.33 
16.08 ± 
1.75 
24.64 ± 
4.17 
36.74 ± 
0.69 
12.61 ± 
3.89 
11.09 ± 
1.46 
490 nm 
13.51 ± 
2.07 
22.03 ± 
1.19 
27.38 ± 
5.98 
32.00 ± 
5.19 
47.43 ± 
1.32 
8.26 ± 
2.05 
9.31 ± 
1.76 
505 nm 
16.75 ± 
1.45 
24.73 ± 
0.10 
19.96 ± 
3.01 
33.09 ± 
5.33 
49.87 ± 
0.06 
8.83 ± 
4.26 
10.29 ± 
0.07 
530 nm 
14.76 ± 
2.18 
31.15 ± 
0.07 
22.66 ± 
3.70 
38.34 ± 
4.41 
56.20 ± 
0.47 
6.05 ± 
3.39 
8.01 ± 
1.72 
590 nm 
10.79 ± 
1.35 
45.86 ± 
2.38 
33.35 ± 
1.81 
30.26 ± 
2.77 
66.65 ± 
0.18 
3.52 ± 
0.36 
2.52 ± 
1.08 
630 nm 
11.62 ± 
0.99 
27.83 ± 
4.84 
27.77 ± 
4.87 
24.95 ± 
1.52 
49.30 ± 
1.38 
4.55 ± 
0.66 
8.41 ± 
5.93 
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7.6 Melting curve analysis 
7.6.1 Melting curves of unmodified DNA duplexes 
Melting curves were performed in a volume of 200 µL of a 0.5 M NaCl solution in Millipore 
water. 8-mer duplexes were diluted to a concentration of 3 µM 8-mer strand plus 3 µM 8-mer 
antisense strand and 2 µM 12-mer strand plus 2 µM 12-mer antisense strand. Melting curves 
were performed with a ramp rate of 1 °C/minute in a range between 10 °C and 60 °C for 8-mer 
duplexes and a range between 20 °C and 80 °C for 12-mer duplexes. Determination of melting 
temperatures Tm was done via the JASCO spectra analysis software by fitting all melting 
curves with a second derivative fit curve. 
 
    
 
Melting curves recorded for the three unmodified DNA duplexes given below.The melting 
temperatures were determined as follows: 
 
Melting temperatures of unmodified DNA duplexes (error = SD): 
Native 8-mer duplex 5’-GAATGGTG-3’ and complement (n = 2):       33.9 °C  0.1 °C 
Native 12-mer duplex 5’-CACCATTCCGGT-3’ and complement (n = 3):      59.4 °C  0.2 °C 
Native 12-mer50 duplex 5’-CACCATTCCAGT-3’ and complement (n = 3):  54.6 °C  0.3 °C 
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7.6.2 Melting curves of modified 8-mer DNA duplexes 
The following modified 8-mer duplexes with X as a given modification were used with the 
unmodified complementary strand:  
A) 5’-GAATXGGTG-3’ 
B) 5’-GAXATGGXTG-3’ 
C) 5’-GAXATXGGXTG-3’ 
 
Melting curves of azobenzene-modified 8-mer DNA sequences A, B and C with X = AB. 
    
 
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 405 nm 350 nm 350 nm 40 °C 
Tm (A) [°C] 35.38 ± 1.89 28.03 ± 1.23 22.89 ± 0.53 
Tm (B) [°C] 38.95 ± 0.25 32.70 ± 3.40 18.77 ± 1.40 
Tm (C) [°C] 32.74 ± 1.05 21.03 ± 0.82 18.33 ± 2.04 
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Melting curves of 2’,6’-dimethylazobenzene-modified 8-mer DNA sequences A, B and C with 
X = DMAB: 
    
 
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 420 nm 350 nm 350 nm 40 °C 
Tm (A) [°C] 40.26 ± 0.53 40.27 ± 0.37 40.79 ± 1.93 
Tm (B) [°C] 47.09 ± 0.84 48.59 ± 0.45 47.81 ± 2.04 
Tm (C) [°C] 46.54 ± 0.98 44.94 ± 0.39 N/A 
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Melting curves of 4’-methylthio-2’,6’-dimethylazobentene-modified 8-mer DNA sequences A, 
B and C with X = S-DMAB: 
    
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 450 nm 385 nm 385 nm 40 °C 
Tm (A) [°C] 38.25 ± 0.39 38.48 ± 0.09 37.62 ± 1.53 
Tm (B) [°C] 39.09 ± 0.82 38.49 ± 3.23 36.10 ± 0.45 
Tm (C) [°C] 39.77 ± 1.53 16.91 ± 2.20 17.05 ± 2.29 
 
Melting curves of 2’,6’-difluoroazobenzene-modified 8-mer DNA sequence A with X = DFAB: 
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 405 nm 350 nm 350 nm 40 °C 530 nm 530 nm 40 °C 
Tm (A) [°C] 36.82 ± 0.38 32.10 ± 0.26 22.96 ± 0.36 34.87 ± 0.96 33.99 ± 0.71 
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Melting curves of 2’,6’-dimethoxylazobenzene-modified 8-mer DNA sequence A with 
X = DOAB: 
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 420 nm 350 nm 350 nm 40 °C 590 nm 590 nm 40 °C 
Tm (A) [°C] 28,44 ± 3,01 16,42 ± 1,16 16,66 ± 0,51 25,14 ± 0,50 21,52 ± 0,79 
 
 
Melting curves of N-methyl-arylazopyrazole-modified 8-mer DNA sequences A, B and C with 
X = AAP1: 
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The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 365 nm 
Tm (A) [°C] 30.27 ± 0.56 21.66 ± 1.32 
Tm (B) [°C] 26.06 ± 1.85 N/A 
Tm (C) [°C] 19.57 ± 0.38 N/A 
 
 
Melting curves of N-phenyl-arylazopyrazole-modified 8-mer DNA sequence A with 
X = AAP2: 
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 365 nm 
Tm (A) [°C] 26.91 ± 0.64 22.09 ± 1.29 
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7.6.3 Melting curves of modified 12-mer DNA duplexes 
The following modified 8-mer duplexes with X = modification were used with the unmodified 
complementary strand:  
D) 5’-CAC CAT X TCC GGT-3’ 
E) 5’-CAC X CAT TCC X GGT-3’ 
F) 5’-CAC X CAT X TCC X GGT-3’ 
G) 5’-CAC CXAT TCXC AGT-3’ 
H) 5’-CAC X CAT X TCC X AGT-3’ 
 
Melting curves of azobenzene-modified 12-mer DNA sequences D, E and F with X = AB: 
    
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 405 nm 350 nm 350 nm 40 °C 
Tm (D) [°C] 65.31 ± 1.10 65.01 ± 0.27 64.65 ± 2.53 
Tm (E) [°C] 65.30 ± 1.70 64.46 ± 1.80 63.05 ± 3.96 
Tm (F) [°C] 66.45 ± 1.63 64.68 ± 1.18 58.69 ± 1.40 
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Melting curves of 2’,6’-dimethylazobenzene-modified 12-mer DNA sequences D, E and F 
with X = DMAB: 
    
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 420 nm 350 nm 350 nm 40 °C 
Tm (D) [°C] 66.48 ± 0.55 66.74 ± 0.19 67.05 ± 3.21 
Tm (E) [°C] 69.96 ± 4.59 67.95 ± 3.73 67.87 ± 4.56 
Tm (F) [°C] 72.13 ± 2.06 72.56 ± 3.79 64.61 ± 10.81 
 
 
Melting curves of 4’-methylthio-2’,6’-dimethylazobenzene-modified 12-mer DNA sequences 
D, E and F with X = S-DMAB: 
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The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 450 nm 385 nm 385 nm 40 °C 
Tm (D) [°C] 64.72 ± 0.99 66.34 ± 0.21 66.62 ± 0.36 
Tm (E) [°C] 64.67 ± 1.27 60.63 ± 1.10 59.64 ± 2.92 
Tm (F) [°C] 59.23 ± 2.45 59.75 ± 4.92 61.58 ± 5.01 
 
 
Melting curves of 2’,6’-difluoroazobenzene-modified 12-mer DNA sequence D with 
X = DFAB: 
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 405 nm 350 nm 350 nm 40 °C 530 nm 530 nm 40 °C 
Tm (D) [°C] 63,48 ± 0,37 63,37 ± 0,31 64,26 ± 1,44 64,29 ± 0,46 65,34 ± 0,35 
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Melting curves of 2’,6’-dimethoxyazobenzene-modified 12-mer DNA sequence D with 
X = DOAB: 
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 420 nm 350 nm 350 nm 40 °C 590 nm 590 nm 40 °C 
Tm (D) [°C] 62,82 ± 0,81 63,79 ± 1,52 65,06 ± 0,91 61,82 ± 0,59 62,94 ± 1,52 
 
Melting curves of N-methylarylazopyrazole-modified 12-mer DNA sequences D, E and F with 
X = AAP1: 
    
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 365 nm 
Tm (D) [°C] 60.55 ± 1.31 62.70 ± 1.43 
Tm (E) [°C] 62.85 ± 0.29 N/A 
Tm (F) [°C] 57.64 ± 3.49 N/A 
   265 
Melting curves of N-phenylarylazopyrazole-modified 12-mer DNA sequences D, E and F with 
X = AAP2: 
    
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 365 nm 
Tm (D) [°C] 57.88 ± 1.08 54.17 ± 0.17 
Tm (E) [°C] 52.30 ± 1.11 43.82 ± 0.78 
Tm (F) [°C] 43.77 ± 0.83 N/A 
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Melting curves of N-methyl-arylazopyrazole-modified 12-mer50 DNA sequences G and H 
with X = AAP1: 
     
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 365 nm 
Tm (G) [°C] 54.67 ± 0.93 58.21 ± 0.52 
Tm (H) [°C] 48.44 ± 2.83 26.83 ± 0.79 
 
 
Melting curves of N-phenyl-arylazopyrazole-modified 12-mer50 DNA sequences G and H 
with X = AAP2: 
     
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 365 nm 
Tm (G) [°C] 38.07 ± 1.22 35.52 ± 0.39 
Tm (H) [°C] N/A N/A 
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7.6.4 Melting curves of modified release-oligomer DNA duplexes 
In addition to the modified 8-mer and 12-mer sequences described in chapter 7.6.1, another 
12-mer sequence with 66 % GC-content and two 10-mer sequences were used for additional 
melting curve measurements for further use in a catenane system.  
    
 
 
Melting points of unmodified DNA duplexes, n = 2, error = SD: 
Native 168ROo duplex 5’-TCC CCA GCA TCG-3’ and complement: 63.8 °C  1.1 °C 
Native 126ROo duplex 5’-CCG ATG CTG T-3’ and complement: 53.9 °C  0.2 °C 
Native 126ROp duplex 5’-GGA ATG GTG A-3’ and complement: 44.3 °C  0.1 °C 
 
The following sequences with X = modification were used: 
I) 5’-TCC X CCA X GCA X TCG-3’ (168ROo) 
J) 5’-CC X GAT X GCT X GT-3’  (126ROo) 
K) 5’-GG X AAT X GGT X GA-3’  (126ROp) 
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Melting curves of azobenzene-modified DNA sequences I, J and K with X = AB: 
    
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 405 nm 350 nm 350 nm 40 °C 
Tm (I) [°C] 74.34 ± 1.11 73.38 ± 1.94 64.30 ± 10.10 
Tm (J) [°C] 62.17 ± 1.09 56.45 ± 3.44 53.35 ± 2.23 
Tm (K) [°C] 52.24 ± 1.72 45.51 ± 0.57 43.62 ± 1.27 
 
 
Melting curves of 2’,6’-dimethylazobenzene-modified DNA sequences I, J and K with 
X = DMAB: 
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The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 420 nm 350 nm 350 nm 40 °C 
Tm (I) [°C] 82.19 ± 4.38 79.15 ± 1.50 56.44 ± 15.18 
Tm (J) [°C] 65.02 ± 1.16 66.89 ± 1.17 64.26 ± 1.84 
Tm (K) [°C] 59.60 ± 1.28 63.09 ± 2.88 53.30 ± 1.79 
 
Melting curves of 4’-methylthio-2’,6’-dimethylazobenzene-modified DNA sequences with 
X = S-DMAB: 
    
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 450 nm 385 nm 385 nm 40 °C 
Tm (I) [°C] 71.05 ± 3.63 68.38 ± 0.88 67.90 ± 1.30 
Tm (J) [°C] 54.53 ± 1.35 47.32 ± 1.38 51.47 ± 3.43 
Tm (K) [°C] 41.44 ± 0.25 41.48 ± 0.73 44.44 ± 2.10 
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Melting curves of N-methyl-arylazopyrazole-modified DNA sequences J and K with 
X = AAP1: 
     
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 
Tm (J) [°C] 54.11 ± 1.87 
Tm (K) [°C] 45.48 ± 3.62 
Further melting curves with the same sequences and modifications have been measured in 
chapter 7.6.5 as reversible melting curve measurements. 
 
 
Melting curves of N-phenyl-arylazopyrazole-modified DNA-sequences J and K with 
X = AAP2: 
     
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 365 nm 
Tm (J) [°C] 40.35 ± 2.72 21.66 ± 1.09 
Tm (K) [°C] 36.24 ± 0.32 no MP 
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7.6.5 Reversible melting curve measurements 
The following modified duplexes with X = modification were used with the complementary 
strand. Melting curves were recorded in forward mode, then the sample was cooled down to 
20 °C and re-hybridized for 30 minutes before starting the next melting curve. 
 
The following sequences with X = modification were used: 
A) 5’-GAATXGGTG-3’ 
B) 5’-GAXATGGXTG-3’ 
C) 5’-GAXATXGGXTG-3’ 
D) 5’-CAC CAT X TCC GGT-3’ 
E) 5’-CAC X CAT TCC X GGT-3’ 
F) 5’-CAC X CAT X TCC X GGT-3’ 
G) 5’-CAC CXAT TCXC AGT-3’ 
H) 5’-CAC X CAT X TCC X AGT-3’ 
I) 5’-TCC X CCA X GCA X TCG-3’ 
J) 5’-CC X GAT X GCT X GT-3’ 
K) 5’-GG X AAT X GGT X GA-3’ 
L) 5’-TCC CXCA GCXA TCG-3’ 
M) 5’-CAC CXAT TCXC GGT-3’ 
 
Reversible melting curves of N-methyl-arylazopyrazole-modified 8-mer DNA-sequences A; 
B and C with X = AAP1: 
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The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm1 365 nm 1 590 nm 2 365 nm 2 
Tm (A) [°C] 30.53 ± 1.15 21.95 ± 0.93 30.87 ± 0.19 22.50 ± 0.88 
Tm (B) [°C] 25.21 ± 0.25 18.28 ± 0.22 26.77 ± 0.92 16.15 ± 0.16 
Tm (C) [°C] 18.53 ± 0.20 N/A 20.72 ± 1.10 N/A 
 
 
Reversible melting curves of N-methyl-arylazopyrazole-modified 12-mer DNA-sequences D, 
E and F with X = AAP1: 
    
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm1 365 nm 1 590 nm 2 365 nm 2 
Tm (D) 61.60 ± 0.41 60.38 ± 0.17 62.59 ± 0.29 58.92 ± 0.71 
Tm (E) 61.66 ± 0.36 49.24 ± 1.71 62.80 ± 1.18 48.20 ± 3.20 
Tm (F) 57.99 ± 1.35 25.90 ± 0.01 62.71 ± 0.70 31.67 ± 0.19 
   273 
Reversible melting curves of N-phenyl-arylazopyrazole-modified 8-mer DNA-sequences A, 
B and C with X = AAP2: 
    
  
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm1 365 nm 1 590 nm 2 365 nm 2 
Tm (A) [°C] 27.60 ± 1.73 20.76 ± 4.00 27.04 ± 0.47 19.49 ± 3.94 
Tm (B) [°C] 17.53 ± 0.98 17.71 ± 0.77 17.83 ± 0.95 16.81 ± 0.38 
Tm (C) [°C] N/A N/A N/A N/A 
 
 
Reversible melting curves of N-phenyl-arylazopyrazole-modified 12-mer DNA-sequences 
D, E and F with X = AAP2: 
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The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm1 365 nm 1 590 nm 2 365 nm 2 
Tm (D) [°C] 57.75 ± 0.23 53.10 ± 0.15 58.05 ± 0.18 52.63 ± 0.63 
Tm (E) [°C] 50.42 ± 0.39 44.73 ± 0.59 49.80 ± 0.72 44.19 ± 0.03 
Tm (F) [°C] 44.79 ± 2.38 24.48 ± 0.56 42.14 ± 1.87 N/A 
 
 
Reversible melting curves of 2 x N-methyl-arylazopyrazole (X = AAP1) and 2 x N-phenyl-
arylazopyrazole (X = AAP2) in 12-mer DNA-sequence M: 
     
The melting temperatures after each irradiation step were determined as follows (n = 2, 
error = SD): 
Mod. 590 nm 1 365 nm 1 590 nm 2 365 nm 2 590 nm 3 
Tm (M, AAP1) [°C] 55.27 ± 3.76 59.13 ± 0.45 57.57 ± 0.29 60.55 ± 0.47 60.45 ± 1.00 
Tm (M, AAP2) [°C] 36.93 ± 2.42 31.05 ± 3.60 38.71 ± 0.44 34.40 ± 1.22 42.37 ± 2.03 
   275 
Reversible melting curves of 3 x N-methyl-arylazopyrazole (X = AAP1) in DNA-sequences 
J and K: 
     
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 1 365 nm 1 590 nm 2 365 nm 2 590 nm 3 
Tm (J) [°C] 53.01 ± 1.59 56.72 ± 1.91 56.18 ± 0.60 58.72 ± 0.12 54.54 ± 1.42 
Tm (K) [°C] 46.96 ± 0.30 N/A 43.45 ± 0.82 N/A 44.01 ± 0.67 
 
 
Reversible melting curves of 2 x N-methyl-arylazopyrazole (X = AAP1) and 2 x N-phenyl-
arylazopyrazole (X = AAP2) in DNA-sequence L: 
     
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 1 365 nm 1 590 nm 2 365 nm 2 590 nm 3 
Tm (L, AAP1) [°C] 66.05 ± 1.35 65.81 ± 0.37 65.14 ± 0.78 66.26 ± 0.15 65.69 ± 1.55 
Tm (L, AAP2) [°C] 38.26 ± 3.32 43.65 ± 3.33 50.83 ± 1.01 47.92 ± 0.69 53.71 ± 1.58 
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Reversible melting curves of 3 x N-methyl-arylazopyrazole (X = AAP1) and 3 x N-phenyl-
arylazopyrazole (X = AAP2) in DNA-sequence I: 
     
The melting temperatures after each irradiation step were determined as follows (n = 3, 
error = SD): 
Mod. 590 nm 1 365 nm 1 590 nm 2 365 nm 2 
Tm (I, AAP1) [°C] 68.23 ± 3.99 62.57 ± 0.56 66.82 ± 3.13 66.68 ± 1.75 
Tm (I, AAP2) [°C] 70.97 ± 3.13 30.63 ± 1.86 61.77 ± 2.76 33.16 ± 0.34 
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7.7 Determination of thermal stabilities 
7.7.1 Determination of thermal stabilities for D-threoninol bound photochromic 
molecules 
Thermal stabilities of D-threoninol bound small molecules were determined by irradiating all 
samples with the wavelengths corresponding to each maximum cis switching effect for 5 
minutes. Irradiation for room temperature measurements were carried out at room 
temperature, irradiation for 40 °C and 60 °C measurements were carried out at 40 °C and 
60 °C. Each sample was left in the dark at the given temperature and UV/Vis spectra were 
recorded after predefined time peiods. The relative change of each absorption maximum was 
plotted against the time period each sample was left at the given temperature. A logarithmic fit 
of each plot allows the calculation of half-life times via the equation 
𝑦 = 𝑦0 + 𝐴1 ∙ exp⁡(−(𝑥 − 𝑥0)/𝑡1) 
wheras y resembles the intensity of absorbance for a given time x while y0 is the initial 
absorbance at the time point x0. Solving the equation for x and insertion of the half maximum 
change in absorbance (y-y0)/2 leads to the calculation of all half-life times for a given tempe-
rature. 
𝑙𝑛 (
𝑦−𝑦0
𝐴1
) = (−(𝑥 − 𝑥0)/𝑡1)  
(−(𝑥 − 𝑥0)) = 𝑙𝑛 (
𝑦−𝑦0
𝐴1
) ∙ 𝑡1  
𝑥 = −𝑙𝑛 (
𝑦 − 𝑦0
𝐴1
) ∙ 𝑡1 − 𝑥0 
The themal half-life times were determined as follows: 
Sample Irr.-WL Abs.-max. t1/2 (20 °C) t1/2 (40 °C) t1/2 (60 °C) 
AB 
DMAB 
S-DMAB 
DFAB 
DFAB-F 
DFAB-Cl 
DCAB 
DOAB 
AAP1 
AAP2 
340 nm 
340 nm 
385 nm 
340 nm 
365 nm 
350 nm 
340 nm 
350 nm 
365 nm 
365 nm 
325 nm 
316 nm 
370 nm 
318 nm- 
346 nm 
325 nm 
307 nm 
341 nm 
341 nm 
341 nm 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
14.0 hours 
108.8 hours 
42.9 hours 
N/A 
N/A 
N/A 
N/A 
85.0 hours 
N/A 
96.1 hours 
4.2 hours 
22.0 hours 
N/A 
87.5 hours 
4.1 hours 
36.7 hours 
47.1 hours 
N/A 
143.0 hours 
13.4 hours 
N/A 
N/A 
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Thermal stability AB-D-threoninol 40 °C 
 
UV/vis-spectra of AB-D-threoninol in cis recorded after defined time intervals after leaving 
the sample in the dark at 40°C (left). Plotting the absorbance at 325 nm against time allows 
calculation of the half-life time (right). 
Sample: AB-D-threoninol, 50 µM dissolved in a 1:1 mixture of Millipore water and acetonitrile. 
Half-life time calculated: 42.9 hours (n = 2). 
 
 
Thermal stability DMAB-D-threoninol 60 °C 
 
UV/vis-spectra of DMAB-D-threoninol in cis recorded after defined time intervals after leaving 
the sample in the dark at 60°C (left). Plotting the absorbance at 316 nm against time allows 
calculation of the half-life time (right). 
Sample: DMAB-D-threoninol, 50 µM dissolved in a 1:1 mixture of Millipore water and aceto-
nitrile. 
Half-life time calculated: 87.5 hours (n = 2). 
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Thermal stability S-DMAB-D-threoninol 60 °C 
 
UV/vis-spectra of S-DMAB-D-threoninol in cis recorded after defined time intervals after 
leaving the sample in the dark at 60°C (left). Plotting the absorbance at 370 nm against time 
allows calculation of the half-life time (right). 
Sample: S-DMAB-D-threoninol, 50 µM dissolved in a 1:1 mixture of Millipore water and 
acetonitrile. 
Half-life time calculated: 4.1 hours (n = 2). 
 
 
Thermal stability AAP1-D-threoninol 20 °C 
 
UV/vis-spectra of AAP1-D-threoninol in cis recorded after defined time intervals after leaving 
the sample in the dark at 20°C (left). Plotting the absorbance at 341 nm against time allows 
calculation of the half-life time (right). 
Sample: AAP1-D-threoninol, 12.5 µM dissolved in a 1:1 mixture of Millipore water and 
acetonitrile. 
Half-life time calculated: 14.0 hours (n = 2). 
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Thermal stability AAP1-D-threoninol 40 °C 
 
UV/vis-spectra of AAP1-D-threoninol in cis recorded after defined time intervals after leaving 
the sample in the dark at 40°C (left). Plotting the absorbance at 341 nm against time allows 
calculation of the half-life time (right). 
Sample: AAP1-D-threoninol, 25 µM dissolved in a 1:1 mixture of Millipore water and aceto-
nitrile. 
Half-life time calculated: 4.2 hours (n = 2). 
 
 
Thermal stability AAP2-D-threoninol 20 °C 
 
UV/vis-spectra of AAP2-D-threoninol in cis recorded after defined time intervals after leaving 
the sample in the dark at 20°C (left). Plotting the absorbance at 341 nm against time allows 
calculation of the half-life time (right). 
Sample: AAP2-D-threoninol, 12.5 µM dissolved in a 1:1 mixture of Millipore water and aceto-
nitrile. 
Half-life time calculated: 108.8 hours (n = 2). 
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Thermal stability AAP2-D-threoninol 40 °C 
 
UV/vis-spectra of AAP2-D-threoninol in cis recorded after defined time intervals after leaving 
the sample in the dark at 40°C (left). Plotting the absorbance at 341 nm against time allows 
calculation of the half-life time (right). 
Sample: AAP2-D-threoninol, 25 µM dissolved in a 1:1 mixture of Millipore water and aceto-
nitrile. 
Half-life time calculated: 22.0 hours (n = 2). 
 
 
Thermal stability DFAB-D-threoninol 60 °C 
 
UV/vis-spectra of DFAB-D-threoninol in cis recorded after defined time intervals after leaving 
the sample in the dark at 60°C (left). Plotting the absorbance at 318 nm against time allows 
calculation of the half-life time (right). 
Sample: DFAB-D-threoninol, 50 µM dissolved in a 1:1 mixture of Millipore water and aceto-
nitrile. 
Half-life time calculated: 36.7 hours (n = 2). 
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Thermal stability DFAB-F-D-threoninol 60 °C 
 
UV/vis-spectra of DFAB-F-D-threoninol in cis recorded after defined time intervals after 
leaving the sample in the dark at 60°C (left). Plotting the absorbance at 347 nm against time 
allows calculation of the half-life time (right). 
Sample: DFAB-F-D-threoninol, 50 µM dissolved in a 1:1 mixture of Millipore water and 
acetonitrile. 
Half-life time calculated: 47.1 hours (n = 2). 
 
 
Thermal stability DFAB-Cl-D-threoninol 40 °C 
 
UV/vis-spectra of DFAB-Cl-D-threoninol in cis recorded after defined time intervals after 
leaving the sample in the dark at 40°C (left). Plotting the absorbance at 325 nm against time 
allows calculation of the half-life time (right). 
Sample: DFAB-Cl-D-threoninol, 50 µM dissolved in a 1:1 mixture of Millipore water and 
acetonitrile. 
Half-life time calculated: 85.0 hours (n = 2). 
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Thermal stability DOAB-D-threoninol 40 °C 
 
UV/vis-spectra of DOAB-D-threoninol in cis recorded after defined time intervals after leaving 
the sample in the dark at 40°C (left). Plotting the absorbance at 341 nm against time allows 
calculation of the half-life time (right). 
Sample: DOAB-D-threoninol, 50 µM dissolved in a 1:1 mixture of Millipore water and aceto-
nitrile. 
Half-life time calculated: 96.1 hours (n = 2). 
 
 
Thermal stability DOAB-D-threoninol 60 °C 
 
UV/vis-spectra of DOAB-D-threoninol in cis recorded after defined time intervals after leaving 
the sample in the dark at 60°C (left). Plotting the absorbance at 341 nm against time allows 
calculation of the half-life time (right). 
Sample: DOAB-D-threoninol, 50 µM dissolved in a 1:1 mixture of Millipore water and aceto-
nitrile. 
Half-life time calculated: 13.4 hours (n = 2). 
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Thermal stability DCAB-D-threoninol 60 °C 
 
UV/vis-spectra of DCAB-D-threoninol in cis recorded after defined time intervals after leaving 
the sample in the dark at 60°C (left). Plotting the absorbance at 307 nm against time allows 
calculation of the half-life time (right). 
Sample: DCAB-D-threoninol, 25 µM dissolved in a 1:1 mixture of Millipore water and aceto-
nitrile. 
Half-life time calculated: 143.0 hours (n = 2). 
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7.7.2 D-threoninol bound small molecules melting curves 
Small molecules melting curves were performed for AAP1-D-threoninol and AAP2-D-
threoninol. Solutions containing 25 µM of each sample in 500 µL of a 19:1 mixture of Millipore 
water and acetonitrile. A temperature gradient was applied starting from 20 °C to 80 °C with a 
gradient of 1 °C per minute while detecting the absorbance at the absorption maximum 
λ = 341 nm. Several cycles were run to monitor the change in absorbance. 
 
Fig. 100: Forward and reverse small molecule melting curves of AAP1-D-threoninol and AAP2-D-
threoninol with an applied thermal gradient of 1°C per minute. Absorbance was recorded at the 
isosbestic point at λ = 341 nm. 
AAP1-D-threoninol in cis conformation shows a constant increase in absorption intensity at 
the absorption maximum over a constant temperature gradient, indicating a fast back 
relaxation into trans conformation even at lower temperatures. The increase in absorption 
intensity becomes more significant with increasing temperatures, indicating a rapid back 
relaxation of the cis state into trans conformation. 
AAP2-D-threoninol in cis conformation on the other hand exhibits no significant increase in 
absorption intensity below 55 °C, indicating a high thermal stability of the cis state below this 
tempera-ture. Above 55 °C, a constant increase in absorption intensity indicates a slow back 
relaxation of the cis state into trans conformation. 
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7.8 Assembly of higher order dsDNA systems 
7.8.1 Assembly of circular dsDNA structures 
All double-stranded DNA constructs were assembled by the following setup: 
4 µM (8 µL) of each single strand was mixed in a total volume of 180 µL containing 20 mM 
NaCl (4 µL 1 M NaCl solution) and the sample mixtures were assembled on a thermocycler. 
The assembly started by heating the sample solutions with all single strands to 60 °C for 
5 minutes followed by consecutive cooldown with a gradient of 3 °C in 5:25 minutes in each 
step down to 15 °C. After cooldown to 15 °C, 20 µL of 10x T4 ligase buffer was added followed 
by addition of 1 µL T4 ligase. The sample solutions were ligated overnight at 15 °C and ligation 
process was monitored by 6 % PAGE gel electrophoresis. 
The base sequences corresponding to all single strands for each construct are given below. 
 
7.8.1.1 Assembly of a double-stranded 126 bp ring structure 
            
The double-stranded 126 bp ring structure was assembled via the previously described 
procedure using the following DNA strands: 
Name Sequence 
126-i1 5‘-AGAGAAAAAAGTGCCAAAAAGAGCTAAAAAATGTTCAAAAATGCTGAAAAAACGC-3’ 
126-i2 5‘-TCACAAAAAAGTCTCAAAAAGAGTCAAAAAATGTTCAAAAATCTATAAAAAACGG-3‘ 
126-o1 
5‘-Phos-TCTTTTTGAGACTTTTTTGTGACAGCATCGGCGTTTTTTCAGCATTTTTGAAC- 
ATTTTTTAGC-3‘ 
126-o2 
5‘-Phos-TCTTTTTGGCACTTTTTTCTCTCACCATTCCCGTTTTTTATAGATTTTTGAACA- 
TTTTTTGAC-3‘ 
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7.8.1.2 Assembly of double-stranded 168 bp ring structures 
 
Three different double-stranded 168 ring constructs containing a 13-mer single-stranded gap 
in ortho position and a single-stranded 13-mer gap in para position were assembled following 
the procedure given in 7.8.1. The base sequences corresponding to all single strands for each 
construct are given below. 
 
168 bp ring containing two non-symmetric gaps (A) 
  
The double-stranded 168 bp ring structure containing two non-symmetric gaps (A) was 
assembled via the previously described procedure using the following DNA strands: 
Name Sequence 
168-i1 5’-TTTTGAACATTTTTCTCCGTTTTTTGACAGTTTTTGGCCCT-3’ 
168-i2 
5’-TTTTGGCACTTTTTTACCGCTTTTTGAACATTTTTTGACAGTTTTTCCGTCTTTTTT- 
GCGCG-3’ 
168-i3 5’-Phos-TTTTTCCATATTTTTTGCGCGTTTTTCCGTCTTTTTTGGCAGT-3’ 
168-o1 
5’-Phos-AAAGTGCCAAAACGATGCTGGGGAGGGCCAAAAACTGTCAAAAAACGGAG- 
AAAAATGTT-3’ 
168-o2 
5’-Phos-CAAAACCGGAATGGTGACTGCCAAAAAAGACGGAAAAACGCGCAAAAAAT- 
ATGGAAAAACGCGC-3’ 
168-o3 5’-GCAGTCCACTCAGACCTGCGTTTCAAAAAGCGGTAAA-3’ 
168-o4 5’-Phos-AAAAAAGACGGAAAAACTGTCAAAAAATGACGCAGGTCTGAGTGGACTGC-3’ 
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168 bp ring shifted containing two symmetric gaps (B) 
  
The double-stranded 168 bp ring structure containing two symmetric gaps and a double-
stranded overhang (B) was assembled via the previously described procedure using the 
following DNA strands: 
Name Sequence 
168-i1 5’-TTTTGAACATTTTTCTCCGTTTTTTGACAGTTTTTGGCCCT-3’ 
168-i2 
5’-TTTTGGCACTTTTTTACCGCTTTTTGAACATTTTTTGACAGTTTTTCCGTCTTTTTTG- 
CGCG-3’ 
168-i3 5’-Phos-TTTTTCCATATTTTTTGCGCGTTTTTCCGTCTTTTTTGGCAGT-3’ 
168-o1 
5’-Phos-AAAGTGCCAAAACGATGCTGGGGAGGGCCAAAAACTGTCAAAAAACGGAG- 
AAAAATGTT-3’ 
168-o2-
shift 
5’-Phos-ACGGGCAAAACCGGAATGGTGACTGCCAAAAAAGACGGAAAAACGC-3’ 
168-o3-
shift 
5’-Phos-TGTCAAAAAATGTTCAAAAAGCGGTAAA-3’ 
168-o4-
shift 
5’-GCAGTCCACTCAGACCTGCGTAGACGGAAAAAC-3’ 
168-o5-
shift 
5’-Phos-GCAAAAAATATGGAAAAACGCGCAAAAAACGCAGGTCTGAGTGGACTGC-3’ 
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168 bp ring truncated containing two symmetric gaps and no overhang (C) 
 
The double-stranded 168 bp ring structure containing two gaps and no double-stranded 
overhang (C) was assembled via the previously described procedure using the following DNA 
strands: 
Name Sequence 
168-i1 5’-TTTTGAACATTTTTCTCCGTTTTTTGACAGTTTTTGGCCCT-3’ 
168-i2 
5’-TTTTGGCACTTTTTTACCGCTTTTTGAACATTTTTTGACAGTTTTTCCGTCTTTTTT- 
GCGCG-3’ 
168-i3 5’-Phos-TTTTTCCATATTTTTTGCGCGTTTTTCCGTCTTTTTTGGCAGT-3’ 
168-o1 
5’-Phos-AAAGTGCCAAAACGATGCTGGGGAGGGCCAAAAACTGTCAAAAAACGGAG- 
AAAAATGTT-3’ 
168-o2 
5’-Phos-CAAAACCGGAATGGTGACTGCCAAAAAAGACGGAAAAACGCGCAAAAAAT- 
ATGGAAAAACGCGC-3’ 
168-o3-
trunc 
5’-Phos-TTCAAAAAGCGGTAAA-3’ 
168-o4-
trunc 
5’-Phos-AAAAAAGACGGAAAAACTGTCAAAAAATG-3’ 
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7.8.2 Assembly of a non-symmetric two-state dsDNA [2]catenane system 
 
Fig. 101: Assembly of a two-state DNA [2]catenane system. Starting from the separate assembly of 
126out (A) and the 168 bp ring (B), the 168 bp ring's ortho gap was blocked with a toehold oligomer 
(B), followed by hybridization of 126o2 to the para gap of the 168 bp ring (C). Consecutive 
hybridization of the 126out construct to the hybridized 126o2 oligomer and ligation of all oligomers 
leads to the [2]catenane product Catenane-TH (C). Addition of the complementary toehold oligomer 
facilitates the isolation of the free [2]catenane. 
The [2]catenane system was assembled as follows: 
The outer construct of the 126 bp ring (126out) was assembled via the following setup: 
Strand Concentration Volume 
Final 
concentration  
126i1 100 µM 8 µL 4 µM 
126i2 100 µM 8 µL 4 µM 
126o2 100 µM 8 µL 4 µM 
126RO-TH 100 µM 8 µL 4 µM 
10xDA buffer  20 µL 1x buffer 
Water  148 µL 200 µL total volume 
All DNA strands, the 10x DA buffer and water were mixed, heated to 60 °C and slowly cooled 
down to 15 °C in a thermocycler (33 °C per hour). A 4.6 µM solution of the 168 bp ring construct 
(21.7 µL) in 1x DA buffer was mixed with 1.2 equivalents of 126o1 (1.2 µL, 100 µM), 8 µL 10x 
DA buffer and 69 µL water and the mixture was incubated for 4 hours at room temperature to 
yield a 1 µM solution of the 168 bp ring with 126o1 attached. 90 µL of the 168 bp construct  
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(1 µM) were mixed with 90 µL of the assembled construct 126out (1 µM) and the resulting 
mixture was incubated at 15 °C for 16 hours followed by a ligation step using 19 µL 10x T4 
ligation buffer and 1 µL T4 DNA ligase. The crude [2]catenane assembly was purified by weak 
anionic exchange HPLC or freeze and squeeze gel extraction to yield the pure [2]catenane 
product. 
 
126bp-ring containing two gaps 
The following DNA strands were used for the assembly of the 126 bp ring construct: 
Name Sequence 
126-i1 
5‘-Cy5-AGAGAAAAAAGTGCCAAAAAGAGCTAAAAAATGTTCAAAAATGCTGAAAAAA- 
CGC-3’ 
126-i2 
5‘-TAMRA-TCACAAAAAAGTCTCAAAAAGAGTCAAAAAATGTTCAAAAATCTATAAAA- 
AACGG-3‘ 
126-o1 
5‘-Phos-TCTTTTTGAGACTTTTTTGTGACAGCATCGGCGTTTTTTCAGCATTTTTGAA- 
CATTTTTTAGC-3‘ 
126-o2 
5‘-Phos-TCTTTTTGGCACTTTTTTCTCTCACCATTCCCGTTTTTTATAGATTTTTGAAC- 
ATTTTTTGAC-3‘ 
 
168 bp ring containing two non-symmetric gaps and a fluorophore quencher pair 
The following DNA strands were used for the assembly of the 168 bp ring construct: 
Name Sequence 
168-i1 5’-TTTTGAACATTTTTCTCCGTTTTTTGACAGTTTTTGGCCCT-BHQ2-3’ 
168-i2 
5’-TTTTGGCACTTTTTTACCGCTTTTTGAACATTTTTTGACAGTTTTTCCGTCTTTTTT- 
GCGCG-3’ 
168-i3 5’-Phos-TTTTTCCATATTTTTTGCGCGTTTTTCCGTCTTTTTTGGCAGT-BHQ3-3’ 
168-o1 
5’-Phos-AAAGTGCCAAAACGATGCTGGGGAGGGCCAAAAACTGTCAAAAAACGGAG- 
AAAAATGTT-3’ 
168-o2 
5’-Phos-CAAAACCGGAATGGTGACTGCCAAAAAAGACGGAAAAACGCGCAAAAAAT- 
ATGGAAAAACGCGC-3’ 
168-o3 5’-GCAGTCCACTCAGACCTGCGTTTCAAAAAGCGGTAAA-3’ 
168-o4 5’-Phos-AAAAAAGACGGAAAAACTGTCAAAAAATGACGCAGGTCTGAGTGGACTGC-3’ 
 
Toehold oligomer sequences used for the catenane assembly 
The following DNA sequences were used as toehold oligomers during the assembly: 
Name Sequence 
Toehold 5‘-GGACTAGGCTCCCCAGCATCG-3‘ 
Toehold comp 5‘-CGATGCTGGGGAGCCTAGTCC-3' 
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7.9 Gel electrophoresis measurements 
7.9.1 Investigation of switching efficiencies in a circular 168bp dsDNA system 
A double-stranded 168 bp DNA ring construct with two gaps and a double-stranded 20-mer 
overhang was used to determine the switching efficiencies of different modified DNA strands. 
For all quantifications, 1 µM ring construct was mixed with the corresponding modified release-
oligomers in 2 µM concentration and incubated for one hour at room temperature. The samples 
were irradiated for 5 minutes under the conditions given below, then subjected to a 6 % PAGE 
gel and run at 200 V for 45 minutes at 4 °C. The modified release-oligomers used for each 
quantification is given in the corresponding quantification step. A GeneRuler Ultra Low Range 
DNA ladder was used and all gels were stained with an ethidiumbromide solution. 
 
 
Unmodified release-oligomers in 168-ring construct ortho (left) and para (right) 
Sample: 1 µM 168 bp ring construct + 2 µM unmodified release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
 
Release oligomer ortho: 5’-TCC CCA GCA TCG-3’ 
Release oligomer para: 5’-CAC CAT TCC GGT-3’ 
 
A: 168 bp ring without release oligomers 
B: 168 bp ring with release oligomer ortho 
C: 168 bp ring with release oligomer para 
D: 168 bp ring with release oligomers ortho and para 
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Azobenzene 168 ortho (left) and para (right) release-oligomers, room temperature irradiation 
Sample: 1 µM 168 bp ring construct + 2 µM release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
       
Ref: 168 bp ring without release oligomers. 
Left: 168 bp ring with modified release oligomer ortho after irradiation into trans conformation 
(lanes A and C) and after irradiation into cis conformation (lanes B and D). 
Right: 168 bp ring with modified release oligomer para after irradiation into trans 
conformation (lanes A and C) and after irradiation into cis conformation (lanes  and D).
Release oligomer ortho: 5’-TCC X CCA X GCA X TCG-3’ with X = AB. 
Release oligomer para: 5’-CAC X CAT X TCC X GGT-3’ with X = AB. 
The samples were irradiated alternatingly with 405 nm (lanes A and C) and 350 nm (lanes B 
and D) for 5 minutes at room temperature in consecutive irradiation steps before running the 
gel. 
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Azobenzene 168 ortho (left) and para (right) release-oligomers, 40 °C irradiation 
Sample: 1 µM 168 bp ring construct + 2 µM release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
      
Ref: 168 bp ring without release oligomers. 
Left: 168 bp ring with modified release oligomer ortho after irradiation into trans conformation 
(lanes A and C) and after irradiation into cis conformation (lanes B and D). 
Right: 168 bp ring with modified release oligomer para after irradiation into trans 
conformation (lanes A and C) and after irradiation into cis conformation (lanes  and D).
Release oligomer ortho: 5’-TCC X CCA X GCA X TCG-3’ with X = AB. 
Release oligomer para: 5’-CAC X CAT X TCC X GGT-3’ with X = AB. 
The samples were irradiated alternatingly with 405 nm (lanes A and C) and 350 nm (lanes B 
and D) for 5 minutes at 40 °C and directly cooled down to room temperature in consecutive 
irradiation steps before running the gel. 
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DMAB 168 ortho (left) and para (right) release-oligomers, room temperature irradiation 
Sample: 1 µM 168 bp ring construct + 2 µM release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
      
Ref: 168 bp ring without release oligomers. 
Left: 168 bp ring with modified release oligomer ortho after irradiation into trans conformation 
(lanes A and C) and after irradiation into cis conformation (lanes B and D). 
Right: 168 bp ring with modified release oligomer para after irradiation into trans 
conformation (lanes A and C) and after irradiation into cis conformation (lanes  and D).
Release oligomer ortho: 5’-TCC X CCA X GCA X TCG-3’ with X = DMAB. 
Release oligomer para: 5’-CAC X CAT X TCC X GGT-3’ with X = DMAB. 
The samples were irradiated alternatingly with 420 nm (lanes A and C) and 350 nm (lanes B 
and D) for 5 minutes at room temperature in consecutive irradiation steps before running the 
gel. 
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DMAB 168 ortho (left) and para (right) release-oligomers, 40 °C irradiation 
Sample: 1 µM 168 bp ring construct + 2 µM release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
      
Ref: 168 bp ring without release oligomers. 
Left: 168 bp ring with modified release oligomer ortho after irradiation into trans conformation 
(lanes A and C) and after irradiation into cis conformation (lanes B and D). 
Right: 168 bp ring with modified release oligomer para after irradiation into trans 
conformation (lanes A and C) and after irradiation into cis conformation (lanes  and D).
Release oligomer ortho: 5’-TCC X CCA X GCA X TCG-3’ with X = DMAB. 
Release oligomer para: 5’-CAC X CAT X TCC X GGT-3’ with X = DMAB. 
The samples were irradiated alternatingly with 420 nm (lanes A and C) and 350 nm (lanes B 
and D) for 5 minutes at 40 °C in consecutive irradiation steps before running the gel. 
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S-DMAB 168 ortho (left) and para (right) release-oligomers, room temperature irradiation 
Sample: 1 µM 168 bp ring construct + 2 µM release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
      
Ref: 168 bp ring without release oligomers. 
Left: 168 bp ring with modified release oligomer ortho after irradiation into trans conformation 
(lanes A and C) and after irradiation into cis conformation (lanes B and D). 
Right: 168 bp ring with modified release oligomer para after irradiation into trans 
conformation (lanes A and C) and after irradiation into cis conformation (lanes  and D).
Release oligomer ortho: 5’-TCC X CCA X GCA X TCG-3’ with X = S-DMAB. 
Release oligomer para: 5’-CAC X CAT X TCC X GGT-3’ with X = S-DMAB. 
The samples were irradiated alternatingly with 450 nm (lanes A and C) and 385 nm (lanes B 
and D) for 5 minutes at room temperature in consecutive irradiation steps before running the 
gel. 
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S-DMAB 168 ortho (left) and para (right) release-oligomers, 40 °C irradiation 
Sample: 1 µM 168 bp ring construct + 2 µM release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
      
Ref: 168 bp ring without release oligomers. 
Left: 168 bp ring with modified release oligomer ortho after irradiation into trans conformation 
(lanes A and C) and after irradiation into cis conformation (lanes B and D). 
Right: 168 bp ring with modified release oligomer para after irradiation into trans 
conformation (lanes A and C) and after irradiation into cis conformation (lanes  and D).
Release oligomer ortho: 5’-TCC X CCA X GCA X TCG-3’ with X = S-DMAB. 
Release oligomer para: 5’-CAC X CAT X TCC X GGT-3’ with X = S-DMAB. 
The samples were irradiated alternatingly with 450 nm (lanes A and C) and 385 nm (lanes B 
and D) for 5 minutes at 40 °C in consecutive irradiation steps before running the gel. 
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AAP1 168 ortho (left) and para (right) release-oligomers, room temperature irradiation 
Sample: 1 µM 168 bp ring construct + 2 µM release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
      
Ref: 168 bp ring without release oligomers. 
Left: 168 bp ring with modified release oligomer ortho after irradiation into trans conformation 
(lanes A and C) and after irradiation into cis conformation (lanes B and D). 
Right: 168 bp ring with modified release oligomer para after irradiation into trans 
conformation (lanes A and C) and after irradiation into cis conformation (lanes  and D).
Release oligomer ortho: 5’-TCC X CCA X GCA X TCG-3’ with X = AAP1. 
Release oligomer para: 5’-CAC X CAT X TCC X GGT-3’ with X = AAP1. 
The samples were irradiated alternatingly with 590 nm (lanes A and C) and 350 nm (lanes B 
and D) for 5 minutes at room temperature in consecutive irradiation steps before running the 
gel. 
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AAP1 168 ortho (left) and para (right) release-oligomers, 40 °C irradiation 
Sample: 1 µM 168 bp ring construct + 2 µM release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
      
Ref: 168 bp ring without release oligomers. 
Left: 168 bp ring with modified release oligomer ortho after irradiation into trans conformation 
(lanes A and C) and after irradiation into cis conformation (lanes B and D). 
Right: 168 bp ring with modified release oligomer para after irradiation into trans 
conformation (lanes A and C) and after irradiation into cis conformation (lanes  and D).
Release oligomer ortho: 5’-TCC X CCA X GCA X TCG-3’ with X = AAP1. 
Release oligomer para: 5’-CAC X CAT X TCC X GGT-3’ with X = AAP1. 
The samples were irradiated alternatingly with 590 nm (lanes A and C) and 350 nm (lanes B 
and D) for 5 minutes at 40 °C in consecutive irradiation steps before running the gel. 
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AAP2 168 ortho (left) and para (right) release-oligomers, room temperature irradiation 
Sample: 1 µM 168 bp ring construct + 2 µM release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
      
Ref: 168 bp ring without release oligomers. 
Left: 168 bp ring with modified release oligomer ortho after irradiation into trans conformation 
(lanes A and C) and after irradiation into cis conformation (lanes B and D). 
Right: 168 bp ring with modified release oligomer para after irradiation into trans 
conformation (lanes A and C) and after irradiation into cis conformation (lanes  and D).
Release oligomer ortho: 5’-TCC X CCA X GCA X TCG-3’ with X = AAP2. 
Release oligomer para: 5’-CAC X CAT X TCC X GGT-3’ with X = AAP2. 
The samples were irradiated alternatingly with 590 nm (lanes A and C) and 350 nm (lanes B 
and D) for 5 minutes at room temperature in consecutive irradiation steps before running the 
gel. 
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AAP2 168 ortho (left) and para (right) release-oligomers, 40 °C irradiation 
Sample: 1 µM 168 bp ring construct + 2 µM release oligomers (2 eq.). 
Gel conditions: 6 % PAGE, 200 V, 45 minutes, 4°C. 
      
Ref: 168 bp ring without release oligomers. 
Left: 168 bp ring with modified release oligomer ortho after irradiation into trans conformation 
(lanes A and C) and after irradiation into cis conformation (lanes B and D). 
Right: 168 bp ring with modified release oligomer para after irradiation into trans 
conformation (lanes A and C) and after irradiation into cis conformation (lanes  and D).
Release oligomer ortho: 5’-TCC X CCA X GCA X TCG-3’ with X = AAP2. 
Release oligomer para: 5’-CAC X CAT X TCC X GGT-3’ with X = AAP2. 
The samples were irradiated alternatingly with 590 nm (lanes A and C) and 350 nm (lanes B 
and D) for 5 minutes at 40 °C in consecutive irradiation steps before running the gel. 
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7.10 Fluorophore quenching experiments 
7.10.1 Fluorophore and quencher bleaching tests 
Fluorescence-studies involving fluorophores and quenchers have to be tested on bleaching 
effects. Since a range of the absorption spectrum of fluorophores and quenchers are 
overlapping with the excitation wavelengths of both fluorophore and quencher, any bleaching 
effects that can occur during the irradiation process have to be excluded. All fluorophores were 
tested on bleaching effects by irradiating a 1 µM solution of the modified oligonucleotide 
5’-Flu-GAATGGTG-3’ in Millipore water and recording the remaining fluorescence intensity. 
Photobleaching of the quenchers were performed by use of the DNA duplex 
5’-Flu-GAATGGTG-3’ and 5’-CACCATTC-Que-3’. The DNA strand containing the quencher 
was irradiated in millipore water, then mixed with the complementary strand containing the 
fluorophore to yield a 1 µM solution of the duplex. The remaining fluorophore intensity of the 
duplex was measured. 
Remaining fluorescence intensities for the fluorophore quencher pair Cy5.5 and BHQ3 are 
given in fig. 102 and 103. 
 
Fig. 102: Bleaching test for Cy5.5 Fluorescence intensites (left) for irradiation with all available 
wavelengths and fluorescence intensities at λ = 663 nm (right). 
 
Fig. 103: Bleaching test for BHQ3. Fluorescence intensites (left) for the DNA duplex after irradiation 
with all available wavelengths and fluorescence intensities at λ = 663 nm (right). 
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7.10.2 Hairpin design and assembly 
Two different hairpin constructs were designed to determine the strand displacement 
efficiency of modified release-oligomers. Both constructs resemble the design of ortho and 
para gaps in the non-symmetric two-state dsDNA catenane system. The designs and the 
corresponding strands for the assembly are depicted below. 
 
 
 
Hairpin ortho 
The following DNA strands were used for the assembly of hairpin ortho: 
Name Sequence 
HP ortho 5’-Cy5.5-
AGCATCGTATAAATTAACGATGCTGGGGACGAATCGCGAACTGGTGCAC-3’ 
HP ortho comp 3’-BHQ3-GCTTAGCGCTTGACCACGTG-5’ 
 
Hairpin para 
The following DNA strands were used for the assembly of hairpin para: 
Name Sequence 
HP para 5’-CGAATCGCGAACTGGTGCACACCGGAATGGTGAATAAATTATCACCATT-
Cy5.5-3’ 
HP para comp 3’-GCTTAGCGCTTGACCACGTG-BHQ3-5’ 
 
Both hairpins were assembled using the following setup: 
Strand Concentration Volume Final concentration 
HP ortho/para 100 µM 8 µL 4 µM 
HP ortho/para comp. 100 µM 8 µL 4 µM 
10x DA buffer  20 µL 1x 
Water  164 µL Total volume: 200 µL 
The two hairpin strands, the 10x DA buffer and water were mixed and heated to 60 °C for 5 
minutes in a thermocycler, followed by cooling down the mixture with a temperature gradient 
of 33 °C per hour down to 15 °C. The samples were stored at 4 °C and warmed up to room 
temperature before usage. 
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7.10.3 Fluorophore quenching experiments of both hairpins with modified 
release oligomers 
All hairpin experiments were executed in 1x DA buffer in a concentration of 1 µM hairpin and 
2 µM release oligomer. All measurements involving modified release-oligomers were 
compared and normalized to the same experiment with unmodified release-oligomers. 
Modified release oligomers were irradiated to trans conformation via the corresponding 
wavelength and incubated for 30 minutes at room temperature in order to achieve a complete 
hybridization before irradiating the system to cis conformation. The following release oligomers 
were used for hairpin opening: 
RO ortho sh: 5’-TCC CXCA GCXA TCG-3’ 
RO ortho:  5’-TCC X CCA X GCA X TCG-3’ 
RO para sh:  5’-CAC CXAT TCXC GGT-3’ 
RO para:  5’-CAC X CAT X TCC X GGT-3’ 
 
Hairpin ortho with AB-, DMAB- and S-DMAB-modified release oligomers 
 
Hairpin opening experiment of hairpin ortho with unmodified and modified release oligomers. 
As modified release oligomers, the sequence 5’-TCC X CCA X GCA X TCG-3’ was used with 
X = AB, DMAB or S-DMAB. Each mixture of hairpin and modified release oligomer was 
irradiated with the maximum trans- and cis-converting irradiation wavelength for 5 minutes at 
room temperature before measurement. 
Fluorescence intensity at 705 nm was monitored for each individual measurement. 
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Hairpin ortho with AB-, DMAB- and S-DMAB-modified release oligomers 
 
Hairpin opening experiment of hairpin ortho with unmodified and modified release oligomers. 
As modified release oligomers, the sequence 5’-TCC X CCA X GCA X TCG-3’ was used with 
X = AB, DMAB or S-DMAB. Each mixture of hairpin ortho and modified release oligomer was 
irradiated with the maximum trans- and cis-converting irradiation wavelength for 5 minutes at 
40 °C before measurement. 
Fluorescence intensity at 705 nm was monitored for each individual measurement. 
 
 
Hairpin para with AB-, DMAB- and S-DMAB-modified release oligomers 
 
Hairpin opening experiment of hairpin para with unmodified and modified release oligomers. 
As modified release oligomers, the sequence 5’-CAC X CAT X TCC X GGT-3’ was used with 
X = AB, DMAB or S-DMAB. Each mixture of hairpin para and modified release oligomer was 
irradiated with the maximum trans- and cis-converting irradiation wavelength for 5 minutes at 
room temperature before measurement. 
Fluorescence intensity at 705 nm was monitored for each individual measurement. 
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Hairpin para with AB-, DMAB- and S-DMAB-modified release oligomers 
 
Hairpin opening experiment of hairpin para with unmodified and modified release oligomers. 
As modified release oligomers, the sequence 5’-CAC X CAT X TCC X GGT-3’ was used with 
X = AB, DMAB or S-DMAB. Each mixture of hairpin para and modified release oligomer was 
irradiated with the maximum trans- and cis-converting irradiation wavelength for 5 minutes at 
40 °C before measurement. 
Fluorescence intensity at 705 nm was monitored for each individual measurement. 
 
 
Hairpin ortho with AAP1-modified release oligomers 
 
Hairpin opening experiment of hairpin ortho with unmodified and modified release oligomers. 
As modified release oligomers, the sequences 5’-TCC X CCA X GCA X TCG-3’ and 5’-TCC 
CXCA GCXA TCG-3’ (sh) were used with X = AAP1. Each mixture of hairpin ortho and modified 
release oligomer was irradiated with the maximum trans- and cis-converting irradiation 
wavelength for 5 minutes at room temperature before measurement. 
Fluorescence intensity at 705 nm was monitored for each individual measurement. 
 
7. Experimental section 
308 
Hairpin para with AAP1-modified release oligomers 
 
Hairpin opening experiment of hairpin para with unmodified and modified release oligomers. 
As modified release oligomers, the sequences 5’-CAC X CAT X TCC X GGT-3’ and 5’-CAC 
CXAT TCXC GGT-3’ (sh) were used with X = AAP1. Each mixture of hairpin para and modified 
release oligomer was irradiated with the maximum trans- and cis-converting irradiation 
wavelength for 5 minutes at room temperature before measurement. 
Fluorescence intensity at 705 nm was monitored for each individual measurement. 
 
 
Hairpin ortho with AAP2-modified release oligomers 
 
Hairpin opening experiment of hairpin ortho with unmodified and modified release oligomers. 
As modified release oligomers, the sequences 5’-TCC X CCA X GCA X TCG-3’ and 5’-TCC 
CXCA GCXA TCG-3’ (sh) were used with X = AAP2. Each mixture of hairpin ortho and modified 
release oligomer was irradiated with the maximum trans- and cis-converting irradiation 
wavelength for 5 minutes at room temperature before measurement. 
Fluorescence intensity at 705 nm was monitored for each individual measurement. 
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Hairpin para with AAP2-modified release oligomers 
 
Hairpin opening experiment of hairpin para with unmodified and modified release oligomers. 
As modified release oligomers, the sequences 5’-CAC X CAT X TCC X GGT-3’ and 5’-CAC 
CXAT TCXC GGT-3’ (sh) were used with X = AAP2. Each mixture of hairpin para and modified 
release oligomer was irradiated with the maximum trans- and cis-converting irradiation 
wavelength for 5 minutes at room temperature before measurement. 
Fluorescence intensity at 705 nm was monitored for each individual measurement. 
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7.10.4 Reversible hairpin switching with modified release-oligomers 
Reversible opening and closing of hairpins were performed under the same conditions as 
described before. The hairpins were mixed with modified release oligomers and irradiated to 
trans conformation with the corresponding wavelength followed by incubation for 30 minutes 
at room temperature before irradiating the system to cis conformation. These successive steps 
were repeated for 5 irradiation cycles. Cy5.5 fluorescence intensity was monitored after each 
irradiation and hybridization step. 
 
Reversible hairpin switching ortho with 2xAAP1sh 
 
Reversible opening and closing of hairpin ortho using the modified sequence 5’-TCC CXCA 
GCXA TCG-3’ with X = AAP1. The mixture of hairpin ortho and modified release oligomer was 
irradiated alternatingly in consecutive irradiation cycles with the maximum trans- and cis-
converting irradiation wavelengths for 5 minutes at room temperature. After irradiation into 
trans conformation, the sample was left in the dark for 30 minutes at room temperature. After 
each irradiation and hybridization step, the fluorescence intensity was measured (left) and the 
fluorescence intensity at 705 nm was plotted (right). 
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Reversible hairpin switching ortho with 3xAAP1 
 
Reversible opening and closing of hairpin ortho using the modified sequence 5’-TCC X CCA 
X GCA X TCG-3’ with X = AAP1. The mixture of hairpin ortho and modified release oligomer 
was irradiated alternatingly in consecutive irradiation cycles with the maximum trans- and cis-
converting irradiation wavelengths for 5 minutes at room temperature. After irradiation into 
trans conformation, the sample was left in the dark for 30 minutes at room temperature. After 
each irradiation and hybridization step, the fluorescence intensity was measured (left) and the 
fluorescence intensity at 705 nm was plotted (right). 
 
 
Reversible hairpin switching para 2xAAP1sh 
 
Reversible opening and closing of hairpin para using the modified sequence 5’-CAC CXAT 
TCXC GGT-3’ with X = AAP1. The mixture of hairpin para and modified release oligomer was 
irradiated alternatingly in consecutive irradiation cycles with the maximum trans- and cis-
converting irradiation wavelengths for 5 minutes at room temperature. After irradiation into 
trans conformation, the sample was left in the dark for 30 minutes at room temperature. After 
each irradiation and hybridization step, the fluorescence intensity was measured (left) and the 
fluorescence intensity at 705 nm was plotted (right). 
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Reversible hairpin switching para 3xAAP1 
 
Reversible opening and closing of hairpin para using the modified sequence 5’-CAC X CAT 
X TCC X GGT-3’ with X = AAP1. The mixture of hairpin para and modified release oligomer 
was irradiated alternatingly in consecutive irradiation cycles with the maximum trans- and cis-
converting irradiation wavelengths for 5 minutes at room temperature. After irradiation into 
trans conformation, the sample was left in the dark for 30 minutes at room temperature. After 
each irradiation and hybridization step, the fluorescence intensity was measured (left) and the 
fluorescence intensity at 705 nm was plotted (right). 
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7.11 Atomic Force Microscopy data (AFM) 
7.11.1 AFM pictures for dsDNA rings and the non-symmetric dsDNA [2]catenane 
system 
The following AFM pictures were recorded by Johannes Weigandt using the 168 bp ring 
system and [2]catenane samples assembled and purified as described before (chapter 7.8.2). 
 
168 bp ring system structural proof via AC-mode 
Sample: 168 bp ring (chapter 7.8.1.2) 1 nM with 1 nM polyornithine. 
Mode: AC, intermittent contanct, wide (left) and close-up (right) picture. 
      
The AFM images reveal the circular structure of the 168 bp DNA ring (left) as well as the 
double-stranded overhang in the close up image (right). 
 
[2]Catenane system structural proof via AC-mode 
Sample: [2]catenane containing all four oligomers complementary to the four gaps, 1 nM 
with 1 nM polyornithine.  
Mode: AC, intermittent contanct, wide (left) and close-up (right) picture. 
      
The AFM images show the two rings of the [2]catenane structure containing all four oligomers  
7. Experimental section 
314 
Complementary to all four gaps. The close up image (right) shows different orientations of 
the double-stranded overhang. 
 
[2]Catenane ortho conformation structural proof via AC-mode 
Sample: [2]catenane containing 2 equivalents of the para release oligomer, 1 nM with 1 nM 
polyornithine. Mode: AC, intermittent contanct, wide (left) and close-up (right) picture. 
      
Both images show the [2]catenane structure in ortho conformation containing oligomers 
complementary to the para gaps. The right image reveals the double-stranded overhand in the 
preferred ortho orientation. 
 
[2]Catenane para conformation structural proof via AC-mode 
Sample: [2]catenane containing 2 equivalents of the ortho release oligomer, 1 nM with 
1 nM polyornithine. 
Mode: AC, intermittent contanct, wide (left) and close-up (right) picture. 
      
The AFM images show the [2]catenane structure in para conformation containing oligomers 
in both ortho gaps. The double-stranded overhang can be observed in para orientation as 
visible in the close up image (right).  
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9. Appendix I 
9.1 List of commonly used abbreviations 
AAP1  N-methyl-arylazopyrazole 
AAP2  N-phenyl-arylazopyrazole 
AAP3  N-4-nitrophenyl-arylazopyrazole 
AB   azobenzene 
ACN   acetonitrile 
AFM   Atomic Force Microscopy 
AMP   adenosine monophosphate 
ATP   adenosine triphosphate 
BHQ3  Blackhole quencher 3 
Cap A  capping mix A for solid phase DNA synthesis 
Cap B  capping mix B for solid phase DNA synthesis 
CPG   controlled pore glass 
Cy5.5  Cyanine 5.5 
DCAB  2‘,6‘-dichloroazobenzene 
DCM   dichloromethane 
DFAB  2’,6’-difluoroazobenzene 
DFAB-F  2‘,4‘,6‘-trifluoroazobenzene 
DFAB-Br  4‘-bromo-2‘,6‘-difluoroazobenzene 
DFAB-Cl  4‘-chloro-2‘,6‘-difluoroazobenzene 
DFAB-Pep  4‘-acetamido-2‘,6‘-difluoroazobenzene 
DNA   deoxyribonucleic acid 
DMAB  2’,6’-dimethylazobenzene 
DMDFAB  2,6-difluoro-2‘,6‘-dimethylazobenzene 
DMSO  dimethylsulfoxide 
DMT-Cl  4,4’-dimethoxytritylchloride 
DNA   deoxyribonucleic acid 
DOAB  2‘,6‘-dimethoxyazobenzene 
Dox (DxR)  doxorubicin 
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HEPES  2-(4-(2-hydroxyethyl)-1-piperazinyl)ethansulfonic acid 
HOMO  highest occupied molecular orbital 
HPLC  high performance liquid chromatography 
LCMS  liquid chromatography mass spectrometry 
LUMO  lowest unoccupied molecular orbital 
MO   molecular orbital 
MS   mass spectrometry 
NMM  N-methyl morpholine 
NMPi  N-methyl pyrrolidine 
NMR   nuclear magnetic resonance 
PA   phosphoramidite 
PBS   phosphate buffered saline 
RNA   ribonucleic acid 
SD   Standard deviation 
SELEX  systematic evolution of ligands by exponential enrichtment 
ssDNA/RNA  single-stranded DNA/RNA 
TBAB  2,2’,6,6’-tetrabromoazobenzene 
TCA   trichloroacetic acid 
TCAB  2,2’,6,6’-tetrachloroazobenzene 
TEAAc  triethylammonium acetate 
TFA   trifluoroacetic acid 
TFAB  2,2’,6,6’-tetrafluoroazobenzene 
TLC   thin layer chromatography 
TMAB  2,2',6,6'-tetramethoxyazobenzene 
TOAB  2,2’,6,6’-tetramethoxyazobenzene 
UV/Vis  ultraviolet and visible light 
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10. Attachments 
10.1 NMR and mass spectra of synthesized compounds 
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10.2 LCMS results for all synthesized 
 
   587 
Sequence: 5’-GAATXGGTG-3’ (A) 
Modification: X = Azobenzene (AB) 
Calculated mass: 2864.79 
Data file: 2016_06_01_1AB8_71_01_1381 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (13.8 – 14.0 min.): 
Deconvoluted mass 1: 2864.65 
 
Extracted mass spectrum 2 (14.3 – 14.5 min.): 
Deconvoluted mass 2: 2864.55 
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Sequence: 5’-GAXATGGXTG-3’ (B) 
Modification: X = Azobenzene (AB) 
Calculated mass: 3239.89 
Data file: 2016_06_01_2AB8_72_01_1382 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (15.1 – 15.2 min.): 
Deconvoluted mass 1: 3239.77 
 
Extracted mass spectrum 2 (15.3 – 15.6 min.): 
Deconvoluted mass 2: 3239.71 
 
 
2016_06_01_2AB8_72_01_1382.d: BPC -All MS
2016_06_01_2AB8_72_01_1382.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
7x10
Intens.
0
10
20
30
Intens.
[mAU]
4 6 8 10 12 14 16 18 Time [min]
538.91
646.97
32-
808.93
28-
1078.92
20-
2016_06_01_2AB8_72_01_1382.d: -MS, 15.1-15.2min #1777-1811
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
538.89
6-
646.94
5-
808.91
4-
1078.89
3-
2016_06_01_2AB8_72_01_1382.d: -MS, 15.3-15.6min #1833-1889
0
1
2
3
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   589 
Sequence: 5’-GAXATXGGXTG-3’ (C) 
Modification: X = Azobenzene (AB) 
Calculated mass: 3614.98 
Data file: 2016_10_17_3AB8_41_01_2458 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (13.0 – 13.5 min.): 
Deconvoluted mass 1: 3614.87 
 
Extracted mass spectrum 2 (13.5 – 14.2 min.): 
Deconvoluted mass 2: 3614.78 
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Sequence: 5’-CACCATXTCCGGT-3’ (D) 
Modification: X = Azobenzene (AB) 
Calculated mass: 3956.49 
Data file: 2016_10_17_3AB8_41_01_2458 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (14.3 –14.4 min.): 
Deconvoluted mass: 3956.20 
 
Extracted mass spectrum 1 (14.6 – 14.8 min.): 
Deconvoluted mass: 3956.15 
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Sequence: 5’-CACXCATTCCXGGT-3’ (E) 
Modification: X = Azobenzene (AB) 
Calculated mass: 4331.59 
Data file: 2016_06_01_2AB12_75_01_1385 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (14.9 – 15.2 min.): 
Deconvoluted mass: 4331.48 
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Sequence: 5’-CACXCATXTCCXGGT-3’ (F) 
Modification: X = Azobenzene (AB) 
Calculated mass: 4706.69 
Data file: 2016_10_17_3AB12_42_01_2461 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (12.3 – 12.9 min.): 
Deconvoluted mass 1: 4706.36 
 
Extracted mass spectrum 2 (12.9 – 13.2 min.): 
Deconvoluted mass 2: 4706.35 
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Sequence: 5‘-TCCXCCAXGCAXTCG-3‘ (I) 
Modification: X = Azobenzene (AB) 
Calculated mass: 4691.67 
Data file: 2016_09_26_AB168ROo_63_01_2321 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (12.5 – 12.7 min.): 
Deconvoluted mass 1: 3473.71 
 
Extracted mass spectrum 2 (13.9 – 14.1 min.): 
Deconvoluted mass 2: 4691.45 
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Sequence: 5‘-CCXGATXGCTXGT-3‘ (J) 
Modification: X = Azobenzene (AB) 
Calculated mass: 4144.32 
Data file: 2016_09_26_AB126ROo_61_01_2319 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.5 – 11.9 min.): 
Deconvoluted mass 1: 3215.63 
 
Extracted mass spectrum 2 (12.8 – 13.3 min.): 
Deconvoluted mass 2: 4144.20 
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Sequence: 5‘-GGXAATXGGTXGA-3‘ (K) 
Modification: X = Azobenzene (AB) 
Calculated mass: 4257.40 
Data file: 2016_09_26_AB126ROp_62_01_2320 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.8 – 12.0 min.): 
Deconvoluted mass 1: 3319.59 
 
Extracted mass spectrum 2 (13.0 – 13.7 min.): 
Deconvoluted mass 2: 4257.20 
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Sequence: 5’-GAATXGGTG-3’ (A) 
Modification: X = 2’,6’-Dimethylazobenzene (DMAB) 
Calculated mass: 2892.82 
Data file: 2016_06_01_1DMAB8_77_01_1387 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (15.5 – 15.6 min.): 
Deconvoluted mass 1: 2892.67 
 
Extracted mass spectrum 2 (16.0 – 16.2 min.): 
Deconvoluted mass 2: 2892.41 
 
2016_06_01_1DMAB8_77_01_1387.d: BPC -All MS
2016_06_01_1DMAB8_77_01_1387.d: UV Chromatogram, 260 nm
0.0
0.2
0.4
0.6
0.8
7x10
Intens.
0
10
20
30
40
Intens.
[mAU]
4 6 8 10 12 14 16 18 Time [min]
577.53
15-
659.84 688.40
722.19
12-
880.21
963.21
9-
1445.28
2016_06_01_1DMAB8_77_01_1387.d: -MS, 15.5-15.8min #1837-1894
0.00
0.25
0.50
0.75
1.00
1.25
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
577.47
15-
659.79 688.36
722.14
12-
739.13 880.10
963.18
7-
1445.26
2016_06_01_1DMAB8_77_01_1387.d: -MS, 16.1-16.3min #1947-2001
0.0
0.5
1.0
1.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   597 
Sequence: 5’-GAXATGGXTG-3’ (B) 
Modification: X = 2’,6’-Dimethylazobenzene (DMAB) 
Calculated mass: 3295.94 
Data file: 2016_10_17_2DA8_43_01_2462 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (13.0 – 13.6 min.): 
Deconvoluted mass 1: 3295.75 
 
Extracted mass spectrum 2 (13.6 – 14.2 min.): 
Deconvoluted mass 2: 3295.61 
 
 
2016_10_17_2DA8_43_01_2462.d: BPC -All MS
2016_10_17_2DA8_43_01_2462.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
7x10
Intens.
0
10
20
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
548.28
658.16
21-
671.31
822.94
12-
1053.26
1097.57
9-
2016_10_17_2DA8_43_01_2462.d: -MS, 13.0-13.3min #1485-1528
0.0
0.5
1.0
1.5
2.0
2.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
548.20
6-
658.11
5-
822.89
4- 1097.53
3-
2016_10_17_2DA8_43_01_2462.d: -MS, 13.6-14.2min #1605-1720
0.0
0.5
1.0
1.5
2.0
2.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
598 
Sequence: 5’-GAXATXGGXTG-3’ (C) 
Modification: X = 2’,6’-Dimethylazobenzene (DMAB) 
Calculated mass: 3699.07 
Data file: 2016_10_17_3DA8_44_01_2463 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (15.5 – 16.3 min.): 
Deconvoluted mass 1: 3698.87 
 
Extracted mass spectrum 2 (16.6 – 17.1 min.): 
Deconvoluted mass 2: 3699.09 
 
 
2016_10_17_3DA8_44_01_2463.d: BPC -All MS
2016_10_17_3DA8_44_01_2463.d: UV Chromatogram, 260 nm
0.00
0.25
0.50
0.75
1.00
7x10
Intens.
0
5
10
15
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
615.53
6-
711.81
738.83
5-
805.55
923.79
4-
973.21 1017.10
1231.95
3-
2016_10_17_3DA8_44_01_2463.d: -MS, 15.5-15.8min #1819-1883
0.0
0.5
1.0
1.5
2.0
2.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
615.50
6-
711.76
738.81
5-
805.51
923.76
4-
1231.94
3-
2016_10_17_3DA8_44_01_2463.d: -MS, 16.6-17.1min #2039-2156
0.0
0.5
1.0
1.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   599 
Sequence: 5’-CACCATXTCCGGT-3’ (D) 
Modification: X = 2’,6’-Dimethylazobenzene (DMAB) 
Calculated mass: 3984.52 
Data file: 2016_06_01_1DMAB12_80_01_1390 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (15.1 – 15.3 min.): 
Deconvoluted mass 1: 3984.25 
 
Extracted mass spectrum 2 (15.6 – 15.8 min.): 
Deconvoluted mass 2: 3984.19 
 
 
2016_06_01_1DMAB12_80_01_1390.d: BPC -All MS
2016_06_01_1DMAB12_80_01_1390.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
7x10
Intens.
0
10
20
30
40
Intens.
[mAU]
4 6 8 10 12 14 16 18 Time [min]
568.14
28-
640.50
663.05
24-
768.79
795.84
45-
995.01
39-
1327.06
2016_06_01_1DMAB12_80_01_1390.d: -MS, 15.0-15.2min #1723-1768
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
568.13
7-
640.46
663.02
6-
768.75
795.83
5-
995.05
4-
1327.11
3-
2016_06_01_1DMAB12_80_01_1390.d: -MS, 15.6-15.8min #1829-1869
0.0
0.5
1.0
1.5
2.0
2.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
600 
Sequence: 5’-CACXCATTCCXGGT-3’ (E) 
Modification: X = 2’,6’-Dimethylazobenzene (DMAB) 
Calculated mass: 4387.65 
Data file: 2016_06_01_2DMAB12_81_01_1391 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.9 – 12.5 min.): 
Deconvoluted mass 1: 4387.14 
 
 
2016_10_17_2DA12_45_01_2464.d: BPC -All MS
2016_10_17_2DA12_45_01_2464.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
7x10
Intens.
0
10
20
30
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
547.32
8- 606.42
625.74
7-
641.46
707.69
730.20
6-
876.44
5-
1095.78
4-
1461.17
3-
2016_10_17_2DA12_45_01_2464.d: -MS, 11.9-12.5min #1402-1522
0.0
0.5
1.0
1.5
2.0
2.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   601 
Sequence: 5’-CACXCATXTCCXGGT-3’ (F) 
Modification: X = 2’,6’-Dimethylazobenzene (DMAB) 
Calculated mass: 4790.77 
Data file: 2016_10_17_3DA12_46_01_2465 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (14.2 – 14.7 min.): 
Deconvoluted mass 1: 4790.65 
 
Extracted mass spectrum 2 (14.9 – 15.3 min.): 
Deconvoluted mass 2: 4790.70 
 
 
2016_10_17_3DA12_46_01_2465.d: BPC -All MS
2016_10_17_3DA12_46_01_2465.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
7x10
Intens.
0
5
10
15
20
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
583.13
597.83
8-
664.08
683.38
7-
699.95
714.18
742.31
797.46
6-
840.08
875.17
957.12
5-
1167.19
2016_10_17_3DA12_46_01_2465.d: -MS, 14.2-14.7min #1684-1797
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
597.80
8-
664.04
683.35
7-
797.43
6-
957.13
5-
1196.57
4-
2016_10_17_3DA12_46_01_2465.d: -MS, 14.9-15.3min #1831-1928
0.0
0.5
1.0
1.5
2.0
2.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
602 
Sequence: 5‘-TCCXCCAXGCAXTCG-3‘ (I) 
Modification: X = 2’,6’-Dimethylazobenzene (DMAB) 
Calculated mass: 4775.76 
Data file: 2016_09_26_DMAB168ROo_66_01_2324 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (13.7 – 14.4 min.): 
Deconvoluted mass 1: 3569.65 + 3529.65 + 3489.86 
 
Extracted mass spectrum 2 (15.2 – 16.4 min.): 
Deconvoluted mass 2: 4775.44 
 
 
2016_09_26_DMAB168ROo_66_01_2324.d: BPC -All MS
2016_09_26_DMAB168ROo_66_01_2324.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
2.5
7x10
Intens.
0
10
20
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
587.33
6-
623.68
26-
668.78
697.01
39-
712.98
29-
727.74
746.92
780.43
823.10
881.47
4-
936.67 980.14
1092.22
1175.54
3-
1311.15
2016_09_26_DMAB168ROo_66_01_2324.d: -MS, 13.7-14.4min #1825-1982
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
595.93
8-
681.22
7-
794.93
6-
954.12
5-
1192.86
4-
2016_09_26_DMAB168ROo_66_01_2324.d: -MS, 15.8-16.4min #2263-2403
0
1
2
3
4
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   603 
Sequence: 5‘-CCXGATXGCTXGT-3‘ (J) 
Modification: X = 2’,6’-Dimethylazobenzene (DMAB) 
Calculated mass: 4228.40 
Data file: 2016_09_26_DMAB126ROo_64_01_2322 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (15.5 – 16.0 min.): 
Deconvoluted mass 1: 4228.41 
 
Extracted mass spectrum 2 (16.3 – 16.5 min.): 
Deconvoluted mass 2: 4228.40 
 
 
2016_09_26_DMAB126ROo_64_01_2322.d: BPC -All MS
2016_09_26_DMAB126ROo_64_01_2322.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
7x10
Intens.
0
10
20
30
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
603.08
7-
681.22
703.74
6-
844.69
5-
1056.09
4-
1408.40
3-
2016_09_26_DMAB126ROo_64_01_2322.d: -MS, 15.5-16.0min #2079-2192
0
2
4
6
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
603.06
7-
681.18
703.73
6-
844.67
5-
1056.09
4-
1408.34
3-
2016_09_26_DMAB126ROo_64_01_2322.d: -MS, 16.3-16.4min #2242-2285
0
1
2
3
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
604 
Sequence: 5‘-GGXAATXGGTXGA-3‘ (K) 
Modification: X = 2’,6’-Dimethylazobenzene (DMAB) 
Calculated mass: 4341.49 
Data file: 2016_09_26_DMAB126ROp_65_01_2323 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (15.2 – 15.7 min.): 
Deconvoluted mass 1: 4341.58 
 
Extracted mass spectrum 2 (15.7 – 16.2 min.): 
Deconvoluted mass 2: 4341.51 
 
 
2016_09_26_DMAB126ROp_65_01_2323.d: BPC -All MS
2016_09_26_DMAB126ROp_65_01_2323.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
2.5
7x10
Intens.
0
5
10
15
20
25
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
619.20
7-
700.08
722.58
6-
867.31
5-
982.28 1084.39
4-
1332.14
2016_09_26_DMAB126ROp_65_01_2323.d: -MS, 15.2-15.7min #1941-2056
0.0
0.2
0.4
0.6
0.8
1.0
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
619.17
7-
700.03
722.56
6-
867.30
5-
1084.37
4-
2016_09_26_DMAB126ROp_65_01_2323.d: -MS, 15.7-16.2min #2071-2177
0
1
2
3
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   605 
Sequence: 5’-GAATXGGTG-3’ (A) 
Modification: X = 2’,6’-Dimethyl-4’-methylthioazobenzene (S-DMAB) 
Calculated mass: 2938.81 
Data file: 2016_10_17_1SD8_47_01_2466 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (10.2 – 10.5 min.): 
Deconvoluted mass 1: 2938.58 
 
Extracted mass spectrum 2 (10.5 – 10.8 min.): 
Deconvoluted mass 2: 2892.49 
 
Extracted mass spectrum 3 (11.2 – 11.7 min.): 
Deconvoluted mass 3: 2938.53 
2016_10_17_1SD8_47_01_2466.d: BPC -All MS
2016_10_17_1SD8_47_01_2466.d: UV Chromatogram, 260 nm
0.00
0.25
0.50
0.75
1.00
1.25
7x10
Intens.
0
10
20
30
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
577.49
41-
688.36
722.13
44-
739.09
43-
806.11
963.19
22-
1445.05
2016_10_17_1SD8_47_01_2466.d: -MS, 10.6-10.9min #1234-1293
0.0
0.5
1.0
1.5
2.0
2.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
586.71
10-
699.83
733.65
8-
978.53
6-
1468.02
2016_10_17_1SD8_47_01_2466.d: -MS, 10.2-10.5min #1159-1223
0
1
2
3
4
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
586.70
5-
699.90
733.63
4- 978.50
3-
1468.03
2-
2016_10_17_1SD8_47_01_2466.d: -MS, 11.2-11.7min #1332-1448
0.0
0.5
1.0
1.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
606 
Sequence: 5’-GAXATGGXTG-3’ (B) 
Modification: X = 2’,6’-Dimethyl-4’-methylthioazobenzene (S-DMAB) 
Calculated mass: 3387.92 
Data file: 2016_10_17_2SD8_48_01_2467 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.5 – 12.3 min.): 
Deconvoluted mass 1: 3254.68 
 
Extracted mass spectrum 2 (14.2 – 14.8 min.): 
Deconvoluted mass 2: 3387.66 
 
2016_10_17_2SD8_48_01_2467.d: BPC -All MS
2016_10_17_2SD8_48_01_2467.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
7x10
Intens.
0
5
10
15
20
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
541.41
593.00 622.95
649.93
47-
812.67
17-
1030.50
1083.89
29-
1187.04
2016_10_17_2SD8_48_01_2467.d: -MS, 11.5-12.3min #1301-1450
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
563.57
6-
649.52
676.54
5-
845.93
4-
1128.21
3-
2016_10_17_2SD8_48_01_2467.d: -MS, 14.2-14.8min #1723-1870
0.0
0.5
1.0
1.5
2.0
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   607 
Sequence: 5’-GAXATXGGXTG-3’ (C) 
Modification: X = 2’,6’-Dimethyl-4’-methylthioazobenzene (S-DMAB) 
Calculated mass: 3837.04 
Data file: 2016_10_17_3SD8_49_01_2468 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (15.6 – 16.0 min.): 
Deconvoluted mass 1: 3703.83 
 
Extracted mass spectrum 2 (16.9 – 17.1 min.): 
Deconvoluted mass 2: 3836.90 
 
Extracted mass spectrum 3 (17.2 – 18.2 min.): 
Deconvoluted mass 3: 3873.22 
2016_10_17_3SD8_49_01_2468.d: BPC -All MS
2016_10_17_3SD8_49_01_2468.d: UV Chromatogram, 260 nm
0
1
2
3
4
5
6x10
Intens.
0
2
4
6
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
593.76
616.36
12-
712.78
739.83
16-
925.02
8-
1233.60
2016_10_17_3SD8_49_01_2468.d: -MS, 15.6-16.0min #1772-1844
0.0
0.5
1.0
1.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
547.20
7-
638.56
41-
766.47
16-
836.37 922.18
958.34
32-
1019.29
1254.79
1277.96
3-
2016_10_17_3SD8_49_01_2468.d: -MS, 16.9-17.1min #1997-2045
0.0
0.5
1.0
1.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
547.17
7-
638.53
56-
739.55
766.44
16-
958.32
4-
1277.97
3-
2016_10_17_3SD8_49_01_2468.d: -MS, 17.2-18.2min #2053-2278
0
1
2
3
4
5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
608 
Sequence: 5’-CACCATXTCCGGT-3’ (D) 
Modification: X = 2’,6’-Dimethyl-4’-methylthioazobenzene (S-DMAB) 
Calculated mass: 4030.51 
Data file: 2016_10_17_1SD12_50_01_2469 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (8.6 – 8.9 min.): 
Deconvoluted mass 1: 3896.59 
 
Extracted mass spectrum 2 (10.6 – 11.0 min.): 
Deconvoluted mass 2: 4029.64 
 
Extracted mass spectrum 3 (11.1 – 11.5 min.): 
Deconvoluted mass 3: 3983.70 
2016_10_17_1SD12_50_01_2469.d: BPC -All MS
2016_10_17_1SD12_50_01_2469.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
7x10
Intens.
0
10
20
30
40
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
555.69
7-
625.96
648.49
6-
673.85
778.35
5-
973.22
4-
1048.52
1297.86
3-
2016_10_17_1SD12_50_01_2469.d: -MS, 8.6-8.9min #963-1020
0.0
0.5
1.0
1.5
2.0
2.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
574.71
7-
648.15
670.66
6-
804.99
5-
1006.51
4-
1342.21
3-
2016_10_17_1SD12_50_01_2469.d: -MS, 10.6-11.0min #1216-1287
0
1
2
3
4
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
568.13
7-
640.50
662.99
6-
768.83
795.78
5-
994.99
4-
1326.89
3-
2016_10_17_1SD12_50_01_2469.d: -MS, 11.1-11.5min #1306-1384
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   609 
Extracted mass spectrum 3 (11.6 – 12.0 min.): 
Deconvoluted mass 3: 4029.61 
574.70
7-
648.14
670.66
37-
778.00
804.97
5-
1006.48
4-
1342.19
3-
2016_10_17_1SD12_50_01_2469.d: -MS, 11.6-12.0min #1390-1487
0.0
0.5
1.0
1.5
2.0
2.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
610 
Sequence: 5’-CACXCATTCCXGGT-3’ (E) 
Modification: X = 2’,6’-Dimethyl-4’-methylthioazobenzene (S-DMAB) 
Calculated mass: 4479.63 
Data file: 2016_10_17_2SD12_51_01_2470 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.2 – 11.6 min.): 
Deconvoluted mass 1: 4346.06 
 
Extracted mass spectrum 2 (11.6 – 11.9 min.): 
Deconvoluted mass 2: 4346.30 
 
Extracted mass spectrum 3 (12.2 – 12.6 min.): 
Deconvoluted mass 3: 4433.33 
2016_10_17_2SD12_51_01_2470.d: BPC -All MS
2016_10_17_2SD12_51_01_2470.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
7x10
Intens.
0
10
20
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
542.25
8- 600.58
619.89
56-
642.68
54-
700.85
723.37
6-
803.65
868.25
5-
1045.00
1085.51
4-
1447.54
3-
2016_10_17_2SD12_51_01_2470.d: -MS, 11.2-11.6min #1255-1327
0.0
0.5
1.0
1.5
2.0
2.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
522.29
574.77
7-
600.64
619.90
28-
653.10
31-
670.70
6-
700.83
723.39
28-
805.05
5-
868.25
44-
1006.51
4- 1048.19
1085.53
1307.02 1342.13
3- 1447.59
2016_10_17_2SD12_51_01_2470.d: -MS, 11.6-11.9min #1338-1402
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
553.26
8-
613.09
632.36
7-
689.99
737.90
6-
822.65
885.68
5-
1107.32
4-
1150.53
1476.58
3-
2016_10_17_2SD12_51_01_2470.d: -MS, 12.2-12.6min #1446-1533
0.0
0.5
1.0
1.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   611 
Extracted mass spectrum 4 (12.6 – 13.3 min.): 
Deconvoluted mass 4: 4479.34 
 
Extracted mass spectrum 5 (13.6 – 14.0 min.): 
Deconvoluted mass 5: 4479.47 
558.82
8-
638.90
7-
745.54
6-
894.88
5-
1118.83
4-
2016_10_17_2SD12_51_01_2470.d: -MS, 12.6-13.3min #1529-1683
0.0
0.5
1.0
1.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
558.91
8-
619.63
638.92
45-
653.05
723.08
745.54
6-
894.89
5-
1118.78
4-
2016_10_17_2SD12_51_01_2470.d: -MS, 13.6-14.0min #1748-1822
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
612 
Sequence: 5’-CACXCATXTCCXGGT-3’ (F) 
Modification: X = 2’,6’-Dimethyl-4’-methylthioazobenzene (S-DMAB) 
Calculated mass: 4928.74 
Data file: 2016_10_17_3SD12_52_01_2471 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (15.4 – 15.8 min.): 
Deconvoluted mass 1: 4928.74 
 
Extracted mass spectrum 2 (15.9 – 16.6 min.): 
Deconvoluted mass 2: 4928.70 
 
2016_10_17_3SD12_52_01_2471.d: BPC -All MS
2016_10_17_3SD12_52_01_2471.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
7x10
Intens.
0
5
10
15
20
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
615.10
8-
703.13
7-
820.46
6-
984.74
5-
1231.08
4-
2016_10_17_3SD12_52_01_2471.d: -MS, 15.4-15.8min #1758-1843
0
1
2
3
4
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
598.18
615.09
8-
683.84
703.11
7-
820.44
6-
984.75
5-
1231.02
4-
2016_10_17_3SD12_52_01_2471.d: -MS, 15.9-16.6min #1864-2032
0.0
0.5
1.0
1.5
2.0
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   613 
Sequence: 5‘-TCCXCCAXGCAXTCG-3‘ (I) 
Modification: X = 2’,6’-Dimethyl-4’-methylthioazobenzene (S-DMAB) 
Calculated mass: 4913.73 
Data file: 2016_10_17_SDA-168ROo_55_01_2474 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (16.2 – 16.7 min.): 
Deconvoluted mass 1: 4913.63 
 
Extracted mass spectrum 2 (16.7 – 17.3 min.): 
Deconvoluted mass 2: 4913.70 
 
 
2016_10_17_SDA-168ROo_55_01_2474.d: BPC -All MS
2016_10_17_SDA-168ROo_55_01_2474.d: UV Chromatogram, 260 nm
0
1
2
7x10
Intens.
0
10
20
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
613.17
8-
700.94
7-
817.94
6-
981.73
5-
2016_10_17_SDA-168ROo_55_01_2474.d: -MS, 16.7-17.3min #2016-2153
0
1
2
3
4
5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
613.18
8-
700.94
7-
817.93
6-
981.75
5-
2016_10_17_SDA-168ROo_55_01_2474.d: -MS, 16.2-16.7min #1895-2000
0.0
0.5
1.0
1.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
614 
Sequence: 5‘-CCXGATXGCTXGT-3‘ (J) 
Modification: X = 2’,6’-Dimethyl-4’-methylthioazobenzene (S-DMAB) 
Calculated mass: 4366.37 
Data file: 2016_10_17_SDA-126ROo_53_01_2472 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (15.8 – 16.2 min.): 
Deconvoluted mass:4366.55 
 
2016_10_17_SDA-126ROo_53_01_2472.d: BPC -All MS
2016_10_17_SDA-126ROo_53_01_2472.d: UV Chromatogram, 260 nm
0.00
0.25
0.50
0.75
1.00
1.25
7x10
Intens.
0
5
10
15
20
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
554.24
622.79
17-
726.75
6-
872.32
5-
1001.19
1090.64
4-
1454.30
3-
2016_10_17_SDA-126ROo_53_01_2472.d: -MS, 15.8-16.2min #1823-1909
0
1
2
3
4
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   615 
Sequence: 5‘-GGXAATXGGTXGA-3‘ (K) 
Modification: X = 2’,6’-Dimethyl-4’-methylthioazobenzene (S-DMAB) 
Calculated mass: 4479.46 
Data file: 2016_10_17_SDA-126ROp_54_01_2473 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (15.8 – 16.2 min.): 
Deconvoluted mass 1: 4479.92 + 4433.75 
 
Extracted mass spectrum 2 (16.2 – 17.2 min.): 
Deconvoluted mass 2: 4479.46 
 
613.71
638.96
39-
723.13
745.65
10-
894.94
5-
931.15
1010.19
1118.86
4-
2016_10_17_SDA-126ROp_54_01_2473.d: -MS, 15.8-16.2min #1845-1908
0.0
0.5
1.0
1.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
638.90
7-
745.57
6-
894.89
5-
1118.89
4-
2016_10_17_SDA-126ROp_54_01_2473.d: -MS, 16.2-17.2min #1916-2146
0.0
0.5
1.0
1.5
2.0
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
2016_10_17_SDA-126ROp_54_01_2473.d: BPC -All MS
2016_10_17_SDA-126ROp_54_01_2473.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
7x10
Intens.
0
5
10
15
20
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
10. Attachments 
616 
Sequence: 5’-GAATXGGTG-3’ (A) 
Modification: X =2’,6’-Difluoroazobenzene (DFAB) 
Calculated mass: 2900.77 
Data file: 2016_06_01_1DF8_21_01_1358 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (13.7 – 14.0 min.): 
Deconvoluted mass: 2900.92 
 
 
2016_06_01_1DF8_21_01_1358.d: BPC -All MS
2016_06_01_1DF8_21_01_1358.d: UV Chromatogram, 260 nm
0
2
4
6
5x10
Intens.
0
1
2
3
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
552.46
579.11
628.46
661.89
45-
690.80
16-
724.22
27-
778.36
810.25 843.29
882.83
921.49
12-
965.85
31-
1011.20
1052.22 1101.66
1168.13 1258.10
1324.31
1382.71
1449.26
2016_06_01_1DF8_21_01_1358.d: -MS, 13.7-14.0min #1650-1712
0
2
4
6
4x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   617 
Sequence: 5’-CACCATXTCCGGT-3’ (D) 
Modification: X = 2’,6’-Difluoroazobenzene (DFAB) 
Calculated mass: 3992.47 
Data file: 2016_06_01_1DF12_28_01_1365 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (13.8 – 14.2 min.): 
Deconvoluted mass 1: 3897.18 
 
Extracted mass spectrum 2 (14.4 – 15.0 min.): 
Deconvoluted mass 2: 3992.39 
 
 
2016_06_01_1DF12_28_01_1365.d: BPC -All MS
2016_06_01_1DF12_28_01_1365.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
6x10
Intens.
0
5
10
15
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
555.71
7-
601.92
626.03
6-
648.54
42-
673.97
687.28
755.07
778.46
5-
799.95 842.68
939.89
4-
973.28
4-
1003.81 1123.87
1258.97
1298.05
3-
2016_06_01_1DF12_28_01_1365.d: -MS, 13.8-14.2min #1625-1699
0
2
4
6
4x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
569.30 641.86
664.38
54-
692.98
774.06
797.47
41-
858.34 967.73
997.05
13-
1155.70 1288.15
1329.67
2016_06_01_1DF12_28_01_1365.d: -MS, 14.4-15.0min #1743-1856
0.0
0.5
1.0
1.5
2.0
2.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
618 
Sequence: 5’-GAATXGGTG-3’ (A) 
Modification: X =2’,6’-Dimethoxyazobenzene (DOAB) 
Calculated mass: 2924.81 
Data file: 2016_09_26_1xDOAB-8_70_01_2328 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (9.2 – 9.8 min.): 
Deconvoluted mass: 2924.47 
 
2016_09_26_1xDOAB-8_70_01_2328.d: BPC -All MS
2016_09_26_1xDOAB-8_70_01_2328.d: UV Chromatogram, 260 nm
0.00
0.25
0.50
0.75
1.00
1.25
7x10
Intens.
0
10
20
30
40
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
583.89
5-
696.38
730.11
4-
973.81
3-
1461.05
2016_09_26_1xDOAB-8_70_01_2328.d: -MS, 9.2-9.8min #1065-1189
0.0
0.5
1.0
1.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   619 
Sequence: 5’-CACCATXTCCGGT-3’ (D) 
Modification: X = 2’,6’-Dimethoxyazobenzene (DOAB) 
Calculated mass: 4016.52 
Data file: 2016_09_26_1xDOAB-12_71_01_2329 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (6.0 – 6.5 min.): 
Deconvoluted mass 1: 1815.57 
 
Extracted mass spectrum 1 (xx – xx min.): 
Deconvoluted mass 2: 4015.99 
 
 
2016_09_26_1xDOAB-12_71_01_2329.d: BPC -All MS
2016_09_26_1xDOAB-12_71_01_2329.d: UV Chromatogram, 260 nm
0.00
0.25
0.50
0.75
1.00
1.25
7x10
Intens.
0
10
20
30
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
604.18
645.55 794.67
906.87
20-
955.57
2016_09_26_1xDOAB-12_71_01_2329.d: -MS, 6.0-6.5min #665-743
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
519.40
572.73
7-
645.82
18-
668.35
21-
697.73
775.28
15-
802.20
5-
866.41
1002.99
4-
1300.04
1337.56
3-
2016_09_26_1xDOAB-12_71_01_2329.d: -MS, 9.9-10.4min #1238-1334
0.0
0.5
1.0
1.5
2.0
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
620 
Sequence: 5’-GAATXGGTG-3’ (A) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 2896.82 
Data file: 2016_06_01_1AP1-8_11_01_1348 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (13.6 – 13.8 min.): 
Deconvoluted mass: 2896.79 
 
2016_06_01_1AP1-8_11_01_1348.d: BPC -All MS
2016_06_01_1AP1-8_11_01_1348.d: UV Chromatogram, 260 nm
0
1
2
3
4
5
6x10
Intens.
0
10
20
30
Intens.
[mAU]
7 8 9 10 11 12 13 14 15 16 Time [min]
578.33
32-
660.92 689.82
723.19
35-
739.15 776.98 808.20 854.80
920.15
944.79
964.56
12-
1006.15 1282.79
1380.74
1417.75
1447.27
2016_06_01_1AP1-8_11_01_1348.d: -MS, 13.6-13.8min #1593-1647
0
2
4
6
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   621 
Sequence: 5’-GAXATGGXTG-3’ (B) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 3303.96 
Data file: 2016_06_01_2AP1-8.1_13_01_1350 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (13.8 – 14.0 min.): 
Deconvoluted mass 1: 2770.60 
 
Extracted mass spectrum 2 (14.9 – 15.3 min.): 
Deconvoluted mass 2: 3303.87 
 
 
2016_06_01_2AP1-8.1_13_01_1350.d: BPC -All MS
2016_06_01_2AP1-8.1_13_01_1350.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
7x10
Intens.
0
10
20
30
40
Intens.
[mAU]
4 6 8 10 12 14 16 18 Time [min]
560.53
584.78
672.66
692.75
753.41
780.09
841.32
889.24
965.76
1009.34
1104.12
1170.61
12-
1253.27 1309.84
1386.32
9-
1408.29
2016_06_01_2AP1-8.1_13_01_1350.d: -MS, 13.9-14.0min #1613-1644
0.0
0.5
1.0
1.5
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
549.55
8-
633.08
50-
659.77
48-
762.59 791.53
824.96
36-
1055.80
1100.28
4-
2016_06_01_2AP1-8.1_13_01_1350.d: -MS, 15.0-15.3min #1821-1890
0.0
0.5
1.0
1.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
622 
Sequence: 5’-GAXATXGGXTG-3’ (C) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 3711.10 
Data file: 2016_06_01_3AP1-8.1_15_01_1352 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (14.7 – 15.0 min.): 
Deconvoluted mass 1: 2750.52 
 
Extracted mass spectrum 2 (15.5 – 15.8 min.): 
Deconvoluted mass 2: 3711.25 
 
2016_06_01_3AP1-8.1_15_01_1352.d: BPC -All MS
2016_06_01_3AP1-8.1_15_01_1352.d: UV Chromatogram, 260 nm
0.00
0.25
0.50
0.75
1.00
7x10
Intens.
0
10
20
30
Intens.
[mAU]
4 6 8 10 12 14 16 18 Time [min]
549.09 604.39 659.85
686.69
27-
805.99 844.66 889.19
915.83
27-
968.34 1100.41 1165.37
1209.70
1267.31 1307.75
1374.28
29-
2016_06_01_3AP1-8.1_15_01_1352.d: -MS, 14.7-14.9min #1767-1820
0.00
0.25
0.50
0.75
1.00
1.25
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
595.33
56-
617.55
54-
691.45
741.27
31-
864.44 893.53
926.81
4-
1191.69
1236.14
3-
2016_06_01_3AP1-8.1_15_01_1352.d: -MS, 15.5-15.9min #1926-2015
0.00
0.25
0.50
0.75
1.00
1.25
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   623 
Sequence: 5’-CACCATXTCCGGT-3’ (D) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 3988.53 
Data file: 2016_06_01_1AP1-12_16_01_1353 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (14.3 – 14.5 min.): 
Deconvoluted mass: 3988.19 
 
2016_06_01_1AP1-12_16_01_1353.d: BPC -All MS
2016_06_01_1AP1-12_16_01_1353.d: UV Chromatogram, 260 nm
0.00
0.25
0.50
0.75
1.00
1.25
7x10
Intens.
0
10
20
30
40
50
Intens.
[mAU]
7 8 9 10 11 12 13 14 15 16 Time [min]
568.69
7-
615.58
641.18
663.70
6-
692.15 738.84 769.51
796.66
5-
996.04
4-
1232.21
1328.37
3-
2016_06_01_1AP1-12_16_01_1353.d: -MS, 14.1-14.5min #1657-1746
0.0
0.5
1.0
1.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
624 
Sequence: 5’-CACXCATTCCXGGT-3’ (E) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 4395.66 
Data file: 2016_06_01_2AP1-12_18_01_1355 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (14.8 – 15.0 min.): 
Deconvoluted mass: 4395.48 
 
2016_06_01_2AP1-12_18_01_1355.d: BPC -All MS
2016_06_01_2AP1-12_18_01_1355.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
7x10
Intens.
0
20
40
60
Intens.
[mAU]
4 6 8 10 12 14 16 18 Time [min]
607.69
626.92
7-
709.12
731.57
6-
878.10
5-
1097.85
4-
1464.12
3-
2016_06_01_2AP1-12_18_01_1355.d: -MS, 14.8-15.0min #1773-1828
0
1
2
3
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   625 
Sequence: 5’-CACXCATXTCCXGGT-3’ (F) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 4802.80 
Data file: 2016_06_01_3AP1-12_19_01_1356 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (15.4 – 15.6 min.): 
Deconvoluted mass 1: 2981.76 
 
Extracted mass spectrum 2 (15.9 – 16.2 min.): 
Deconvoluted mass 2: 4803.00 
 
2016_06_01_3AP1-12_19_01_1356.d: BPC -All MS
2016_06_01_3AP1-12_19_01_1356.d: UV Chromatogram, 260 nm
0
1
2
7x10
Intens.
0
20
40
60
Intens.
[mAU]
6 8 10 12 14 16 18 Time [min]
595.35
39-
626.94
47-
654.87
45-
667.92
701.65
724.48
744.43
11-
764.17
779.31
842.04
877.29 917.15
932.50
962.61
992.84
24-
1097.72 1146.88
1169.96
7-
1231.65 1317.25
2016_06_01_3AP1-12_19_01_1356.d: -MS, 15.3-15.7min #1837-1908
0
2
4
6
4x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
599.35
8-
665.80
685.13
7-
776.92
799.50
6-
959.59
5-
1199.67
4-
2016_06_01_3AP1-12_19_01_1356.d: -MS, 15.9-16.3min #1937-2028
0
1
2
3
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
626 
Sequence: 5’-CACCXATTCXCAGT-3’ (G) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 4379.68 
Data file: 2017_03_02_2xAAP1_12-mer_71_01_3851 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (10.5 – 11.0 min.): 
Deconvoluted mass 1: 4379.78 
 
Extracted mass spectrum 2 (11.2 – 11.8 min.): 
Deconvoluted mass 2: 4379.78 
 
 
2017_03_02_2xAAP1_12-mer_71_01_3851.d: BPC -All MS
2017_03_02_2xAAP1_12-mer_71_01_3851.d: UV Chromatogram, 260 nm
0
1
2
3
4
5
7x10
Intens.
0
20
40
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
624.73
7-
706.52
729.00
6-
770.43 848.08
875.01
5-
1060.02
1093.94
4-
2017_03_02_2xAAP1_12-mer_71_01_3851.d: -MS, 10.5-11.0min #1668-1786
0.0
0.5
1.0
1.5
2.0
2.5
3.0
6x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
624.72
7-
641.81 706.38
729.00
6-
780.32
874.98
5-
887.08
1093.94
4-
2017_03_02_2xAAP1_12-mer_71_01_3851.d: -MS, 11.2-11.8min #1817-1967
0.0
0.5
1.0
1.5
2.0
2.5
7x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
   627 
Sequence: 5’-CACXCATXTCCXAGT-3’ (H) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 4786.82 
Data file: 2017_03_02_3xAAP1_12-mer-50_72_01_3852 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (11.8 – 12.4 min.): 
Deconvoluted mass: 4787.29 
 
2017_03_02_3xAAP1_12-mer-50_72_01_3852.d: BPC -All MS
2017_03_02_3xAAP1_12-mer-50_72_01_3852.d: UV Chromatogram, 260 nm
0
2
4
6
8
7x10
Intens.
0
10
20
30
40
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
597.45
8-
663.62
682.90
7-
774.32
796.89
6-
956.47
5-
1195.81
4-
2017_03_02_3xAAP1_12-mer-50_72_01_3852.d: -MS, 11.8-12.4min #1872-1997
0
1
2
3
7x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
628 
Sequence: 5‘-TCCXCCAXGCAXTCG-3‘ (I) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 4787.89 
Data file: 2016_10_17_AAP1-168ROo-1_59_01_2478 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (12.1 – 12.5 min.): 
Deconvoluted mass: 4787.41 
 
2016_10_17_AAP1-168ROo-1_59_01_2478.d: BPC -All MS
2016_10_17_AAP1-168ROo-1_59_01_2478.d: UV Chromatogram, 260 nm
0
2
4
6
8
7x10
Intens.
0
50
100
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
597.43
8-
682.90
7-
759.47
796.89
6-
956.49
5-
1195.84
4-
2016_10_17_AAP1-168ROo-1_59_01_2478.d: -MS, 12.1-12.5min #1447-1539
0.00
0.25
0.50
0.75
1.00
1.25
7x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   629 
Sequence: 5‘-CCXGATXGCTXGT-3‘ (J) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 4240.43 
Data file: 2016_10_17_AAP1-126ROo_57_01_2476 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (11.7 – 12.2 min.): 
Deconvoluted mass: 4240.19 
 
2016_10_17_AAP1-126ROo_57_01_2476.d: BPC -All MS
2016_10_17_AAP1-126ROo_57_01_2476.d: UV Chromatogram, 260 nm
0
1
2
3
4
7x10
Intens.
0
20
40
60
80
100
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
604.71
7-
683.17
705.69
6-
847.03
5-
1059.05
4-
1412.15
3-
2016_10_17_AAP1-126ROo_57_01_2476.d: -MS, 11.7-12.2min #1378-1501
0
2
4
6
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
630 
Sequence: 5‘-GGXAATXGGTXGA-3‘ (K) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 4353.52 
Data file: 2016_10_17_AAP1-126ROp_58_01_2477 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (11.6 – 12.2 min.): 
Deconvoluted mass: 4353.23 
 
2016_10_17_AAP1-126ROp_58_01_2477.d: BPC -All MS
2016_10_17_AAP1-126ROp_58_01_2477.d: UV Chromatogram, 260 nm
0
2
4
6
7x10
Intens.
0
20
40
60
80
100
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
620.86
7-
702.01
724.53
6-
869.64
5-
1087.27
4-
2016_10_17_AAP1-126ROp_58_01_2477.d: -MS, 11.6-12.2min #1407-1540
0
2
4
6
8
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   631 
Sequence: 5‘-TCCCXCAGCXATCG-3‘ (L) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 4380.68 
Data file: 2016_11_23_AAP1-168ROo-sh_82_01_2827 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (11.7 – 12.1 min.): 
Deconvoluted mass: 4380.39 
 
2016_11_23_AAP1-168ROo-sh_82_01_2827.d: BPC -All MS
2016_11_23_AAP1-168ROo-sh_82_01_2827.d: UV Chromatogram, 260 nm
0
1
2
3
4
7x10
Intens.
0
50
100
150
Intens.
[mAU]
5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 Time [min]
546.58
8-
624.79
7-
706.59
729.06
6-
875.07
5-
1094.06
4-
2016_11_23_AAP1-168ROo-sh_82_01_2827.d: -MS, 11.7-12.1min #1398-1502
0.0
0.5
1.0
1.5
7x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
632 
Sequence: 5’-CACCXATTCXCGGT-3’ (M) 
Modification: X = N-Methyl-arylazopyrazole (AAP1) 
Calculated mass: 4395.68 
Data file: 2016_11_23_2xAAP1-12mer-sh_81_01_2826 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (10.7 – 11.0 min.): 
Deconvoluted mass: 4395.39 
 
2016_11_23_2xAAP1-12mer-sh_81_01_2826.d: BPC -All MS
2016_11_23_2xAAP1-12mer-sh_81_01_2826.d: UV Chromatogram, 260 nm
0
1
2
3
7x10
Intens.
0
25
50
75
100
125
Intens.
[mAU]
5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 Time [min]
548.40
8-
626.91
7-
709.06
731.56
6-
878.07
5-
1097.80
4-
2016_11_23_2xAAP1-12mer-sh_81_01_2826.d: -MS, 10.7-11.0min #1239-1316
0.0
0.5
1.0
1.5
7x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
   633 
Sequence: 5’-GAATXGGTG-3’ (A) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 2958.84 
Data file: 2016_10_23_AAP2-1_old_97_01_2565 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.1 – 11.4 min.): 
Deconvoluted mass 1: 2958.83 
 
Extracted mass spectrum 2 (11.8 – 12.1 min.): 
Deconvoluted mass 2: 2958.59 
 
2016_10_23_AAP2-1_old_97_01_2565.d: BPC -All MS
2016_10_23_AAP2-1_old_97_01_2565.d: UV Chromatogram, 260 nm
0.00
0.25
0.50
0.75
1.00
7x10
Intens.
0
10
20
30
40
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
590.73
53-
704.89
44-
738.70
42-
985.22
24-
1478.09
8-
2016_10_23_AAP2-1_old_97_01_2565.d: -MS, 11.1-11.4min #1220-1283
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
590.71
5-
704.90
738.67
4-
985.19
3-
1478.09
2-
2016_10_23_AAP2-1_old_97_01_2565.d: -MS, 11.8-12.1min #1340-1422
0.0
0.5
1.0
1.5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
634 
Sequence: 5’-GAXATGGXTG-3’ (B) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 3427.99 
Data file: 2016_11_23_2xAAP2-in-8mer-2_73_01_2818 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.6 – 12.3 min.): 
Deconvoluted mass 1: 2405.71 
 
Extracted mass spectrum 2 (13.9 – 14.2 min.): 
Deconvoluted mass 2: 2081.03 
 
Extracted mass spectrum 3 (14.4 – 15.0 min.): 
Deconvoluted mass 3: 3427.90 
2016_11_23_2xAAP2-in-8mer-2_73_01_2818.d: BPC -All MS
2016_11_23_2xAAP2-in-8mer-2_73_01_2818.d: UV Chromatogram, 260 nm
0
1
2
3
7x10
Intens.
0
20
40
60
80
Intens.
[mAU]
5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 Time [min]
538.22
600.42
662.69 693.44
738.72
800.83
11-
883.85 940.87
985.27
1040.55 1094.99
1135.02
2-
1161.46
1201.54
2-
2016_11_23_2xAAP2-in-8mer-2_73_01_2818.d: -MS, 11.6-12.3min #1319-1460
0.0
0.2
0.4
0.6
0.8
1.0
6x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
519.27
621.88 684.68
1039.52
1244.24
2016_11_23_2xAAP2-in-8mer-2_73_01_2818.d: -MS, 13.9-14.2min #1777-1841
0.0
0.5
1.0
1.5
6x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
570.35
6-
634.77
657.97
684.61
5-
822.70
856.02
4-
1097.26
1141.63
3-
2016_11_23_2xAAP2-in-8mer-2_73_01_2818.d: -MS, 14.4-15.0min #1900-2024
0.00
0.25
0.50
0.75
1.00
1.25
7x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
   635 
Extracted mass spectrum 4 (18.1 – 18.4 min.): 
Deconvoluted mass 4: 2080.90 
 
Extracted mass spectrum 5 (21.1 – 21.4 min.): 
Deconvoluted mass 5: 2080.90 
519.20
1039.51
1061.24
2016_11_23_2xAAP2-in-8mer-2_73_01_2818.d: -MS, 18.1-18.4min #2641-2696
0.0
0.2
0.4
0.6
0.8
1.0
7x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
519.17 719.16
1039.51
1061.23
2016_11_23_2xAAP2-in-8mer-2_73_01_2818.d: -MS, 21.1-21.4min #3204-3264
0
1
2
3
4
5
6x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
636 
Sequence: 5’-GAXATXGGXTG-3’ (C) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 3897.14 
Data file: 2016_10_23_3xAAP2_8mer-2_87_01_2555 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.8 – 12.6 min.): 
Deconvoluted mass 1: 1746.77 
 
Extracted mass spectrum 2 (14.0 – 14.6 min.): 
Deconvoluted mass 2: 2240.76 
 
Extracted mass spectrum 3 (15.0 – 15.3 min.): 
Deconvoluted mass 3: 2874.26 
2016_10_23_3xAAP2_8mer-2_87_01_2555.d: BPC -All MS
2016_10_23_3xAAP2_8mer-2_87_01_2555.d: UV Chromatogram, 260 nm
0
1
2
3
6x10
Intens.
2
4
6
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
581.25
657.17
723.90
36-
747.74 805.70
872.42
26-
931.75 975.25 1199.25 1315.21
1448.25
2016_10_23_3xAAP2_8mer-2_87_01_2555.d: -MS, 11.8-12.6min #1306-1461
0.0
0.5
1.0
1.5
2.0
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
559.14
870.24 986.32 1039.36
1119.37
9-
1141.18
2016_10_23_3xAAP2_8mer-2_87_01_2555.d: -MS, 14.0-14.6min #1683-1788
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
574.08
655.50 684.46
717.74
44-
738.93
815.29
18-
874.21 912.78
957.28
22-
999.29
1103.30 1369.65
1436.12
3-
2016_10_23_3xAAP2_8mer-2_87_01_2555.d: -MS, 15.0-15.3min #1842-1890
0
2
4
6
8
4x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   637 
Extracted mass spectrum 4 (15.3 – 15.9 min.): 
Deconvoluted mass 4: 5320.72 + 5105.13 or 2552.57 
 
Extracted mass spectrum 5 (16.8 – 17.6 min.): 
Deconvoluted mass 5: 3897.11 + 3764.06 + 3647.87 
 
514.40 573.15 603.90
637.17
8-
664.25
737.55
823.21
849.85
6-
886.07 973.34
1048.37
1150.70
1204.76
1275.14
27-
1329.17
2016_10_23_3xAAP2_8mer-2_87_01_2555.d: -MS, 15.3-15.9min #1906-2001
0
2
4
6
8
4x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
519.12 555.79
626.39
29-
648.62
28-
728.70
751.87
778.55
14-
911.10 940.06
973.41
38-
1039.39
31-
1061.23 1214.95 1253.68
1298.03
2016_10_23_3xAAP2_8mer-2_87_01_2555.d: -MS, 16.8-17.6min #2151-2320
0.0
0.5
1.0
1.5
2.0
2.5
3.0
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
638 
Sequence: 5’-CACCATXTCCGGT-3’ (D) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 4050.54 
Data file: 2017_01_20_1AP2-12mer-MS_81_01_3310 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (10.3 – 10.6 min.): 
Deconvoluted mass 1: 4050.19 
 
Extracted mass spectrum 2 (11.1 – 11.8 min.): 
Deconvoluted mass 2: 4050.33 
 
2017_01_20_1AP2-12mer-MS_81_01_3310.d: BPC -All MS
2017_01_20_1AP2-12mer-MS_81_01_3310.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
7x10
Intens.
0
20
40
60
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
577.65
7-
651.57
674.10
6-
704.49 742.27
809.09
5-
1011.55
4-
1349.06
3-
2017_01_20_1AP2-12mer-MS_81_01_3310.d: -MS, 10.3-10.6min #1621-1704
0.0
0.5
1.0
1.5
6x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
577.65
7-
651.55
674.07
6-
704.47
809.07
5-
1011.60
4-
1349.10
3-
2017_01_20_1AP2-12mer-MS_81_01_3310.d: -MS, 11.1-11.8min #1810-1973
0
2
4
6
8
6x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
   639 
Sequence: 5’-CACXCATTCCXGGT-3’ (E) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 4519.69 
Data file: 2016_09_26_2xAAP2-12_83_01_2341 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.7 – 11.8 min.): 
Deconvoluted mass 1: 3167.62 
 
Extracted mass spectrum 2 (13.2 – 13.6 min.): 
Deconvoluted mass 2: 4519.46 
 
Extracted mass spectrum 3 (14.0 – 14.2 min.): 
Deconvoluted mass 3: 2738.70 
2016_09_26_2xAAP2-12_83_01_2341.d: BPC -All MS
2016_09_26_2xAAP2-12_83_01_2341.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
7x10
Intens.
0
20
40
60
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
526.92
8-
581.51
605.50
56-
632.54
48-
660.31
46-
721.76 757.19
790.89
38-
872.75
1054.87
4-
1279.20
2016_09_26_2xAAP2-12_83_01_2341.d: -MS, 11.7-11.8min #1355-1388
0
1
2
3
4
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
563.89
8-
625.30
644.60
7-
729.69
752.25
6-
902.89
5-
1128.83
4-
2016_09_26_2xAAP2-12_83_01_2341.d: -MS, 13.2-13.6min #1591-1690
0
1
2
3
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
620.66 665.25
683.83
41-
895.25
1368.34
18-
1390.16
1412.13
2016_09_26_2xAAP2-12_83_01_2341.d: -MS, 14.0-14.2min #1769-1807
0
1
2
3
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
640 
Sequence: 5’-CACXCATXTCCXGGT-3’ (F) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 4988.85 
Data file: 2016_09_26_3xAAP2-12_85_01_2343 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (14.4 – 14.7 min.): 
Deconvoluted mass 1: 3636.86 
 
Extracted mass spectrum 2 (15.0 – 15.9 min.): 
Deconvoluted mass 2: 4988.77 
 
2016_09_26_3xAAP2-12_85_01_2343.d: BPC -All MS
2016_09_26_3xAAP2-12_85_01_2343.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
7x10
Intens.
0
10
20
30
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
582.66
605.17
41-
621.99
683.52
34-
726.40
32-
777.66 835.77 872.74
908.25
33-
957.11 1102.89
1211.28
3-
1297.19 1368.10
2016_09_26_3xAAP2-12_85_01_2343.d: -MS, 14.4-14.7min #1803-1860
0.0
0.5
1.0
1.5
2.0
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
605.68
622.58
8-
692.37
711.67
7-
830.46
6-
996.75
5-
1246.11
4-
2016_09_26_3xAAP2-12_85_01_2343.d: -MS, 15.0-15.9min #1917-2109
0.0
0.5
1.0
1.5
2.0
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   641 
Sequence: 5’-CACCXATTCXCAGT-3’ (G) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 4503.70 
Data file: 2017_03_03_2xAAP2_12-mer-50_75_01_3855 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (13.3 – 13.8 min.): 
Deconvoluted mass 1: 4504.15 
 
Extracted mass spectrum 2 (13.8 – 14.6 min.): 
Deconvoluted mass 2: 4503.94 
 
2017_03_03_2xAAP2_12-mer-50_75_01_3855.d: BPC -All MS
2017_03_03_2xAAP2_12-mer-50_75_01_3855.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
7x10
Intens.
0
5
10
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
546.68
642.48
7-
727.19
749.72
6-
820.46
872.72
899.82
5-
1125.00
4-
2017_03_03_2xAAP2_12-mer-50_75_01_3855.d: -MS, 13.3-13.8min #2067-2176
0.0
0.5
1.0
1.5
2.0
6x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
562.02
8-
642.46
7-
727.21
749.69
6-
820.36
899.83
5-
1124.98
4-
2017_03_03_2xAAP2_12-mer-50_75_01_3855.d: -MS, 13.8-14.6min #2183-2360
0
2
4
6
6x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
642 
Sequence: 5’-CACXCATXTCCXAGT-3’ (H) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 4972.85 
Data file: 2017_03_02_3xAAP2_12-mer-50 1_76_01_3856 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (15.5 – 16.2 min.): 
Deconvoluted mass: 4973.26 
 
2017_03_02_3xAAP2_12-mer-50 1_76_01_3856.d: BPC -All MS
2017_03_02_3xAAP2_12-mer-50 1_76_01_3856.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
7x10
Intens.
0
5
10
Intens.
[mAU]
5 10 15 20 25 30 35 Time [min]
519.28
620.71
8-
709.52
7-
827.96
6-
900.77
993.70
5-
1039.36
1061.29
1242.31
4-
2017_03_02_3xAAP2_12-mer-50 1_76_01_3856.d: -MS, 15.8-16.0min #2632-2701
0.0
0.2
0.4
0.6
0.8
1.0
1.2
7x10
Intens.
600 700 800 900 1000 1100 1200 1300 1400 m/z
   643 
Sequence: 5‘-TCCXCCAXGCAXTCG-3‘ (I) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 4973.83 
Data file: 2016_10_23_AAP2_168ROo-2_85_01_2553 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum (16.2 – 17.2 min.): 
Deconvoluted mass: 4973.90 
 
2016_10_23_AAP2_168ROo-2_85_01_2553.d: BPC -All MS
2016_10_23_AAP2_168ROo-2_85_01_2553.d: UV Chromatogram, 260 nm
0
1
2
3
7x10
Intens.
0
20
40
60
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
620.71
8-
690.27
709.54
7-
827.96
6-
993.77
5-
2016_10_23_AAP2_168ROo-2_85_01_2553.d: -MS, 16.2-17.2min #2048-2275
0
1
2
3
4
5
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
10. Attachments 
644 
Sequence: 5‘-CCXGATXGCTXGT-3‘ (J) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 4426.48 
Data file: 2016_10_23_AAP2_126ROo-2_83_01_2551 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (13.1 – 13.3 min.): 
Deconvoluted mass 1: 2011.80 
 
Extracted mass spectrum 2 (15.3 – 15.6 min.): 
Deconvoluted mass 2: 3404.06 
 
Extracted mass spectrum 3 (16.9 – 17.3 min.): 
Deconvoluted mass 3: 4426.49 
2016_10_23_AAP2_126ROo-2_83_01_2551.d: BPC -All MS
2016_10_23_AAP2_126ROo-2_83_01_2551.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
7x10
Intens.
0
10
20
30
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
669.59
6-
1004.99
4-
2016_10_23_AAP2_126ROo-2_83_01_2551.d: -MS, 13.1-13.3min #1495-1537
0.0
0.2
0.4
0.6
0.8
1.0
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
566.35
51-
624.98 652.77
679.84
41-
706.32 736.19 793.91 830.00
850.01
34-
1042.31
1133.64
35-
2016_10_23_AAP2_126ROo-2_83_01_2551.d: -MS, 15.3-15.6min #1859-1936
0.0
0.5
1.0
1.5
2.0
2.5
3.0
5x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
631.37
42-
714.27
736.77
24-
884.34
20-
1039.28
1105.62
1474.30
2016_10_23_AAP2_126ROo-2_83_01_2551.d: -MS, 16.9-17.3min #2160-2245
0.0
0.5
1.0
1.5
2.0
6x10
Intens.
500 600 700 800 900 1000 1100 1200 1300 1400 m/z
   645 
Sequence: 5‘-GGXAATXGGTXGA-3‘ (K) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 4539.56 
Data file: 2016_10_23_AAP2_126ROp_88_01_2556 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.9 – 12.8 min.): 
Deconvoluted mass 1: 2917.36 + 2075.90 
 
Extracted mass spectrum 2 (13.1 – 13.6 min.): 
Deconvoluted mass 2: 4301.25 + 4197.82 
 
Extracted mass spectrum 3 (14.6 – 15.6 min.): 
Deconvoluted mass 3: 3508.26 + 3178.92 + 3061.68 + 2865.83 
2016_10_23_AAP2_126ROp_88_01_2556.d: BPC -All MS
2016_10_23_AAP2_126ROp_88_01_2556.d: UV Chromatogram, 260 nm
0.0
0.5
1.0
1.5
2.0
7x10
Intens.
0
10
20
30
Intens.
[mAU]
0 5 10 15 20 25 30 35 Time [min]
586.60
690.96
728.33
786.04 821.72 855.91
880.45
21-
912.38 970.27 1005.03
1037.01
36-
1208.14 1457.14
2016_10_23_AAP2_126ROp_88_01_2556.d: -MS, 11.9-12.8min #1330-1508
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2016_10_23_AAP2_126ROp_88_01_2556.d: -MS, 13.1-13.6min #1562-1676
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2016_10_23_AAP2_126ROp_88_01_2556.d: -MS, 14.6-15.6min #1847-2075
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10. Attachments 
646 
Extracted mass spectrum 4 (14.6 – 15.6 min.): 
Deconvoluted mass 4: 4540.02 
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2016_10_23_AAP2_126ROp_88_01_2556.d: -MS, 16.4-16.9min #2245-2345
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   647 
Sequence: 5‘-TCCCXCAGCXATCG-3‘ (L) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 4504.70 
Data file: 2016_11_23_AAP2-168ROo-sh2_80_01_2825 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (12.0 – 12.2 min.): 
Deconvoluted mass 1: 2879.78 
 
Extracted mass spectrum 2 (14.4 – 15.0 min.): 
Deconvoluted mass 2: 4504.26 
 
2016_11_23_AAP2-168ROo-sh2_80_01_2825.d: BPC -All MS
2016_11_23_AAP2-168ROo-sh2_80_01_2825.d: UV Chromatogram, 260 nm
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2016_11_23_AAP2-168ROo-sh2_80_01_2825.d: -MS, 12.0-12.2min #1365-1408
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2016_11_23_AAP2-168ROo-sh2_80_01_2825.d: -MS, 14.5-15.0min #1777-1894
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10. Attachments 
648 
Sequence: 5’-CACCXATTCXCGGT-3’ (M) 
Modification: X = N-Phenyl-arylazopyrazole (AAP2) 
Calculated mass: 4519.70 
Data file: 2016_11_23_2xAAP2-in-12mer-sh1_77_01_2822 
 
UV-chromatogram (260 nm): 
 
Extracted mass spectrum 1 (11.9 – 12.3 min.): 
Deconvoluted mass 1: 2897.50 
 
Extracted mass spectrum 2 (13.0 – 13.3 min.): 
Deconvoluted mass 2: 4519.59 
 
Extracted mass spectrum 3 (14.6 – 14.9 min.): 
Deconvoluted mass 3: 2211.81 + 1658.92 
 
2016_11_23_2xAAP2-in-12mer-sh1_77_01_2822.d: BPC -All MS
2016_11_23_2xAAP2-in-12mer-sh1_77_01_2822.d: UV Chromatogram, 260 nm
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2016_11_23_2xAAP2-in-12mer-sh1_77_01_2822.d: -MS, 11.9-12.3min #1331-1428
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2016_11_23_2xAAP2-in-12mer-sh1_77_01_2822.d: -MS, 14.6-14.9min #1874-1935
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